<!DOCTYPE html><html lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" data-vue-meta-server-rendered><head><title data-vue-meta="true">Artificial Neural Networks - Methodological Advances and Biomedical Applications | IntechOpen</title><meta data-vue-meta="true" charset="utf-8"><meta data-vue-meta="true" http-equiv="X-UA-Compatible" content="IE=edge"><meta data-vue-meta="true" name="viewport" content="width=device-width,initial-scale=1"><meta data-vue-meta="true" name="description" content="Artificial Neural Networks - Methodological Advances and Biomedical Applications. Edited by: Kenji Suzuki. ISBN 978-953-307-243-2, Published 2011-04-11"><meta data-vue-meta="true" name="title" content="Artificial Neural Networks - Methodological Advances and Biomedical Applications | IntechOpen"><meta data-vue-meta="true" property="og:type" content="book"><meta data-vue-meta="true" property="og:url" content="https://www.intechopen.com/books/artificial-neural-networks-methodological-advances-and-biomedical-applications"><meta data-vue-meta="true" property="og:title" content="Artificial Neural Networks - Methodological Advances and Biomedical Applications | IntechOpen"><meta data-vue-meta="true" property="og:image" content="https://cdn.intechopen.com/books/images_new/117.jpg"><meta data-vue-meta="true" property="og:description" content="Artificial neural networks may probably be the single most successful technology in the last two decades which has been widely used in a large variety of applications in various areas.  The purpose of this book is to provide recent advances of artificial neural networks in biomedical applications.  The book begins with fundamentals of artificial neural networks, which cover an introduction, design, and optimization.  Advanced architectures for biomedical applications, which offer improved performance and desirable properties, follow.  Parts continue with biological applications such as gene, plant biology, and stem cell, medical applications such as skin diseases, sclerosis, anesthesia, and physiotherapy, and clinical and other applications such as clinical outcome, telecare, and pre-med student failure prediction.  Thus, this book will be a fundamental source of recent advances and applications of artificial neural networks in biomedical areas.  The target audience includes professors and students in engineering and medical schools, researchers and engineers in biomedical industries, medical doctors, and healthcare professionals."><meta data-vue-meta="true" name="twitter:card" content="summary"><meta data-vue-meta="true" name="twitter:title" content="Artificial Neural Networks - Methodological Advances and Biomedical Applications | IntechOpen"><meta data-vue-meta="true" name="twitter:description" content="Artificial neural networks may probably be the single most successful technology in the last two decades which has been widely used in a large variety of applications in various areas.  The purpose of this book is to provide recent advances of artificial neural networks in biomedical applications.  The book begins with fundamentals of artificial neural networks, which cover an introduction, design, and optimization.  Advanced architectures for biomedical applications, which offer improved performance and desirable properties, follow.  Parts continue with biological applications such as gene, plant biology, and stem cell, medical applications such as skin diseases, sclerosis, anesthesia, and physiotherapy, and clinical and other applications such as clinical outcome, telecare, and pre-med student failure prediction.  Thus, this book will be a fundamental source of recent advances and applications of artificial neural networks in biomedical areas.  The target audience includes professors and students in engineering and medical schools, researchers and engineers in biomedical industries, medical doctors, and healthcare professionals."><meta data-vue-meta="true" name="twitter:image" content="https://cdn.intechopen.com/books/images_new/117.jpg"><meta data-vue-meta="true" name="DC.Identifier" content="10.5772/644"><meta data-vue-meta="true" name="DC.Title" content="Artificial Neural Networks - Methodological Advances and Biomedical Applications"><meta data-vue-meta="true" name="DC.Date" content="2011-04-11"><meta data-vue-meta="true" name="citation_doi" content="10.5772/644"><meta data-vue-meta="true" name="citation_title" content="Artificial Neural Networks - Methodological Advances and Biomedical Applications"><meta data-vue-meta="true" name="citation_publication_date" content="2011-04-11"><meta data-vue-meta="true" name="citation_online_date" content="2011-04-11"><meta data-vue-meta="true" name="citation_isbn" content="978-953-307-243-2"><meta data-vue-meta="true" name="citation_author" content="Kenji Suzuki"><script src="https://www.google.com/recaptcha/api.js?onload=vueRecaptchaApiLoaded&render=explicit" async defer="defer"></script><script async src="https://badge.dimensions.ai/badge.js" charset="utf-8"></script><script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script><link rel="apple-touch-icon" sizes="120x120" href="/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/favicon-16x16.png"><link rel="manifest" href="/site.webmanifest"><link rel="mask-icon" href="/safari-pinned-tab.svg" color="red"><meta name="msapplication-TileColor" content="#e10000"><meta name="theme-color" content="#ffffff"><link rel="stylesheet" type="text/css" href="//cdnjs.cloudflare.com/ajax/libs/cookieconsent2/3.1.0/cookieconsent.min.css"><style>@font-face{font-family:'Relative Faux';font-style:normal;font-weight:400;src:url(//cdnintech.com/web/frontend/www/dist/fonts/relative-faux.eot);src:local("Relative Faux"),local("Relative-Faux"),url(//cdnintech.com/web/frontend/www/dist/fonts/relative-faux.eot#iefix) format("embedded-opentype"),url(//cdnintech.com/web/frontend/www/dist/fonts/relative-faux.woff) format("woff"),url(//cdnintech.com/web/frontend/www/dist/fonts/relative-faux.otf) format("otf"),url(//cdnintech.com/web/frontend/www/dist/fonts/relative-faux.woff2) format("woff2"),url(//cdnintech.com/web/frontend/www/dist/fonts/relative-faux.ttf) format("ttf")}.cc-window{font-family:'Relative Faux',Helvetica;border-top:.2em solid rgba(0,0,0,.1)}</style><script src="//cdnjs.cloudflare.com/ajax/libs/cookieconsent2/3.1.0/cookieconsent.min.js"></script><script>window.addEventListener("load",function(){window.cookieconsent.initialise({palette:{popup:{background:"#e10000",text:"#fffad2"},button:{background:"transparent",text:"#fffad2",border:"#fffad2"}},content:{message:"IntechOpen uses cookies to offer you the best online experience. By continuing to use our site, you agree to our",link:"Privacy Policy",href:"https://www.intechopen.com/privacy-policy"}})})</script><script type="text/javascript">!function(){var e=document.createElement("script");e.type="text/javascript",e.async=!0,e.src="//siteimproveanalytics.com/js/siteanalyze_6176321.js";var t=document.getElementsByTagName("script")[0];t.parentNode.insertBefore(e,t)}()</script><link rel="preload" href="//cdnintech.com/web/frontend/www/dist/manifest.2509d95849ada7fe3993.js" as="script"><link rel="preload" href="//cdnintech.com/web/frontend/www/dist/vendor.8bcb89411cbd7a7e7ea9.js" as="script"><link rel="preload" href="//cdnintech.com/web/frontend/www/dist/app.4b8d60a89a0755da921f.js" as="script"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/25.9cb4349ebc4ce63891f7.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/0.3c932e54f081e15af9e3.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/2.4fb06fe385cde7cae8ac.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/3.743060a99c5599426ad9.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/4.502f603b763714ae5d4f.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/5.e2f5574fe8af59ac1c92.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/6.e97fd061378310830326.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/7.22d30384cd69ea2ce78f.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/8.909758b29009f70392ca.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/9.c4a25ecfa2f1c668f00a.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/10.88c682f0059521f0d148.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/11.3cd685a8cc140d31725e.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/12.40804ff4ef8a82942e49.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/13.27ef1437b60cc7afda97.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/14.385c77b4f544d1d52046.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/15.bbfccaac73dd36a791ee.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/16.dc25d0495fa73acf7114.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/17.6a7f6cb9558a04c57a34.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/18.4d63ffa828d5419b02d1.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/19.6b83aceb47afca8bbf02.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/20.9694c101d7f57236ca53.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/21.40e7f26e5a50de80f55a.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/22.8af8ac574c7972c3ca76.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/23.4600ee4d480ec5761e30.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/24.9a4f3db89397520a3a3c.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/1.81f97a53413bbca30803.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/26.f78ce365fc321c1e272f.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/27.18570a8c1c8fc28242a2.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/30.0ee01293b043d9a9a316.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/31.512f34737b6e1337acf5.js"><link rel="prefetch" href="//cdnintech.com/web/frontend/www/dist/32.24bcb720612d5fd32758.js"><style data-vue-ssr-id="1e9d83b0:0 7d7c984a:0 5c4c94d0:0 c19edfb8:0 2b1ab0f9:0 31f95441:0 18ee2166:0 30957c59:0 1b80ecfa:0 4200cc62:0 2f3a5cb7:0 47d1b228:0 4185c4ce:0 3cb2c55f:0 3fd65f46:0 7a827be0:0 0be1fca7:0 b7c94984:0 4b2ffd14:0 6757e475:0 1ea3abac:0 86e3588c:0 17621ad4:0 5b94bcac:0 df3c8094:0">@charset "UTF-8";@font-face{font-family:FSBrabo;font-style:normal;font-weight:400;src:url(//cdnintech.com/web/frontend/www/dist/fonts/FSBraboWeb-Regular.eot);src:local("FS Brabo Regular"),local("FSBrabo-Regular"),url(//cdnintech.com/web/frontend/www/dist/fonts/FSBraboWeb-Regular.eot#iefix) format("embedded-opentype"),url(//cdnintech.com/web/frontend/www/dist/fonts/FSBraboWeb-Regular.woff) format("woff")}@font-face{font-family:FSBrabo;font-style:italic;font-weight:400;src:url(//cdnintech.com/web/frontend/www/dist/fonts/FSBraboWeb-Italic.eot);src:local("FS Brabo Italic"),local("FSBrabo-Italic"),url(//cdnintech.com/web/frontend/www/dist/fonts/FSBraboWeb-Italic.eot#iefix) format("embedded-opentype"),url(//cdnintech.com/web/frontend/www/dist/fonts/FSBraboWeb-Italic.woff) format("woff")}@font-face{font-family:FSBrabo;font-style:normal;font-weight:700;src:url(//cdnintech.com/web/frontend/www/dist/fonts/FSBraboWeb-Bold.eot);src:local("FS Brabo Bold"),local("FSBrabo-Bold"),url(//cdnintech.com/web/frontend/www/dist/fonts/FSBraboWeb-Bold.eot#iefix) format("embedded-opentype"),url(//cdnintech.com/web/frontend/www/dist/fonts/FSBraboWeb-Bold.woff) format("woff")}@font-face{font-family:FSBrabo;font-style:italic;font-weight:700;src:url(//cdnintech.com/web/frontend/www/dist/fonts/FSBraboWeb-BoldItalic.eot);src:local("FS Brabo BoldItalic"),local("FSBrabo-BoldItalic"),url(//cdnintech.com/web/frontend/www/dist/fonts/FSBraboWeb-BoldItalic.eot#iefix) format("embedded-opentype"),url(//cdnintech.com/web/frontend/www/dist/fonts/FSBraboWeb-BoldItalic.woff) format("woff")}@font-face{font-family:'Relative Faux';font-style:normal;font-weight:400;src:url(//cdnintech.com/web/frontend/www/dist/fonts/relative-faux.eot);src:local("Relative Faux"),local("Relative-Faux"),url(//cdnintech.com/web/frontend/www/dist/fonts/relative-faux.eot#iefix) format("embedded-opentype"),url(//cdnintech.com/web/frontend/www/dist/fonts/relative-faux.woff) format("woff"),url(//cdnintech.com/web/frontend/www/dist/fonts/relative-faux.otf) format("otf"),url(//cdnintech.com/web/frontend/www/dist/fonts/relative-faux.woff2) format("woff2"),url(//cdnintech.com/web/frontend/www/dist/fonts/relative-faux.ttf) format("ttf")}.button-type-1{font-family:'Relative Faux',sans-serif;font-weight:400;font-style:normal;font-size:1.4em;letter-spacing:1px;color:#fffad2;text-transform:uppercase;text-align:center;display:inline-block;padding:1.2rem 0;border:1px solid #e10000;border-radius:2px;box-shadow:0 1px 2px 0 rgba(0,0,0,.2);background-color:#e10000;box-sizing:border-box}.button-type-1:hover{color:#fffad2;background-color:#b40000;border-color:#b40000}.button-type-2{font-family:'Relative Faux',sans-serif;font-weight:400;font-style:normal;font-size:1.4em;letter-spacing:1px;text-transform:uppercase;text-align:center;display:inline-block;padding:1.2rem 0;border:1px solid #e10000;border-radius:2px;box-shadow:0 1px 2px 0 rgba(0,0,0,.2);color:#e10000;box-sizing:border-box}.button-type-2:hover{color:#fffad2;background-color:#b40000;border-color:#b40000}.button-type-3{font-family:'Relative Faux',sans-serif;font-weight:400;font-style:normal;font-size:1.4em;letter-spacing:1px;text-transform:uppercase;text-align:center;display:inline-block;padding:1.5rem 0;border:1px solid #fffad2;border-radius:2px;color:#fffad2;box-sizing:border-box}.button-type-3:hover{color:#e10000;background-color:#fffad2}.link-type-1{text-decoration:underline}.link-type-2{font-family:'Relative Faux',sans-serif;font-weight:400;font-style:normal;color:#e10000}.link-type-2:hover{text-decoration:underline}.ais-highlight em,.ais-snippet em{font-style:normal;background-color:#e10000;color:#fffad2}.clear{clear:both}@font-face{font-family:intech;src:url(//cdnintech.com/web/frontend/www/dist/fonts/InTech.eot?v1.0);src:url(//cdnintech.com/web/frontend/www/dist/fonts/InTech.eot?v1.0#iefix) format("embedded-opentype"),url(//cdnintech.com/web/frontend/www/dist/fonts/InTech.woff?v1.0) format("woff"),url(//cdnintech.com/web/frontend/www/dist/fonts/InTech.ttf?v1.0) format("truetype"),url(//cdnintech.com/web/frontend/www/dist/fonts/InTech.svg?v1.0//cdnintech.com/web/frontend/www/dist/fonts/InTech) format("svg");font-weight:400;font-style:normal}[class*=" icon"],[class^=icon]{display:inline-block;position:relative;padding-left:40px}[class*=" icon"]:before,[class^=icon]:before{font-family:intech;speak:none;font-style:normal;font-weight:400;font-variant:normal;text-transform:none;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale;position:absolute;left:0;top:50%;margin:0;width:40px;height:40px;line-height:40px;margin-top:-20px;text-align:center;text-indent:0}.iconFb:before{content:"\E912"}.iconLinkedIn:before{content:"\E913"}.iconTwitter:before{content:"\E914"}.iconYt:before{content:"\E915"}.iconGoogle:before{content:"\E916"}.iconStumbleupon:before{content:"\E917"}.iconCiteulike:before{content:"\E919"}.iconReddit:before{content:"\E91A"}.iconBibsonomy:before{content:"\E918"}.iconCheck:before{content:"\E902"}.iconBook:before{content:"\E901"}.iconArrowRight:before{content:"\E903"}.iconArrowRightThin:before{content:"\E904"}.iconArrowDown:before{content:"\E900"}.iconCirclePlus:before{content:"\E905"}.iconLike:before{content:"\E906"}.iconPdf:before{content:"\E907"}.iconPlay:before{content:"\E908"}.iconPrint:before{content:"\E909"}.iconQuoteRight:before{content:"\E90A"}.iconQuoteLeft:before{content:"\E90B"}.iconSearch:before{content:"\E90C"}.iconShare:before{content:"\E90D"}.iconTimer:before{content:"\E90E"}.iconTranslate:before{content:"\E90F"}.iconUser:before{content:"\E910"}.iconClose:before{content:"\E911"}a{text-decoration:none;cursor:pointer;color:inherit}a::-moz-focus-inner,a:focus{outline:0}a,dd,dl,dt,fieldset,h1,h2,h3,h4,li,ol,p,td,ul{margin:0;padding:0;list-style:none;border:0;font-size:1em}table{border-collapse:collapse;border-spacing:0}img{vertical-align:bottom}button,input,select,textarea{font-family:inherit;font-size:100%;margin:0;outline:0;box-sizing:border-box;border-radius:0}textarea{overflow:auto;vertical-align:top;resize:vertical}button,label{cursor:pointer}html{font-size:62.5%}body{font-size:1em}figure{margin:0}.cf::after{clear:both;content:"";display:block}.icr{padding:0;display:inline-block;width:40px;height:40px;text-indent:-9999em;overflow:hidden}.icr:before{right:0;width:auto;text-indent:0}.nBtn{margin:0;padding:0;border:0;cursor:pointer;background:0 0;text-align:left}.nBtn::-moz-focus-inner{padding:0;border:0}body,html{min-height:100%;background-color:#fffad2}a{color:inherit}body{font-family:FSBrabo,serif;font-weight:400;font-style:normal;min-width:32em;position:relative;overflow-x:hidden;color:#000;margin:0}.capitalize{display:inline-block}.capitalize:first-letter{text-transform:uppercase}@media screen and (max-width:62.5em){.page-header[data-v-58e00f46]{min-height:5.6em;background:#e10000}.page-header .search-term[data-v-58e00f46]{display:none}.page-header.has-search .search-term[data-v-58e00f46]{display:block}.page-header .wrap[data-v-58e00f46]{display:none}.page-header .wrap.expanded[data-v-58e00f46]{display:block}.search-term[data-v-58e00f46]{background:#000;position:absolute!important;z-index:100;left:0;right:0}.search-term[data-v-58e00f46] input{padding:1.5rem 1rem!important;border-width:0!important;width:100%}.search-term[data-v-58e00f46] span{display:none}.toggle[data-v-58e00f46]{font-family:'Relative Faux',sans-serif;font-weight:400;font-style:normal;font-size:1.4em;line-height:1;color:#fffad2;text-transform:uppercase;display:inline-block;padding:1rem 2rem;border:1px solid #fffad2;border-radius:2px;box-shadow:0 1px 2px 0 rgba(0,0,0,.2)}.branding[data-v-58e00f46]{position:absolute;left:50%;top:1.1em;margin-left:-1.7em}.branding img[data-v-58e00f46]{display:block;width:3.4em}.bar[data-v-58e00f46]{position:relative;padding:1em}.bar .aside[data-v-58e00f46]{float:right}.bar .user-profile[data-v-58e00f46]{font-size:2.7rem;color:#fffad2;margin-right:.5rem}.bar .search[data-v-58e00f46]{font-size:2.8em;color:#fffad2;margin-left:.5rem}.wrap[data-v-58e00f46]{position:fixed;top:0;left:0;right:0;bottom:0;z-index:1000;padding:1em;background:#000;overflow-y:auto;-webkit-overflow-scrolling:touch}.site-nav[data-v-58e00f46]{margin:2em -1rem 0}.nav-item[data-v-58e00f46]{font-family:'Relative Faux',sans-serif;font-weight:400;font-style:normal;font-size:1.8em;line-height:1.33333;color:#fffad2;text-align:center;display:block;border-bottom:1px solid #333;padding:2rem 1rem}.nav-item.router-link-exact-active[data-v-58e00f46]{color:#000;background:#fffad2}.sub-nav[data-v-58e00f46]{padding:1em 0;border-bottom:1px solid #333}.drop-item[data-v-58e00f46],.sub-nav-item[data-v-58e00f46]{font-family:'Relative Faux',sans-serif;font-weight:400;font-style:normal;font-size:1.4em;line-height:1.42857;color:#fffad2;text-align:center;display:block}.drop-item.router-link-exact-active[data-v-58e00f46],.sub-nav-item.router-link-exact-active[data-v-58e00f46]{text-decoration:underline}.sub-nav-item[data-v-58e00f46]{padding:2rem 1rem}.drop-item[data-v-58e00f46]{padding:1.5rem 1rem}.cta[data-v-58e00f46]{width:100%;margin:2rem 0}.nav-dropdown[data-v-58e00f46]{margin-bottom:2em}.nav-dropdown .nav-item[data-v-58e00f46],.nav-dropdown p[data-v-58e00f46]{display:none}}@media screen and (min-width:34.4375em) and (max-width:62.5em){.bar .link[data-v-58e00f46]{font-family:'Relative Faux',sans-serif;font-weight:400;font-style:normal;font-size:1.6em;line-height:2.2;color:#fffad2;float:left;position:relative;padding:0 1.2rem}.bar .link[data-v-58e00f46]:first-child:before{content:"";position:absolute;top:50%;right:0;height:2rem;width:1px;margin-top:-1rem;background:#fffad2}.drop-item[data-v-58e00f46],.sub-nav-item[data-v-58e00f46]{font-size:1.6em}.sub-nav li[data-v-58e00f46]{display:inline-block;width:50%}.cta-wrap[data-v-58e00f46]{text-align:center}.cta[data-v-58e00f46]{width:23rem;margin:6rem 0 4rem}.nav-dropdown[data-v-58e00f46]{text-align:center;max-width:60em;margin:0 auto 2em}.drop-box[data-v-58e00f46],.drop-item[data-v-58e00f46]{display:inline-block}}@media screen and (min-width:62.5625em){.page-header[data-v-58e00f46]{height:9em;background:#e10000}.page-header.has-subnav[data-v-58e00f46]{height:13em}.page-header.has-double-subnav[data-v-58e00f46]{height:17em}.page-header .wrap[data-v-58e00f46]{transition:transform .2s ease-in .3s;position:fixed;z-index:1000;top:0;left:0;right:0;background:#e10000}.page-header .wrap[data-v-58e00f46]::after{clear:both;content:"";display:block}.branding[data-v-58e00f46]{position:absolute;left:50%;top:50%;margin:-2.45em 0 0 -2.45em;width:4.9em}.page-header.home .branding[data-v-58e00f46]{margin:-1.25em 0 0 -8.5em;width:17em}.site-nav[data-v-58e00f46]{padding:0 2em;float:left}.site-nav li[data-v-58e00f46]{display:inline-block}.site-nav .nav-item[data-v-58e00f46]{padding:3.5rem 1.5rem 3.5rem 2rem}.site-nav .nav-item.iconArrowDown[data-v-58e00f46]{padding-left:2rem;padding-right:3.5rem}.site-nav .nav-item.iconArrowDown[data-v-58e00f46]:before{font-size:.6em;left:auto;right:0;margin-top:-18px}.nav-item[data-v-58e00f46]{font-family:'Relative Faux',sans-serif;font-weight:400;font-style:normal;font-size:1.6em;line-height:1.25;color:#fffad2;display:block}.nav-item.router-link-exact-active[data-v-58e00f46],.nav-item[data-v-58e00f46]:hover{text-decoration:underline}.nav-item.active-drop[data-v-58e00f46]{background:#000;text-decoration:underline}.sub-nav[data-v-58e00f46]{position:absolute;top:9em;left:0;right:0;background:#f2edc7;text-align:center}.sub-nav-item[data-v-58e00f46]{font-family:'Relative Faux',sans-serif;font-weight:400;font-style:normal;font-size:1.5em;line-height:2rem;color:#e10000;display:inline-block;padding:1rem 2rem}.sub-nav-item.router-link-active[data-v-58e00f46],.sub-nav-item[data-v-58e00f46]:hover{text-decoration:underline}.p-link[data-v-58e00f46]{color:#e10000}.p-link[data-v-58e00f46]:hover{color:#870000}.aside[data-v-58e00f46]{float:right;margin-right:2em}.aside ul[data-v-58e00f46]{display:inline-block;margin-right:3em}.aside li[data-v-58e00f46]{display:inline-block}.aside .nav-item[data-v-58e00f46]{padding:3.5rem 0}.nav-dropdown[data-v-58e00f46]{position:absolute;top:9em;left:0;right:0;background:#000}.nav-dropdown.collapsed[data-v-58e00f46]{display:none}.nav-dropdown .inner[data-v-58e00f46]{max-width:129em;margin:0 auto}.drop-box[data-v-58e00f46]{display:inline-block;vertical-align:top;width:25%;box-sizing:border-box;padding:6em 3em}.drop-box .nav-item[data-v-58e00f46]{margin-bottom:2rem}.drop-box p[data-v-58e00f46]{font-family:FSBrabo,serif;font-weight:400;font-style:normal;font-size:1.5em;line-height:1.6;color:#fff;margin-bottom:2rem}.drop-box p a[data-v-58e00f46]{color:#fffad2}.drop-box p a[data-v-58e00f46]:hover{text-decoration:underline}.drop-item[data-v-58e00f46]{font-size:1.8em;line-height:1.33;color:#fffad2;display:block;margin-bottom:3rem}.drop-item.router-link-active[data-v-58e00f46],.drop-item[data-v-58e00f46]:hover{text-decoration:underline}}@media screen and (min-width:62.5625em){#app[data-scrolldir=up] .page-header .wrap{transform:translateY(0)}#app[data-scrolldir=down] .page-header .wrap{transform:translateY(-100%)}#app[data-scrolldir=down] .page-header.has-subnav .wrap{transform:translateY(-13em)}#app[data-scrolldir=down] .page-header.has-double-subnav .wrap{transform:translateY(-17em)}}.search-term[data-v-36b4823c]{position:relative;display:inline-block}.search-term input[data-v-36b4823c]{font-family:'Relative Faux',sans-serif;font-weight:400;font-style:normal;font-size:1.6em;line-height:1.5;color:#fff;padding:.5rem 1rem;border:2px solid #fffad2;border-radius:2px;background:0 0}.search-term input[data-v-36b4823c]::placeholder{color:#fffad2;opacity:1}.search-term .iconSearch[data-v-36b4823c]{position:absolute;left:initial;right:0;top:50%;margin-top:-2rem;color:#fffad2;background:0 0;border:0}.search-term .iconSearch[data-v-36b4823c]:before{font-size:2em}.breadcrumbs[data-v-fe8ce696]{max-width:117em;margin:3rem auto 0;box-sizing:border-box;padding:0 2em}.breadcrumbs p[data-v-fe8ce696]{font-family:'Relative Faux',sans-serif;font-weight:400;font-style:normal;font-size:1.5em}.breadcrumbs a[data-v-fe8ce696]{color:#e10000}.breadcrumbs a[data-v-fe8ce696]:hover{color:#870000}.breadcrumbs span[data-v-fe8ce696]{color:#e10000}@media screen and (max-width:34.375em){.breadcrumbs[data-v-fe8ce696]{padding:0 0 0 1.5em;position:relative}.breadcrumbs[data-v-fe8ce696]:after{content:" ";position:absolute;top:0;right:0;bottom:0;width:2.5em;background-image:linear-gradient(to right,transparent,#fffad2)}.breadcrumbs .wrap[data-v-fe8ce696]{overflow-x:scroll;padding-bottom:1.5rem;white-space:nowrap;-webkit-overflow-scrolling:touch}.breadcrumbs p span[data-v-fe8ce696]{margin-right:3rem}}@media screen and (min-width:34.4375em) and (max-width:50em){.breadcrumbs[data-v-fe8ce696]{margin-bottom:3em}}@media screen and (min-width:50.0625em){.breadcrumbs[data-v-fe8ce696]{margin-bottom:4em}}.book-intro[data-v-14995c67]{max-width:117em;margin:0 auto;box-sizing:border-box;padding:0 2em;margin-bottom:6rem}@media screen and (max-width:34.375em){.book-intro[data-v-14995c67]{padding:0 1.5em}.book-intro .aside[data-v-14995c67]{margin-bottom:5rem}}@media screen and (min-width:34.4375em){.book-intro[data-v-14995c67]{padding:0 2em}.book-intro .aside[data-v-14995c67]{margin-bottom:5rem}.book-intro .main .inner[data-v-14995c67]{max-width:60em;margin:0 auto}}@media screen and (min-width:62.5625em){.book-intro .wrap[data-v-14995c67]{display:table;width:100%}.book-intro .aside[data-v-14995c67]{display:table-cell;vertical-align:top;width:27em;padding-left:2em}.book-intro .aside .track[data-v-14995c67]{transition:top .2s ease-in .3s;transform:translate3d(0,0,0);position:sticky;top:2rem}.book-intro .main[data-v-14995c67]{display:table-cell;vertical-align:top}.book-intro .main .inner[data-v-14995c67]{max-width:68em;margin:0 auto}}.leadTitle[data-v-14995c67]{font-size:1.7rem;line-height:1.6;font-style:italic;margin-bottom:1rem}.title[data-v-14995c67]{font-family:FSBrabo,serif;font-weight:400;font-style:normal;margin-bottom:1rem}@media screen and (max-width:34.375em){.title[data-v-14995c67]{font-size:2.2rem;margin-bottom:2rem}}@media screen and (min-width:34.4375em) and (max-width:50em){.title[data-v-14995c67]{font-size:3.4rem;margin-bottom:2rem}}@media screen and (min-width:50.0625em){.title[data-v-14995c67]{font-size:4rem;margin-bottom:3rem}}.subTitle[data-v-14995c67]{font-size:2rem;line-height:1.6;margin-bottom:.5rem}.description[data-v-14995c67]{font-size:1.7rem;line-height:1.6;margin-bottom:4rem}.description.hide[data-v-14995c67]{display:none}.author.hide[data-v-14995c67]{display:none}.cta-toggle[data-v-14995c67]{font-size:1.6em;line-height:1.5;display:inline-block;margin:-1rem 0 4rem}.book-meta[data-v-14995c67]{font-family:'Relative Faux',sans-serif;font-weight:400;font-style:normal;font-size:1.4em;line-height:1.5;margin-top:3rem}.book-meta p[data-v-14995c67]{margin-bottom:1rem}.book-cover-box>.cover-wrap[data-v-14995c67]{display:block}@media screen and (max-width:34.375em){.jump-to-section[data-v-14995c67]{position:relative;margin-bottom:2rem;margin-top:2rem}.jump-to-section select[data-v-14995c67]{font-family:'Relative Faux',sans-serif;font-weight:400;font-style:normal;font-size:1.6em;letter-spacing:1.1px;position:relative;z-index:5;width:100%;padding:.8rem 5rem .8rem 1.5rem;border:1px solid #e10000;border-radius:2px;background:0 0;-moz-appearance:none;-ms-progress-appearance:none;-webkit-appearance:none}.jump-to-section select[data-v-14995c67]::-ms-expand{display:none}.jump-to-section[data-v-14995c67]:before{content:'';position:absolute;right:0;top:0;bottom:0;width:4rem;background:#e10000;border-top-right-radius:2px;border-bottom-right-radius:2px;z-index:1}.jump-to-section .iconArrowDown[data-v-14995c67]{position:absolute;right:0;z-index:1;color:#fff}.jump-to-section select[data-v-14995c67]{border:1px solid #e10000}}@media screen and (max-width:50em){.book-meta[data-v-14995c67]{float:left;padding-left:1.5rem;box-sizing:border-box;width:50%;margin-top:2rem}.cover-wrap[data-v-14995c67]{max-width:15rem;width:50%;float:left}.cta[data-v-14995c67]{margin-bottom:3rem;width:100%;max-width:40rem}}@media screen and (min-width:50.0625em){.book-details[data-v-14995c67]{width:calc(100% - 33.5em);box-sizing:border-box;float:left;padding-right:10rem}.book-cover-box[data-v-14995c67]{width:33.5em;box-sizing:border-box;float:left;padding-left:3.5rem;margin-top:4rem}.cta[data-v-14995c67]{margin-bottom:4rem;width:100%;max-width:27rem;display:block}.book-meta p[data-v-14995c67]{text-align:right}}.author[data-v-7ba456ce]{margin:3em 0 2rem;min-height:9rem;padding:.5rem 0 0 11rem;position:relative}.profile-img[data-v-7ba456ce]{width:9rem!important;position:absolute!important;top:0;left:0}.edited-by[data-v-7ba456ce]{color:#e10000;font-family:FSBrabo,serif;font-weight:400;font-style:normal;margin-bottom:2rem}.edited-by[data-v-7ba456ce]:hover{color:#870000}@media screen and (max-width:50em){.edited-by[data-v-7ba456ce]{font-size:2rem}}@media screen and (min-width:50.0625em){.edited-by[data-v-7ba456ce]{font-size:2.2rem}}.author-position[data-v-7ba456ce]{font-size:2em;line-height:1.5;font-style:italic}@media screen and (max-width:34.375em){.author-position[data-v-7ba456ce]{font-size:1.8em}}.profile-img[data-v-4eaadae2]{display:inline-block;position:relative;width:100%}.profile-img>.lazy-image[data-v-4eaadae2]{display:block;width:100%;background:0 0}.profile-img.filter[data-v-4eaadae2]:after{content:"";position:absolute;top:0;left:0;right:0;bottom:0;background:rgba(225,0,0,.1);mix-blend-mode:multiply}.lazy-image[data-v-d261b71c]{position:relative;display:block;overflow:hidden;width:100%;background-color:#fff9c5}.lazy-image.ar1[data-v-d261b71c]{padding-bottom:144.3%}.lazy-image.ar2[data-v-d261b71c]{padding-bottom:100%}.image[data-v-d261b71c]{position:absolute;left:0;right:0;top:0;bottom:0;margin:auto;width:100%;min-height:100%}.fade-enter-active[data-v-d261b71c],.fade-leave-active[data-v-d261b71c]{transition:opacity .5s ease-in}.fade-enter[data-v-d261b71c],.fade-leave-to[data-v-d261b71c]{transform:scale(1);opacity:0}.cover-wrap[data-v-51685050]{position:relative;display:block;overflow:hidden}.cover-wrap a[data-v-51685050]{display:block}.cover-wrap[data-v-51685050]:after{content:'';position:absolute;left:-1px;top:0;bottom:0;width:1px;box-shadow:3px 0 2px rgba(0,0,0,.6);z-index:10}.cover-wrap[data-v-51685050]:before{content:'';position:absolute;left:3%;right:0;top:0;bottom:0;width:1px;background:rgba(0,0,0,.05);border-right:1px solid rgba(0,0,0,.08);box-shadow:-1px 0 2px rgba(255,255,255,.3);z-index:10}.lazy-image[data-v-51685050]{display:block;width:100%}.svg[data-v-51685050]{position:absolute;top:50%;left:0;z-index:1;width:100%;transform:translateY(-50%)}.text[data-v-51685050]{color:#fffad2;padding:0 2em;box-sizing:border-box;text-align:center;position:absolute;left:0;z-index:2;width:100%;white-space:normal}.text .title[data-v-51685050]{font-size:1.8em;display:block}.text .sub-title[data-v-51685050]{font-size:1.1em;display:block}.text .editors[data-v-51685050]{font-size:1em;font-style:italic;margin-top:1rem;display:block}.cover-wrap.top .text[data-v-51685050]{top:40%}.cover-wrap.middle .text[data-v-51685050]{top:50%;transform:translateY(-50%)}.book-statistics[data-v-bdfa72c6]{max-width:117em;margin:0 auto;box-sizing:border-box;padding:0 2em}@media screen and (max-width:34.375em){.book-statistics[data-v-bdfa72c6]{padding:0 1.5em}.book-statistics .aside[data-v-bdfa72c6]{margin-bottom:5rem}}@media screen and (min-width:34.4375em){.book-statistics[data-v-bdfa72c6]{padding:0 2em}.book-statistics .aside[data-v-bdfa72c6]{margin-bottom:5rem}.book-statistics .main .inner[data-v-bdfa72c6]{max-width:60em;margin:0 auto}}@media screen and (min-width:62.5625em){.book-statistics .wrap[data-v-bdfa72c6]{display:table;width:100%}.book-statistics .aside[data-v-bdfa72c6]{display:table-cell;vertical-align:top;width:27em;padding-left:2em}.book-statistics .aside .track[data-v-bdfa72c6]{transition:top .2s ease-in .3s;transform:translate3d(0,0,0);position:sticky;top:2rem}.book-statistics .main[data-v-bdfa72c6]{display:table-cell;vertical-align:top}.book-statistics .main .inner[data-v-bdfa72c6]{max-width:68em;margin:0 auto}}.statistics[data-v-bdfa72c6]{text-align:center;margin:6rem 0}.stat-item[data-v-bdfa72c6]{font-family:'Relative Faux',sans-serif;font-weight:400;font-style:normal;font-size:1.8em;line-height:1;color:#e10000;display:inline-block;box-sizing:border-box;padding:0 2em}.stat-item .text[data-v-bdfa72c6]{line-height:1.3}.stat-item li[data-v-bdfa72c6]{line-height:1.5}.stats[data-v-bdfa72c6]{max-width:117em;margin:0 auto;box-sizing:border-box;padding:0 2em;padding:0;clear:both}@media screen and (max-width:34.375em){.stats[data-v-bdfa72c6]{padding:0 1.5em}.stats .aside[data-v-bdfa72c6]{margin-bottom:5rem}}@media screen and (min-width:34.4375em){.stats[data-v-bdfa72c6]{padding:0 2em}.stats .aside[data-v-bdfa72c6]{margin-bottom:5rem}.stats .main .inner[data-v-bdfa72c6]{max-width:60em;margin:0 auto}}@media screen and (min-width:62.5625em){.stats .wrap[data-v-bdfa72c6]{display:table;width:100%}.stats .aside[data-v-bdfa72c6]{display:table-cell;vertical-align:top;width:27em;padding-left:2em}.stats .aside .track[data-v-bdfa72c6]{transition:top .2s ease-in .3s;transform:translate3d(0,0,0);position:sticky;top:2rem}.stats .main[data-v-bdfa72c6]{display:table-cell;vertical-align:top}.stats .main .inner[data-v-bdfa72c6]{max-width:68em;margin:0 auto}}.link[data-v-bdfa72c6]{font-family:'Relative Faux',sans-serif;font-weight:400;font-style:normal;position:relative;color:#e10000;font-size:1.6em;line-height:2;margin-bottom:2rem;display:inline-block;padding-left:0;float:right}.link[data-v-bdfa72c6]:after{content:"";position:absolute;left:0;right:0;bottom:0;top:0;background-image:linear-gradient(to right,#e10000 0,#e10000 100%);background-repeat:repeat-x;background-position:0 90%;background-size:100% 1px}.link[data-v-bdfa72c6]:before{content:"\E903";font-family:intech;font-size:.6em;position:absolute;right:-1.5em;top:50%;bottom:0;margin-top:-.8rem}.link[data-v-bdfa72c6]:hover{color:#870000}.link[data-v-bdfa72c6]:hover:after{background-image:linear-gradient(to right,#ae0000 0,#ae0000 100%)}@media screen and (max-width:34.375em){.book-statistics[data-v-bdfa72c6]{padding:5rem 1.5rem}.link[data-v-bdfa72c6]{float:none}}@media screen and (min-width:34.4375em){.book-statistics[data-v-bdfa72c6]{padding:0 2rem 6rem}}@media screen and (max-width:43.75em){.stat-item[data-v-bdfa72c6]{margin-bottom:4rem}.stat-item[data-v-bdfa72c6]:last-child{margin-bottom:0}.data[data-v-bdfa72c6]{font-size:2.22222em;margin-bottom:2rem;display:block}}@media screen and (min-width:43.8125em){.data[data-v-bdfa72c6]{font-size:3.88889em;display:block}}@media screen and (min-width:43.8125em) and (max-width:62.5em){.data[data-v-bdfa72c6]{font-size:2.77778em}}.stats[data-v-48a702c7]{text-align:center}.item[data-v-48a702c7]{font-family:'Relative Faux',sans-serif;font-weight:400;font-style:normal;font-size:1.8em;color:#e10000;display:inline-block;box-sizing:border-box}.item>span[data-v-48a702c7]{display:block;margin-bottom:2rem}@media screen and (max-width:34.375em){.stats[data-v-48a702c7]{margin-top:5rem}.item[data-v-48a702c7]{width:50%;margin-bottom:5rem}.item>span[data-v-48a702c7]{font-size:2.22222em}}@media screen and (min-width:34.4375em){.stats[data-v-48a702c7]{margin:6rem auto}.item[data-v-48a702c7]{padding:0 1em;vertical-align:middle}.item>span[data-v-48a702c7]{font-size:3.88889em}}@media screen and (min-width:34.4375em) and (max-width:50em){.item[data-v-48a702c7]{padding:0}.item>span[data-v-48a702c7]{font-size:2.77778em}}.chapters[data-v-3aa59521]{max-width:117em;margin:0 auto;box-sizing:border-box;padding:0 2em}@media screen and (max-width:34.375em){.chapters[data-v-3aa59521]{padding:0 1.5em}.chapters .aside[data-v-3aa59521]{margin-bottom:5rem}}@media screen and (min-width:34.4375em){.chapters[data-v-3aa59521]{padding:0 2em}.chapters .aside[data-v-3aa59521]{margin-bottom:5rem}.chapters .main .inner[data-v-3aa59521]{max-width:60em;margin:0 auto}}@media screen and (min-width:62.5625em){.chapters .wrap[data-v-3aa59521]{display:table;width:100%}.chapters .aside[data-v-3aa59521]{display:table-cell;vertical-align:top;width:27em;padding-left:2em}.chapters .aside .track[data-v-3aa59521]{transition:top .2s ease-in .3s;transform:translate3d(0,0,0);position:sticky;top:2rem}.chapters .main[data-v-3aa59521]{display:table-cell;vertical-align:top}.chapters .main .inner[data-v-3aa59521]{max-width:68em;margin:0 auto}}.leadTitle[data-v-3aa59521]{font-size:1.7rem;line-height:1.6;font-style:italic;margin-bottom:1rem}.title[data-v-3aa59521]{font-family:FSBrabo,serif;font-weight:400;font-style:normal;text-align:left;padding-bottom:1rem}@media screen and (max-width:34.375em){.title[data-v-3aa59521]{font-size:2.2rem;margin-bottom:2rem}}@media screen and (min-width:34.4375em) and (max-width:50em){.title[data-v-3aa59521]{font-size:2.4rem;margin-bottom:3rem}}@media screen and (min-width:50.0625em){.title[data-v-3aa59521]{font-size:2.6rem;margin-bottom:4rem}}.title[data-v-3aa59521]:first-letter{text-transform:uppercase}.subTitle[data-v-3aa59521]{font-family:FSBrabo,serif;font-weight:400;font-style:normal;font-size:1.7rem;line-height:1.6;text-align:right;padding-left:4rem}.chapters-table[data-v-3aa59521]{width:100%}.table-header[data-v-3aa59521]{border-bottom:1px solid #999;padding:1rem 0}.table-row td[data-v-3aa59521]{padding:2.2rem 0;border-bottom:1px solid rgba(153,153,153,.2)}.chapter-name[data-v-3aa59521]{font-size:2em}.chapter-editors[data-v-3aa59521]{font-style:italic;margin-top:1rem}.chapter-data[data-v-3aa59521]{font-family:FSBrabo,serif;font-weight:700;font-style:normal;font-size:2em;text-align:right}.linkType1[data-v-3aa59521]{color:#e10000;display:block;line-height:1.4}.linkType1[data-v-3aa59521]:hover{color:#870000}.linkType2[data-v-3aa59521]{position:relative;color:#000}.linkType2[data-v-3aa59521]:after{content:"";position:absolute;left:0;right:0;bottom:0;top:0;background-image:linear-gradient(to right,#000 0,#000 100%);background-repeat:repeat-x;background-position:0 90%;background-size:100% 1px}.linkType2[data-v-3aa59521]:hover:after{display:none}.hide[data-v-3aa59521]{display:none}@media screen and (max-width:34.375em){.chapter-data[data-v-3aa59521],.subTitle[data-v-3aa59521]{display:none}.chapter-data-mobile[data-v-3aa59521]{font-size:.8em;margin-top:2rem;margin-right:2rem;display:inline-block}}@media screen and (max-width:50em){.chapter-name[data-v-3aa59521]{font-size:1.9em}}.indexed-in[data-v-9fc121d2]{max-width:117em;margin:0 auto;box-sizing:border-box;padding:0 2em}@media screen and (max-width:34.375em){.indexed-in[data-v-9fc121d2]{padding:0 1.5em}.indexed-in .aside[data-v-9fc121d2]{margin-bottom:5rem}}@media screen and (min-width:34.4375em){.indexed-in[data-v-9fc121d2]{padding:0 2em}.indexed-in .aside[data-v-9fc121d2]{margin-bottom:5rem}.indexed-in .main .inner[data-v-9fc121d2]{max-width:60em;margin:0 auto}}@media screen and (min-width:62.5625em){.indexed-in .wrap[data-v-9fc121d2]{display:table;width:100%}.indexed-in .aside[data-v-9fc121d2]{display:table-cell;vertical-align:top;width:27em;padding-left:2em}.indexed-in .aside .track[data-v-9fc121d2]{transition:top .2s ease-in .3s;transform:translate3d(0,0,0);position:sticky;top:2rem}.indexed-in .main[data-v-9fc121d2]{display:table-cell;vertical-align:top}.indexed-in .main .inner[data-v-9fc121d2]{max-width:68em;margin:0 auto}}.title[data-v-9fc121d2]{font-family:FSBrabo,serif;font-weight:400;font-style:normal;text-align:center;margin-bottom:0!important}@media screen and (max-width:34.375em){.title[data-v-9fc121d2]{font-size:2.2rem;margin-bottom:2rem}}@media screen and (min-width:34.4375em) and (max-width:50em){.title[data-v-9fc121d2]{font-size:2.4rem;margin-bottom:3rem}}@media screen and (min-width:50.0625em){.title[data-v-9fc121d2]{font-size:2.6rem;margin-bottom:4rem}}.list[data-v-9fc121d2]{text-align:center}.item[data-v-9fc121d2]{display:inline-block}.item a[data-v-9fc121d2]{display:block}@media screen and (max-width:34.375em){.indexed-in[data-v-9fc121d2]{padding:4em 0 1em}.list[data-v-9fc121d2]{margin:0 -1em}.item[data-v-9fc121d2]{box-sizing:border-box;width:50%;padding:2em 3em;text-align:center}.item img[data-v-9fc121d2]{max-width:100%}}@media screen and (min-width:34.4375em){.indexed-in[data-v-9fc121d2]{padding:6em 0 2em}.item[data-v-9fc121d2]{padding:3em 2em 1em;width:20%;box-sizing:border-box}.item img[data-v-9fc121d2]{width:100%;max-height:12em}}.order-book[data-v-7ba8523d]{max-width:117em;margin:0 auto;box-sizing:border-box;padding:0 2em}@media screen and (max-width:34.375em){.order-book[data-v-7ba8523d]{padding:0 1.5em}.order-book .aside[data-v-7ba8523d]{margin-bottom:5rem}}@media screen and (min-width:34.4375em){.order-book[data-v-7ba8523d]{padding:0 2em}.order-book .aside[data-v-7ba8523d]{margin-bottom:5rem}.order-book .main .inner[data-v-7ba8523d]{max-width:60em;margin:0 auto}}@media screen and (min-width:62.5625em){.order-book .wrap[data-v-7ba8523d]{display:table;width:100%}.order-book .aside[data-v-7ba8523d]{display:table-cell;vertical-align:top;width:27em;padding-left:2em}.order-book .aside .track[data-v-7ba8523d]{transition:top .2s ease-in .3s;transform:translate3d(0,0,0);position:sticky;top:2rem}.order-book .main[data-v-7ba8523d]{display:table-cell;vertical-align:top}.order-book .main .inner[data-v-7ba8523d]{max-width:68em;margin:0 auto}}.title[data-v-7ba8523d]{font-family:FSBrabo,serif;font-weight:400;font-style:normal;text-align:center}@media screen and (max-width:34.375em){.title[data-v-7ba8523d]{font-size:2.2rem;margin-bottom:2rem}}@media screen and (min-width:34.4375em) and (max-width:50em){.title[data-v-7ba8523d]{font-size:2.4rem;margin-bottom:3rem}}@media screen and (min-width:50.0625em){.title[data-v-7ba8523d]{font-size:2.6rem;margin-bottom:4rem}}.cover-wrap[data-v-7ba8523d]{display:block}.shipping[data-v-7ba8523d]{font-family:FSBrabo,serif;font-weight:700;font-style:normal;font-size:1.7rem;line-height:1.6;margin-bottom:3rem}.price[data-v-7ba8523d]{font-size:1.7rem;line-height:1.6;margin-bottom:3rem}.price span[data-v-7ba8523d]{font-size:1.8em;display:block}.cta[data-v-7ba8523d]{width:27rem}.meta[data-v-7ba8523d]{font-family:'Relative Faux',sans-serif;font-weight:400;font-style:normal;font-size:1.4em;line-height:1.5;margin-top:3rem}@media screen and (max-width:34.375em){.order-book[data-v-7ba8523d]{padding-top:4rem}.cta[data-v-7ba8523d]{width:100%}}@media screen and (min-width:34.4375em) and (max-width:50em){.order-book[data-v-7ba8523d]{padding-top:5rem}}@media screen and (max-width:50em){.title[data-v-7ba8523d]{margin-bottom:4rem}.book[data-v-7ba8523d]{margin-bottom:3rem}.book-cover-box[data-v-7ba8523d]{max-width:20rem;margin:0 auto 4rem}.price span[data-v-7ba8523d]{font-size:1.5em;float:right;margin-top:-.8rem}}@media screen and (min-width:50.0625em){.order-book[data-v-7ba8523d]{padding-top:5rem}.book[data-v-7ba8523d]{margin-bottom:6rem}.book-cover-box[data-v-7ba8523d]{width:calc(100% / 3);float:left;box-sizing:border-box;padding:0 2rem 0 0}.book-details[data-v-7ba8523d]{width:calc((100% / 3)*2);float:left;box-sizing:border-box}}@media screen and (min-width:62.5625em){.book-cover-box[data-v-7ba8523d]{padding:0 6.5rem 0 3.5rem}}.box-type-1[data-v-43803c6a]{border:1px solid #000;text-align:center}.title[data-v-43803c6a]{font-family:FSBrabo,serif;font-weight:400;font-style:normal;font-family:FSBrabo,serif;font-weight:400;font-style:normal;padding:0 1rem}@media screen and (max-width:34.375em){.title[data-v-43803c6a]{font-size:2.2rem;margin-bottom:2rem}}@media screen and (min-width:34.4375em) and (max-width:50em){.title[data-v-43803c6a]{font-size:2.4rem;margin-bottom:3rem}}@media screen and (min-width:50.0625em){.title[data-v-43803c6a]{font-size:2.6rem;margin-bottom:4rem}}.description[data-v-43803c6a]{font-family:FSBrabo,serif;font-weight:400;font-style:normal;font-size:1.7rem;line-height:1.6;margin:0 auto 4rem}.cta[data-v-43803c6a]{padding-right:3rem;padding-left:3rem}@media screen and (max-width:34.375em){.box-type-1[data-v-43803c6a]{padding:4rem 2rem}.cta[data-v-43803c6a]{width:100%}}@media screen and (min-width:34.4375em){.box-type-1[data-v-43803c6a]{padding:5rem 3rem}.description[data-v-43803c6a]{max-width:60rem}}@media screen and (min-width:50.0625em){.box-type-1[data-v-43803c6a]{padding:5rem 4rem 6rem}.description[data-v-43803c6a]{margin-bottom:3rem}}@media screen and (min-width:50.0625em) and (max-width:62.5em){.cta[data-v-43803c6a]{width:100%;max-width:40rem}}@media screen and (min-width:62.5625em){.description[data-v-43803c6a]{max-width:77rem}}.hasBackground[data-v-15ec5eca]{background-color:rgba(0,0,0,.1)}.inner[data-v-15ec5eca]{max-width:117em;margin:0 auto;box-sizing:border-box;padding:0 2em;position:relative}@media screen and (max-width:34.375em){.inner[data-v-15ec5eca]{padding:0 1.5em}.inner .aside[data-v-15ec5eca]{margin-bottom:5rem}}@media screen and (min-width:34.4375em){.inner[data-v-15ec5eca]{padding:0 2em}.inner .aside[data-v-15ec5eca]{margin-bottom:5rem}.inner .main .inner[data-v-15ec5eca]{max-width:60em;margin:0 auto}}@media screen and (min-width:62.5625em){.inner .wrap[data-v-15ec5eca]{display:table;width:100%}.inner .aside[data-v-15ec5eca]{display:table-cell;vertical-align:top;width:27em;padding-left:2em}.inner .aside .track[data-v-15ec5eca]{transition:top .2s ease-in .3s;transform:translate3d(0,0,0);position:sticky;top:2rem}.inner .main[data-v-15ec5eca]{display:table-cell;vertical-align:top}.inner .main .inner[data-v-15ec5eca]{max-width:68em;margin:0 auto}}.title[data-v-15ec5eca]{font-family:FSBrabo,serif;font-weight:400;font-style:normal;text-align:center}@media screen and (max-width:34.375em){.title[data-v-15ec5eca]{font-size:2.2rem;margin-bottom:2rem}}@media screen and (min-width:34.4375em) and (max-width:50em){.title[data-v-15ec5eca]{font-size:2.4rem;margin-bottom:3rem}}@media screen and (min-width:50.0625em){.title[data-v-15ec5eca]{font-size:2.6rem;margin-bottom:4rem}}.book-item[data-v-15ec5eca],.chapter-item[data-v-15ec5eca]{width:25.25rem;padding:0 1.5rem}.cta-list[data-v-15ec5eca]{font-family:'Relative Faux',sans-serif;font-weight:400;font-style:normal;font-size:1.6em;line-height:1.6;position:absolute;top:7.2rem;right:3.2rem}.cta-list .cta[data-v-15ec5eca]{position:relative;color:#e10000;margin-left:3rem}.cta-list .cta[data-v-15ec5eca]:after{content:"";position:absolute;left:0;right:0;bottom:0;top:0;background-image:linear-gradient(to right,#e10000 0,#e10000 100%);background-repeat:repeat-x;background-position:0 90%;background-size:100% 1px}.cta-list .cta[data-v-15ec5eca]:before{content:"\E903";font-family:intech;font-size:.6em;position:absolute;right:-1.5em;top:50%;bottom:0;margin-top:-.8rem}.cta-list .cta[data-v-15ec5eca]:hover{color:#870000}.cta-list .cta[data-v-15ec5eca]:hover:after{background-image:linear-gradient(to right,#ae0000 0,#ae0000 100%)}.cta-list .cta[data-v-15ec5eca]:before{margin-top:-.5rem}@media screen and (max-width:34.375em){.inner[data-v-15ec5eca]{padding:5rem 1.5rem}}@media screen and (max-width:56.25em){.title[data-v-15ec5eca]{margin-bottom:6rem}.cta-list[data-v-15ec5eca]{top:9rem}}@media screen and (min-width:34.4375em) and (max-width:50em){.inner[data-v-15ec5eca]{padding:6rem 2rem}}@media screen and (min-width:50.0625em){.inner[data-v-15ec5eca]{padding:7rem 2rem 6rem}}@media screen and (min-width:62.5625em){.cta-list[data-v-15ec5eca]{right:2rem}.cta-list .cta[data-v-15ec5eca]{margin-left:4rem}}.VueCarousel-slide{text-align:center}.VueCarousel-navigation-button{z-index:10;top:11.5em!important;border:0;border-radius:2px;background-color:#fffad2;box-shadow:0 6px 12px 0 rgba(0,0,0,.1)}.smallSlider .VueCarousel-navigation-button{top:5.5em!important}.VueCarousel-navigation-button .icr{color:#e10000;font-size:2em}.VueCarousel-navigation-button:hover .icr{color:#870000}.VueCarousel-navigation-next,.VueCarousel-navigation-prev{transform:translateY(0) translateX(0)!important}.VueCarousel-navigation-prev .icr{transform:rotate(180deg)}.VueCarousel-navigation--disabled{display:none}.book-item[data-v-6ee8567d]{display:inline-block;text-align:center;vertical-align:top}.cover-wrap[data-v-6ee8567d]{max-width:20rem;margin:0 auto}.title[data-v-6ee8567d]{font-family:FSBrabo,serif;font-weight:400;font-style:normal;font-size:1.7em;line-height:1.5;margin:2rem auto 1.5rem;max-width:27rem;box-sizing:border-box;white-space:normal}.edited[data-v-6ee8567d]{font-size:1.6em;font-style:italic;max-width:27rem;white-space:normal;margin:0 auto}.edited a[data-v-6ee8567d]{color:#000;text-decoration:underline}.edited a[data-v-6ee8567d]:hover{color:#870000}.tag[data-v-6ee8567d]{font-family:'Relative Faux',sans-serif;font-weight:400;font-style:normal;font-size:1.3em;line-height:1.69231em;color:#fffad2;padding:1px .76923em 0;background:#e10000;border-radius:2px;display:inline-block;margin-top:1.5rem}.tag[data-v-6ee8567d]:hover{background:#b40000}.ofs[data-v-3c1b22ea]{background:rgba(0,0,0,.1);padding:4rem 0}.inner[data-v-3c1b22ea]{max-width:117em;margin:0 auto;box-sizing:border-box;padding:0 2em}@media screen and (max-width:34.375em){.inner[data-v-3c1b22ea]{padding:0 1.5em}}@media screen and (min-width:34.4375em){.inner[data-v-3c1b22ea]{padding:0 2em}}.title[data-v-3c1b22ea]{font-family:FSBrabo,serif;font-weight:400;font-style:normal}@media screen and (max-width:34.375em){.title[data-v-3c1b22ea]{font-size:2.2rem;margin-bottom:2rem}}@media screen and (min-width:34.4375em) and (max-width:50em){.title[data-v-3c1b22ea]{font-size:2.4rem;margin-bottom:3rem}}@media screen and (min-width:50.0625em){.title[data-v-3c1b22ea]{font-size:2.6rem;margin-bottom:4rem}}.calling .sub-title[data-v-3c1b22ea]{font-family:FSBrabo,serif;font-weight:400;font-style:normal;margin-bottom:2rem}@media screen and (max-width:50em){.calling .sub-title[data-v-3c1b22ea]{font-size:2rem}}@media screen and (min-width:50.0625em){.calling .sub-title[data-v-3c1b22ea]{font-size:2.2rem}}.calling .description[data-v-3c1b22ea]{font-size:1.7rem;line-height:1.6;margin-bottom:3rem}.calling .link[data-v-3c1b22ea]{position:relative;color:#e10000;font-size:1.6em;line-height:2;display:inline-block;margin-bottom:4rem}.calling .link[data-v-3c1b22ea]:after{content:"";position:absolute;left:0;right:0;bottom:0;top:0;background-image:linear-gradient(to right,#e10000 0,#e10000 100%);background-repeat:repeat-x;background-position:0 90%;background-size:100% 1px}.calling .link[data-v-3c1b22ea]:before{content:"\E903";font-family:intech;font-size:.6em;position:absolute;right:-1.5em;top:50%;bottom:0;margin-top:-.8rem}.calling .link[data-v-3c1b22ea]:hover{color:#870000}.calling .link[data-v-3c1b22ea]:hover:after{background-image:linear-gradient(to right,#ae0000 0,#ae0000 100%)}.calling .cta[data-v-3c1b22ea]{width:100%;max-width:37rem}.books-list[data-v-3c1b22ea] .inner{padding:0}.books-list[data-v-3c1b22ea] .prev{left:-1.5em}.books-list[data-v-3c1b22ea] .next{right:-2em}@media screen and (max-width:34.375em){.ofs[data-v-3c1b22ea]{padding:6rem 0 3rem}}@media screen and (min-width:34.4375em) and (max-width:62.5em){.ofs[data-v-3c1b22ea]{padding:6rem 0 3rem}}@media screen and (max-width:62.5em){.calling[data-v-3c1b22ea]{text-align:center}.books[data-v-3c1b22ea]{text-align:center;margin-top:4rem}.title[data-v-3c1b22ea]{margin-bottom:3rem}}@media screen and (min-width:62.5625em){.inner[data-v-3c1b22ea]{position:relative}.inner[data-v-3c1b22ea]:before{content:"";position:absolute;top:0;left:49rem;bottom:0;width:1px;background:#000}.calling[data-v-3c1b22ea]{width:47rem;box-sizing:border-box;float:left;padding:3rem 10rem 0 0}.books[data-v-3c1b22ea]{width:calc(100% - 470px);box-sizing:border-box;float:left;padding:3rem 0 0 3rem}.books .books-list[data-v-3c1b22ea]{margin:0 5rem 0 -2.9rem}.books[data-v-3c1b22ea] .VueCarousel-navigation-prev{left:2rem!important}.books[data-v-3c1b22ea] .VueCarousel-navigation-next{right:-3rem!important}}.footer[data-v-21365b21]{background:#000;color:#fffad2}.inner[data-v-21365b21]{max-width:117em;margin:0 auto;box-sizing:border-box;padding:0 2em}@media screen and (max-width:34.375em){.inner[data-v-21365b21]{padding:0 1.5em}.inner .aside[data-v-21365b21]{margin-bottom:5rem}}@media screen and (min-width:34.4375em){.inner[data-v-21365b21]{padding:0 2em}.inner .aside[data-v-21365b21]{margin-bottom:5rem}.inner .main .inner[data-v-21365b21]{max-width:60em;margin:0 auto}}@media screen and (min-width:62.5625em){.inner .wrap[data-v-21365b21]{display:table;width:100%}.inner .aside[data-v-21365b21]{display:table-cell;vertical-align:top;width:27em;padding-left:2em}.inner .aside .track[data-v-21365b21]{transition:top .2s ease-in .3s;transform:translate3d(0,0,0);position:sticky;top:2rem}.inner .main[data-v-21365b21]{display:table-cell;vertical-align:top}.inner .main .inner[data-v-21365b21]{max-width:68em;margin:0 auto}}.title[data-v-21365b21]{font-family:'Relative Faux',sans-serif;font-weight:400;font-style:normal;color:#fffad2;font-size:1.6em;line-height:1.3;display:block;margin-bottom:1.5rem}.title[data-v-21365b21]:hover{text-decoration:underline}.link[data-v-21365b21]{font-family:'Relative Faux',sans-serif;font-weight:400;font-style:normal;color:#fffad2;font-size:1.4em;line-height:1.6;display:block;margin-bottom:1.5rem}.link[data-v-21365b21]:hover{text-decoration:underline}.icr[data-v-21365b21]{display:inline-block;font-size:2em;left:0;margin-right:.5rem}.icr[data-v-21365b21]:last-child{margin-right:0}.address[data-v-21365b21],.meta[data-v-21365b21]{font-family:'Relative Faux',sans-serif;font-weight:400;font-style:normal;font-size:1.4em;line-height:1.7;color:#fff}.address[data-v-21365b21]{margin:3rem 0 2rem}.meta[data-v-21365b21]{margin-bottom:2rem}.search-wrap[data-v-21365b21]{margin:4rem 0}.search-term[data-v-21365b21] input{padding:.8rem 4rem .8rem 1.5rem}.legal-wrap[data-v-21365b21]{font-family:'Relative Faux',sans-serif;font-weight:400;font-style:normal;font-size:1.3rem;line-height:1.85;padding:2rem 0;border-top:1px solid #666}.legal-nav li[data-v-21365b21]{display:inline-block}.legal-nav li a[data-v-21365b21]{color:#fffad2;padding:0 1rem;border-right:1px solid #666}.legal-nav li a[data-v-21365b21]:hover{text-decoration:underline}.legal-nav li:last-child a[data-v-21365b21]{border:none;padding-right:0}.copyright[data-v-21365b21]{color:#fff}@media screen and (max-width:34.375em){.inner[data-v-21365b21]{padding-top:5rem}.link[data-v-21365b21]:not(.mail){display:none}.title[data-v-21365b21]{font-size:1.5em}.nav-box[data-v-21365b21]{width:50%;float:left;box-sizing:border-box}.nav-box[data-v-21365b21]:last-child{clear:both;width:100%}.social-wrap[data-v-21365b21]{margin:2rem 0 4rem;text-align:center}.icr[data-v-21365b21]{margin-right:2rem}.address[data-v-21365b21]{width:50%;float:left;margin:0}.meta-wrap[data-v-21365b21]{width:50%;float:right;box-sizing:border-box;padding-left:2rem}.meta[data-v-21365b21]{margin-bottom:1rem}.search-term[data-v-21365b21]{width:100%}.search-term[data-v-21365b21] input{font-size:2em;width:100%}.cta[data-v-21365b21]{display:block;margin-top:3rem}.legal-wrap[data-v-21365b21]{text-align:center}.legal-nav[data-v-21365b21]{max-width:30rem;margin:0 auto}.legal-nav li[data-v-21365b21]{margin-bottom:2rem}}@media screen and (min-width:34.4375em){.legal-nav[data-v-21365b21]{float:right}.cta[data-v-21365b21]{float:right;width:25%}}@media screen and (min-width:34.4375em) and (max-width:50em){.inner[data-v-21365b21]{padding-top:6rem}.nav-box[data-v-21365b21]{width:calc(100% / 3);float:left;box-sizing:border-box}.nav-box[data-v-21365b21]:last-child{clear:both;width:100%;margin-top:5rem}.icr[data-v-21365b21]{margin-right:.3rem}.social-wrap[data-v-21365b21]{width:calc(100% / 3);float:right}.company-info-wrap[data-v-21365b21]{width:calc((100% / 3)*2);float:left}.address[data-v-21365b21]{width:50%;float:left;margin:0}.meta-wrap[data-v-21365b21]{width:50%;float:right}.search-wrap[data-v-21365b21]{margin:5rem 0}.cta[data-v-21365b21]{width:calc(100% /3)}}@media screen and (min-width:50.0625em){.inner[data-v-21365b21]{padding-top:8rem}.nav-box[data-v-21365b21]{width:25%;float:left;box-sizing:border-box}.nav-box[data-v-21365b21]:first-of-type{padding-left:0}.nav-box[data-v-21365b21]:last-of-type{padding-right:0}}@media screen and (min-width:62.5625em){.icr[data-v-21365b21]{margin-right:2rem}}.book-subject-area[data-v-3339c76d]{background-color:#e10000;color:#fffad2}.book-subject-area .inner[data-v-3339c76d]{max-width:117em;margin:0 auto;box-sizing:border-box;padding:0 2em}@media screen and (max-width:34.375em){.book-subject-area .inner[data-v-3339c76d]{padding:0 1.5em}.book-subject-area .inner .aside[data-v-3339c76d]{margin-bottom:5rem}}@media screen and (min-width:34.4375em){.book-subject-area .inner[data-v-3339c76d]{padding:0 2em}.book-subject-area .inner .aside[data-v-3339c76d]{margin-bottom:5rem}.book-subject-area .inner .main .inner[data-v-3339c76d]{max-width:60em;margin:0 auto}}@media screen and (min-width:62.5625em){.book-subject-area .inner .wrap[data-v-3339c76d]{display:table;width:100%}.book-subject-area .inner .aside[data-v-3339c76d]{display:table-cell;vertical-align:top;width:27em;padding-left:2em}.book-subject-area .inner .aside .track[data-v-3339c76d]{transition:top .2s ease-in .3s;transform:translate3d(0,0,0);position:sticky;top:2rem}.book-subject-area .inner .main[data-v-3339c76d]{display:table-cell;vertical-align:top}.book-subject-area .inner .main .inner[data-v-3339c76d]{max-width:68em;margin:0 auto}}.book-subject-area .title[data-v-3339c76d]{font-family:FSBrabo,serif;font-weight:400;font-style:normal;font-family:FSBrabo,serif;font-weight:400;font-style:normal;text-align:center;margin-bottom:5rem}@media screen and (max-width:34.375em){.book-subject-area .title[data-v-3339c76d]{font-size:2.2rem;margin-bottom:2rem}}@media screen and (min-width:34.4375em) and (max-width:50em){.book-subject-area .title[data-v-3339c76d]{font-size:2.4rem;margin-bottom:3rem}}@media screen and (min-width:50.0625em){.book-subject-area .title[data-v-3339c76d]{font-size:2.6rem;margin-bottom:4rem}}.book-subject-area .sub-title[data-v-3339c76d]{color:#fffad2;font-family:FSBrabo,serif;font-weight:700;font-style:normal;font-size:1.7rem;line-height:1.6;display:block;margin-bottom:2rem}.book-subject-area .sub-title[data-v-3339c76d]:hover{text-decoration:underline}.book-subject-area .link[data-v-3339c76d]{color:#fffad2;font-family:FSBrabo,serif;font-weight:400;font-style:normal;font-size:1.7rem;line-height:1.6;display:block;margin-bottom:1.5rem}.book-subject-area .link[data-v-3339c76d]:hover{text-decoration:underline}.book-subject-area .link-more[data-v-3339c76d]{color:#fffad2;font-family:FSBrabo,serif;font-weight:400;font-style:normal;font-size:1.6em;line-height:1.5;padding-left:0}.book-subject-area .link-more[data-v-3339c76d]:hover{text-decoration:underline}.book-subject-area .link-more[data-v-3339c76d]:before{font-size:.6em;right:-3em;left:inherit}.book-subject-area .view-all[data-v-3339c76d]{font-family:FSBrabo,serif;font-weight:400;font-style:normal;position:relative;color:#fffad2;font-size:1.6em;line-height:1.5;padding-left:0}.book-subject-area .view-all[data-v-3339c76d]:after{content:"";position:absolute;left:0;right:0;bottom:0;top:0;background-image:linear-gradient(to right,#fffad2 0,#fffad2 100%);background-repeat:repeat-x;background-position:0 90%;background-size:100% 1px}.book-subject-area .view-all[data-v-3339c76d]:hover:after{display:none}.book-subject-area .view-all[data-v-3339c76d]:before{font-size:.6em;right:-3em;left:inherit}@media screen and (max-width:34.375em){.book-subject-area[data-v-3339c76d]{padding-top:5rem;padding-bottom:5rem}.book-subject-area .title[data-v-3339c76d]{margin-bottom:5rem}}@media screen and (min-width:34.4375em) and (max-width:50em){.book-subject-area[data-v-3339c76d]{padding-top:6rem;padding-bottom:6rem}.book-subject-area .title[data-v-3339c76d]{margin-bottom:5rem}}@media screen and (max-width:50em){.book-subject-area .sub-title[data-v-3339c76d]{margin-bottom:3rem}.book-subject-area .link-more[data-v-3339c76d],.book-subject-area .link[data-v-3339c76d]{display:none}.book-subject-area .view-all[data-v-3339c76d]{display:table;margin:0 auto}}@media screen and (min-width:50.0625em){.book-subject-area[data-v-3339c76d]{padding-top:7rem;padding-bottom:8rem}.book-subject-area .inner[data-v-3339c76d]{position:relative}.book-subject-area .title[data-v-3339c76d]{margin-bottom:5rem}.book-subject-area .sub-title[data-v-3339c76d]{min-height:5rem}.book-subject-area .box[data-v-3339c76d]{width:25%;float:left;box-sizing:border-box;padding:0 1.5rem}.book-subject-area .box[data-v-3339c76d]:first-of-type{padding-left:0}.book-subject-area .box[data-v-3339c76d]:last-of-type{padding-right:0}.book-subject-area .box .link[data-v-3339c76d]{display:none}.book-subject-area .box .link[data-v-3339c76d]:nth-child(2),.book-subject-area .box .link[data-v-3339c76d]:nth-child(3),.book-subject-area .box .link[data-v-3339c76d]:nth-child(4){display:block}.book-subject-area .box.show-all .link[data-v-3339c76d]{display:block}.book-subject-area .view-all[data-v-3339c76d]{position:absolute;right:3rem;top:5px}}</style></head><body><div id="app"><div id="app" data-server-rendered="true"><div data-v-76acb989><header id="page-header" class="page-header" data-v-58e00f46 data-v-76acb989><!----><!----><div class="wrap" data-v-58e00f46><a href="/" class="router-link-active" data-v-58e00f46><img src="//cdnintech.com/web/frontend/www/assets/svg/logo.svg" alt="IntechOpen" class="branding" data-v-58e00f46></a><nav class="site-nav" data-v-58e00f46><ul data-v-58e00f46><li data-v-58e00f46><a href="/books" class="nav-item router-link-active" data-v-58e00f46>Books</a></li><li data-v-58e00f46><a href="/publish" class="nav-item" data-v-58e00f46>Publish</a><!----></li><li data-v-58e00f46><a href="/about-intechopen" class="nav-item" data-v-58e00f46>About</a><!----></li><li data-v-58e00f46><a href="/news" class="nav-item" data-v-58e00f46>News</a><!----></li><li data-v-58e00f46><a href="/page/contact-us" class="nav-item" data-v-58e00f46>Contact</a><!----></li></ul></nav><aside class="aside" data-v-58e00f46><ul data-v-58e00f46><li data-v-58e00f46><a href="//mts.intechopen.com/account/login" target="_blank" class="nav-item" data-v-58e00f46>Author Panel Sign in</a></li></ul><form class="search-term" data-v-36b4823c data-v-58e00f46><input placeholder="Search" required="required" value="" data-v-36b4823c><button type="submit" class="icr iconSearch" data-v-36b4823c>Submit</button></form></aside><div class="nav-dropdown collapsed" data-v-58e00f46><div class="inner" data-v-58e00f46><div class="drop-box" data-v-58e00f46><a href="/how-open-access-publishing-with-intechopen-works" class="drop-item" data-v-58e00f46>What is Open Access?</a><p data-v-58e00f46>Open Access is an initiative that aims to make scientific research freely available to all. To date our community has made over 100 million downloads. Its based on principles of collaboration, unobstructed discovery, and, most importantly, scientific progression. As PhD students, we found it difficult to access the research we needed, so we decided to create a new Open Access publisher that levels the playing field for scientists across the world. How? By making research easy to access, and puts the academic needs of the researchers before the business interests of publishers.</p></div><div class="drop-box" data-v-58e00f46><a href="/authors-and-editors" class="drop-item" data-v-58e00f46>Our authors and editors</a><p data-v-58e00f46>We are a community of more than 103,000 authors and editors from 3,291 institutions spanning 160 countries, including Nobel Prize winners and some of the worlds most-cited researchers. Publishing on IntechOpen allows authors to earn citations and find new collaborators, meaning more people see your work not only from your own field of study, but from other related fields too.</p></div><div class="drop-box" data-v-58e00f46><a href="/page/content-alerts" class="drop-item" data-v-58e00f46>Content Alerts</a><p data-v-58e00f46>Brief introduction to this section that descibes Open Access especially from an IntechOpen perspective</p><a href="/how-open-access-publishing-with-intechopen-works" class="nav-item" data-v-58e00f46>How it works</a><a href="#" class="nav-item" data-v-58e00f46>Manage preferences</a></div><div class="drop-box" data-v-58e00f46><a href="/page/contact-us" class="drop-item" data-v-58e00f46>Contact</a><p data-v-58e00f46>Want to get in touch? Contact our London head office or <a href="#" data-v-58e00f46>media team here</a></p><a href="/page/careers-at-intechopen" class="drop-item" data-v-58e00f46>Careers</a><p data-v-58e00f46>Our team is growing all the time, so were always on the lookout for smart people who want to help us reshape the world of scientific publishing.</p></div></div></div></div></header><section data-v-6083f38b data-v-76acb989><div class="breadcrumbs" data-v-fe8ce696 data-v-6083f38b><div class="wrap" data-v-fe8ce696><p data-v-fe8ce696><a href="/" class="router-link-active" data-v-6083f38b>Home</a> &gt; <a href="/books" class="router-link-active" data-v-6083f38b>Books</a> &gt; <a href="/books/subject/numerical-analysis-and-scientific-computing-neural-network" class="capitalize" data-v-6083f38b>Neural Network</a></p></div></div><div class="book-intro" data-v-14995c67 data-v-6083f38b><div class="cf" data-v-14995c67><div class="book-details" data-v-14995c67><p class="leadTitle" data-v-14995c67>Open access peer-reviewed Edited Volume</p><!----><h1 class="title" data-v-14995c67>Artificial Neural Networks</h1><p class="subTitle" data-v-14995c67>Methodological Advances and Biomedical Applications</p><div class="author cf" data-v-7ba456ce data-v-14995c67><figure class="profile-img filter" data-v-4eaadae2 data-v-7ba456ce><span class="lazy-image ar2" data-v-d261b71c data-v-4eaadae2><!----></span></figure><!----><!----><a href="/profiles/3095/kenji-suzuki" class="edited-by" data-v-7ba456ce>Edited by Kenji Suzuki</a><!----><p class="author-position" data-v-7ba456ce>University of Chicago<span data-v-7ba456ce>, United States of America</span></p></div><!----><!----><!----><!----><!----><!----><!----><p aria-hidden="true" class="description" data-v-14995c67>Artificial neural networks may probably be the single most successful technology in the last two decades which has been widely used in a large variety of applications in various areas. The purpose of this book is to provide recent advances of artificial neural networks in biomedical applications. The book begins with fundamentals of artificial neural networks, which cover an introduction, design...</p><p class="description hide" data-v-14995c67>Artificial neural networks may probably be the single most successful technology in the last two decades which has been widely used in a large variety of applications in various areas. The purpose of this book is to provide recent advances of artificial neural networks in biomedical applications. The book begins with fundamentals of artificial neural networks, which cover an introduction, design, and optimization. Advanced architectures for biomedical applications, which offer improved performance and desirable properties, follow. Parts continue with biological applications such as gene, plant biology, and stem cell, medical applications such as skin diseases, sclerosis, anesthesia, and physiotherapy, and clinical and other applications such as clinical outcome, telecare, and pre-med student failure prediction. Thus, this book will be a fundamental source of recent advances and applications of artificial neural networks in biomedical areas. The target audience includes professors and students in engineering and medical schools, researchers and engineers in biomedical industries, medical doctors, and healthcare professionals.</p><a class="cta-toggle link-type-2" data-v-14995c67>Read more &gt;</a><a class="cta button-type-1" data-v-14995c67>Order hardcopy</a></div><div class="book-cover-box cf" data-v-14995c67><figure class="cover-wrap middle" data-v-51685050 data-v-14995c67><a href="/books/artificial-neural-networks-methodological-advances-and-biomedical-applications" class="router-link-exact-active router-link-active" data-v-51685050><span class="lazy-image ar1" data-v-d261b71c data-v-51685050><!----></span><svg viewBox="0 0 300 270" preserveAspectRatio="xMidYMid meet" class="svg" data-v-51685050><rect width="300" height="270" style="fill:#e10000" data-v-51685050></rect><text x="150" y="35" font-family="Arial" text-anchor="middle" fill="#fffad2" font-size="12" data-v-51685050>IntechOpen</text><g transform="translate(140, 220)" fill="#FFFAD2" data-v-51685050><g transform="scale(0.7)" data-v-51685050><path d="M18.4091275,7.09361268 L3.66754648,15.3478697 C2.61853239,15.939493 1.9668669,17.0549331 1.9668669,18.2588838 L1.9668669,33.0542958 L0.869542958,32.6455599 C0.346761268,32.4507676 -3.45070423e-05,31.9516232 -3.45070423e-05,31.3936444 L-3.45070423e-05,1.37079225 C-3.45070423e-05,0.417880282 0.94908169,-0.243792254 1.84298662,0.08575 L18.3356275,6.16347535 C18.7472965,6.3151338 18.791638,6.87932394 18.4091275,7.09361268 M38.2955359,22.6833768 C38.178212,23.1238592 37.8226169,23.4794542 37.382307,23.5967782 C36.3688352,23.8671408 35.4695817,22.9675423 35.7401169,21.9540704 C35.8576134,21.5139331 36.2132085,21.158338 36.6536908,21.0411866 C37.6666451,20.7715141 38.565381,21.6704225 38.2955359,22.6833768 M48.0927754,30.247493 C47.5629197,30.0078415 46.9350641,30.1798592 46.5494479,30.614993 L46.5221873,30.6455317 C45.2633704,32.0789542 43.7110711,33.1881831 41.9971063,33.9233556 C41.9917577,33.9255986 41.9971063,22.341757 41.9971063,22.341757 C41.9971063,13.8637218 35.1127789,6.99078169 26.6345711,6.99078169 C24.2718739,6.99078169 21.8610394,7.48388732 19.7830254,8.63297183 C17.9817577,9.62901761 7.46211338,15.5312746 4.66255704,17.1022077 C4.23846549,17.3401338 3.97845493,17.7871725 3.97845493,18.2733768 L3.97845493,47.5848662 C3.97845493,48.5941972 5.06456408,49.230507 5.9451838,48.7372289 L19.0174866,41.4119014 C19.4345042,41.1781162 19.6927894,40.7374613 19.6927894,40.2593662 L19.6927894,17.7378275 C19.6927894,17.2512782 20.0211239,16.8006162 20.5000817,16.7141761 C21.1293176,16.6008204 21.6765993,17.0811585 21.6765993,17.6893451 L21.6765993,22.2984507 L21.6821204,22.287581 C21.6821204,22.2912042 21.6817754,22.2948275 21.6817754,22.2984507 C21.6817754,30.752331 28.5590289,37.6295845 37.0127366,37.6295845 C37.7863845,37.6295845 38.5527859,37.5676444 39.3076275,37.4532535 L39.3076275,47.5686479 C39.3076275,48.3079613 39.9071873,48.9076937 40.6466732,48.9076937 C41.3859866,48.9076937 41.9853739,48.3079613 41.9853739,47.5686479 L41.9853739,36.796757 C44.484719,35.9396021 46.7488986,34.4454472 48.5267014,32.4212641 L48.5669021,32.3755423 C49.1533493,31.7199085 48.9746028,30.6460493 48.0927754,30.247493" data-v-51685050></path></g></g></svg><div class="text" style="font-size:150em" data-v-51685050><span class="title" data-v-51685050>Artificial Neural Networks</span><span class="sub-title" data-v-51685050>Methodological Advances and Biomedical Applications</span><span class="editors" data-v-51685050>Edited by Kenji Suzuki</span></div></a></figure><div class="book-meta" data-v-14995c67><p data-v-14995c67>Published: April 11th 2011</p><p data-v-14995c67>DOI: 10.5772/644</p><p data-v-14995c67>ISBN: 978-953-307-243-2</p><!----><p data-v-14995c67>Copyright year: 2011</p></div></div><!----><!----></div></div><div id="statistics" class="book-statistics" data-v-bdfa72c6 data-v-6083f38b><a href="/open-for-submissions" class="link" data-v-bdfa72c6>Books open for chapter submissions</a><div class="stats cf" data-v-48a702c7 data-v-bdfa72c6><p class="item" data-v-48a702c7><span data-v-48a702c7>85986</span> Total Chapter Downloads</p><p class="item" data-v-48a702c7><span data-v-48a702c7>115</span> Crossref Citations</p><p class="item" data-v-48a702c7><span data-v-48a702c7>124</span> Web of Science Citations</p><p class="item" data-v-48a702c7><span data-v-48a702c7>266</span> Dimensions Citations</p><p class="item" data-v-48a702c7><span data-badge-popover="top" data-badge-type="medium-donut" data-doi="10.5772/644" data-hide-no-mentions="true" class="altmetric-embed" data-v-48a702c7></span></p></div></div><div id="chapters" class="chapters" data-v-3aa59521 data-v-6083f38b><table class="chapters-table" data-v-3aa59521><tr class="table-header" data-v-3aa59521><th class="title" data-v-3aa59521>chapters</th><th class="subTitle" data-v-3aa59521></th><th class="subTitle" data-v-3aa59521>Downloads</th></tr><tbody data-v-3aa59521><tr class="table-row" data-v-3aa59521><td class="chapter-name" data-v-3aa59521><p class="leadTitle" data-v-3aa59521>Open access peer-reviewed</p><a href="/books/artificial-neural-networks-methodological-advances-and-biomedical-applications/introduction-to-the-artificial-neural-networks" class="linkType1" data-v-3aa59521>1. Introduction to the Artificial Neural Networks</a><p class="chapter-editors" data-v-3aa59521><span data-v-3aa59521>By Andrej Krenker, Janez Bester and Andrej Kos</span></p><!----><!----></td><td class="chapter-data" data-v-3aa59521><span data-doi="10.5772/15751" data-hide-zero-citations="true" data-legend="hover-top" data-style="large_rectangle" class="__dimensions_badge_embed__" data-v-3aa59521></span></td><td class="chapter-data" data-v-3aa59521>24927</td></tr></tbody><tbody data-v-3aa59521><tr class="table-row" data-v-3aa59521><td class="chapter-name" data-v-3aa59521><p class="leadTitle" data-v-3aa59521>Open access peer-reviewed</p><a href="/books/artificial-neural-networks-methodological-advances-and-biomedical-applications/review-of-input-variable-selection-methods-for-artificial-neural-networks" class="linkType1" data-v-3aa59521>2. Review of Input Variable Selection Methods for Artificial Neural Networks</a><p class="chapter-editors" data-v-3aa59521><span data-v-3aa59521>By Robert May, Graeme Dandy and Holger Maier</span></p><!----><!----></td><td class="chapter-data" data-v-3aa59521><span data-doi="10.5772/16004" data-hide-zero-citations="true" data-legend="hover-top" data-style="large_rectangle" class="__dimensions_badge_embed__" data-v-3aa59521></span></td><td class="chapter-data" data-v-3aa59521>8329</td></tr></tbody><tbody data-v-3aa59521><tr class="table-row" data-v-3aa59521><td class="chapter-name" data-v-3aa59521><p class="leadTitle" data-v-3aa59521>Open access peer-reviewed</p><a href="/books/artificial-neural-networks-methodological-advances-and-biomedical-applications/artificial-neural-networks-and-efficient-optimization-techniques-for-applications-in-engineering" class="linkType1" data-v-3aa59521>3. Artificial Neural Networks and Efficient Optimization Techniques for Applications in Engineering</a><p class="chapter-editors" data-v-3aa59521><span data-v-3aa59521>By Rossana M. S. Cruz, Helton M. Peixoto and Rafael M. Magalhaes</span></p><!----><!----></td><td class="chapter-data" data-v-3aa59521><span data-doi="10.5772/15293" data-hide-zero-citations="true" data-legend="hover-top" data-style="large_rectangle" class="__dimensions_badge_embed__" data-v-3aa59521></span></td><td class="chapter-data" data-v-3aa59521>4843</td></tr></tbody><tbody data-v-3aa59521><tr class="table-row" data-v-3aa59521><td class="chapter-name" data-v-3aa59521><p class="leadTitle" data-v-3aa59521>Open access peer-reviewed</p><a href="/books/artificial-neural-networks-methodological-advances-and-biomedical-applications/pixel-based-artificial-neural-networks-in-computer-aided-diagnosis" class="linkType1" data-v-3aa59521>4. Pixel-Based Artificial Neural Networks in Computer-Aided Diagnosis</a><p class="chapter-editors" data-v-3aa59521><span data-v-3aa59521>By Kenji Suzuki</span></p><!----><!----></td><td class="chapter-data" data-v-3aa59521><span data-doi="10.5772/16084" data-hide-zero-citations="true" data-legend="hover-top" data-style="large_rectangle" class="__dimensions_badge_embed__" data-v-3aa59521></span></td><td class="chapter-data" data-v-3aa59521>3284</td></tr></tbody><tbody data-v-3aa59521><tr class="table-row" data-v-3aa59521><td class="chapter-name" data-v-3aa59521><p class="leadTitle" data-v-3aa59521>Open access peer-reviewed</p><a href="/books/artificial-neural-networks-methodological-advances-and-biomedical-applications/applied-artificial-neural-networks-from-associative-memories-to-biomedical-applications" class="linkType1" data-v-3aa59521>5. Applied Artificial Neural Networks: from Associative Memories to Biomedical Applications</a><p class="chapter-editors" data-v-3aa59521><span data-v-3aa59521>By Mahmood Amiri and Katayoun Derakhshandeh</span></p><!----><!----></td><td class="chapter-data" data-v-3aa59521><span data-doi="10.5772/15325" data-hide-zero-citations="true" data-legend="hover-top" data-style="large_rectangle" class="__dimensions_badge_embed__" data-v-3aa59521></span></td><td class="chapter-data" data-v-3aa59521>3460</td></tr></tbody><tbody data-v-3aa59521><tr class="table-row" data-v-3aa59521><td class="chapter-name" data-v-3aa59521><p class="leadTitle" data-v-3aa59521>Open access peer-reviewed</p><a href="/books/artificial-neural-networks-methodological-advances-and-biomedical-applications/medical-image-segmentation-using-artificial-neural-networks" class="linkType1" data-v-3aa59521>6. Medical Image Segmentation Using Artificial Neural Networks</a><p class="chapter-editors" data-v-3aa59521><span data-v-3aa59521>By Mostafa Jabarouti Moghaddam and Hamid Soltanian-Zadeh</span></p><!----><!----></td><td class="chapter-data" data-v-3aa59521><span data-doi="10.5772/16103" data-hide-zero-citations="true" data-legend="hover-top" data-style="large_rectangle" class="__dimensions_badge_embed__" data-v-3aa59521></span></td><td class="chapter-data" data-v-3aa59521>7467</td></tr></tbody><tbody data-v-3aa59521><tr class="table-row" data-v-3aa59521><td class="chapter-name" data-v-3aa59521><p class="leadTitle" data-v-3aa59521>Open access peer-reviewed</p><a href="/books/artificial-neural-networks-methodological-advances-and-biomedical-applications/artificial-neural-networks-and-predictive-medicine-a-revolutionary-paradigm-shift" class="linkType1" data-v-3aa59521>7. Artificial Neural Networks and Predictive Medicine: a Revolutionary Paradigm Shift</a><p class="chapter-editors" data-v-3aa59521><span data-v-3aa59521>By Enzo Grossi</span></p><!----><!----></td><td class="chapter-data" data-v-3aa59521><span data-doi="10.5772/15810" data-hide-zero-citations="true" data-legend="hover-top" data-style="large_rectangle" class="__dimensions_badge_embed__" data-v-3aa59521></span></td><td class="chapter-data" data-v-3aa59521>2819</td></tr></tbody><tbody data-v-3aa59521><tr class="table-row" data-v-3aa59521><td class="chapter-name" data-v-3aa59521><p class="leadTitle" data-v-3aa59521>Open access peer-reviewed</p><a href="/books/artificial-neural-networks-methodological-advances-and-biomedical-applications/reputation-based-neural-network-combinations" class="linkType1" data-v-3aa59521>8. Reputation-Based Neural Network Combinations</a><p class="chapter-editors" data-v-3aa59521><span data-v-3aa59521>By Mohammad Nikjoo, Azadeh Kushki, Joon Lee, Catriona Steele and Tom Chau</span></p><!----><!----></td><td class="chapter-data" data-v-3aa59521><!----></td><td class="chapter-data" data-v-3aa59521>1879</td></tr></tbody><tbody data-v-3aa59521><tr class="table-row" data-v-3aa59521><td class="chapter-name" data-v-3aa59521><p class="leadTitle" data-v-3aa59521>Open access peer-reviewed</p><a href="/books/artificial-neural-networks-methodological-advances-and-biomedical-applications/prioritising-genes-with-an-artificial-neural-network-comprising-medical-documents-to-accelerate-posi" class="linkType1" data-v-3aa59521>9. Prioritising Genes with an Artificial Neural Network Comprising Medical Documents to Accelerate Positional Cloning in Biological Research</a><p class="chapter-editors" data-v-3aa59521><span data-v-3aa59521>By Norio Kobayashi and Tetsuro Toyoda</span></p><!----><!----></td><td class="chapter-data" data-v-3aa59521><span data-doi="10.5772/16135" data-hide-zero-citations="true" data-legend="hover-top" data-style="large_rectangle" class="__dimensions_badge_embed__" data-v-3aa59521></span></td><td class="chapter-data" data-v-3aa59521>1780</td></tr></tbody><tbody data-v-3aa59521><tr class="table-row" data-v-3aa59521><td class="chapter-name" data-v-3aa59521><p class="leadTitle" data-v-3aa59521>Open access peer-reviewed</p><a href="/books/artificial-neural-networks-methodological-advances-and-biomedical-applications/artificial-neural-networks-technology-to-model-and-predict-plant-biology-process" class="linkType1" data-v-3aa59521>10. Artificial Neural Networks Technology to Model and Predict Plant Biology Process</a><p class="chapter-editors" data-v-3aa59521><span data-v-3aa59521>By Pedro P. Gallego, Jorge Gago and Mariana Landin</span></p><!----><!----></td><td class="chapter-data" data-v-3aa59521><span data-doi="10.5772/14945" data-hide-zero-citations="true" data-legend="hover-top" data-style="large_rectangle" class="__dimensions_badge_embed__" data-v-3aa59521></span></td><td class="chapter-data" data-v-3aa59521>3782</td></tr></tbody><tbody data-v-3aa59521><tr class="table-row" data-v-3aa59521><td class="chapter-name" data-v-3aa59521><p class="leadTitle" data-v-3aa59521>Open access peer-reviewed</p><a href="/books/artificial-neural-networks-methodological-advances-and-biomedical-applications/the-usefulness-of-artificial-neural-networks-in-predicting-the-outcome-of-hematopoietic-stem-cell-tr" class="linkType1" data-v-3aa59521>11. The Usefulness of Artificial Neural Networks in Predicting the Outcome of Hematopoietic Stem Cell Transplantation</a><p class="chapter-editors" data-v-3aa59521><span data-v-3aa59521>By Giovanni Caocci, Roberto Baccoli and Giorgio La Nasa</span></p><!----><!----></td><td class="chapter-data" data-v-3aa59521><span data-doi="10.5772/16042" data-hide-zero-citations="true" data-legend="hover-top" data-style="large_rectangle" class="__dimensions_badge_embed__" data-v-3aa59521></span></td><td class="chapter-data" data-v-3aa59521>2702</td></tr></tbody><tbody data-v-3aa59521><tr class="table-row" data-v-3aa59521><td class="chapter-name" data-v-3aa59521><p class="leadTitle" data-v-3aa59521>Open access peer-reviewed</p><a href="/books/artificial-neural-networks-methodological-advances-and-biomedical-applications/artificial-neural-networks-and-retinal-ganglion-cell-responses" class="linkType1" data-v-3aa59521>12. Artificial Neural Networks and Retinal Ganglion Cell Responses</a><p class="chapter-editors" data-v-3aa59521><span data-v-3aa59521>By Maria P. Bonomini, Jose M. Ferrandez and Eduardo Fernandez</span></p><!----><!----></td><td class="chapter-data" data-v-3aa59521><span data-doi="10.5772/15954" data-hide-zero-citations="true" data-legend="hover-top" data-style="large_rectangle" class="__dimensions_badge_embed__" data-v-3aa59521></span></td><td class="chapter-data" data-v-3aa59521>2175</td></tr></tbody><tbody data-v-3aa59521><tr class="table-row" data-v-3aa59521><td class="chapter-name" data-v-3aa59521><p class="leadTitle" data-v-3aa59521>Open access peer-reviewed</p><a href="/books/artificial-neural-networks-methodological-advances-and-biomedical-applications/diagnosing-skin-diseases-using-an-artificial-neural-network" class="linkType1" data-v-3aa59521>13. Diagnosing Skin Diseases Using an Artificial Neural Network</a><p class="chapter-editors" data-v-3aa59521><span data-v-3aa59521>By Bakpo, F. S. and Kabari, L. G</span></p><!----><!----></td><td class="chapter-data" data-v-3aa59521><span data-doi="10.5772/16232" data-hide-zero-citations="true" data-legend="hover-top" data-style="large_rectangle" class="__dimensions_badge_embed__" data-v-3aa59521></span></td><td class="chapter-data" data-v-3aa59521>4550</td></tr></tbody><tbody data-v-3aa59521><tr class="table-row" data-v-3aa59521><td class="chapter-name" data-v-3aa59521><p class="leadTitle" data-v-3aa59521>Open access peer-reviewed</p><a href="/books/artificial-neural-networks-methodological-advances-and-biomedical-applications/artificial-neural-networks-used-to-study-the-evolution-of-the-multiple-sclerosis" class="linkType1" data-v-3aa59521>14. Artificial Neural Networks Used to Study the Evolution of the Multiple Sclerosis</a><p class="chapter-editors" data-v-3aa59521><span data-v-3aa59521>By Tabares Ospina and Hector Anibal</span></p><!----><!----></td><td class="chapter-data" data-v-3aa59521><!----></td><td class="chapter-data" data-v-3aa59521>2464</td></tr></tbody><tbody data-v-3aa59521><tr class="table-row" data-v-3aa59521><td class="chapter-name" data-v-3aa59521><p class="leadTitle" data-v-3aa59521>Open access peer-reviewed</p><a href="/books/artificial-neural-networks-methodological-advances-and-biomedical-applications/estimation-the-depth-of-anesthesia-by-the-use-of-artificial-neural-network" class="linkType1" data-v-3aa59521>15. Estimation the Depth of Anesthesia by the Use of Artificial Neural Network</a><p class="chapter-editors" data-v-3aa59521><span data-v-3aa59521>By Hossein Rabbani, Alireza Mehri Dehnavi and Mehrab Ghanatbari</span></p><!----><!----></td><td class="chapter-data" data-v-3aa59521><span data-doi="10.5772/15139" data-hide-zero-citations="true" data-legend="hover-top" data-style="large_rectangle" class="__dimensions_badge_embed__" data-v-3aa59521></span></td><td class="chapter-data" data-v-3aa59521>2688</td></tr></tbody><tbody data-v-3aa59521><tr class="table-row" data-v-3aa59521><td class="chapter-name" data-v-3aa59521><p class="leadTitle" data-v-3aa59521>Open access peer-reviewed</p><a href="/books/artificial-neural-networks-methodological-advances-and-biomedical-applications/artificial-neural-networks-ann-applied-for-gait-classification-and-physiotherapy-monitoring-in-post-" class="linkType1" data-v-3aa59521>16. Artificial Neural Networks (ANN) Applied for Gait Classification and Physiotherapy Monitoring in Post Stroke Patients</a><p class="chapter-editors" data-v-3aa59521><span data-v-3aa59521>By Katarzyna Kaczmarczyk, Andrzej Wit, Maciej Krawczyk, Jacek Zaborski and Jozef Pisudski</span></p><!----><!----></td><td class="chapter-data" data-v-3aa59521><span data-doi="10.5772/15363" data-hide-zero-citations="true" data-legend="hover-top" data-style="large_rectangle" class="__dimensions_badge_embed__" data-v-3aa59521></span></td><td class="chapter-data" data-v-3aa59521>2538</td></tr></tbody><tbody data-v-3aa59521><tr class="table-row" data-v-3aa59521><td class="chapter-name" data-v-3aa59521><p class="leadTitle" data-v-3aa59521>Open access peer-reviewed</p><a href="/books/artificial-neural-networks-methodological-advances-and-biomedical-applications/forcasting-the-clinical-outcome-artificial-neural-networks-or-multivariate-statistical-models-" class="linkType1" data-v-3aa59521>17. Forcasting the Clinical Outcome: Artificial Neural Networks or Multivariate Statistical Models?</a><p class="chapter-editors" data-v-3aa59521><span data-v-3aa59521>By Ahmed Akl and Mohamed A Ghoneim</span></p><!----><!----></td><td class="chapter-data" data-v-3aa59521><span data-doi="10.5772/15974" data-hide-zero-citations="true" data-legend="hover-top" data-style="large_rectangle" class="__dimensions_badge_embed__" data-v-3aa59521></span></td><td class="chapter-data" data-v-3aa59521>2086</td></tr></tbody><tbody data-v-3aa59521><tr class="table-row" data-v-3aa59521><td class="chapter-name" data-v-3aa59521><p class="leadTitle" data-v-3aa59521>Open access peer-reviewed</p><a href="/books/artificial-neural-networks-methodological-advances-and-biomedical-applications/telecare-adoption-model-based-on-artificial-neural-networks" class="linkType1" data-v-3aa59521>18. Telecare Adoption Model Based on Artificial Neural Networks</a><p class="chapter-editors" data-v-3aa59521><span data-v-3aa59521>By Jui-Chen Huang</span></p><!----><!----></td><td class="chapter-data" data-v-3aa59521><!----></td><td class="chapter-data" data-v-3aa59521>2090</td></tr></tbody><tbody data-v-3aa59521><tr class="table-row" data-v-3aa59521><td class="chapter-name" data-v-3aa59521><p class="leadTitle" data-v-3aa59521>Open access peer-reviewed</p><a href="/books/artificial-neural-networks-methodological-advances-and-biomedical-applications/effectiveness-of-artificial-neural-networks-in-forecasting-failure-risk-for-pre-medical-students" class="linkType1" data-v-3aa59521>19. Effectiveness of Artificial Neural Networks in Forecasting Failure Risk for Pre-Medical Students</a><p class="chapter-editors" data-v-3aa59521><span data-v-3aa59521>By Jawaher K. Alenezi, Mohammed M. Awny and Maged M. M. Fahmy</span></p><!----><!----></td><td class="chapter-data" data-v-3aa59521><!----></td><td class="chapter-data" data-v-3aa59521>2123</td></tr></tbody></table></div><div class="indexed-in" data-v-9fc121d2 data-v-6083f38b><h3 class="title" data-v-9fc121d2>Edited Volume and chapters are indexed in</h3><ul class="list" data-v-9fc121d2><li class="item" data-v-9fc121d2><a href="https://www.worldcat.org/" target="_blank" data-v-9fc121d2><img src="//cdnintech.com/web/frontend/www/assets/institutions/worldCat.svg" alt="Worldcat" width="194" height="120" data-v-9fc121d2></a></li><li class="item" data-v-9fc121d2><a href="https://www.openaire.eu/" target="_blank" data-v-9fc121d2><img src="//cdnintech.com/web/frontend/www/assets/institutions/openAire.svg" alt="OpenAIRE" width="194" height="120" data-v-9fc121d2></a></li><li class="item" data-v-9fc121d2><a href="https://scholar.google.hr/" target="_blank" data-v-9fc121d2><img src="//cdnintech.com/web/frontend/www/assets/institutions/google.svg" alt="Google Scholar" width="194" height="74.7" data-v-9fc121d2></a></li><li class="item" data-v-9fc121d2><a href="https://www.ebscohost.com/discovery/technology/a-to-z" target="_blank" data-v-9fc121d2><img src="//cdnintech.com/web/frontend/www/assets/institutions/az.svg" alt="AZ ebsco" width="194" height="120" data-v-9fc121d2></a></li><li class="item" data-v-9fc121d2><a href="https://www.base-search.net/" target="_blank" data-v-9fc121d2><img src="//cdnintech.com/web/frontend/www/assets/institutions/base.svg" alt="Base" width="194" height="109.14" data-v-9fc121d2></a></li><li class="item" data-v-9fc121d2><a href="http://www.cnki.net/" target="_blank" data-v-9fc121d2><img src="//cdnintech.com/web/frontend/www/assets/institutions/cnki.svg" alt="CNKI" width="194" height="79.55" data-v-9fc121d2></a></li><li class="item" data-v-9fc121d2><a href="http://www.theiet.org/resources/inspec/" target="_blank" data-v-9fc121d2><img src="//cdnintech.com/web/frontend/www/assets/institutions/iet.svg" alt="IET Inspec" width="194" height="65.5" data-v-9fc121d2></a></li><li class="item" data-v-9fc121d2><a href="http://wokinfo.com/products_tools/multidisciplinary/bookcitationindex/" target="_blank" data-v-9fc121d2><img src="//cdnintech.com/web/frontend/www/assets/institutions/bkci.svg" alt="BKCI" width="194" height="120" data-v-9fc121d2></a></li></ul></div><div id="order-boook-section" class="order-book" data-v-7ba8523d data-v-6083f38b><div class="book cf" data-v-7ba8523d><h3 class="title" data-v-7ba8523d>Order a hardcopy of the Edited Volume</h3><div class="book-cover-box" data-v-7ba8523d><figure class="cover-wrap middle" data-v-51685050 data-v-7ba8523d><a href="/books/artificial-neural-networks-methodological-advances-and-biomedical-applications" class="router-link-exact-active router-link-active" data-v-51685050><span class="lazy-image ar1" data-v-d261b71c data-v-51685050><!----></span><svg viewBox="0 0 300 270" preserveAspectRatio="xMidYMid meet" class="svg" data-v-51685050><rect width="300" height="270" style="fill:#e10000" data-v-51685050></rect><text x="150" y="35" font-family="Arial" text-anchor="middle" fill="#fffad2" font-size="12" data-v-51685050>IntechOpen</text><g transform="translate(140, 220)" fill="#FFFAD2" data-v-51685050><g transform="scale(0.7)" data-v-51685050><path d="M18.4091275,7.09361268 L3.66754648,15.3478697 C2.61853239,15.939493 1.9668669,17.0549331 1.9668669,18.2588838 L1.9668669,33.0542958 L0.869542958,32.6455599 C0.346761268,32.4507676 -3.45070423e-05,31.9516232 -3.45070423e-05,31.3936444 L-3.45070423e-05,1.37079225 C-3.45070423e-05,0.417880282 0.94908169,-0.243792254 1.84298662,0.08575 L18.3356275,6.16347535 C18.7472965,6.3151338 18.791638,6.87932394 18.4091275,7.09361268 M38.2955359,22.6833768 C38.178212,23.1238592 37.8226169,23.4794542 37.382307,23.5967782 C36.3688352,23.8671408 35.4695817,22.9675423 35.7401169,21.9540704 C35.8576134,21.5139331 36.2132085,21.158338 36.6536908,21.0411866 C37.6666451,20.7715141 38.565381,21.6704225 38.2955359,22.6833768 M48.0927754,30.247493 C47.5629197,30.0078415 46.9350641,30.1798592 46.5494479,30.614993 L46.5221873,30.6455317 C45.2633704,32.0789542 43.7110711,33.1881831 41.9971063,33.9233556 C41.9917577,33.9255986 41.9971063,22.341757 41.9971063,22.341757 C41.9971063,13.8637218 35.1127789,6.99078169 26.6345711,6.99078169 C24.2718739,6.99078169 21.8610394,7.48388732 19.7830254,8.63297183 C17.9817577,9.62901761 7.46211338,15.5312746 4.66255704,17.1022077 C4.23846549,17.3401338 3.97845493,17.7871725 3.97845493,18.2733768 L3.97845493,47.5848662 C3.97845493,48.5941972 5.06456408,49.230507 5.9451838,48.7372289 L19.0174866,41.4119014 C19.4345042,41.1781162 19.6927894,40.7374613 19.6927894,40.2593662 L19.6927894,17.7378275 C19.6927894,17.2512782 20.0211239,16.8006162 20.5000817,16.7141761 C21.1293176,16.6008204 21.6765993,17.0811585 21.6765993,17.6893451 L21.6765993,22.2984507 L21.6821204,22.287581 C21.6821204,22.2912042 21.6817754,22.2948275 21.6817754,22.2984507 C21.6817754,30.752331 28.5590289,37.6295845 37.0127366,37.6295845 C37.7863845,37.6295845 38.5527859,37.5676444 39.3076275,37.4532535 L39.3076275,47.5686479 C39.3076275,48.3079613 39.9071873,48.9076937 40.6466732,48.9076937 C41.3859866,48.9076937 41.9853739,48.3079613 41.9853739,47.5686479 L41.9853739,36.796757 C44.484719,35.9396021 46.7488986,34.4454472 48.5267014,32.4212641 L48.5669021,32.3755423 C49.1533493,31.7199085 48.9746028,30.6460493 48.0927754,30.247493" data-v-51685050></path></g></g></svg><div class="text" style="font-size:150em" data-v-51685050><span class="title" data-v-51685050>Artificial Neural Networks</span><span class="sub-title" data-v-51685050>Methodological Advances and Biomedical Applications</span><span class="editors" data-v-51685050>Edited by Kenji Suzuki</span></div></a></figure></div><div class="book-details" data-v-7ba8523d><p class="shipping" data-v-7ba8523d>Free shipping with DHL Express</p><p class="price" data-v-7ba8523d>Hardcover (ex. VAT)<span data-v-7ba8523d>170</span></p><a href="mailto:orders@intechopen.com" class="cta button-type-1" data-v-7ba8523d>Order now</a><p class="meta" data-v-7ba8523d>Residents of European Union countries need to add a Book Value-Added Tax of 5%. Institutions and companies, registered as VAT taxable entities in their own EU member state, will not pay VAT by providing IntechOpen with their VAT registration number. This is made possible by the EU reverse charge method.</p></div></div><div class="box-type-1" data-v-43803c6a data-v-7ba8523d><h3 class="title" data-v-43803c6a>Special discount for IntechOpen contributors</h3><p class="description" data-v-43803c6a>All IntechOpen contributors are offered special discounts starting at 40% OFF available through your personal dashboard</p><a href="https://mts.intechopen.com/account/login" target="_blank" class="cta button-type-2" data-v-43803c6a>Login and purchase</a></div></div><div class="books-list" data-v-15ec5eca data-v-6083f38b><div class="inner" data-v-15ec5eca><h3 class="title" data-v-15ec5eca>Related books</h3><!----><div style="overflow:hidden;white-space:nowrap" data-v-15ec5eca><div style="display:inline" data-v-12a4d3b7 data-v-15ec5eca><div class="book-item" data-v-6ee8567d data-v-15ec5eca><figure class="cover-wrap top" data-v-51685050 data-v-6ee8567d><a href="/books/artificial-neural-networks-industrial-and-control-engineering-applications" data-v-51685050><span class="lazy-image ar1" data-v-d261b71c data-v-51685050><!----></span><svg viewBox="0 0 300 270" preserveAspectRatio="xMidYMid meet" class="svg" data-v-51685050><rect width="300" height="270" style="fill:#e10000" data-v-51685050></rect><text x="150" y="35" font-family="Arial" text-anchor="middle" fill="#fffad2" font-size="12" data-v-51685050>IntechOpen</text><g transform="translate(140, 220)" fill="#FFFAD2" data-v-51685050><g transform="scale(0.7)" data-v-51685050><path d="M18.4091275,7.09361268 L3.66754648,15.3478697 C2.61853239,15.939493 1.9668669,17.0549331 1.9668669,18.2588838 L1.9668669,33.0542958 L0.869542958,32.6455599 C0.346761268,32.4507676 -3.45070423e-05,31.9516232 -3.45070423e-05,31.3936444 L-3.45070423e-05,1.37079225 C-3.45070423e-05,0.417880282 0.94908169,-0.243792254 1.84298662,0.08575 L18.3356275,6.16347535 C18.7472965,6.3151338 18.791638,6.87932394 18.4091275,7.09361268 M38.2955359,22.6833768 C38.178212,23.1238592 37.8226169,23.4794542 37.382307,23.5967782 C36.3688352,23.8671408 35.4695817,22.9675423 35.7401169,21.9540704 C35.8576134,21.5139331 36.2132085,21.158338 36.6536908,21.0411866 C37.6666451,20.7715141 38.565381,21.6704225 38.2955359,22.6833768 M48.0927754,30.247493 C47.5629197,30.0078415 46.9350641,30.1798592 46.5494479,30.614993 L46.5221873,30.6455317 C45.2633704,32.0789542 43.7110711,33.1881831 41.9971063,33.9233556 C41.9917577,33.9255986 41.9971063,22.341757 41.9971063,22.341757 C41.9971063,13.8637218 35.1127789,6.99078169 26.6345711,6.99078169 C24.2718739,6.99078169 21.8610394,7.48388732 19.7830254,8.63297183 C17.9817577,9.62901761 7.46211338,15.5312746 4.66255704,17.1022077 C4.23846549,17.3401338 3.97845493,17.7871725 3.97845493,18.2733768 L3.97845493,47.5848662 C3.97845493,48.5941972 5.06456408,49.230507 5.9451838,48.7372289 L19.0174866,41.4119014 C19.4345042,41.1781162 19.6927894,40.7374613 19.6927894,40.2593662 L19.6927894,17.7378275 C19.6927894,17.2512782 20.0211239,16.8006162 20.5000817,16.7141761 C21.1293176,16.6008204 21.6765993,17.0811585 21.6765993,17.6893451 L21.6765993,22.2984507 L21.6821204,22.287581 C21.6821204,22.2912042 21.6817754,22.2948275 21.6817754,22.2984507 C21.6817754,30.752331 28.5590289,37.6295845 37.0127366,37.6295845 C37.7863845,37.6295845 38.5527859,37.5676444 39.3076275,37.4532535 L39.3076275,47.5686479 C39.3076275,48.3079613 39.9071873,48.9076937 40.6466732,48.9076937 C41.3859866,48.9076937 41.9853739,48.3079613 41.9853739,47.5686479 L41.9853739,36.796757 C44.484719,35.9396021 46.7488986,34.4454472 48.5267014,32.4212641 L48.5669021,32.3755423 C49.1533493,31.7199085 48.9746028,30.6460493 48.0927754,30.247493" data-v-51685050></path></g></g></svg><div class="text" style="font-size:150em" data-v-51685050><span class="title" data-v-51685050>Artificial Neural Networks</span><span class="sub-title" data-v-51685050>Industrial and Control Engineering Applications</span><span class="editors" data-v-51685050>Edited by Kenji Suzuki</span></div></a></figure><h4 class="title" data-v-6ee8567d><a href="/books/artificial-neural-networks-industrial-and-control-engineering-applications" data-v-6ee8567d>Artificial Neural Networks</a></h4><p class="edited" data-v-6ee8567d>Edited by <a href="/profiles/3095/kenji-suzuki" data-v-6ee8567d>Kenji Suzuki</a></p><!----></div><!----></div><div style="display:inline" data-v-12a4d3b7 data-v-15ec5eca><div class="book-item" data-v-6ee8567d data-v-15ec5eca><figure class="cover-wrap top" data-v-51685050 data-v-6ee8567d><a href="/books/artificial-neural-networks-architectures-and-applications" data-v-51685050><span class="lazy-image ar1" data-v-d261b71c data-v-51685050><!----></span><svg viewBox="0 0 300 270" preserveAspectRatio="xMidYMid meet" class="svg" data-v-51685050><rect width="300" height="270" style="fill:#e10000" data-v-51685050></rect><text x="150" y="35" font-family="Arial" text-anchor="middle" fill="#fffad2" font-size="12" data-v-51685050>IntechOpen</text><g transform="translate(140, 220)" fill="#FFFAD2" data-v-51685050><g transform="scale(0.7)" data-v-51685050><path d="M18.4091275,7.09361268 L3.66754648,15.3478697 C2.61853239,15.939493 1.9668669,17.0549331 1.9668669,18.2588838 L1.9668669,33.0542958 L0.869542958,32.6455599 C0.346761268,32.4507676 -3.45070423e-05,31.9516232 -3.45070423e-05,31.3936444 L-3.45070423e-05,1.37079225 C-3.45070423e-05,0.417880282 0.94908169,-0.243792254 1.84298662,0.08575 L18.3356275,6.16347535 C18.7472965,6.3151338 18.791638,6.87932394 18.4091275,7.09361268 M38.2955359,22.6833768 C38.178212,23.1238592 37.8226169,23.4794542 37.382307,23.5967782 C36.3688352,23.8671408 35.4695817,22.9675423 35.7401169,21.9540704 C35.8576134,21.5139331 36.2132085,21.158338 36.6536908,21.0411866 C37.6666451,20.7715141 38.565381,21.6704225 38.2955359,22.6833768 M48.0927754,30.247493 C47.5629197,30.0078415 46.9350641,30.1798592 46.5494479,30.614993 L46.5221873,30.6455317 C45.2633704,32.0789542 43.7110711,33.1881831 41.9971063,33.9233556 C41.9917577,33.9255986 41.9971063,22.341757 41.9971063,22.341757 C41.9971063,13.8637218 35.1127789,6.99078169 26.6345711,6.99078169 C24.2718739,6.99078169 21.8610394,7.48388732 19.7830254,8.63297183 C17.9817577,9.62901761 7.46211338,15.5312746 4.66255704,17.1022077 C4.23846549,17.3401338 3.97845493,17.7871725 3.97845493,18.2733768 L3.97845493,47.5848662 C3.97845493,48.5941972 5.06456408,49.230507 5.9451838,48.7372289 L19.0174866,41.4119014 C19.4345042,41.1781162 19.6927894,40.7374613 19.6927894,40.2593662 L19.6927894,17.7378275 C19.6927894,17.2512782 20.0211239,16.8006162 20.5000817,16.7141761 C21.1293176,16.6008204 21.6765993,17.0811585 21.6765993,17.6893451 L21.6765993,22.2984507 L21.6821204,22.287581 C21.6821204,22.2912042 21.6817754,22.2948275 21.6817754,22.2984507 C21.6817754,30.752331 28.5590289,37.6295845 37.0127366,37.6295845 C37.7863845,37.6295845 38.5527859,37.5676444 39.3076275,37.4532535 L39.3076275,47.5686479 C39.3076275,48.3079613 39.9071873,48.9076937 40.6466732,48.9076937 C41.3859866,48.9076937 41.9853739,48.3079613 41.9853739,47.5686479 L41.9853739,36.796757 C44.484719,35.9396021 46.7488986,34.4454472 48.5267014,32.4212641 L48.5669021,32.3755423 C49.1533493,31.7199085 48.9746028,30.6460493 48.0927754,30.247493" data-v-51685050></path></g></g></svg><div class="text" style="font-size:150em" data-v-51685050><span class="title" data-v-51685050>Artificial Neural Networks</span><span class="sub-title" data-v-51685050>Architectures and Applications</span><span class="editors" data-v-51685050>Edited by Kenji Suzuki</span></div></a></figure><h4 class="title" data-v-6ee8567d><a href="/books/artificial-neural-networks-architectures-and-applications" data-v-6ee8567d>Artificial Neural Networks</a></h4><p class="edited" data-v-6ee8567d>Edited by <a href="/profiles/3095/kenji-suzuki" data-v-6ee8567d>Kenji Suzuki</a></p><!----></div><!----></div><div style="display:inline" data-v-12a4d3b7 data-v-15ec5eca><div class="book-item" data-v-6ee8567d data-v-15ec5eca><figure class="cover-wrap top" data-v-51685050 data-v-6ee8567d><a href="/books/self-organizing-maps-applications-and-novel-algorithm-design" data-v-51685050><span class="lazy-image ar1" data-v-d261b71c data-v-51685050><!----></span><svg viewBox="0 0 300 270" preserveAspectRatio="xMidYMid meet" class="svg" data-v-51685050><rect width="300" height="270" style="fill:#e10000" data-v-51685050></rect><text x="150" y="35" font-family="Arial" text-anchor="middle" fill="#fffad2" font-size="12" data-v-51685050>IntechOpen</text><g transform="translate(140, 220)" fill="#FFFAD2" data-v-51685050><g transform="scale(0.7)" data-v-51685050><path d="M18.4091275,7.09361268 L3.66754648,15.3478697 C2.61853239,15.939493 1.9668669,17.0549331 1.9668669,18.2588838 L1.9668669,33.0542958 L0.869542958,32.6455599 C0.346761268,32.4507676 -3.45070423e-05,31.9516232 -3.45070423e-05,31.3936444 L-3.45070423e-05,1.37079225 C-3.45070423e-05,0.417880282 0.94908169,-0.243792254 1.84298662,0.08575 L18.3356275,6.16347535 C18.7472965,6.3151338 18.791638,6.87932394 18.4091275,7.09361268 M38.2955359,22.6833768 C38.178212,23.1238592 37.8226169,23.4794542 37.382307,23.5967782 C36.3688352,23.8671408 35.4695817,22.9675423 35.7401169,21.9540704 C35.8576134,21.5139331 36.2132085,21.158338 36.6536908,21.0411866 C37.6666451,20.7715141 38.565381,21.6704225 38.2955359,22.6833768 M48.0927754,30.247493 C47.5629197,30.0078415 46.9350641,30.1798592 46.5494479,30.614993 L46.5221873,30.6455317 C45.2633704,32.0789542 43.7110711,33.1881831 41.9971063,33.9233556 C41.9917577,33.9255986 41.9971063,22.341757 41.9971063,22.341757 C41.9971063,13.8637218 35.1127789,6.99078169 26.6345711,6.99078169 C24.2718739,6.99078169 21.8610394,7.48388732 19.7830254,8.63297183 C17.9817577,9.62901761 7.46211338,15.5312746 4.66255704,17.1022077 C4.23846549,17.3401338 3.97845493,17.7871725 3.97845493,18.2733768 L3.97845493,47.5848662 C3.97845493,48.5941972 5.06456408,49.230507 5.9451838,48.7372289 L19.0174866,41.4119014 C19.4345042,41.1781162 19.6927894,40.7374613 19.6927894,40.2593662 L19.6927894,17.7378275 C19.6927894,17.2512782 20.0211239,16.8006162 20.5000817,16.7141761 C21.1293176,16.6008204 21.6765993,17.0811585 21.6765993,17.6893451 L21.6765993,22.2984507 L21.6821204,22.287581 C21.6821204,22.2912042 21.6817754,22.2948275 21.6817754,22.2984507 C21.6817754,30.752331 28.5590289,37.6295845 37.0127366,37.6295845 C37.7863845,37.6295845 38.5527859,37.5676444 39.3076275,37.4532535 L39.3076275,47.5686479 C39.3076275,48.3079613 39.9071873,48.9076937 40.6466732,48.9076937 C41.3859866,48.9076937 41.9853739,48.3079613 41.9853739,47.5686479 L41.9853739,36.796757 C44.484719,35.9396021 46.7488986,34.4454472 48.5267014,32.4212641 L48.5669021,32.3755423 C49.1533493,31.7199085 48.9746028,30.6460493 48.0927754,30.247493" data-v-51685050></path></g></g></svg><div class="text" style="font-size:150em" data-v-51685050><span class="title" data-v-51685050>Self Organizing Maps</span><span class="sub-title" data-v-51685050>Applications and Novel Algorithm Design</span><span class="editors" data-v-51685050>Edited by Josphat Igadwa Mwasiagi</span></div></a></figure><h4 class="title" data-v-6ee8567d><a href="/books/self-organizing-maps-applications-and-novel-algorithm-design" data-v-6ee8567d>Self Organizing Maps</a></h4><p class="edited" data-v-6ee8567d>Edited by <a href="/profiles/16821/josphat-igadwa-mwasiagi" data-v-6ee8567d>Josphat Igadwa Mwasiagi</a></p><!----></div><!----></div><div style="display:inline" data-v-12a4d3b7 data-v-15ec5eca><div class="book-item" data-v-6ee8567d data-v-15ec5eca><figure class="cover-wrap top" data-v-51685050 data-v-6ee8567d><a href="/books/artificial-neural-networks-application" data-v-51685050><span class="lazy-image ar1" data-v-d261b71c data-v-51685050><!----></span><svg viewBox="0 0 300 270" preserveAspectRatio="xMidYMid meet" class="svg" data-v-51685050><rect width="300" height="270" style="fill:#e10000" data-v-51685050></rect><text x="150" y="35" font-family="Arial" text-anchor="middle" fill="#fffad2" font-size="12" data-v-51685050>IntechOpen</text><g transform="translate(140, 220)" fill="#FFFAD2" data-v-51685050><g transform="scale(0.7)" data-v-51685050><path d="M18.4091275,7.09361268 L3.66754648,15.3478697 C2.61853239,15.939493 1.9668669,17.0549331 1.9668669,18.2588838 L1.9668669,33.0542958 L0.869542958,32.6455599 C0.346761268,32.4507676 -3.45070423e-05,31.9516232 -3.45070423e-05,31.3936444 L-3.45070423e-05,1.37079225 C-3.45070423e-05,0.417880282 0.94908169,-0.243792254 1.84298662,0.08575 L18.3356275,6.16347535 C18.7472965,6.3151338 18.791638,6.87932394 18.4091275,7.09361268 M38.2955359,22.6833768 C38.178212,23.1238592 37.8226169,23.4794542 37.382307,23.5967782 C36.3688352,23.8671408 35.4695817,22.9675423 35.7401169,21.9540704 C35.8576134,21.5139331 36.2132085,21.158338 36.6536908,21.0411866 C37.6666451,20.7715141 38.565381,21.6704225 38.2955359,22.6833768 M48.0927754,30.247493 C47.5629197,30.0078415 46.9350641,30.1798592 46.5494479,30.614993 L46.5221873,30.6455317 C45.2633704,32.0789542 43.7110711,33.1881831 41.9971063,33.9233556 C41.9917577,33.9255986 41.9971063,22.341757 41.9971063,22.341757 C41.9971063,13.8637218 35.1127789,6.99078169 26.6345711,6.99078169 C24.2718739,6.99078169 21.8610394,7.48388732 19.7830254,8.63297183 C17.9817577,9.62901761 7.46211338,15.5312746 4.66255704,17.1022077 C4.23846549,17.3401338 3.97845493,17.7871725 3.97845493,18.2733768 L3.97845493,47.5848662 C3.97845493,48.5941972 5.06456408,49.230507 5.9451838,48.7372289 L19.0174866,41.4119014 C19.4345042,41.1781162 19.6927894,40.7374613 19.6927894,40.2593662 L19.6927894,17.7378275 C19.6927894,17.2512782 20.0211239,16.8006162 20.5000817,16.7141761 C21.1293176,16.6008204 21.6765993,17.0811585 21.6765993,17.6893451 L21.6765993,22.2984507 L21.6821204,22.287581 C21.6821204,22.2912042 21.6817754,22.2948275 21.6817754,22.2984507 C21.6817754,30.752331 28.5590289,37.6295845 37.0127366,37.6295845 C37.7863845,37.6295845 38.5527859,37.5676444 39.3076275,37.4532535 L39.3076275,47.5686479 C39.3076275,48.3079613 39.9071873,48.9076937 40.6466732,48.9076937 C41.3859866,48.9076937 41.9853739,48.3079613 41.9853739,47.5686479 L41.9853739,36.796757 C44.484719,35.9396021 46.7488986,34.4454472 48.5267014,32.4212641 L48.5669021,32.3755423 C49.1533493,31.7199085 48.9746028,30.6460493 48.0927754,30.247493" data-v-51685050></path></g></g></svg><div class="text" style="font-size:150em" data-v-51685050><span class="title" data-v-51685050>Artificial Neural Networks</span><span class="sub-title" data-v-51685050>Application</span><span class="editors" data-v-51685050>Edited by Chi Leung Patrick Hui</span></div></a></figure><h4 class="title" data-v-6ee8567d><a href="/books/artificial-neural-networks-application" data-v-6ee8567d>Artificial Neural Networks</a></h4><p class="edited" data-v-6ee8567d>Edited by <a href="/profiles/22866/chi-leung-patrick-hui" data-v-6ee8567d>Chi Leung Patrick Hui</a></p><!----></div><!----></div><div style="display:inline" data-v-12a4d3b7 data-v-15ec5eca><div class="book-item" data-v-6ee8567d data-v-15ec5eca><figure class="cover-wrap top" data-v-51685050 data-v-6ee8567d><a href="/books/ant-colony-optimization-methods-and-applications" data-v-51685050><span class="lazy-image ar1" data-v-d261b71c data-v-51685050><!----></span><svg viewBox="0 0 300 270" preserveAspectRatio="xMidYMid meet" class="svg" data-v-51685050><rect width="300" height="270" style="fill:#e10000" data-v-51685050></rect><text x="150" y="35" font-family="Arial" text-anchor="middle" fill="#fffad2" font-size="12" data-v-51685050>IntechOpen</text><g transform="translate(140, 220)" fill="#FFFAD2" data-v-51685050><g transform="scale(0.7)" data-v-51685050><path d="M18.4091275,7.09361268 L3.66754648,15.3478697 C2.61853239,15.939493 1.9668669,17.0549331 1.9668669,18.2588838 L1.9668669,33.0542958 L0.869542958,32.6455599 C0.346761268,32.4507676 -3.45070423e-05,31.9516232 -3.45070423e-05,31.3936444 L-3.45070423e-05,1.37079225 C-3.45070423e-05,0.417880282 0.94908169,-0.243792254 1.84298662,0.08575 L18.3356275,6.16347535 C18.7472965,6.3151338 18.791638,6.87932394 18.4091275,7.09361268 M38.2955359,22.6833768 C38.178212,23.1238592 37.8226169,23.4794542 37.382307,23.5967782 C36.3688352,23.8671408 35.4695817,22.9675423 35.7401169,21.9540704 C35.8576134,21.5139331 36.2132085,21.158338 36.6536908,21.0411866 C37.6666451,20.7715141 38.565381,21.6704225 38.2955359,22.6833768 M48.0927754,30.247493 C47.5629197,30.0078415 46.9350641,30.1798592 46.5494479,30.614993 L46.5221873,30.6455317 C45.2633704,32.0789542 43.7110711,33.1881831 41.9971063,33.9233556 C41.9917577,33.9255986 41.9971063,22.341757 41.9971063,22.341757 C41.9971063,13.8637218 35.1127789,6.99078169 26.6345711,6.99078169 C24.2718739,6.99078169 21.8610394,7.48388732 19.7830254,8.63297183 C17.9817577,9.62901761 7.46211338,15.5312746 4.66255704,17.1022077 C4.23846549,17.3401338 3.97845493,17.7871725 3.97845493,18.2733768 L3.97845493,47.5848662 C3.97845493,48.5941972 5.06456408,49.230507 5.9451838,48.7372289 L19.0174866,41.4119014 C19.4345042,41.1781162 19.6927894,40.7374613 19.6927894,40.2593662 L19.6927894,17.7378275 C19.6927894,17.2512782 20.0211239,16.8006162 20.5000817,16.7141761 C21.1293176,16.6008204 21.6765993,17.0811585 21.6765993,17.6893451 L21.6765993,22.2984507 L21.6821204,22.287581 C21.6821204,22.2912042 21.6817754,22.2948275 21.6817754,22.2984507 C21.6817754,30.752331 28.5590289,37.6295845 37.0127366,37.6295845 C37.7863845,37.6295845 38.5527859,37.5676444 39.3076275,37.4532535 L39.3076275,47.5686479 C39.3076275,48.3079613 39.9071873,48.9076937 40.6466732,48.9076937 C41.3859866,48.9076937 41.9853739,48.3079613 41.9853739,47.5686479 L41.9853739,36.796757 C44.484719,35.9396021 46.7488986,34.4454472 48.5267014,32.4212641 L48.5669021,32.3755423 C49.1533493,31.7199085 48.9746028,30.6460493 48.0927754,30.247493" data-v-51685050></path></g></g></svg><div class="text" style="font-size:150em" data-v-51685050><span class="title" data-v-51685050>Ant Colony Optimization</span><span class="sub-title" data-v-51685050>Methods and Applications</span><span class="editors" data-v-51685050>Edited by Avi Ostfeld</span></div></a></figure><h4 class="title" data-v-6ee8567d><a href="/books/ant-colony-optimization-methods-and-applications" data-v-6ee8567d>Ant Colony Optimization</a></h4><p class="edited" data-v-6ee8567d>Edited by <a href="/profiles/15000/avi-ostfeld" data-v-6ee8567d>Avi Ostfeld</a></p><!----></div><!----></div><div style="display:inline" data-v-12a4d3b7 data-v-15ec5eca><div class="book-item" data-v-6ee8567d data-v-15ec5eca><figure class="cover-wrap top" data-v-51685050 data-v-6ee8567d><a href="/books/recurrent-neural-networks-for-temporal-data-processing" data-v-51685050><span class="lazy-image ar1" data-v-d261b71c data-v-51685050><!----></span><svg viewBox="0 0 300 270" preserveAspectRatio="xMidYMid meet" class="svg" data-v-51685050><rect width="300" height="270" style="fill:#e10000" data-v-51685050></rect><text x="150" y="35" font-family="Arial" text-anchor="middle" fill="#fffad2" font-size="12" data-v-51685050>IntechOpen</text><g transform="translate(140, 220)" fill="#FFFAD2" data-v-51685050><g transform="scale(0.7)" data-v-51685050><path d="M18.4091275,7.09361268 L3.66754648,15.3478697 C2.61853239,15.939493 1.9668669,17.0549331 1.9668669,18.2588838 L1.9668669,33.0542958 L0.869542958,32.6455599 C0.346761268,32.4507676 -3.45070423e-05,31.9516232 -3.45070423e-05,31.3936444 L-3.45070423e-05,1.37079225 C-3.45070423e-05,0.417880282 0.94908169,-0.243792254 1.84298662,0.08575 L18.3356275,6.16347535 C18.7472965,6.3151338 18.791638,6.87932394 18.4091275,7.09361268 M38.2955359,22.6833768 C38.178212,23.1238592 37.8226169,23.4794542 37.382307,23.5967782 C36.3688352,23.8671408 35.4695817,22.9675423 35.7401169,21.9540704 C35.8576134,21.5139331 36.2132085,21.158338 36.6536908,21.0411866 C37.6666451,20.7715141 38.565381,21.6704225 38.2955359,22.6833768 M48.0927754,30.247493 C47.5629197,30.0078415 46.9350641,30.1798592 46.5494479,30.614993 L46.5221873,30.6455317 C45.2633704,32.0789542 43.7110711,33.1881831 41.9971063,33.9233556 C41.9917577,33.9255986 41.9971063,22.341757 41.9971063,22.341757 C41.9971063,13.8637218 35.1127789,6.99078169 26.6345711,6.99078169 C24.2718739,6.99078169 21.8610394,7.48388732 19.7830254,8.63297183 C17.9817577,9.62901761 7.46211338,15.5312746 4.66255704,17.1022077 C4.23846549,17.3401338 3.97845493,17.7871725 3.97845493,18.2733768 L3.97845493,47.5848662 C3.97845493,48.5941972 5.06456408,49.230507 5.9451838,48.7372289 L19.0174866,41.4119014 C19.4345042,41.1781162 19.6927894,40.7374613 19.6927894,40.2593662 L19.6927894,17.7378275 C19.6927894,17.2512782 20.0211239,16.8006162 20.5000817,16.7141761 C21.1293176,16.6008204 21.6765993,17.0811585 21.6765993,17.6893451 L21.6765993,22.2984507 L21.6821204,22.287581 C21.6821204,22.2912042 21.6817754,22.2948275 21.6817754,22.2984507 C21.6817754,30.752331 28.5590289,37.6295845 37.0127366,37.6295845 C37.7863845,37.6295845 38.5527859,37.5676444 39.3076275,37.4532535 L39.3076275,47.5686479 C39.3076275,48.3079613 39.9071873,48.9076937 40.6466732,48.9076937 C41.3859866,48.9076937 41.9853739,48.3079613 41.9853739,47.5686479 L41.9853739,36.796757 C44.484719,35.9396021 46.7488986,34.4454472 48.5267014,32.4212641 L48.5669021,32.3755423 C49.1533493,31.7199085 48.9746028,30.6460493 48.0927754,30.247493" data-v-51685050></path></g></g></svg><div class="text" style="font-size:150em" data-v-51685050><span class="title" data-v-51685050>Recurrent Neural Networks for Temporal Data Processing</span><!----><span class="editors" data-v-51685050>Edited by Hubert Cardot</span></div></a></figure><h4 class="title" data-v-6ee8567d><a href="/books/recurrent-neural-networks-for-temporal-data-processing" data-v-6ee8567d>Recurrent Neural Networks for Temporal Data Processing</a></h4><p class="edited" data-v-6ee8567d>Edited by <a href="/profiles/10879/hubert-cardot" data-v-6ee8567d>Hubert Cardot</a></p><!----></div><!----></div><div style="display:inline" data-v-12a4d3b7 data-v-15ec5eca><div class="book-item" data-v-6ee8567d data-v-15ec5eca><figure class="cover-wrap top" data-v-51685050 data-v-6ee8567d><a href="/books/recurrent_neural_networks" data-v-51685050><span class="lazy-image ar1" data-v-d261b71c data-v-51685050><!----></span><svg viewBox="0 0 300 270" preserveAspectRatio="xMidYMid meet" class="svg" data-v-51685050><rect width="300" height="270" style="fill:#e10000" data-v-51685050></rect><text x="150" y="35" font-family="Arial" text-anchor="middle" fill="#fffad2" font-size="12" data-v-51685050>IntechOpen</text><g transform="translate(140, 220)" fill="#FFFAD2" data-v-51685050><g transform="scale(0.7)" data-v-51685050><path d="M18.4091275,7.09361268 L3.66754648,15.3478697 C2.61853239,15.939493 1.9668669,17.0549331 1.9668669,18.2588838 L1.9668669,33.0542958 L0.869542958,32.6455599 C0.346761268,32.4507676 -3.45070423e-05,31.9516232 -3.45070423e-05,31.3936444 L-3.45070423e-05,1.37079225 C-3.45070423e-05,0.417880282 0.94908169,-0.243792254 1.84298662,0.08575 L18.3356275,6.16347535 C18.7472965,6.3151338 18.791638,6.87932394 18.4091275,7.09361268 M38.2955359,22.6833768 C38.178212,23.1238592 37.8226169,23.4794542 37.382307,23.5967782 C36.3688352,23.8671408 35.4695817,22.9675423 35.7401169,21.9540704 C35.8576134,21.5139331 36.2132085,21.158338 36.6536908,21.0411866 C37.6666451,20.7715141 38.565381,21.6704225 38.2955359,22.6833768 M48.0927754,30.247493 C47.5629197,30.0078415 46.9350641,30.1798592 46.5494479,30.614993 L46.5221873,30.6455317 C45.2633704,32.0789542 43.7110711,33.1881831 41.9971063,33.9233556 C41.9917577,33.9255986 41.9971063,22.341757 41.9971063,22.341757 C41.9971063,13.8637218 35.1127789,6.99078169 26.6345711,6.99078169 C24.2718739,6.99078169 21.8610394,7.48388732 19.7830254,8.63297183 C17.9817577,9.62901761 7.46211338,15.5312746 4.66255704,17.1022077 C4.23846549,17.3401338 3.97845493,17.7871725 3.97845493,18.2733768 L3.97845493,47.5848662 C3.97845493,48.5941972 5.06456408,49.230507 5.9451838,48.7372289 L19.0174866,41.4119014 C19.4345042,41.1781162 19.6927894,40.7374613 19.6927894,40.2593662 L19.6927894,17.7378275 C19.6927894,17.2512782 20.0211239,16.8006162 20.5000817,16.7141761 C21.1293176,16.6008204 21.6765993,17.0811585 21.6765993,17.6893451 L21.6765993,22.2984507 L21.6821204,22.287581 C21.6821204,22.2912042 21.6817754,22.2948275 21.6817754,22.2984507 C21.6817754,30.752331 28.5590289,37.6295845 37.0127366,37.6295845 C37.7863845,37.6295845 38.5527859,37.5676444 39.3076275,37.4532535 L39.3076275,47.5686479 C39.3076275,48.3079613 39.9071873,48.9076937 40.6466732,48.9076937 C41.3859866,48.9076937 41.9853739,48.3079613 41.9853739,47.5686479 L41.9853739,36.796757 C44.484719,35.9396021 46.7488986,34.4454472 48.5267014,32.4212641 L48.5669021,32.3755423 C49.1533493,31.7199085 48.9746028,30.6460493 48.0927754,30.247493" data-v-51685050></path></g></g></svg><div class="text" style="font-size:150em" data-v-51685050><span class="title" data-v-51685050>Recurrent Neural Networks</span><!----><span class="editors" data-v-51685050>Edited by Xiaolin Hu</span></div></a></figure><h4 class="title" data-v-6ee8567d><a href="/books/recurrent_neural_networks" data-v-6ee8567d>Recurrent Neural Networks</a></h4><p class="edited" data-v-6ee8567d>Edited by <a href="/profiles/252213/xiaolin-hu" data-v-6ee8567d>Xiaolin Hu</a></p><!----></div><!----></div><div style="display:inline" data-v-12a4d3b7 data-v-15ec5eca><div class="book-item" data-v-6ee8567d data-v-15ec5eca><figure class="cover-wrap top" data-v-51685050 data-v-6ee8567d><a href="/books/recurrent-neural-networks-and-soft-computing" data-v-51685050><span class="lazy-image ar1" data-v-d261b71c data-v-51685050><!----></span><svg viewBox="0 0 300 270" preserveAspectRatio="xMidYMid meet" class="svg" data-v-51685050><rect width="300" height="270" style="fill:#e10000" data-v-51685050></rect><text x="150" y="35" font-family="Arial" text-anchor="middle" fill="#fffad2" font-size="12" data-v-51685050>IntechOpen</text><g transform="translate(140, 220)" fill="#FFFAD2" data-v-51685050><g transform="scale(0.7)" data-v-51685050><path d="M18.4091275,7.09361268 L3.66754648,15.3478697 C2.61853239,15.939493 1.9668669,17.0549331 1.9668669,18.2588838 L1.9668669,33.0542958 L0.869542958,32.6455599 C0.346761268,32.4507676 -3.45070423e-05,31.9516232 -3.45070423e-05,31.3936444 L-3.45070423e-05,1.37079225 C-3.45070423e-05,0.417880282 0.94908169,-0.243792254 1.84298662,0.08575 L18.3356275,6.16347535 C18.7472965,6.3151338 18.791638,6.87932394 18.4091275,7.09361268 M38.2955359,22.6833768 C38.178212,23.1238592 37.8226169,23.4794542 37.382307,23.5967782 C36.3688352,23.8671408 35.4695817,22.9675423 35.7401169,21.9540704 C35.8576134,21.5139331 36.2132085,21.158338 36.6536908,21.0411866 C37.6666451,20.7715141 38.565381,21.6704225 38.2955359,22.6833768 M48.0927754,30.247493 C47.5629197,30.0078415 46.9350641,30.1798592 46.5494479,30.614993 L46.5221873,30.6455317 C45.2633704,32.0789542 43.7110711,33.1881831 41.9971063,33.9233556 C41.9917577,33.9255986 41.9971063,22.341757 41.9971063,22.341757 C41.9971063,13.8637218 35.1127789,6.99078169 26.6345711,6.99078169 C24.2718739,6.99078169 21.8610394,7.48388732 19.7830254,8.63297183 C17.9817577,9.62901761 7.46211338,15.5312746 4.66255704,17.1022077 C4.23846549,17.3401338 3.97845493,17.7871725 3.97845493,18.2733768 L3.97845493,47.5848662 C3.97845493,48.5941972 5.06456408,49.230507 5.9451838,48.7372289 L19.0174866,41.4119014 C19.4345042,41.1781162 19.6927894,40.7374613 19.6927894,40.2593662 L19.6927894,17.7378275 C19.6927894,17.2512782 20.0211239,16.8006162 20.5000817,16.7141761 C21.1293176,16.6008204 21.6765993,17.0811585 21.6765993,17.6893451 L21.6765993,22.2984507 L21.6821204,22.287581 C21.6821204,22.2912042 21.6817754,22.2948275 21.6817754,22.2984507 C21.6817754,30.752331 28.5590289,37.6295845 37.0127366,37.6295845 C37.7863845,37.6295845 38.5527859,37.5676444 39.3076275,37.4532535 L39.3076275,47.5686479 C39.3076275,48.3079613 39.9071873,48.9076937 40.6466732,48.9076937 C41.3859866,48.9076937 41.9853739,48.3079613 41.9853739,47.5686479 L41.9853739,36.796757 C44.484719,35.9396021 46.7488986,34.4454472 48.5267014,32.4212641 L48.5669021,32.3755423 C49.1533493,31.7199085 48.9746028,30.6460493 48.0927754,30.247493" data-v-51685050></path></g></g></svg><div class="text" style="font-size:150em" data-v-51685050><span class="title" data-v-51685050>Recurrent Neural Networks and Soft Computing</span><!----><span class="editors" data-v-51685050>Edited by Mahmoud ElHefnawi</span></div></a></figure><h4 class="title" data-v-6ee8567d><a href="/books/recurrent-neural-networks-and-soft-computing" data-v-6ee8567d>Recurrent Neural Networks and Soft Computing</a></h4><p class="edited" data-v-6ee8567d>Edited by <a href="/profiles/31550/mahmoud-elhefnawi" data-v-6ee8567d>Mahmoud ElHefnawi</a></p><!----></div><!----></div><div style="display:inline" data-v-12a4d3b7 data-v-15ec5eca><div class="book-item" data-v-6ee8567d data-v-15ec5eca><figure class="cover-wrap top" data-v-51685050 data-v-6ee8567d><a href="/books/digital-systems" data-v-51685050><span class="lazy-image ar1" data-v-d261b71c data-v-51685050><!----></span><svg viewBox="0 0 300 270" preserveAspectRatio="xMidYMid meet" class="svg" data-v-51685050><rect width="300" height="270" style="fill:#e10000" data-v-51685050></rect><text x="150" y="35" font-family="Arial" text-anchor="middle" fill="#fffad2" font-size="12" data-v-51685050>IntechOpen</text><g transform="translate(140, 220)" fill="#FFFAD2" data-v-51685050><g transform="scale(0.7)" data-v-51685050><path d="M18.4091275,7.09361268 L3.66754648,15.3478697 C2.61853239,15.939493 1.9668669,17.0549331 1.9668669,18.2588838 L1.9668669,33.0542958 L0.869542958,32.6455599 C0.346761268,32.4507676 -3.45070423e-05,31.9516232 -3.45070423e-05,31.3936444 L-3.45070423e-05,1.37079225 C-3.45070423e-05,0.417880282 0.94908169,-0.243792254 1.84298662,0.08575 L18.3356275,6.16347535 C18.7472965,6.3151338 18.791638,6.87932394 18.4091275,7.09361268 M38.2955359,22.6833768 C38.178212,23.1238592 37.8226169,23.4794542 37.382307,23.5967782 C36.3688352,23.8671408 35.4695817,22.9675423 35.7401169,21.9540704 C35.8576134,21.5139331 36.2132085,21.158338 36.6536908,21.0411866 C37.6666451,20.7715141 38.565381,21.6704225 38.2955359,22.6833768 M48.0927754,30.247493 C47.5629197,30.0078415 46.9350641,30.1798592 46.5494479,30.614993 L46.5221873,30.6455317 C45.2633704,32.0789542 43.7110711,33.1881831 41.9971063,33.9233556 C41.9917577,33.9255986 41.9971063,22.341757 41.9971063,22.341757 C41.9971063,13.8637218 35.1127789,6.99078169 26.6345711,6.99078169 C24.2718739,6.99078169 21.8610394,7.48388732 19.7830254,8.63297183 C17.9817577,9.62901761 7.46211338,15.5312746 4.66255704,17.1022077 C4.23846549,17.3401338 3.97845493,17.7871725 3.97845493,18.2733768 L3.97845493,47.5848662 C3.97845493,48.5941972 5.06456408,49.230507 5.9451838,48.7372289 L19.0174866,41.4119014 C19.4345042,41.1781162 19.6927894,40.7374613 19.6927894,40.2593662 L19.6927894,17.7378275 C19.6927894,17.2512782 20.0211239,16.8006162 20.5000817,16.7141761 C21.1293176,16.6008204 21.6765993,17.0811585 21.6765993,17.6893451 L21.6765993,22.2984507 L21.6821204,22.287581 C21.6821204,22.2912042 21.6817754,22.2948275 21.6817754,22.2984507 C21.6817754,30.752331 28.5590289,37.6295845 37.0127366,37.6295845 C37.7863845,37.6295845 38.5527859,37.5676444 39.3076275,37.4532535 L39.3076275,47.5686479 C39.3076275,48.3079613 39.9071873,48.9076937 40.6466732,48.9076937 C41.3859866,48.9076937 41.9853739,48.3079613 41.9853739,47.5686479 L41.9853739,36.796757 C44.484719,35.9396021 46.7488986,34.4454472 48.5267014,32.4212641 L48.5669021,32.3755423 C49.1533493,31.7199085 48.9746028,30.6460493 48.0927754,30.247493" data-v-51685050></path></g></g></svg><div class="text" style="font-size:150em" data-v-51685050><span class="title" data-v-51685050>Digital Systems</span><!----><span class="editors" data-v-51685050>Edited by Vahid Asadpour</span></div></a></figure><h4 class="title" data-v-6ee8567d><a href="/books/digital-systems" data-v-6ee8567d>Digital Systems</a></h4><p class="edited" data-v-6ee8567d>Edited by <a href="/profiles/165328/vahid-asadpour" data-v-6ee8567d>Vahid Asadpour</a></p><!----></div><!----></div><div style="display:inline" data-v-12a4d3b7 data-v-15ec5eca><div class="book-item" data-v-6ee8567d data-v-15ec5eca><figure class="cover-wrap top" data-v-51685050 data-v-6ee8567d><a href="/books/memristor-and-memristive-neural-networks" data-v-51685050><span class="lazy-image ar1" data-v-d261b71c data-v-51685050><!----></span><svg viewBox="0 0 300 270" preserveAspectRatio="xMidYMid meet" class="svg" data-v-51685050><rect width="300" height="270" style="fill:#e10000" data-v-51685050></rect><text x="150" y="35" font-family="Arial" text-anchor="middle" fill="#fffad2" font-size="12" data-v-51685050>IntechOpen</text><g transform="translate(140, 220)" fill="#FFFAD2" data-v-51685050><g transform="scale(0.7)" data-v-51685050><path d="M18.4091275,7.09361268 L3.66754648,15.3478697 C2.61853239,15.939493 1.9668669,17.0549331 1.9668669,18.2588838 L1.9668669,33.0542958 L0.869542958,32.6455599 C0.346761268,32.4507676 -3.45070423e-05,31.9516232 -3.45070423e-05,31.3936444 L-3.45070423e-05,1.37079225 C-3.45070423e-05,0.417880282 0.94908169,-0.243792254 1.84298662,0.08575 L18.3356275,6.16347535 C18.7472965,6.3151338 18.791638,6.87932394 18.4091275,7.09361268 M38.2955359,22.6833768 C38.178212,23.1238592 37.8226169,23.4794542 37.382307,23.5967782 C36.3688352,23.8671408 35.4695817,22.9675423 35.7401169,21.9540704 C35.8576134,21.5139331 36.2132085,21.158338 36.6536908,21.0411866 C37.6666451,20.7715141 38.565381,21.6704225 38.2955359,22.6833768 M48.0927754,30.247493 C47.5629197,30.0078415 46.9350641,30.1798592 46.5494479,30.614993 L46.5221873,30.6455317 C45.2633704,32.0789542 43.7110711,33.1881831 41.9971063,33.9233556 C41.9917577,33.9255986 41.9971063,22.341757 41.9971063,22.341757 C41.9971063,13.8637218 35.1127789,6.99078169 26.6345711,6.99078169 C24.2718739,6.99078169 21.8610394,7.48388732 19.7830254,8.63297183 C17.9817577,9.62901761 7.46211338,15.5312746 4.66255704,17.1022077 C4.23846549,17.3401338 3.97845493,17.7871725 3.97845493,18.2733768 L3.97845493,47.5848662 C3.97845493,48.5941972 5.06456408,49.230507 5.9451838,48.7372289 L19.0174866,41.4119014 C19.4345042,41.1781162 19.6927894,40.7374613 19.6927894,40.2593662 L19.6927894,17.7378275 C19.6927894,17.2512782 20.0211239,16.8006162 20.5000817,16.7141761 C21.1293176,16.6008204 21.6765993,17.0811585 21.6765993,17.6893451 L21.6765993,22.2984507 L21.6821204,22.287581 C21.6821204,22.2912042 21.6817754,22.2948275 21.6817754,22.2984507 C21.6817754,30.752331 28.5590289,37.6295845 37.0127366,37.6295845 C37.7863845,37.6295845 38.5527859,37.5676444 39.3076275,37.4532535 L39.3076275,47.5686479 C39.3076275,48.3079613 39.9071873,48.9076937 40.6466732,48.9076937 C41.3859866,48.9076937 41.9853739,48.3079613 41.9853739,47.5686479 L41.9853739,36.796757 C44.484719,35.9396021 46.7488986,34.4454472 48.5267014,32.4212641 L48.5669021,32.3755423 C49.1533493,31.7199085 48.9746028,30.6460493 48.0927754,30.247493" data-v-51685050></path></g></g></svg><div class="text" style="font-size:150em" data-v-51685050><span class="title" data-v-51685050>Memristor and Memristive Neural Networks</span><!----><span class="editors" data-v-51685050>Edited by Alex James</span></div></a></figure><h4 class="title" data-v-6ee8567d><a href="/books/memristor-and-memristive-neural-networks" data-v-6ee8567d>Memristor and Memristive Neural Networks</a></h4><p class="edited" data-v-6ee8567d>Edited by <a href="/profiles/6992/alex-james" data-v-6ee8567d>Alex James</a></p><!----></div><!----></div></div></div></div><!----><!----></section><footer data-v-21365b21 data-v-76acb989><div class="book-subject-area" data-v-3339c76d data-v-21365b21><div class="inner cf" data-v-3339c76d><h2 class="title" data-v-3339c76d>Book subject areas</h2><a href="/books" class="view-all iconArrowRight router-link-active" data-v-3339c76d>View all books</a></div></div><div class="footer" data-v-21365b21><div class="inner" data-v-21365b21><div class="footer-nav cf" data-v-21365b21><div class="nav-box" data-v-21365b21><a href="/" class="title router-link-active" data-v-21365b21>Home</a><a href="/news" class="title" data-v-21365b21>News</a><a href="/page/contact-us" class="title" data-v-21365b21>Contact</a><a href="/page/careers-at-intechopen" class="title" data-v-21365b21>Careers</a></div><div class="nav-box" data-v-21365b21><!----><a href="/about-intechopen" class="title" data-v-21365b21>About us</a><a href="/authors-and-editors" class="link" data-v-21365b21>Our Authors and Editors</a><a href="/page/scientific-advisors" class="link" data-v-21365b21>Scientific Advisors</a><a href="/page/team" class="link" data-v-21365b21>Team</a><a href="/page/events" class="link" data-v-21365b21>Events</a><a href="/page/partnerships" class="link" data-v-21365b21>Partnerships</a></div><div class="nav-box" data-v-21365b21><a href="/publish" class="title" data-v-21365b21>Publish with us</a><a href="/page/about-open-access" class="link" data-v-21365b21>About Open Access</a><a href="/how-open-access-publishing-with-intechopen-works" class="link" data-v-21365b21>How it works</a><a href="/page/OA-publishing-fees" class="link" data-v-21365b21>OA Publishing Fees</a><a href="/page/open-access-funding" class="link" data-v-21365b21>Open Access funding</a><a href="/peer-reviewing" class="link" data-v-21365b21>Peer reviewing</a><a href="/page/editorial-policies" class="link" data-v-21365b21>Editorial policies</a></div><div class="nav-box" data-v-21365b21><div class="social-wrap" data-v-21365b21><a href="https://twitter.com/intechopen" target="_blank" class="icr iconTwitter" data-v-21365b21>Twitter</a><a href="https://www.facebook.com/IntechOpen" target="_blank" class="icr iconFb" data-v-21365b21>Facebook</a><a href="https://www.linkedin.com/company/intech_4" target="_blank" class="icr iconLinkedIn" data-v-21365b21>LinkedIn</a></div><div class="company-info-wrap cf" data-v-21365b21><p class="address" data-v-21365b21>Headquarters<br data-v-21365b21>IntechOpen Limited<br data-v-21365b21>The Shard<br data-v-21365b21>25th floor<br data-v-21365b21>32 London Bridge Street<br data-v-21365b21>London, SE1 9SG, UNITED KINGDOM</p><div class="meta-wrap" data-v-21365b21><p class="meta" data-v-21365b21>Phone: +44 (0) 20 3457 0462</p></div></div></div></div><div class="search-wrap cf" data-v-21365b21><form class="search-term" data-v-36b4823c data-v-21365b21><input placeholder="Search" required="required" value="" data-v-36b4823c><button type="submit" class="icr iconSearch" data-v-36b4823c>Submit</button></form><a href="//mts.intechopen.com/account/login" target="_blank" class="cta button-type-1" data-v-21365b21>Author Panel Sign in</a></div><div class="legal-wrap" data-v-21365b21><ul class="legal-nav" data-v-21365b21><li data-v-21365b21><a href="/page/terms-and-conditions" data-v-21365b21>Terms and conditions</a></li><li data-v-21365b21><a href="/privacy-policy" data-v-21365b21>Privacy policy</a></li><li data-v-21365b21><a href="/page/customer-complaints" data-v-21365b21>Customer Complaints</a></li></ul><p class="copyright" data-v-21365b21> 2019 IntechOpen. All rights reserved.</p></div></div></div></footer></div><!----></div><script>window.__INITIAL_STATE__={errorStatus:null,topics:null,windowContext:"large",lastViewed:[],ofsBooksList:[],statistics:null,featuredNews:null,testimonials:null,loader:!1,home:{featuredBooks:[{type:"book",id:"7228",title:"Blockchain and Cryptocurrencies",subtitle:null,isOpenForSubmission:!1,hash:"44c73dd3c9afa94a3db7731254babaf2",slug:"blockchain-and-cryptocurrencies",bookSignature:"Asma Salman and Muthanna G. Abdul Razzaq",coverURL:"https://cdn.intechopen.com/books/images_new/7228.jpg",editors:[{id:"206443",title:"Dr.",name:"Asma",middleName:null,surname:"Salman",slug:"asma-salman",fullName:"Asma Salman"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8011",title:"Natural Hazards",subtitle:"Risk, Exposure, Response, and Resilience",isOpenForSubmission:!1,hash:"43ca8c43ab0963f6c43350764f696b63",slug:"natural-hazards-risk-exposure-response-and-resilience",bookSignature:"John P. Tiefenbacher",coverURL:"https://cdn.intechopen.com/books/images_new/8011.jpg",editors:[{id:"73876",title:"Prof.",name:"John",middleName:"P.",surname:"Tiefenbacher",slug:"john-tiefenbacher",fullName:"John Tiefenbacher"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7836",title:"The Art of Body Contouring",subtitle:null,isOpenForSubmission:!1,hash:"983c155c9b836c8e4947bb3946694bc9",slug:"the-art-of-body-contouring",bookSignature:"Alexandro Aguilera",coverURL:"https://cdn.intechopen.com/books/images_new/7836.jpg",editors:[{id:"162339",title:"Dr.",name:"Alexandro",middleName:null,surname:"Aguilera Salgado",slug:"alexandro-aguilera-salgado",fullName:"Alexandro Aguilera Salgado"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7581",title:"Neuroprotection",subtitle:null,isOpenForSubmission:!1,hash:"0a01b892051ad12c316ddf17801b962e",slug:"neuroprotection",bookSignature:"Raymond Chuen-Chung Chang and Yuen-Shan Ho",coverURL:"https://cdn.intechopen.com/books/images_new/7581.jpg",editors:[{id:"33396",title:"Dr.",name:"Raymond Chuen-Chung",middleName:null,surname:"Chang",slug:"raymond-chuen-chung-chang",fullName:"Raymond Chuen-Chung Chang"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8892",title:"Textile Manufacturing Processes",subtitle:null,isOpenForSubmission:!1,hash:"1437c101708777875352cbfd31f6241b",slug:"textile-manufacturing-processes",bookSignature:"Faheem Uddin",coverURL:"https://cdn.intechopen.com/books/images_new/8892.jpg",editors:[{id:"228107",title:"Prof.",name:"Faheem",middleName:null,surname:"Uddin",slug:"faheem-uddin",fullName:"Faheem Uddin"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"2160",title:"MATLAB",subtitle:"A Fundamental Tool for Scientific Computing and Engineering Applications - Volume 1",isOpenForSubmission:!1,hash:"dd9c658341fbd264ed4f8d9e6aa8ca29",slug:"matlab-a-fundamental-tool-for-scientific-computing-and-engineering-applications-volume-1",bookSignature:"Vasilios N. Katsikis",coverURL:"https://cdn.intechopen.com/books/images_new/2160.jpg",editors:[{id:"12289",title:"Prof.",name:"Vasilios",middleName:"N.",surname:"Katsikis",slug:"vasilios-katsikis",fullName:"Vasilios Katsikis"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"3568",title:"Recent Advances in Plant in vitro Culture",subtitle:null,isOpenForSubmission:!1,hash:"830bbb601742c85a3fb0eeafe1454c43",slug:"recent-advances-in-plant-in-vitro-culture",bookSignature:"Annarita Leva and Laura M. R. Rinaldi",coverURL:"https://cdn.intechopen.com/books/images_new/3568.jpg",editors:[{id:"142145",title:"Dr.",name:"Annarita",middleName:null,surname:"Leva",slug:"annarita-leva",fullName:"Annarita Leva"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7594",title:"Current Topics in Biochemical Engineering",subtitle:null,isOpenForSubmission:!1,hash:"391609f1f0cb3bba32befeb3aa40ccf3",slug:"current-topics-in-biochemical-engineering",bookSignature:"Naofumi Shiomi",coverURL:"https://cdn.intechopen.com/books/images_new/7594.jpg",editors:[{id:"163777",title:"Prof.",name:"Naofumi",middleName:null,surname:"Shiomi",slug:"naofumi-shiomi",fullName:"Naofumi Shiomi"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"3560",title:"Advances in Landscape Architecture",subtitle:null,isOpenForSubmission:!1,hash:"a20614517ec5f7e91188fe8e42832138",slug:"advances-in-landscape-architecture",bookSignature:"Murat zyavuz",coverURL:"https://cdn.intechopen.com/books/images_new/3560.jpg",editors:[{id:"93073",title:"Dr.",name:"Murat",middleName:null,surname:"Ozyavuz",slug:"murat-ozyavuz",fullName:"Murat Ozyavuz"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"1069",title:"Paresthesia",subtitle:null,isOpenForSubmission:!1,hash:"c0225cd8274b4384cd1c91e586645958",slug:"paresthesia",bookSignature:"Luiz E. Imbelloni and Marildo A. Gouveia",coverURL:"https://cdn.intechopen.com/books/images_new/1069.jpg",editors:[{id:"80284",title:"Dr.",name:"Luiz Eduardo",middleName:null,surname:"Imbelloni",slug:"luiz-eduardo-imbelloni",fullName:"Luiz Eduardo Imbelloni"}],productType:{id:"1",chapterContentType:"chapter"}}],featuredProfiles:[{id:"179809",title:"Dr.",name:"Mahidzal",middleName:null,surname:"Dahari",slug:"mahidzal-dahari",fullName:"Mahidzal Dahari",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"528",title:"Dr.",name:"Kresimir",middleName:null,surname:"Delac",slug:"kresimir-delac",fullName:"Kresimir Delac",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/528/images/system/528.jpg",biography:"K. Delac received his B.Sc.E.E. degree in 2003 and is currentlypursuing a Ph.D. degree at the University of Zagreb, Faculty of Electrical Engineering andComputing. His current research interests are digital image analysis, pattern recognition andbiometrics.",institutionString:null,institution:{name:"University of Zagreb",country:{name:"Croatia"}}},{id:"46434",title:"Prof.",name:"Ioannis",middleName:null,surname:"Xenarios",slug:"ioannis-xenarios",fullName:"Ioannis Xenarios",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null}]},newsLanding:{offset:4,limit:4,total:160,newsList:[{slug:"intechopen-welcomes-new-head-of-sales-strategy-20190813",title:"IntechOpen welcomes new Head of Sales Strategy",intro:"<p>IntechOpen has appointed a new Head of Sales Strategy, Brett Thomas. Brett is a business development strategist with many years experience in the publishing industry, most recently at the American Institute of Physics and the American Chemical Society.</p>\n\n<p>The Head of Sales Strategy will be responsible for the full commercialization and sales of IntechOpen&rsquo;s suite of product-lines around the world. He will look after the product needs of customers and set-up, maintain and expand IntechOpen&acute;s vendor and institutional relationships.</p>",publishedDatetime:"13th August 2019",mainMedia:null},{slug:"intechopen-joins-oaspa-20190723",title:"IntechOpen joins OASPA",intro:"<p>As part of its commitment to quality and standards in Open Access book publishing, IntechOpen has joined the Open Access Scholarly Publishers Association (OASPA).&nbsp;</p>",publishedDatetime:"23rd July 2019",mainMedia:null},{slug:"anke-beck-interviewed-on-beyond-the-book-podcast-20190717",title:"Anke Beck interviewed on Beyond the Book podcast",intro:'<p><em>&ldquo;We focus on books where we believe there&rsquo;s a greater space for ideas to flourish, and for collections of ideas to come together,&rdquo; Anke Beck, <a href="https://beyondthebookcast.com/building-a-science-community-one-oa-book-at-a-time/">Beyond the Book</a> podcast</em>.</p>',publishedDatetime:"15th July 2019",mainMedia:null},{slug:"intechopen-welcomes-new-head-of-marketing-20190430",title:"IntechOpen welcomes new Head of Marketing",intro:"<p>IntechOpen has appointed Marcus Parker as Head of Marketing. Marcus brings many years experience in the publishing industry in various marketing, sales and publisher roles and will be based in the IntechOpen London office. &nbsp;</p>",publishedDatetime:"30th April 2019",mainMedia:null}]},news:{item:{slug:"intech-regional-research-spotlight-series-middle-east",title:"IntechOpen Regional Research Spotlight Series - Middle East",subtitle:null,metaTitle:"InTech Regional Research Spotlight Series - Middle East",metaDescription:"Partnerships aimed at improving science and technology in the Middle East are in the best interests of both the developed and the developing worlds, where more opportunities would arise to excel in particular fields of science leading to more varied contributions to global research trends.",metaKeywords:null,publishedDatetime:"19th June 2015",contentRaw:'[{"type":"htmlEditorComponent","content":"<p>Partnerships aimed at improving science and technology in the Middle East are in the best interests of both the developed and the developing worlds, where more opportunities would arise to excel in particular fields of science leading to more varied contributions to global research trends.</p>\\n\\n<p>In order to open up further to international scientific communities and exchange knowledge on a global basis, IntechOpen has been collaborating with universities, and has been publishing the works of authors and editors from the Middle East for 10 years now.</p>\\n\\n<p>With the goal to strengthen these partnerships our team visited Oman (German University of Science and Technology, Arab Open University and the Muscat College), Qatar (Qatar University, Hamad Medical Corporation and the College of North Atlantic) and the UAE ( UAE University, Al Ain University of Science and Technology, Zayed University, Abu Dhabi University, Al Maktoum Medical Library and Dubai Health Authority).</p>\\n\\n<p>To promote further a 2-way exchange of knowledge, IntechOpen partnered recently with <a href=\\"http://www.panworldeducation.com/\\" target=\\"_blank\\">Panworld Education</a> whose goal is to support educational institutions, corporates, governments and ministries, as well as various industry sectors with the latest research outputs.</p>\\n\\n<p>In this view, IntechOpen and its publications have been presented at the Abu Dhabi&#39;s Book Fair 2015.</p>\\n\\n<p><strong>Future Events</strong></p>\\n\\n<p>IntechOpen and Panworld Education will be participating to the following local book fair:</p>\\n\\n<p>34. Sharjah International Book Fair 4th - 14th November 2015</p>\\n\\n<p><strong>Collaborations</strong></p>\\n\\n<p>We are looking forward to continue working on projects, publications and partnerships in the region. Our main goal remains promoting the locally based research efforts and applications on an international level, as well as give a more direct access to our portfolio of international titles to those living in the region and with a stake in science.</p>\\n\\n<p>The book department <a href=\\"/publish\\" target=\\"_blank\\">welcomes projects</a>, publications and partnerships involving Middle East based science communities as part of its mission to promote their latest research efforts and applications on a global level.</p>\\n"}]',published:!0,mainMedia:null},components:[{type:"htmlEditorComponent",content:'<p>Partnerships aimed at improving science and technology in the Middle East are in the best interests of both the developed and the developing worlds, where more opportunities would arise to excel in particular fields of science leading to more varied contributions to global research trends.</p>\n\n<p>In order to open up further to international scientific communities and exchange knowledge on a global basis, IntechOpen has been collaborating with universities, and has been publishing the works of authors and editors from the Middle East for 10 years now.</p>\n\n<p>With the goal to strengthen these partnerships our team visited Oman (German University of Science and Technology, Arab Open University and the Muscat College), Qatar (Qatar University, Hamad Medical Corporation and the College of North Atlantic) and the UAE ( UAE University, Al Ain University of Science and Technology, Zayed University, Abu Dhabi University, Al Maktoum Medical Library and Dubai Health Authority).</p>\n\n<p>To promote further a 2-way exchange of knowledge, IntechOpen partnered recently with <a href="http://www.panworldeducation.com/" target="_blank">Panworld Education</a> whose goal is to support educational institutions, corporates, governments and ministries, as well as various industry sectors with the latest research outputs.</p>\n\n<p>In this view, IntechOpen and its publications have been presented at the Abu Dhabi&#39;s Book Fair 2015.</p>\n\n<p><strong>Future Events</strong></p>\n\n<p>IntechOpen and Panworld Education will be participating to the following local book fair:</p>\n\n<p>34. Sharjah International Book Fair 4th - 14th November 2015</p>\n\n<p><strong>Collaborations</strong></p>\n\n<p>We are looking forward to continue working on projects, publications and partnerships in the region. Our main goal remains promoting the locally based research efforts and applications on an international level, as well as give a more direct access to our portfolio of international titles to those living in the region and with a stake in science.</p>\n\n<p>The book department <a href="/publish" target="_blank">welcomes projects</a>, publications and partnerships involving Middle East based science communities as part of its mission to promote their latest research efforts and applications on a global level.</p>\n'}],latestNews:[{slug:"intechopen-welcomes-new-head-of-sales-strategy-20190813",title:"IntechOpen welcomes new Head of Sales Strategy"},{slug:"intechopen-joins-oaspa-20190723",title:"IntechOpen joins OASPA"},{slug:"anke-beck-interviewed-on-beyond-the-book-podcast-20190717",title:"Anke Beck interviewed on Beyond the Book podcast"},{slug:"intechopen-welcomes-new-head-of-marketing-20190430",title:"IntechOpen welcomes new Head of Marketing"},{slug:"intechopen-partners-with-enago-to-help-scientists-make-their-books-accessible-to-readers-worldwide-20190402",title:"IntechOpen Partners with Enago to Help Scientists Make Their Books Accessible to Readers Worldwide"},{slug:"mysciencework-and-intechopen-agreement-for-indexing-of-open-access-books-20190403",title:"MyScienceWork and IntechOpen agreement for indexing of Open Access Books"},{slug:"4-000-thank-yous-from-intechopen-20190315",title:"4,000 thank yous from IntechOpen"},{slug:"new-program-directors-at-intechopen-20190311",title:"New Program Directors at IntechOpen"}]},book:{item:{type:"book",id:"117",leadTitle:null,fullTitle:"Artificial Neural Networks - Methodological Advances and Biomedical Applications",title:"Artificial Neural Networks",subtitle:"Methodological Advances and Biomedical Applications",reviewType:"peer-reviewed",abstract:"Artificial neural networks may probably be the single most successful technology in the last two decades which has been widely used in a large variety of applications in various areas.  The purpose of this book is to provide recent advances of artificial neural networks in biomedical applications.  The book begins with fundamentals of artificial neural networks, which cover an introduction, design, and optimization.  Advanced architectures for biomedical applications, which offer improved performance and desirable properties, follow.  Parts continue with biological applications such as gene, plant biology, and stem cell, medical applications such as skin diseases, sclerosis, anesthesia, and physiotherapy, and clinical and other applications such as clinical outcome, telecare, and pre-med student failure prediction.  Thus, this book will be a fundamental source of recent advances and applications of artificial neural networks in biomedical areas.  The target audience includes professors and students in engineering and medical schools, researchers and engineers in biomedical industries, medical doctors, and healthcare professionals.",isbn:null,printIsbn:"978-953-307-243-2",pdfIsbn:null,doi:"10.5772/644",price:170,slug:"artificial-neural-networks-methodological-advances-and-biomedical-applications",numberOfPages:376,isOpenForSubmission:!1,hash:null,bookSignature:"Kenji Suzuki",publishedDate:"April 11th 2011",coverURL:"https://cdn.intechopen.com/books/images_new/117.jpg",numberOfDownloads:85986,numberOfWosCitations:124,numberOfCrossrefCitations:115,numberOfDimensionsCitations:266,hasAltmetrics:1,numberOfTotalCitations:505,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"June 1st 2010",dateEndSecondStepPublish:"June 29th 2010",dateEndThirdStepPublish:"November 3rd 2010",dateEndFourthStepPublish:"December 3rd 2010",dateEndFifthStepPublish:"February 1st 2011",currentStepOfPublishingProcess:5,indexedIn:"1,2,3,4,5,6,7,8",editedByType:"Edited by",editors:[{id:"3095",title:"Prof.",name:"Kenji",middleName:null,surname:"Suzuki",slug:"kenji-suzuki",fullName:"Kenji Suzuki",profilePictureURL:"https://mts.intechopen.com/storage/users/3095/images/1592_n.jpg",biography:"Kenji Suzuki received his Ph.D. degree in information engineering from Nagoya University in 2001.  From 1993 to 2001, he worked at Hitachi Medical Corporation, and then Aichi Prefectural University as faculty.  In 2001, he joined Department of Radiology at University of Chicago.  Since 2006, he has been Assistant Professor of Radiology, Medical Physics, and Cancer Research Center there.  Dr. Suzuki research interests include computer-aided diagnosis and machine learning.  He has published 220 papers (including 88 peer-reviewed journal papers).  He has been serving as the Editor-in-Chief and an Associate Editor of 23 leading international journals including Medical Physics, International Journal of Biomedical Imaging, and Academic Radiology.  He has received Paul Hodges Award, three RSNA Certificate of Merit Awards and Research Trainee Prize, Cancer Research Foundation Young Investigator Award, SPIE Honorable Mention Poster Award, IEEE Outstanding Member Award, and Kurt Rossmann Excellence in Teaching Award.  He has been a Senior Member of IEEE since 2004.",institutionString:null,position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"3",institution:{name:"University of Chicago",institutionURL:null,country:{name:"United States of America"}}}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"609",title:"Neural Network",slug:"numerical-analysis-and-scientific-computing-neural-network"}],chapters:[{id:"14881",title:"Introduction to the Artificial Neural Networks",doi:"10.5772/15751",slug:"introduction-to-the-artificial-neural-networks",totalDownloads:24927,totalCrossrefCites:29,totalDimensionsCites:55,signatures:"Andrej Krenker, Janez Bester and Andrej Kos",authors:[{id:"21859",title:"Dr.",name:"Andrej",surname:"Kos",slug:"andrej-kos",fullName:"Andrej Kos"},{id:"62151",title:"Dr.",name:"Andrej",surname:"Krenker",slug:"andrej-krenker",fullName:"Andrej Krenker"}],corrections:null},{id:"14882",title:"Review of Input Variable Selection Methods for Artificial Neural Networks",doi:"10.5772/16004",slug:"review-of-input-variable-selection-methods-for-artificial-neural-networks",totalDownloads:8329,totalCrossrefCites:61,totalDimensionsCites:139,signatures:"Robert May, Graeme Dandy and Holger Maier",authors:[{id:"22868",title:"Dr.",name:"Robert",surname:"May",slug:"robert-may",fullName:"Robert May"},{id:"23014",title:"Dr.",name:"Holger",surname:"Maier",slug:"holger-maier",fullName:"Holger Maier"},{id:"26897",title:"Prof.",name:"Graeme",surname:"Dandy",slug:"graeme-dandy",fullName:"Graeme Dandy"}],corrections:null},{id:"14883",title:"Artificial Neural Networks and Efficient Optimization Techniques for Applications in Engineering",doi:"10.5772/15293",slug:"artificial-neural-networks-and-efficient-optimization-techniques-for-applications-in-engineering",totalDownloads:4843,totalCrossrefCites:3,totalDimensionsCites:4,signatures:"Rossana M. S. Cruz, Helton M. Peixoto and Rafael M. Magalhaes",authors:[{id:"20227",title:"Dr.",name:"Rossana",surname:"Moreno Santa Cruz",slug:"rossana-moreno-santa-cruz",fullName:"Rossana Moreno Santa Cruz"},{id:"23214",title:"MSc.",name:"Helton",surname:"Maia Peixoto",slug:"helton-maia-peixoto",fullName:"Helton Maia Peixoto"},{id:"23215",title:"Prof.",name:"Rafael",surname:"Marrocos Magalhes",slug:"rafael-marrocos-magalhaes",fullName:"Rafael Marrocos Magalhes"}],corrections:null},{id:"14884",title:"Pixel-Based Artificial Neural Networks in Computer-Aided Diagnosis",doi:"10.5772/16084",slug:"pixel-based-artificial-neural-networks-in-computer-aided-diagnosis",totalDownloads:3284,totalCrossrefCites:1,totalDimensionsCites:1,signatures:"Kenji Suzuki",authors:[{id:"3095",title:"Prof.",name:"Kenji",surname:"Suzuki",slug:"kenji-suzuki",fullName:"Kenji Suzuki"}],corrections:null},{id:"14885",title:"Applied Artificial Neural Networks: from Associative Memories to Biomedical Applications",doi:"10.5772/15325",slug:"applied-artificial-neural-networks-from-associative-memories-to-biomedical-applications",totalDownloads:3460,totalCrossrefCites:0,totalDimensionsCites:1,signatures:"Mahmood Amiri and Katayoun Derakhshandeh",authors:[{id:"20356",title:"Dr.",name:"Mahmood",surname:"Amiri",slug:"mahmood-amiri",fullName:"Mahmood Amiri"},{id:"22988",title:"Dr.",name:"Katayoun",surname:"Derakhshandeh",slug:"katayoun-derakhshandeh",fullName:"Katayoun Derakhshandeh"}],corrections:null},{id:"14886",title:"Medical Image Segmentation Using Artificial Neural Networks",doi:"10.5772/16103",slug:"medical-image-segmentation-using-artificial-neural-networks",totalDownloads:7467,totalCrossrefCites:3,totalDimensionsCites:16,signatures:"Mostafa Jabarouti Moghaddam and Hamid Soltanian-Zadeh",authors:[{id:"23180",title:"PhD.",name:"Hamid",surname:"Soltanian-Zadeh",slug:"hamid-soltanian-zadeh",fullName:"Hamid Soltanian-Zadeh"},{id:"23181",title:"PhD.",name:"Mostafa",surname:"Jabarouti Moghaddam",slug:"mostafa-jabarouti-moghaddam",fullName:"Mostafa Jabarouti Moghaddam"}],corrections:null},{id:"14887",title:"Artificial Neural Networks and Predictive Medicine: a Revolutionary Paradigm Shift",doi:"10.5772/15810",slug:"artificial-neural-networks-and-predictive-medicine-a-revolutionary-paradigm-shift",totalDownloads:2819,totalCrossrefCites:0,totalDimensionsCites:5,signatures:"Enzo Grossi",authors:[{id:"22119",title:"Dr.",name:"Enzo",surname:"Grossi",slug:"enzo-grossi",fullName:"Enzo Grossi"}],corrections:null},{id:"14888",title:"Reputation-Based Neural Network Combinations",doi:"10.5772/16194",slug:"reputation-based-neural-network-combinations",totalDownloads:1879,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Mohammad Nikjoo, Azadeh Kushki, Joon Lee, Catriona Steele and Tom Chau",authors:[{id:"5960",title:"Dr.",name:"Tom",surname:"Chau",slug:"tom-chau",fullName:"Tom Chau"},{id:"23592",title:"PhD.",name:"Mohammad",surname:"Nikjoo",slug:"mohammad-nikjoo",fullName:"Mohammad Nikjoo"},{id:"29754",title:"PhD.",name:"Azadeh",surname:"Kushki",slug:"azadeh-kushki",fullName:"Azadeh Kushki"},{id:"29755",title:"Dr.",name:"Catriona",surname:"Steele",slug:"catriona-steele",fullName:"Catriona Steele"}],corrections:null},{id:"14889",title:"Prioritising Genes with an Artificial Neural Network Comprising Medical Documents to Accelerate Positional Cloning in Biological Research",doi:"10.5772/16135",slug:"prioritising-genes-with-an-artificial-neural-network-comprising-medical-documents-to-accelerate-posi",totalDownloads:1780,totalCrossrefCites:1,totalDimensionsCites:1,signatures:"Norio Kobayashi and Tetsuro Toyoda",authors:[{id:"23334",title:"Dr.",name:"Tetsuro",surname:"Toyoda",slug:"tetsuro-toyoda",fullName:"Tetsuro Toyoda"},{id:"27263",title:"Dr.",name:"Norio",surname:"Kobayashi",slug:"norio-kobayashi",fullName:"Norio Kobayashi"}],corrections:null},{id:"14890",title:"Artificial Neural Networks Technology to Model and Predict Plant Biology Process",doi:"10.5772/14945",slug:"artificial-neural-networks-technology-to-model-and-predict-plant-biology-process",totalDownloads:3782,totalCrossrefCites:3,totalDimensionsCites:22,signatures:"Pedro P. Gallego, Jorge Gago and Mariana Landin",authors:[{id:"19226",title:"Prof.",name:"Pedro",surname:"Gallego",slug:"pedro-gallego",fullName:"Pedro Gallego"},{id:"23361",title:"Prof.",name:"Mariana",surname:"Landin",slug:"mariana-landin",fullName:"Mariana Landin"},{id:"23362",title:"Dr.",name:"Jorge",surname:"Gago",slug:"jorge-gago",fullName:"Jorge Gago"}],corrections:null},{id:"14891",title:"The Usefulness of Artificial Neural Networks in Predicting the Outcome of Hematopoietic Stem Cell Transplantation",doi:"10.5772/16042",slug:"the-usefulness-of-artificial-neural-networks-in-predicting-the-outcome-of-hematopoietic-stem-cell-tr",totalDownloads:2702,totalCrossrefCites:0,totalDimensionsCites:1,signatures:"Giovanni Caocci, Roberto Baccoli and Giorgio La Nasa",authors:[{id:"22963",title:"Dr.",name:"Giovanni",surname:"Caocci",slug:"giovanni-caocci",fullName:"Giovanni Caocci"},{id:"22965",title:"Dr.",name:"Roberto",surname:"Baccoli",slug:"roberto-baccoli",fullName:"Roberto Baccoli"},{id:"22966",title:"Dr.",name:"Giorgio",surname:"La Nasa",slug:"giorgio-la-nasa",fullName:"Giorgio La Nasa"}],corrections:null},{id:"14892",title:"Artificial Neural Networks and Retinal Ganglion Cell Responses",doi:"10.5772/15954",slug:"artificial-neural-networks-and-retinal-ganglion-cell-responses",totalDownloads:2175,totalCrossrefCites:0,totalDimensionsCites:1,signatures:"Maria P. Bonomini, Jose M. Ferrandez and Eduardo Fernandez",authors:[{id:"22652",title:"Prof.",name:"Jose M.",surname:"Ferrandez",slug:"jose-m.-ferrandez",fullName:"Jose M. Ferrandez"},{id:"22982",title:"Dr.",name:"Maria P.",surname:"Bonomini",slug:"maria-p.-bonomini",fullName:"Maria P. Bonomini"},{id:"22983",title:"Prof.",name:"Eduardo",surname:"Fernndez",slug:"eduardo-fernandez",fullName:"Eduardo Fernndez"}],corrections:null},{id:"14893",title:"Diagnosing Skin Diseases Using an Artificial Neural Network",doi:"10.5772/16232",slug:"diagnosing-skin-diseases-using-an-artificial-neural-network",totalDownloads:4550,totalCrossrefCites:5,totalDimensionsCites:6,signatures:"Bakpo, F. S. and Kabari, L. G",authors:[{id:"20357",title:"Dr.",name:"Francis",surname:"Bakpo",slug:"francis-bakpo",fullName:"Francis Bakpo"}],corrections:null},{id:"14894",title:"Artificial Neural Networks Used to Study the Evolution of the Multiple Sclerosis",doi:"10.5772/14952",slug:"artificial-neural-networks-used-to-study-the-evolution-of-the-multiple-sclerosis",totalDownloads:2464,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Tabares Ospina and Hector Anibal",authors:[{id:"19213",title:"Dr.",name:"Hctor",surname:"Tabares Ospina",slug:"hector-tabares-ospina",fullName:"Hctor Tabares Ospina"}],corrections:null},{id:"14895",title:"Estimation the Depth of Anesthesia by the Use of Artificial Neural Network",doi:"10.5772/15139",slug:"estimation-the-depth-of-anesthesia-by-the-use-of-artificial-neural-network",totalDownloads:2688,totalCrossrefCites:5,totalDimensionsCites:5,signatures:"Hossein Rabbani, Alireza Mehri Dehnavi and Mehrab Ghanatbari",authors:[{id:"19794",title:"Dr.",name:"Hossein",surname:"Rabbani",slug:"hossein-rabbani",fullName:"Hossein Rabbani"},{id:"19795",title:"Dr.",name:"Alireza",surname:"Mehri Dehnavi",slug:"alireza-mehri-dehnavi",fullName:"Alireza Mehri Dehnavi"},{id:"23086",title:"Dr.",name:"Mehrab",surname:"Ghanatbari",slug:"mehrab-ghanatbari",fullName:"Mehrab Ghanatbari"}],corrections:null},{id:"14896",title:"Artificial Neural Networks (ANN) Applied for Gait Classification and Physiotherapy Monitoring in Post Stroke Patients",doi:"10.5772/15363",slug:"artificial-neural-networks-ann-applied-for-gait-classification-and-physiotherapy-monitoring-in-post-",totalDownloads:2538,totalCrossrefCites:3,totalDimensionsCites:4,signatures:"Katarzyna Kaczmarczyk, Andrzej Wit, Maciej Krawczyk, Jacek Zaborski and Jozef Pisudski",authors:[{id:"20501",title:"Dr.",name:"Katarzyna",surname:"Kaczmarczyk",slug:"katarzyna-kaczmarczyk",fullName:"Katarzyna Kaczmarczyk"},{id:"23066",title:"Dr.",name:"Andrzej",surname:"Wit",slug:"andrzej-wit",fullName:"Andrzej Wit"},{id:"23067",title:"Dr.",name:"Maciej",surname:"Krawczyk",slug:"maciej-krawczyk",fullName:"Maciej Krawczyk"},{id:"23068",title:"Dr.",name:"Jacek",surname:"Zaborski",slug:"jacek-zaborski",fullName:"Jacek Zaborski"}],corrections:null},{id:"14897",title:"Forcasting the Clinical Outcome: Artificial Neural Networks or Multivariate Statistical Models?",doi:"10.5772/15974",slug:"forcasting-the-clinical-outcome-artificial-neural-networks-or-multivariate-statistical-models-",totalDownloads:2086,totalCrossrefCites:1,totalDimensionsCites:5,signatures:"Ahmed Akl and Mohamed A Ghoneim",authors:[{id:"22724",title:"Dr.",name:"Mohamed A.",surname:"Ghoneim",slug:"mohamed-a.-ghoneim",fullName:"Mohamed A. Ghoneim"},{id:"25964",title:"Dr.",name:"Ahmed",surname:"Akl",slug:"ahmed-akl",fullName:"Ahmed Akl"}],corrections:null},{id:"14898",title:"Telecare Adoption Model Based on Artificial Neural Networks",doi:"10.5772/16100",slug:"telecare-adoption-model-based-on-artificial-neural-networks",totalDownloads:2090,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Jui-Chen Huang",authors:[{id:"23163",title:"Prof.",name:"Jui-Chen",surname:"Huang",slug:"jui-chen-huang",fullName:"Jui-Chen Huang"}],corrections:null},{id:"14899",title:"Effectiveness of Artificial Neural Networks in Forecasting Failure Risk for Pre-Medical Students",doi:"10.5772/16021",slug:"effectiveness-of-artificial-neural-networks-in-forecasting-failure-risk-for-pre-medical-students",totalDownloads:2123,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Jawaher K. Alenezi, Mohammed M. Awny and Maged M. M. Fahmy",authors:[{id:"22900",title:"PhD.",name:"Jawaher K.",surname:"Alenezi",slug:"jawaher-k.-alenezi",fullName:"Jawaher K. Alenezi"},{id:"22901",title:"Dr.",name:"Mohammed",surname:"Awny",slug:"mohammed-awny",fullName:"Mohammed Awny"},{id:"22902",title:"Dr.",name:"Maged M.M.",surname:"Fahmy",slug:"maged-m.m.-fahmy",fullName:"Maged M.M. Fahmy"}],corrections:null}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},relatedBooks:[{type:"book",id:"1586",title:"Artificial Neural Networks",subtitle:"Industrial and Control Engineering Applications",isOpenForSubmission:!1,hash:"64fde94410f80afcb569fa85aad70473",slug:"artificial-neural-networks-industrial-and-control-engineering-applications",bookSignature:"Kenji Suzuki",coverURL:"https://cdn.intechopen.com/books/images_new/1586.jpg",editedByType:"Edited by",editors:[{id:"3095",title:"Prof.",name:"Kenji",surname:"Suzuki",slug:"kenji-suzuki",fullName:"Kenji Suzuki"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3110",title:"Artificial Neural Networks",subtitle:"Architectures and Applications",isOpenForSubmission:!1,hash:"04f4fdbc45ccb86f7441e13605c1f2f4",slug:"artificial-neural-networks-architectures-and-applications",bookSignature:"Kenji Suzuki",coverURL:"https://cdn.intechopen.com/books/images_new/3110.jpg",editedByType:"Edited by",editors:[{id:"3095",title:"Prof.",name:"Kenji",surname:"Suzuki",slug:"kenji-suzuki",fullName:"Kenji Suzuki"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"33",title:"Self Organizing Maps",subtitle:"Applications and Novel Algorithm Design",isOpenForSubmission:!1,hash:null,slug:"self-organizing-maps-applications-and-novel-algorithm-design",bookSignature:"Josphat Igadwa Mwasiagi",coverURL:"https://cdn.intechopen.com/books/images_new/33.jpg",editedByType:"Edited by",editors:[{id:"16821",title:"Dr.",name:"Josphat Igadwa",surname:"Mwasiagi",slug:"josphat-igadwa-mwasiagi",fullName:"Josphat Igadwa Mwasiagi"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1587",title:"Artificial Neural Networks",subtitle:"Application",isOpenForSubmission:!1,hash:"2eba6989e74898028ddf52302dc10577",slug:"artificial-neural-networks-application",bookSignature:"Chi Leung Patrick Hui",coverURL:"https://cdn.intechopen.com/books/images_new/1587.jpg",editedByType:"Edited by",editors:[{id:"22866",title:"Dr.",name:"Chi Leung Patrick",surname:"Hui",slug:"chi-leung-patrick-hui",fullName:"Chi Leung Patrick Hui"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"45",title:"Ant Colony Optimization",subtitle:"Methods and Applications",isOpenForSubmission:!1,hash:null,slug:"ant-colony-optimization-methods-and-applications",bookSignature:"Avi Ostfeld",coverURL:"https://cdn.intechopen.com/books/images_new/45.jpg",editedByType:"Edited by",editors:[{id:"15000",title:"Dr.",name:"Avi",surname:"Ostfeld",slug:"avi-ostfeld",fullName:"Avi Ostfeld"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"102",title:"Recurrent Neural Networks for Temporal Data Processing",subtitle:null,isOpenForSubmission:!1,hash:"7089e08bb69d3ec2993cb5eb1d8f5e5a",slug:"recurrent-neural-networks-for-temporal-data-processing",bookSignature:"Hubert Cardot",coverURL:"https://cdn.intechopen.com/books/images_new/102.jpg",editedByType:"Edited by",editors:[{id:"10879",title:"Prof.",name:"Hubert",surname:"Cardot",slug:"hubert-cardot",fullName:"Hubert Cardot"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6118",title:"Recurrent Neural Networks",subtitle:null,isOpenForSubmission:!1,hash:"50220ea2482aebdb822dfdb5d4bfd6a1",slug:"recurrent_neural_networks",bookSignature:"Xiaolin Hu and P. Balasubramaniam",coverURL:"https://cdn.intechopen.com/books/images_new/6118.jpg",editedByType:"Edited by",editors:[{id:"252213",title:"Dr.",name:"Xiaolin",surname:"Hu",slug:"xiaolin-hu",fullName:"Xiaolin Hu"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1871",title:"Recurrent Neural Networks and Soft Computing",subtitle:null,isOpenForSubmission:!1,hash:"d3024ad4a23da3efee2eb8db0adab9ba",slug:"recurrent-neural-networks-and-soft-computing",bookSignature:"Mahmoud ElHefnawi and Mohamed Mysara",coverURL:"https://cdn.intechopen.com/books/images_new/1871.jpg",editedByType:"Edited by",editors:[{id:"31550",title:"Dr.",name:"Mahmoud",surname:"ElHefnawi",slug:"mahmoud-elhefnawi",fullName:"Mahmoud ElHefnawi"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7324",title:"Digital Systems",subtitle:null,isOpenForSubmission:!1,hash:"adf940a607ffa7fc2b3d27fb9afd906a",slug:"digital-systems",bookSignature:"Vahid Asadpour",coverURL:"https://cdn.intechopen.com/books/images_new/7324.jpg",editedByType:"Edited by",editors:[{id:"165328",title:"Dr.",name:"Vahid",surname:"Asadpour",slug:"vahid-asadpour",fullName:"Vahid Asadpour"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5973",title:"Memristor and Memristive Neural Networks",subtitle:null,isOpenForSubmission:!1,hash:"57e216c84cb7703f8ad59555b2a11ede",slug:"memristor-and-memristive-neural-networks",bookSignature:"Alex Pappachen James",coverURL:"https://cdn.intechopen.com/books/images_new/5973.jpg",editedByType:"Edited by",editors:[{id:"6992",title:"Prof.",name:"Alex",surname:"James",slug:"alex-james",fullName:"Alex James"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],ofsBooks:[]},correction:{item:{id:"66063",slug:"corrigendum-to-introductory-chapter-historical-perspective-and-brief-overview-of-insulin",title:"Corrigendum to: Introductory Chapter: Historical Perspective and Brief Overview of Insulin",doi:null,correctionPDFUrl:"https://cdn.intechopen.com/pdfs/66063.pdf",downloadPdfUrl:"/chapter/pdf-download/66063",previewPdfUrl:"/chapter/pdf-preview/66063",totalDownloads:null,totalCrossrefCites:null,bibtexUrl:"/chapter/bibtex/66063",risUrl:"/chapter/ris/66063",chapter:{id:"63640",slug:"introductory-chapter-historical-perspective-and-brief-overview-of-insulin",signatures:"Gaffar Sarwar Zaman",dateSubmitted:"June 29th 2018",dateReviewed:"August 28th 2018",datePrePublished:"November 5th 2018",datePublished:"February 6th 2019",book:{id:"6675",title:"Ultimate Guide to Insulin",subtitle:null,fullTitle:"Ultimate Guide to Insulin",slug:"ultimate-guide-to-insulin",publishedDate:"February 6th 2019",bookSignature:"Gaffar Zaman",coverURL:"https://cdn.intechopen.com/books/images_new/6675.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"203015",title:"Dr.",name:"Gaffar",middleName:"Sarwar",surname:"Zaman",slug:"gaffar-zaman",fullName:"Gaffar Zaman"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"203015",title:"Dr.",name:"Gaffar",middleName:"Sarwar",surname:"Zaman",fullName:"Gaffar Zaman",slug:"gaffar-zaman",email:"gffrzaman@gmail.com",position:null,institution:{name:"King Khalid University",institutionURL:null,country:{name:"Saudi Arabia"}}}]}},chapter:{id:"63640",slug:"introductory-chapter-historical-perspective-and-brief-overview-of-insulin",signatures:"Gaffar Sarwar Zaman",dateSubmitted:"June 29th 2018",dateReviewed:"August 28th 2018",datePrePublished:"November 5th 2018",datePublished:"February 6th 2019",book:{id:"6675",title:"Ultimate Guide to Insulin",subtitle:null,fullTitle:"Ultimate Guide to Insulin",slug:"ultimate-guide-to-insulin",publishedDate:"February 6th 2019",bookSignature:"Gaffar Zaman",coverURL:"https://cdn.intechopen.com/books/images_new/6675.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"203015",title:"Dr.",name:"Gaffar",middleName:"Sarwar",surname:"Zaman",slug:"gaffar-zaman",fullName:"Gaffar Zaman"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"203015",title:"Dr.",name:"Gaffar",middleName:"Sarwar",surname:"Zaman",fullName:"Gaffar Zaman",slug:"gaffar-zaman",email:"gffrzaman@gmail.com",position:null,institution:{name:"King Khalid University",institutionURL:null,country:{name:"Saudi Arabia"}}}]},book:{id:"6675",title:"Ultimate Guide to Insulin",subtitle:null,fullTitle:"Ultimate Guide to Insulin",slug:"ultimate-guide-to-insulin",publishedDate:"February 6th 2019",bookSignature:"Gaffar Zaman",coverURL:"https://cdn.intechopen.com/books/images_new/6675.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"203015",title:"Dr.",name:"Gaffar",middleName:"Sarwar",surname:"Zaman",slug:"gaffar-zaman",fullName:"Gaffar Zaman"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},ofsBook:{item:{type:"book",id:"10056",leadTitle:null,title:"Metal Heat Treatments",subtitle:null,reviewType:"peer-reviewed",abstract:"This book will be a self-contained collection of scholarly papers targeting an audience of practicing researchers, academics, PhD students and other scientists. The contents of the book will be written by multiple authors and edited by experts in the field.",isbn:null,printIsbn:null,pdfIsbn:null,doi:null,price:0,slug:null,numberOfPages:0,isOpenForSubmission:!1,hash:"4d2be0df78da1e2df21a9eb81784a5ce",bookSignature:"",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/10056.jpg",keywords:null,numberOfDownloads:null,numberOfWosCitations:0,numberOfCrossrefCitations:null,numberOfDimensionsCitations:null,numberOfTotalCitations:null,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"June 7th 2019",dateEndSecondStepPublish:"June 28th 2019",dateEndThirdStepPublish:"August 27th 2019",dateEndFourthStepPublish:"November 15th 2019",dateEndFifthStepPublish:"January 14th 2020",remainingDaysToSecondStep:"2 months",secondStepPassed:!0,currentStepOfPublishingProcess:1,editedByType:null,kuFlag:!1,editors:null,coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"14",title:"Materials Science",slug:"materials-science"}],chapters:null,productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:null},relatedBooks:[{type:"book",id:"7360",title:"Fillers",subtitle:"Synthesis, Characterization and Industrial Application",isOpenForSubmission:!1,hash:"4cb5f0dcdfc23d6ec4c1d5f72f726ab4",slug:"fillers-synthesis-characterization-and-industrial-application",bookSignature:"Amar Patnaik",coverURL:"https://cdn.intechopen.com/books/images_new/7360.jpg",editedByType:"Edited by",editors:[{id:"43660",title:"Associate Prof.",name:"Amar",surname:"Patnaik",slug:"amar-patnaik",fullName:"Amar Patnaik"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6805",title:"Electrical and Electronic Properties of Materials",subtitle:null,isOpenForSubmission:!1,hash:"f6b6930e7ae9d0704f68b5c180526309",slug:"electrical-and-electronic-properties-of-materials",bookSignature:"Md. Kawsar Alam",coverURL:"https://cdn.intechopen.com/books/images_new/6805.jpg",editedByType:"Edited by",editors:[{id:"199691",title:"Dr.",name:"Md. Kawsar",surname:"Alam",slug:"md.-kawsar-alam",fullName:"Md. Kawsar Alam"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6851",title:"New Uses of Micro and Nanomaterials",subtitle:null,isOpenForSubmission:!1,hash:"49e0ab8961c52c159da40dd3ec039be0",slug:"new-uses-of-micro-and-nanomaterials",bookSignature:"Marcelo Rubn Pagnola, Jairo Useche Vivero and Andres Guillermo Marrugo",coverURL:"https://cdn.intechopen.com/books/images_new/6851.jpg",editedByType:"Edited by",editors:[{id:"112233",title:"Dr.Ing.",name:"Marcelo Rubn",surname:"Pagnola",slug:"marcelo-ruben-pagnola",fullName:"Marcelo Rubn Pagnola"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6802",title:"Graphene Oxide",subtitle:"Applications and Opportunities",isOpenForSubmission:!1,hash:"075b313e11be74c55a1f66be5dd56b40",slug:"graphene-oxide-applications-and-opportunities",bookSignature:"Ganesh Kamble",coverURL:"https://cdn.intechopen.com/books/images_new/6802.jpg",editedByType:"Edited by",editors:[{id:"236420",title:"Dr.",name:"Ganesh  Shamrao",surname:"Kamble",slug:"ganesh-shamrao-kamble",fullName:"Ganesh  Shamrao Kamble"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6656",title:"Phase Change Materials and Their Applications",subtitle:null,isOpenForSubmission:!1,hash:"9b257f8386280bdde4633d36124787f2",slug:"phase-change-materials-and-their-applications",bookSignature:"Mohsen Mhadhbi",coverURL:"https://cdn.intechopen.com/books/images_new/6656.jpg",editedByType:"Edited by",editors:[{id:"228366",title:"Dr.",name:"Mohsen",surname:"Mhadhbi",slug:"mohsen-mhadhbi",fullName:"Mohsen Mhadhbi"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6517",title:"Emerging Solar Energy Materials",subtitle:null,isOpenForSubmission:!1,hash:"186936bb201bb186fb04b095aa39d9b8",slug:"emerging-solar-energy-materials",bookSignature:"Sadia Ameen, M. Shaheer Akhtar and  Hyung-Shik Shin",coverURL:"https://cdn.intechopen.com/books/images_new/6517.jpg",editedByType:"Edited by",editors:[{id:"52613",title:"Dr.",name:"Sadia",surname:"Ameen",slug:"sadia-ameen",fullName:"Sadia Ameen"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6320",title:"Advances in Glass Science and Technology",subtitle:null,isOpenForSubmission:!1,hash:"6d0a32a0cf9806bccd04101a8b6e1b95",slug:"advances-in-glass-science-and-technology",bookSignature:"Vincenzo M. Sglavo",coverURL:"https://cdn.intechopen.com/books/images_new/6320.jpg",editedByType:"Edited by",editors:[{id:"17426",title:"Prof.",name:"Vincenzo Maria",surname:"Sglavo",slug:"vincenzo-maria-sglavo",fullName:"Vincenzo Maria Sglavo"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6188",title:"Solidification",subtitle:null,isOpenForSubmission:!1,hash:"0405c42586170a1def7a4b011c5f2b60",slug:"solidification",bookSignature:"Alicia Esther Ares",coverURL:"https://cdn.intechopen.com/books/images_new/6188.jpg",editedByType:"Edited by",editors:[{id:"91095",title:"Dr.",name:"Alicia Esther",surname:"Ares",slug:"alicia-esther-ares",fullName:"Alicia Esther Ares"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"57797",title:"Advances in Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease and Associated Conditions",doi:"10.5772/intechopen.70920",slug:"advances-in-pulmonary-rehabilitation-for-chronic-obstructive-pulmonary-disease-and-associated-condit",body:'\n<div class="section" id="sec_1" data-lvl="1">\n<h2 class="heading main-title">1. Introduction</h2>\n<p id="p2">Chronic obstructive pulmonary disease (COPD), a systemic progressive disease that results in reduced exercise capacity and quality of life, progressive dyspnea, and mortality. It causes health and economic burdens unless pharmacologic and nonpharmacologic treatments are optimized. One of the most important interventions is pulmonary rehabilitation (PR). It is a proven modality and is included in COPD treatment guidelines. The evidence-based benefits are improvement in exercise capacity and quality of life, recovery time after hospitalization, and survival; and reduction in perceived intensity of breathlessness, number of hospitalizations, and days in hospital; and enhancement of the effect of long-acting bronchodilators. Although most studies included patients with moderate-to-severe COPD and demonstrated evidence for these patients, PR is recommended for all patients who are symptomatic with reduced exercise capacity and quality of life, regardless of disease severity. PR is also an effective, feasible modality during the intensive care unit (ICU) period and early periods after exacerbation. The recommended time for PR is during the perioperative period in lung transplantation. Additionally, PR is required before endobronchial volume reduction (EBVR) and has shown to be beneficial before and after lung cancer surgery. This chapter outlines the pathophysiologies that give rise to indications for PR, the latest developments in PR, and PR modalities associated with COPD.</p>\n</div>\n<div class="section" id="sec_2" data-lvl="1">\n<h2 class="heading main-title">2. The definition of PR</h2>\n<p id="p3">PR is described as &ldquo;a comprehensive intervention based on a thorough patient assessment followed by patient-tailored therapies that include, but are not limited to, exercise training, education, and behavior changes, that is designed to improve the physical and psychological conditions of people with chronic respiratory disease, and to promote the long-term adherence to health-enhancing behaviors [<a href="#B1" class="ref-link" data-ref-style="bibr">1</a>].&rdquo;</p>\n</div>\n<div class="section" id="sec_3" data-lvl="1">\n<h2 class="heading main-title">3. Pathophysiologies indicated for PR</h2>\n<div class="section" id="sec_3_2" data-lvl="2">\n<h3 class="heading section-title">3.1. Exercise limitation</h3>\n<p id="p4">Exercise intolarence is one of the most important and common symptoms experienced by patients with mild-to-severe COPD and are related to reduced health-related quality of life. Exercise intolerance in patients with COPD is primarily due to impaired ventilatory mechanics, but it is also associated with gas exchange limitation, cardiovascular factors, peripheral skeletal muscle dysfunction and a combination of these [<a href="#B2" class="ref-link" data-ref-style="bibr">2</a>, <a href="#B3" class="ref-link" data-ref-style="bibr">3</a>]. Additionally, anxiety and poor motivation are other factors of exercise intolerance. Although the exact association has yet to be found, it is thought that anxiety and depression contribute to exercise intolerance [<a href="#B4" class="ref-link" data-ref-style="bibr">4</a>], due to the effect that these have on increased symptom perception [<a href="#B5" class="ref-link" data-ref-style="bibr">5</a>, <a href="#B6" class="ref-link" data-ref-style="bibr">6</a>].</p>\n<p id="p5"><em>Ventilatory limitation:</em> Multiple factors determine ventilatory limitation, which consists of abnormalities in ventilatory mechanics and ventilatory muscle function. Other reasons for ventilatory limitation are increased ventilatory demands as a result of changes in gas exchange, and discordance in the neuroregulatory control of breathing. The most important pathophysiology in patients with COPD is expiratory flow limitation. During exercise, air becomes trapped, which results in dynamic lung hyperinflation (DH) above the already increased resting volumes. Additionally, DH inhibits tidal volume expansion during exercise and contributes to cardiac dysfunction by increasing the positive intrathoracic pressures, which likely contribute to cardiac impairment [<a href="#B7" class="ref-link" data-ref-style="bibr">7</a>].</p>\n<p id="p6"><em>Gas exchange limitation:</em> Hypoxia is likely to limit exercise tolerance. Hypoxia increases pulmonary ventilation by enhancing output of peripheral chemoreceptors and production of lactic acid. Lactic acidemia results in increased pulmonary ventilation because of an increase in carbon dioxide production due to buffered lactic acid [<a href="#B8" class="ref-link" data-ref-style="bibr">8</a>]. Above the lactic threshold, severe dyspnea correlates with increased work rates. Dyspnea may quickly increase. Furthermore, plasma norepinephrine and epinephrine also increase during exercise [<a href="#B9" class="ref-link" data-ref-style="bibr">9</a>, <a href="#B10" class="ref-link" data-ref-style="bibr">10</a>].</p>\n<p id="p7"><em>Cardiovascular factors:</em> In patients with COPD, the cardiovascular system is influenced by various mechanisms. The most important is an increase in right ventricular afterload through elevated pulmonary vascular resistance from direct vascular injury [<a href="#B11" class="ref-link" data-ref-style="bibr">11</a>, <a href="#B12" class="ref-link" data-ref-style="bibr">12</a>], hypoxic vasoconstriction [<a href="#B13" class="ref-link" data-ref-style="bibr">13</a>], and/or increases in effective pulmonary vascular resistance due to erythrocytosis [<a href="#B14" class="ref-link" data-ref-style="bibr">14</a>]. In the course of time, the overloaded right ventricle leads to right ventricular hypertrophy, which could result in right ventricular failure [<a href="#B15" class="ref-link" data-ref-style="bibr">15</a>]. During exercise, pulmonary vascular resistance is rapidly increased due to breathing at lung volumes close to total lung capacity [<a href="#B16" class="ref-link" data-ref-style="bibr">16</a>, <a href="#B17" class="ref-link" data-ref-style="bibr">17</a>]. Lung hyperinflation and excessive expiratory muscle recruitment are likely to reduce venous return and right ventricular preload in COPD [<a href="#B18" class="ref-link" data-ref-style="bibr">18</a>, <a href="#B19" class="ref-link" data-ref-style="bibr">19</a>]. Moreover, during exercise, large intrathoracic pressure swings for the purpose of overcoming the increased elastic and resistive loads, may result in left ventricular dysfunction by increasing left ventricular afterload [<a href="#B20" class="ref-link" data-ref-style="bibr">20</a>, <a href="#B21" class="ref-link" data-ref-style="bibr">21</a>]. These right ventricular effects can also compromise left ventricular filling through septal shifts that further reduce the ability of the heart to meet exercise demands [<a href="#B22" class="ref-link" data-ref-style="bibr">22</a>].</p>\n<p id="p8"><em>Peripheral skeletal muscle dysfunction:</em> Skeletal muscle dysfunction in patients with COPD is characterized by remarkably decreased muscle strength and endurance. The mechanisms are reduction in muscle mass and proportion of oxidative fibers, increases in the proportion of glycolytic fibers and muscle atrophy, and also a detoriation of oxidative metabolic capacity due to reductions in mitochondrial enzyme activities and capillary density. Additionally, systemic inflammation; malnutrition; corticosteroid use; hypoxemia; aging; smoking; the production of reactive oxygen and nitrogen species; enhanced protein degradation inside muscle fibers; increased activities of the proteasomal and lysosomal pathways; and activation of calpains and caspases contribute to muscle dysfunction. Therefore, patients with COPD enter into a vicious circle owing to disuse and inactivity due to the aforementioned mechanisms [<a href="#B23" class="ref-link" data-ref-style="bibr">23</a>].</p>\n</div>\n<div class="section" id="sec_4_2" data-lvl="2">\n<h3 class="heading section-title">3.2. Body composition disorders</h3>\n<p id="p9">Unexplained weight loss occurs in about 50% of patients with severe COPD and 15% of patients with mild-to-moderate COPD [<a href="#B24" class="ref-link" data-ref-style="bibr">24</a>, <a href="#B25" class="ref-link" data-ref-style="bibr">25</a>]. The main cause of weight loss in COPD is the reduction in skeletal muscle mass rather than loss of fat mass. Based on the reduction of fat mass or fat-free mass index (FFMI), nutritional abnormalities in COPD have been categorized into four types. Normal body mass index (BMI) with normal FFMI is normal, low BMI with normal or above-normal FFMI is defined as semistarvation, normal or above-normal BMI with low FFMI is defined as muscle atrophy, and low BMI with low FFMI as cachexia [<a href="#B26" class="ref-link" data-ref-style="bibr">26</a>]. There are several reasons for weight loss in patients with COPD, even if during a stable period. In patients with stable COPD, there is an increased metabolic rate due to abnormal respiratory dynamics, chronic systemic inflammation, and drugs [<a href="#B27" class="ref-link" data-ref-style="bibr">27</a>, <a href="#B28" class="ref-link" data-ref-style="bibr">28</a>, <a href="#B29" class="ref-link" data-ref-style="bibr">29</a>, <a href="#B30" class="ref-link" data-ref-style="bibr">30</a>, <a href="#B31" class="ref-link" data-ref-style="bibr">31</a>]. In malnourished mobile patients with COPD, although the basal metabolic rate is reduced, the resting energy expenditure is high. During exercise, inefficient muscle contractions due to increased consumption of adenosine triphosphate are added on. Also, there is an increase in the levels of inflammatory cytokines such as tumor necrosis factor-alpha (TNF-&alpha;) and interleukin (IL) 1&nbsp;in circulation. TNF-&alpha; and IL1 have been shown to contribute to weight loss even in healthy individuals [<a href="#B32" class="ref-link" data-ref-style="bibr">32</a>].</p>\n</div>\n<div class="section" id="sec_5_2" data-lvl="2">\n<h3 class="heading section-title">3.3. Psychological status</h3>\n<p id="p10">Patients with COPD have a higher prevalence of depression and anxiety than the general population [<a href="#B33" class="ref-link" data-ref-style="bibr">33</a>] and a higher risk for developing depression [<a href="#B34" class="ref-link" data-ref-style="bibr">34</a>]. The etiology of the association between depression and COPD has not been revealed clearly. The most important risk factor for COPD is smoking. Depressed individuals are more likely to smoke [<a href="#B35" class="ref-link" data-ref-style="bibr">35</a>], have a tendency to smoking [<a href="#B36" class="ref-link" data-ref-style="bibr">36</a>, <a href="#B37" class="ref-link" data-ref-style="bibr">37</a>], and find smoking cessation more difficult [<a href="#B35" class="ref-link" data-ref-style="bibr">35</a>, <a href="#B38" class="ref-link" data-ref-style="bibr">38</a>]. Conversely, smokers are more likely to be depressed [<a href="#B39" class="ref-link" data-ref-style="bibr">39</a>], which could be caused by activation of nicotinic acetylcholine receptors [<a href="#B40" class="ref-link" data-ref-style="bibr">40</a>], and the inflammatory effects of smoking [<a href="#B41" class="ref-link" data-ref-style="bibr">41</a>]. Soluble tumor necrosis factor receptor-1 has shown to be associated with rates of depression in patients with COPD [<a href="#B42" class="ref-link" data-ref-style="bibr">42</a>], but there is not exact relationship between TNF-&alpha; and COPD [<a href="#B43" class="ref-link" data-ref-style="bibr">43</a>, <a href="#B44" class="ref-link" data-ref-style="bibr">44</a>]. Hypoxia is thought be an additional factor in the development of depression in COPD.&nbsp;Low arterial oxygen saturation has been shown to be associated with periventricular white matter lesions [<a href="#B45" class="ref-link" data-ref-style="bibr">45</a>], which are found in patients with depression [<a href="#B46" class="ref-link" data-ref-style="bibr">46</a>]. Other important risk factors are the severity of symptoms and reported quality of life [<a href="#B47" class="ref-link" data-ref-style="bibr">47</a>]. Depression is found more frequently in support-bound patients with COPD [<a href="#B48" class="ref-link" data-ref-style="bibr">48</a>].</p>\n</div>\n</div>\n<div class="section" id="sec_7" data-lvl="1">\n<h2 class="heading main-title">4. Content of PR programs</h2>\n<div class="section" id="sec_7_2" data-lvl="2">\n<h3 class="heading section-title">4.1. Exercise training</h3>\n<p id="p11">Exercise training is a cornerstone of PR programs. Exercise training is shown to be the best approach for increasing muscle strength, is likely to improve motivation for exercise, reduce mood abnormalities [<a href="#B49" class="ref-link" data-ref-style="bibr">49</a>, <a href="#B50" class="ref-link" data-ref-style="bibr">50</a>], decrease symptoms [<a href="#B51" class="ref-link" data-ref-style="bibr">51</a>], and improve cardiovascular function [<a href="#B1" class="ref-link" data-ref-style="bibr">1</a>]. As recent major guidelines recommend, the main components of exercise training programs for patients with COPD are endurance and resistance training, which should be included in PR programs. Although none of the guidelines make clear, specific, and accurate recommendations for whole exercise training, they agree on endurance training at least 3 to 5 times weekly &gt;60% of the maximal work rate. However, there is no consensus of initial workloads or in increasing the exercise load or program duration; the duration of exercise is recommended for at least 20&nbsp;minutes and a target program duration of up to 12&nbsp;weeks [<a href="#B52" class="ref-link" data-ref-style="bibr">52</a>].</p>\n<p id="p12"><em>Inspiratory muscle training (IMT):</em> Respiratory muscle training is a part of rehabilitation in selected patients with COPD.&nbsp;Respiratory strength has been found to correlate with improved pulmonary function, reduction of dyspnea severity, improved exercise tolerance, and enhanced functionality and quality of life [<a href="#B53" class="ref-link" data-ref-style="bibr">53</a>, <a href="#B54" class="ref-link" data-ref-style="bibr">54</a>]. IMT is thought to contribute to contraction of the diaphragm by increasing type II fibers [<a href="#B55" class="ref-link" data-ref-style="bibr">55</a>], which results in reduced inspiratory time [<a href="#B56" class="ref-link" data-ref-style="bibr">56</a>] and subsequently increased expiratory time. Hyperinflation is expected to eventually diminish [<a href="#B57" class="ref-link" data-ref-style="bibr">57</a>]; therefore, IMT is thought to impact on dyspnea without any significant change in inspiratory pressure [<a href="#B58" class="ref-link" data-ref-style="bibr">58</a>, <a href="#B59" class="ref-link" data-ref-style="bibr">59</a>].</p>\n<p id="p13"><em>Neuromuscular electrical stimulation (NMES):</em> NMES is one of the recent rehabilitation modalities that involve passive stimulation of contraction of the peripheral muscles through the application of an electric current via electrodes placed on the skin over the targeted muscles by depolarizing motor neurons. It aims to elicit beneficial training effects without causing dyspnea in patients who are unable to participate in PR programs. The stimulation-pulse duration is usually 250&ndash;400&nbsp;&mu;s, and stimulation frequency ranges from 8 to 120&nbsp;Hz. Intensities range from 10 to 100&nbsp;mA, and these are gradually increased throughout the entire stimulation according to the patient&rsquo;s individual tolerance. In a meta-analysis published in 2016, it was found that NMES improved quadriceps strength and exercise capacity; however, there was no statistically significant improvement in the degree of health-related quality of life in patients with moderate-to-severe COPD [<a href="#B60" class="ref-link" data-ref-style="bibr">60</a>]. In several studies, it has been reported that NMES had an impact on the increase in type II fiber cross-sectional area with a decrease in type I fiber cross-sectional area of the muscle, and on the decrease in muscle oxidative stress in patients with COPD.&nbsp;Owing to the fact that NMES has a low impact on ventilation, heart rate, and dyspnea, it could be applied during periods of exacerbation, and during admission to the ICU for acute COPD exacerbation [<a href="#B61" class="ref-link" data-ref-style="bibr">61</a>, <a href="#B62" class="ref-link" data-ref-style="bibr">62</a>].</p>\n<p id="p14"><em>Recent exercise training approaches:</em> Besides conventional exercise trainings, there have been a few papers published recently about alternative exercise training modalities in patients with COPD.&nbsp;According to these studies, water-based rehabilitation [<a href="#B63" class="ref-link" data-ref-style="bibr">63</a>] and tai chi were found as well tolerated and enjoyable [<a href="#B64" class="ref-link" data-ref-style="bibr">64</a>, <a href="#B65" class="ref-link" data-ref-style="bibr">65</a>].</p>\n</div>\n<div class="section" id="sec_8_2" data-lvl="2">\n<h3 class="heading section-title">4.2. Other interventions</h3>\n<p id="p15">PR programs should be comprehensive and individualized according to patients&rsquo; needs. Other interventions are breathing strategies, bronchial hygiene techniques, psychological and nutritional recommendations and support if needed, and education of patients and care givers. Body composition abnormalities, especially malnutrition, have already been found to increase risks of mortality among patients with COPD.&nbsp;A significant improvement has been shown in pulmonary function in patients with COPD who have a higher fat, lower carbohydrate diet than the traditional high-carbohydrate diet [<a href="#B66" class="ref-link" data-ref-style="bibr">66</a>]. Omega-3 polyunsaturated fatty acids (PUFA) have been shown to have an antiinflammatory effect and be effective in patients with COPD [<a href="#B67" class="ref-link" data-ref-style="bibr">67</a>]. It is also important to relapse any deficiency of vitamin D due to the association with early progression, myopathy/muscle weakness, and the immune-modulatory effect of vitamin D [<a href="#B27" class="ref-link" data-ref-style="bibr">27</a>].</p>\n</div>\n</div>\n<div class="section" id="sec_10" data-lvl="1">\n<h2 class="heading main-title">5. Outcomes and response to PR</h2>\n<p id="p16">It has been demonstrated that PR is the most effective therapeutic approach for improving dyspnea, health status, and exercise tolerance [<a href="#B68" class="ref-link" data-ref-style="bibr">68</a>]. It is also one of the most cost effective therapeutic strategies. Additionally, it reduces hospitalizations among patients who have had recent exacerbations [<a href="#B69" class="ref-link" data-ref-style="bibr">69</a>]. Improvements are seen among all grades of COPD severity, but recommendations are stronger in moderate-to-severe COPD.&nbsp;In some studies, improvements of outcomes were seen regardless of baseline lung function, dyspnea, and exercise capacity [<a href="#B70" class="ref-link" data-ref-style="bibr">70</a>].</p>\n<div class="section" id="sec_10_2" data-lvl="2">\n<h3 class="heading section-title">5.1. Exercise capacity</h3>\n<p id="p17">Various exercise tests are used for evaluating exercise capacity, the mechanisms of main disruption, and the response to PR.&nbsp;Some are also strong independent prognostic factors in patients with COPD.&nbsp;There are several laboratory-based exercise tests that use either maximal incremental or constant workload protocols to evaluate exercise performance after PR.&nbsp;Field tests are more widely used and more practical to perform. The six-minute walk test (6MWT), incremental and endurance shuttle walk test (ISWT, ESWT) are standardized and have also been used in PR and various clinical trials. In COPD, endurance tests [constant work rate exercise test (CWRET) and ESWT] are more responsive to interventions than other types of tests. The cycle ergometer CWRET has been used more widely than ESWT.&nbsp;By using CWRET, the work rate, inspiratory capacity, and isotime responses, which verify potential mechanisms of improvement or deterioration, are accurately measured [<a href="#B71" class="ref-link" data-ref-style="bibr">71</a>].</p>\n<p id="p18">The ISWT is a significant predictor of survival, readmission, and is usually sensitive to PR in patients with COPD [<a href="#B72" class="ref-link" data-ref-style="bibr">72</a>]. In a recent meta-analysis of nine trials, a mean improvement of 38&nbsp;m was found [<a href="#B68" class="ref-link" data-ref-style="bibr">68</a>]. After recovering from a stay in the ICU, ISWT was found to improve by a mean of 64&nbsp;m after rehabilitation [<a href="#B72" class="ref-link" data-ref-style="bibr">72</a>]. ESWT duration was found as moderately correlated with FEV1, but not with muscle mass or strength in patients with COPD [<a href="#B73" class="ref-link" data-ref-style="bibr">73</a>]. ESWT is responsive to PR improving by 100&ndash;400&nbsp;s. [<a href="#B71" class="ref-link" data-ref-style="bibr">71</a>]. According to a meta-analysis of rehabilitative interventions in COPD, the mean effect of rehabilitation on 6MWD was 44&nbsp;m when treatment and control groups were compared [<a href="#B74" class="ref-link" data-ref-style="bibr">74</a>].</p>\n<p id="p19">Peak oxygen uptake (V&prime;O2peak) shows the highest oxygen uptake during incremental exercise tests by achieving the subject&rsquo;s limit of tolerance. With good subject effort, V&prime;O2peak is closely reflective of the subject&rsquo;s &ldquo;maximum&rdquo; V&prime;O2, the gold standard index of aerobic capacity [<a href="#B75" class="ref-link" data-ref-style="bibr">75</a>]. There is very little information about what constitutes a minimal clinically important difference (MCID) in V&prime;O2peak. In the National Emphysema Treatment Trial (NETT), 4&nbsp;&plusmn;&nbsp;1&nbsp;W was considered the symptoms-anchored MCID in patients with severe COPD [<a href="#B76" class="ref-link" data-ref-style="bibr">76</a>], with a V&prime;O2peak change of &sim;0.04&nbsp;&plusmn;&nbsp;0.01&nbsp;L&middot;min<sup>&minus;1</sup>. In several studies including patients with Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages 2&ndash;4 COPD V&prime;O2peak has been shown to moderately significantly increase after lower limb endurance muscle training. After PR in patients with COPD, V&prime;O2peak was found to be in the range 0.1&ndash;0.5&nbsp;L&middot;min<sup>&minus;1</sup> or &sim;10&ndash;40% of baseline, with a mean improvement of &sim;11% [<a href="#B77" class="ref-link" data-ref-style="bibr">77</a>, <a href="#B78" class="ref-link" data-ref-style="bibr">78</a>].</p>\n</div>\n<div class="section" id="sec_11_2" data-lvl="2">\n<h3 class="heading section-title">5.2. Health-related quality of life daily living activities</h3>\n<p id="p20">In a recent study, it was aimed to determine the responsiveness of St. George&rsquo;s Respiratory Questionnaire (SGRQ), COPD Assessment Test (CAT), COPD Clinical Questionnaire (CCQ), and Hospital Anxiety and Depression Scale (HADS) to PR in 419 patients with COPD, and also estimate the MCID for CAT, CCQ, and HADS.&nbsp;It was demonstrated that SGRQ, CAT, CCQ, and HADS were responsive to PR in patients with moderate-to-very-severe COPD.&nbsp;The calculated MCID ranges were &minus;3.0 to &minus;2.0 points for CAT; &minus;0.5 to &minus;0.3 points for CCQ; &minus;1.8 to &minus;1.3 points for HADS-A, and &minus;1.7 to &minus;1.5 points for HADS-D [<a href="#B79" class="ref-link" data-ref-style="bibr">79</a>].</p>\n</div>\n</div>\n<div class="section" id="sec_13" data-lvl="1">\n<h2 class="heading main-title">6. PR in special conditions</h2>\n<div class="section" id="sec_13_2" data-lvl="2">\n<h3 class="heading section-title">6.1. Before and after transplantation</h3>\n<p id="p21">Lung transplantation is a recommended intervention in patients with advanced-stage pulmonary disease who are unresponsive to pharmacologic and nonpharmacologic treatment. Factors such as chronic respiratory failure, cardiovascular risk factors, muscular and nutritional conditions, which are likely to influence the prognosis for a successful lung transplantation, usually accompany advanced chronic respiratory disorders. Therefore, PR is an important approach that modifies and controls potential risk factors. PR plays an important role for the maintenance of exercise tolerance and physical functioning [<a href="#B80" class="ref-link" data-ref-style="bibr">80</a>] both before and after the lung transplantation because common extra pulmonary manifestations could be persistent or deteriorate. As such, PR is recommended both before and after lung transplantation. Although there is an absence of a specific PR protocol for patients for lung transplant, it was shown to improve maximal and functional exercise capacity, quality of life, and skeletal muscle function [<a href="#B81" class="ref-link" data-ref-style="bibr">81</a>].</p>\n<p id="p22"><em>Before transplantation:</em> The role of PR in preoperative patients is essential for quitting smoking, improving body composition, optimizing medical treatment, and restoring patients&rsquo; independence for functioning, relieving symptoms, decreasing disability, and improving quality of life by increasing their participation in social and physical activities. It has been shown that the rate of success in lung transplantation was linked to exercise capacity and resting carbon dioxide in arterial blood values [<a href="#B82" class="ref-link" data-ref-style="bibr">82</a>]. Those parameters were also found to predict hospital stay after surgery and mortality. Additionally, pretransplant PR was also found to be associated with decreased posttransplant ICU days, mechanical ventilation, and chest tube days and survey [<a href="#B83" class="ref-link" data-ref-style="bibr">83</a>]. Multidisciplinary, comprehensive PR must be individualized and the modality and intensity of training must be selected for each patient. The duration of training can vary from 6&nbsp;weeks to 6&nbsp;months [<a href="#B84" class="ref-link" data-ref-style="bibr">84</a>]. The program should consist of education (including the following topics: bronchial hygiene, breathing control techniques, relaxation, education about COPD, and education of relatives and energy conservation), exercise training (upper and lower limb aerobic exercise, resistance training, flexibility, inspiratory muscle training), psychological support, and nutritional support. The intensity of exercise is dynamically increased according to the progress of each individual patient.</p>\n<p id="p23"><em>After transplantation:</em> Although pulmonary functions are improved after transplantation, limited exercise capacity is persistent due to different mechanisms. Persistent limited exercise capacity is not only associated with ventilatory or cardiovascular factors [<a href="#B85" class="ref-link" data-ref-style="bibr">85</a>, <a href="#B86" class="ref-link" data-ref-style="bibr">86</a>], skeletal muscle dysfunction is the main problem. Skeletal muscle changes include impaired oxidative capacity, lactate threshold changes, and a lower proportion of type I muscle fibers [<a href="#B87" class="ref-link" data-ref-style="bibr">87</a>]. A sedentary life style both before and after transplantation contributes to skeletal muscle weakness [<a href="#B88" class="ref-link" data-ref-style="bibr">88</a>]. Hospitalizations due to infections or acute rejections and the use of immunosuppressive medication further impact muscle function in lung recipients [<a href="#B89" class="ref-link" data-ref-style="bibr">89</a>]. It was found that V&prime;O2 peak was 45&ndash;52% predicted in patients after lung transplantation for up to 2 years. Patients stop exercise because of leg fatigue, rather than dyspnea [<a href="#B90" class="ref-link" data-ref-style="bibr">90</a>]. Additionally, maximal cycle-work capacity correlates better with isokinetic cycling work capacity than with pulmonary function after lung transplantation [<a href="#B91" class="ref-link" data-ref-style="bibr">91</a>]. PR should be started in the ICU with positioning of the patient, ventilation of all lung lobes, and mobilization of secretions by managing cough. Deep breathing exercises should be initiated because tachypnoea and pursed-lip breathing persist postoperatively and old breathing patterns must be overcome. Sitting and mobilization out of bed should then be performed. After all chest drains have been removed, walking or cycle ergometry should performed. Muscle strength and function, and endurance training should focus on lower extremities, and weights can be limited to 3&nbsp;kg initially for upper extremities [<a href="#B92" class="ref-link" data-ref-style="bibr">92</a>]. After discharge, patients should be referred to PR center/units as soon as possible. Although there is no consensus on optimal exercise training and education programs, aerobic and strength exercise training of the lower and upper extremities 2&ndash;3 times per week for 6&ndash;8&nbsp;weeks, are recommended. The intensity of exercise can be increased according to patient tolerance. High-intensity aerobic exercise training at 60&ndash;80% of maximal work capacity has been found to be correlated with physiologic improvements in patients with stable COPD.&nbsp;Hence, high-intensity training is preferred. Interval training could be applied in patients who cannot sustain continuous high-intensity. Stretching, flexibility, and chest-mobility exercises may also be an important component of exercise after LVRS or transplantation [<a href="#B1" class="ref-link" data-ref-style="bibr">1</a>, <a href="#B82" class="ref-link" data-ref-style="bibr">82</a>, <a href="#B93" class="ref-link" data-ref-style="bibr">93</a>]. Education of patients and care givers is also an important issue.</p>\n</div>\n<div class="section" id="sec_14_2" data-lvl="2">\n<h3 class="heading section-title">6.2. Lung volume resection surgery (LVRS)</h3>\n<p id="p24">Similar recommendations are valid for LVRS, which is not usually an effective intervention for exercise intolerance and functional disability. Baseline skeletal muscle dysfunction, time needed to achieve postoperative improvement in lung function (peak benefits are usually seen 6&ndash;12&nbsp;months after surgery), and inactivity/immobility associated with the perioperative period are factors that reduce exercise capacity. Several studies compared the benefits of LVRS and several-weeks&rsquo;&ndash;duration comprehensive PR in patients with severe emphysema. PR was found to significantly improve exercise tolerance, health status, and dyspnea, without significant changes in lung function as compared with PR and LVRS, even if highly selected patients showed significantly better improvement in lung function [<a href="#B94" class="ref-link" data-ref-style="bibr">94</a>, <a href="#B95" class="ref-link" data-ref-style="bibr">95</a>, <a href="#B96" class="ref-link" data-ref-style="bibr">96</a>, <a href="#B97" class="ref-link" data-ref-style="bibr">97</a>], exercise capacity [<a href="#B95" class="ref-link" data-ref-style="bibr">95</a>, <a href="#B96" class="ref-link" data-ref-style="bibr">96</a>, <a href="#B97" class="ref-link" data-ref-style="bibr">97</a>], and quality of life [<a href="#B96" class="ref-link" data-ref-style="bibr">96</a>, <a href="#B97" class="ref-link" data-ref-style="bibr">97</a>].</p>\n</div>\n<div class="section" id="sec_15_2" data-lvl="2">\n<h3 class="heading section-title">6.3. Endobronchial volume reduction (EBVR)</h3>\n<p id="p25">Endobronchial volume reduction interventions result in improved spirometric measures and 6MWD at 6&nbsp;months, only if in correctly selected subjects. PR is recommended before and after EBVR, which is indicated in the presence of persistent dyspnea despite maximal medical therapy and PR, and reduced exercise capacity (6MWD &ge;140&nbsp;m after rehabilitation) [<a href="#B97" class="ref-link" data-ref-style="bibr">97</a>].</p>\n</div>\n<div class="section" id="sec_16_2" data-lvl="2">\n<h3 class="heading section-title">6.4. Lung cancer</h3>\n<p id="p26">In patients with lung cancer, exercise limitations can be due to the effects of the cancer, coexisting morbidities, and/or the effects of treatment and surgery. Cancer-related anemia, and muscle atrophy and dysfunction contribute to limited exercise capacity. Inactivity due to cancer and its comorbidities further compound this situation. In the pre- and postoperative period, quitting smoking, optimizing COPD medical treatment, educating patients, prophylaxis for thrombosis, and PR are the recommended approaches that decrease risks. PR is an effective and feasible intervention before and after surgery, during the chemotherapy period, and as a component of palliative care. Even though PR consists of an exercise program for lower and upper extremities, breathing, airway clearance techniques, oxygen therapy, bronchodilator optimization, and self-management training similar to other conditions, it should also be individualized and multidisciplinary in patients with cancer.</p>\n<p id="p27">Even though surgical procedures have improved and patients are highly selected, morbidity and mortality rates are still increasing as a consequence of cardiopulmonary complications after surgery. Limited exercise capacity as a modifiable risk factor is the best independent predictor of postoperative complications. Multidisciplinary preoperative PR improves exercise capacity and postoperative recovery, and reduces hospital stay and pulmonary infections [<a href="#B98" class="ref-link" data-ref-style="bibr">98</a>]. During the chemotherapy period, symptoms such as fatigue, breathlessness, and quality of life are likely to deteriorate. Exercise training improves fatigue, aerobic capacity, muscular strength, and physical and functional activity in patients with cancer, even though they are undergoing chemotherapy [<a href="#B99" class="ref-link" data-ref-style="bibr">99</a>]. Breathing techniques and medications that result in reduced inflammation and opened airways in combination with exercise training have recently become a part of supportive care for patients undergoing chemotherapy and radiation therapy [<a href="#B100" class="ref-link" data-ref-style="bibr">100</a>]. PR plays a role in the management of terminal cancer. Exercise training modalities include walking with/without assistance or device, passive or active strengthening exercises, continuous passive motion, passive or active range of motion, NMES, and pain management interventions such as massage and heating pads [<a href="#B101" class="ref-link" data-ref-style="bibr">101</a>]. Oxygen therapy has an important role in palliative care because it both treats hypoxemia and reduces the sensation of dyspnea. Additionally, education about mobilization with assistive devices, environmental modification, energy conservation, and work simplification techniques are also beneficial. These interventions have been investigated and were shown to be effective in cancer-related fatigue in several studies [<a href="#B102" class="ref-link" data-ref-style="bibr">102</a>, <a href="#B103" class="ref-link" data-ref-style="bibr">103</a>, <a href="#B104" class="ref-link" data-ref-style="bibr">104</a>]. In another study, it was shown that exercise training decreased anxiety, stress, depression, and there were improvements in pain, fatigue, shortness of breath, constipation, and insomnia in patients with cancer, even at advanced stages [<a href="#B105" class="ref-link" data-ref-style="bibr">105</a>].</p>\n</div>\n<div class="section" id="sec_17_2" data-lvl="2">\n<h3 class="heading section-title">6.5. Exacerbation of COPD</h3>\n<p id="p28">COPD exacerbations are known to deteriorate life quality, disease progression, and mortality. The British Thoracic Society (BTS) recommends the initiation of PR within 1 month of hospital discharge after exacerbation, consisting of a minimum of twice-weekly supervised sessions lasting between 6 and 12&nbsp;weeks [<a href="#B106" class="ref-link" data-ref-style="bibr">106</a>]. Exercise should combine progressive muscle resistance and aerobic training [<a href="#B106" class="ref-link" data-ref-style="bibr">106</a>]. Systematic reviews have shown that quality of life and daily functioning were improved with large and important clinical effects of PR [<a href="#B107" class="ref-link" data-ref-style="bibr">107</a>, <a href="#B108" class="ref-link" data-ref-style="bibr">108</a>]. According to the European Respiratory Society (ERS)/American Thoracic Society (ATS) guidelines of management of COPD exacerbations, PR added to medical treatment during hospitalization increases mortality [<a href="#B109" class="ref-link" data-ref-style="bibr">109</a>]; however, NMES and resisted quadriceps exercises performed during hospitalization during exacerbation have been shown to improve muscle strength without increasing systemic inflammation. PR that is started within 3&nbsp;weeks of discharge following a COPD exacerbation reduces hospital admissions, improves quality of life, and also increases exercise capacity when implemented within 8&nbsp;weeks of discharge. Although the best approach is indistinct and further investigations are necessary, a combination of regular exercise with breathing technique training has been shown to be superior [<a href="#B109" class="ref-link" data-ref-style="bibr">109</a>].</p>\n</div>\n<div class="section" id="sec_18_2" data-lvl="2">\n<h3 class="heading section-title">6.6. PR in the intensive unit care</h3>\n<p id="p29">In the ICU, skeletal muscle mass is lost at a rate of 5% per week. This neuromuscular weakness has been found to be correlated with the duration of mechanical ventilation, and associated with functional disability and decreased quality of life for up to 5&nbsp;years after hospitalization. Mobilization and rehabilitation of critically ill patients might improve physical functioning and decrease duration of mechanical ventilation and ICU length of stay [<a href="#B110" class="ref-link" data-ref-style="bibr">110</a>, <a href="#B111" class="ref-link" data-ref-style="bibr">111</a>]. A meta-analysis was published in 2017 that consisted of studies with PR programs containing patient mobilization, walking, standing, breathing exercises, in-bed supine cycle ergometry, passive-active range of motion (ROM), and NMES.&nbsp;It was shown that early mobilization and physical rehabilitation of critically ill patients seemed to be safe, with a low risk of potential safety events, even if as a usual care. Although the definition of safety assessments was heterogeneous, it was emphasized that the awareness and implementation of existing recommendations should be increased [<a href="#B112" class="ref-link" data-ref-style="bibr">112</a>].</p>\n</div>\n<div class="section" id="sec_19_2" data-lvl="2">\n<h3 class="heading section-title">6.7. Patients with hypercapnia</h3>\n<p id="p30">Hypercapnia is an indicator of alveolar hypoventilation due to an overload on the ventilatory pump that is greater than its capacity. In patients with COPD, diminished ventilatory response usually results in chronic retention of carbon dioxide. Chronic respiratory failure is frequently seen in the end stage of the progression of COPD.&nbsp;In the BTS guidelines, it is mentioned that patients with chronic respiratory failure gain as much benefit as those without chronic respiratory failure from PR with level 3 evidence [<a href="#B106" class="ref-link" data-ref-style="bibr">106</a>]. A study showed that pCO2 levels were significantly more reduced in patients with COPD with pursed-lip and diaphragmatic breathing exercises during hospitalization period than in a control group. It was suggested that respiratory exercise training was quite effective in reducing pCO2 levels. As the guidelines recommend, patients with COPD should be referred for PR regardless of having chronic respiratory failure [<a href="#B113" class="ref-link" data-ref-style="bibr">113</a>].</p>\n<p id="p31"><em>Noninvasive mechanical ventilation (NIMV)</em>: Noninvasive mechanical ventilation (NIMV) reduces breathlessness and increases exercise tolerance by reducing the acute load on the respiratory muscles. According to these mechanisms, the effect of NIMV on PR outcomes has been investigated in several studies in which NIMV was applied during exercise training or at night. In a review of the Cochrane Database in which the effect of NIMV was investigated during exercise training as a part of PR, it was shown that NIMV during exercise training improved exercise capacity of the lower limbs, and enabled exercise at higher training intensities. There was no definite evidence about quality of life and none of the studies investigated the effect of NIMV during exercise training on physical activity [<a href="#B114" class="ref-link" data-ref-style="bibr">114</a>]. It has also been shown that exercise tolerance and quality of life were improved in patients with severe COPD using nocturnal NIMV after PR, presumably through resting the respiratory muscles at night [<a href="#B115" class="ref-link" data-ref-style="bibr">115</a>]. As a recommendation of the ERS/ATS guidelines, NIMV could be an adjunctive therapy to unload the respiratory muscles for the purpose of increasing the intensity of exercise training in selected patients with severe chronic respiratory disease who have a suboptimal response to exercise [<a href="#B1" class="ref-link" data-ref-style="bibr">1</a>].</p>\n</div>\n<div class="section" id="sec_20_2" data-lvl="2">\n<h3 class="heading section-title">6.8. Comorbidities</h3>\n<p id="p32">The most common comorbidities associated with COPD are cardiovascular disease, orthopedic problems, metabolic disease, depression, and anxiety. It is expected that comorbidities may effect the outcomes of PR as an impact on COPD outcomes such as quality of life, health care costs, and mortality rate. Various comorbidities such as anxiety and depression, cardiovascular disease, metabolic disease, and osteoporosis affected PR outcomes in some studies [<a href="#B116" class="ref-link" data-ref-style="bibr">116</a>, <a href="#B117" class="ref-link" data-ref-style="bibr">117</a>, <a href="#B118" class="ref-link" data-ref-style="bibr">118</a>, <a href="#B119" class="ref-link" data-ref-style="bibr">119</a>, <a href="#B120" class="ref-link" data-ref-style="bibr">120</a>, <a href="#B121" class="ref-link" data-ref-style="bibr">121</a>]; a meta-analysis could not be performed according to the heterogeneous results. Only four studies investigated the influence of the number of comorbidities on PR outcomes. Three of which showed that the number of comorbidities was not related to PR outcomes [<a href="#B117" class="ref-link" data-ref-style="bibr">117</a>, <a href="#B119" class="ref-link" data-ref-style="bibr">119</a>, <a href="#B120" class="ref-link" data-ref-style="bibr">120</a>]. A study showed that metabolic disease negatively influenced 6MWT distance, whereas cardiac disease negatively influenced the St. George&rsquo;s Respiratory Questionnaire [<a href="#B118" class="ref-link" data-ref-style="bibr">118</a>]. A prior study of patients with COPD with osteoarthritis and neurologic problems who were assigned to water-based exercise training reported a greater improvement in outcomes compared with land-based exercise training [<a href="#B121" class="ref-link" data-ref-style="bibr">121</a>]. Previous studies have identified that patients with psychiatric problems experienced a lesser improvement in dyspnea [<a href="#B117" class="ref-link" data-ref-style="bibr">117</a>], and patients with metabolic disease demonstrated a greater improvement in dyspnea after PR compared with controls [<a href="#B118" class="ref-link" data-ref-style="bibr">118</a>]. A study was published in 2017 that included 165 patients with COPD with exercise limitations. Comorbidity was classified as cardiac, metabolic, orthopedic, behavioral health problems, or other diseases. Comorbidities were found to have no effect on the maximal incremental exercise test and constant workload cycle endurance time after PR.&nbsp;Patients with cardiac disease were found to have greater improvements in dyspnea scores than those with no cardiac disease, and patients with orthopedic problems had a smaller but clinically significant improvement in dyspnea after PR [<a href="#B122" class="ref-link" data-ref-style="bibr">122</a>]. Modifying PR programs with consideration to comorbidities might lead to greater improvement in outcomes, but how to structure programs according to comorbidities is still to be determined.</p>\n</div>\n</div>\n<div class="section" id="sec_22" data-lvl="1">\n<h2 class="heading main-title">7. Follow-up programs of PR and Tele-PR</h2>\n<p id="p33">The best and the most effective follow-up program have not been found. After PR, the important points are to follow prescribed home exercise programs and follow-up programs in the PR center/unit, and to be more active in daily living life for the purpose of preserving improvements. Accordingly, family members have a role that is as important as that of the PR center staff in encouraging and motivating the patients. In a cohort of patients with COPD who completed a 10-week comprehensive PR program, a structured follow-up home program was prescribed and the patients were monitored for 1 year. At the 1-year follow-up evaluation, only the patients who continued with the home program had maintained the improvements of the initial PR program in endurance capacity, and psychological and cognitive functioning [<a href="#B123" class="ref-link" data-ref-style="bibr">123</a>, <a href="#B124" class="ref-link" data-ref-style="bibr">124</a>]. Despite the clear benefits of PR, it is often an under-utilized resource. Limited access and poor adherence result in &lt;5% of eligible people with COPD receiving PR each year. Although the traditional models of inpatient and outpatient PR are suitable for many patients, alternative models may also be effective and may improve patient access, particularly in regions or healthcare systems where traditional models of PR are not feasible. For example, tele-rehabilitation, which links expert rehabilitation healthcare providers with others at a remote site or with patients in their homes, also has the potential to improve access [<a href="#B125" class="ref-link" data-ref-style="bibr">125</a>]. A recent study showed that home-based maintenance tele-rehabilitation was equally as effective as hospital-based, outpatient, maintenance PR in reducing the risk for acute exacerbations of COPD and hospitalizations with lower risk for emergency department visits. It was suggested that tele-rehabilitation was likely to be an effective alternative strategy to hospital-based, outpatient, maintenance PR.&nbsp;In addition, it had a potential economic advantage compared with standard PR [<a href="#B126" class="ref-link" data-ref-style="bibr">126</a>]. Tele-PR has been developed to improve patients&rsquo; participation and treatment adherence, but the most important point is awareness. The awareness of PR should be increased in patients and among health professionals.</p>\n</div>\n\n',keywords:"PR, exercise capacity, quality of life, perioperative lung transplantation, EBVR",chapterPDFUrl:"https://cdn.intechopen.com/pdfs/57797.pdf",chapterXML:"https://mts.intechopen.com/source/xml/57797.xml",downloadPdfUrl:"/chapter/pdf-download/57797",previewPdfUrl:"/chapter/pdf-preview/57797",totalDownloads:384,totalViews:451,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,dateSubmitted:"March 14th 2017",dateReviewed:"September 12th 2017",datePrePublished:"December 20th 2017",datePublished:"February 21st 2018",readingETA:"0",abstract:"Pulmonary rehabilitation (PR) is an evidenced-based, proven treatment as mentioned recent guidelines in patients with chronic obstructive pulmonary disease (COPD). Exercise training is a cornerstone of PR programs, Inspiratory muscle training, neuromuscular electrical stimulation (NMES) are effective in selected patients. Water-based rehabilitation and tai chi are well tolerated recent modalities. Although there is an absence of a specific PR protocol for special conditions, PR is recommended before and also after endobronchial volume reduction (EBVR), lung volume reduction surgery (LVRS), both before and after lung transplantation periods, before, after surgery, during the intensive care unit (ICU) period, the chemotherapy period and as a component of palliative care. After COPD exacerbation, it is recommended within 3 weeks of hospital discharge. Modifying PR programs while considering comorbidities might lead to greater improvement in outcomes. After PR, the important points are to follow prescribed home exercise programs, control programs in the PR center/unit, and being more active in daily living life for the purpose of preserving improvements. Tele-PR is an alternative to conventional modalities due to similar improvements. Although PR is effective, it is an under-utilized resource. The awareness of PR should be increased in patients and among health professionals.",reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/57797",risUrl:"/chapter/ris/57797",book:{slug:"copd-an-update-in-pathogenesis-and-clinical-management"},signatures:"Ipek Candemir",authors:[{id:"206660",title:"M.D.",name:"Ipek",middleName:null,surname:"Candemir",fullName:"Ipek Candemir",slug:"ipek-candemir",email:"ipekcayli@yahoo.com",position:null,institution:{name:"Atatrk University",institutionURL:null,country:{name:"Turkey"}}}],sections:[{id:"sec_1",title:"1. Introduction",level:"1"},{id:"sec_2",title:"2. The definition of PR",level:"1"},{id:"sec_3",title:"3. Pathophysiologies indicated for PR",level:"1"},{id:"sec_3_2",title:"3.1. Exercise limitation",level:"2"},{id:"sec_4_2",title:"3.2. Body composition disorders",level:"2"},{id:"sec_5_2",title:"3.3. Psychological status",level:"2"},{id:"sec_7",title:"4. Content of PR programs",level:"1"},{id:"sec_7_2",title:"4.1. Exercise training",level:"2"},{id:"sec_8_2",title:"4.2. Other interventions",level:"2"},{id:"sec_10",title:"5. Outcomes and response to PR",level:"1"},{id:"sec_10_2",title:"5.1. Exercise capacity",level:"2"},{id:"sec_11_2",title:"5.2. Health-related quality of life daily living activities",level:"2"},{id:"sec_13",title:"6. PR in special conditions",level:"1"},{id:"sec_13_2",title:"6.1. Before and after transplantation",level:"2"},{id:"sec_14_2",title:"6.2. Lung volume resection surgery (LVRS)",level:"2"},{id:"sec_15_2",title:"6.3. Endobronchial volume reduction (EBVR)",level:"2"},{id:"sec_16_2",title:"6.4. Lung cancer",level:"2"},{id:"sec_17_2",title:"6.5. Exacerbation of COPD",level:"2"},{id:"sec_18_2",title:"6.6. PR in the intensive unit care",level:"2"},{id:"sec_19_2",title:"6.7. Patients with hypercapnia",level:"2"},{id:"sec_20_2",title:"6.8. Comorbidities",level:"2"},{id:"sec_22",title:"7. Follow-up programs of PR and Tele-PR",level:"1"}],chapterReferences:[{id:"B1",body:'<ref id="B1"><mixed-citation publication-type="journal">Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, etal. An official American Thoracic Society/European Respiratory Society statement: Key concepts and advances in pulmonary rehabilitation. American Journal of Respiratory and Critical Care Medicine. 2013;<bold>188</bold>(8):13-64</mixed-citation>\n</ref>'},{id:"B2",body:'<ref id="B2"><mixed-citation publication-type="journal">MacIntyre NR.Mechanisms of functional loss in patients with chronic lung disease. Respiratory Care. 2008;<bold>53</bold>(9):1177-1184</mixed-citation>\n</ref>'},{id:"B3",body:'<ref id="B3"><mixed-citation publication-type="journal">European Respiratory Society Task Force. Clinical exercise testing with reference to lung diseases: Indications, standardization and interpretation strategies. The European Respiratory Journal. 1997;<bold>10</bold>(11):2662-2689</mixed-citation>\n</ref>'},{id:"B4",body:'<ref id="B4"><mixed-citation publication-type="journal">Borak J, Chodosowska E, Matuszewski A, Zielinski J.Emotional status does not alter exercise tolerance in patients with chronic obstructive pulmonary disease. The European Respiratory Journal. 1998;<bold>12</bold>:370-373</mixed-citation>\n</ref>'},{id:"B5",body:'<ref id="B5"><mixed-citation publication-type="journal">Janson C, Bjornsson E, Hetta J, Boman G.Anxiety and depression in relation to respiratory symptoms and asthma. American Journal of Respiratory and Critical Care Medicine. 1994;<bold>149</bold>:930-934</mixed-citation>\n</ref>'},{id:"B6",body:'<ref id="B6"><mixed-citation publication-type="journal">Parekh PI, Blumenthal JA, Babyak MA, Merrill K, Carney RM, Davis RD, Palmer SM.Psychiatric disorder and quality of life in patients awaiting lung transplantation. Chest. 2003;<bold>124</bold>:1682-1688</mixed-citation>\n</ref>'},{id:"B7",body:'<ref id="B7"><mixed-citation publication-type="journal">O\'Donnell DE.Ventilatory limitations in chronic obstructive pulmonary disease. Medicine and Science in Sports and Exercise. 2001 Jul;<bold>33</bold>(7 Suppl):S647-S655</mixed-citation>\n</ref>'},{id:"B8",body:'<ref id="B8"><mixed-citation publication-type="journal">Somfay A, Porszasz J, Lee SM, Casaburi R. Effect of hyperoxia on gas exchange and lactate kinetics following exercise onset in nonhypoxemic COPD patients. Chest. 2002;<bold>121</bold>:393-400</mixed-citation>\n</ref>'},{id:"B9",body:'<ref id="B9"><mixed-citation publication-type="book">Wasserman K, Hansen JE, Sue DY, Stringer W, Whipp BJ.Principles of Exercise Testing and Interpretation. 4th ed. Philadelphia: Lippincott Williams &amp; Wilkins; 2005. p.41</mixed-citation>\n</ref>'},{id:"B10",body:'<ref id="B10"><mixed-citation publication-type="journal">Weltman A, Wood CM, Womack CJ, Davis SE, Blumer JL, Alvarez J, etal. Catecholamine and blood lactate responses to incremental rowing and running exercise. Journal of Applied Physiology. 1994;<bold>76</bold>(3):1144-1149</mixed-citation>\n</ref>'},{id:"B11",body:'<ref id="B11"><mixed-citation publication-type="journal">World Health Organization. Definition of chronic corpulmonale. Circulation. 1963;<bold>27</bold>:594-615</mixed-citation>\n</ref>'},{id:"B12",body:'<ref id="B12"><mixed-citation publication-type="journal">Santos S, Peinado VI, Ramirez J, Melgosa T, Roca J, Rodriguez-Roisin R, Barbera JA.Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD.The European Respiratory Journal. 2002;<bold>19</bold>:632-638</mixed-citation>\n</ref>'},{id:"B13",body:'<ref id="B13"><mixed-citation publication-type="journal">Voelkel NF, Tuder RM.Hypoxia-induced pulmonary vascular remodeling: A model for what human disease? The Journal of Clinical Investigation. 2000;<bold>106</bold>:733-738</mixed-citation>\n</ref>'},{id:"B14",body:'<ref id="B14"><mixed-citation publication-type="journal">Chetty KG, Brown SE, Light RW.Improved exercise tolerance of the polycythemic lung patient following phlebotomy. The American Journal of Medicine. 1983;<bold>74</bold>:415-420</mixed-citation>\n</ref>'},{id:"B15",body:'<ref id="B15"><mixed-citation publication-type="journal">Sietsema K.Cardiovascular limitations in chronic pulmonary disease. Medicine and Science in Sports and Exercise. 2001;<bold>33</bold>:S656-S661</mixed-citation>\n</ref>'},{id:"B16",body:'<ref id="B16"><mixed-citation publication-type="journal">Ranieri VM, Dambrosio M, Brienza N.Intrinsic PEEP and cardiopulmonary interaction in patients with COPD and acute ventilatory failure. The European Respiratory Journal. 1996;<bold>9</bold>:1283-1292</mixed-citation>\n</ref>'},{id:"B17",body:'<ref id="B17"><mixed-citation publication-type="journal">Oswald-Mammosser M, Kessler R, Massard G, etal. Effect of lung volume reduction surgery on gas exchange and pulmonary hemodynamics at rest and during exercise. American Journal of Respiratory and Critical Care Medicine. 1998;<bold>158</bold>:1020-1025</mixed-citation>\n</ref>'},{id:"B18",body:'<ref id="B18"><mixed-citation publication-type="journal">Mahler DA, Brent BN, Loke J, etal. Right ventricular performance and central circulatory hemodynamics during upright exercise in patients with chronic obstructive pulmonary disease. The American Review of Respiratory Disease. 1984;<bold>130</bold>:722-729</mixed-citation>\n</ref>'},{id:"B19",body:'<ref id="B19"><mixed-citation publication-type="journal">Miller JD, Pegelow DF, Jacques AJ, etal. Effects of augmented respiratory muscle pressure production on locomotor limb venous return during calf contraction exercise. Journal of Applied Physiology. 2005;<bold>99</bold>:1802-1815</mixed-citation>\n</ref>'},{id:"B20",body:'<ref id="B20"><mixed-citation publication-type="journal">Oswald-Mammosser M, Apprill M, Bachez P, etal. Pulmonary hemodynamics in chronic obstructive pulmonary disease of the emphysematous type. Respiration. 1991;<bold>58</bold>:304-310</mixed-citation>\n</ref>'},{id:"B21",body:'<ref id="B21"><mixed-citation publication-type="journal">Montes de Oca M, Rassulo J, Celli BR.Respiratory muscle and cardiopulmonary function during exercise in very severe COPD.American Journal of Respiratory and Critical Care Medicine. 1996;<bold>154</bold>:1284-1289</mixed-citation>\n</ref>'},{id:"B22",body:'<ref id="B22"><mixed-citation publication-type="journal">MacNee W.Pathophysiology of corpulmonale in chronic obstructive pulmonary disease: Part one. American Journal of Respiratory and Critical Care Medicine. 1994;<bold>150</bold>:833-852</mixed-citation>\n</ref>'},{id:"B23",body:'<ref id="B23"><mixed-citation publication-type="journal">Kim HC, Mofarrahi M, Hussain NA.Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease. International Journal of COPD. 2008;<bold>3</bold>(4):637-658</mixed-citation>\n</ref>'},{id:"B24",body:'<ref id="B24"><mixed-citation publication-type="journal">Creutzberg EC, Schols AM, Bothmer-Quaedvlieg FC, Wouters EF.Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function. European Journal of Clinical Nutrition. 1998;<bold>52</bold>:396-401</mixed-citation>\n</ref>'},{id:"B25",body:'<ref id="B25"><mixed-citation publication-type="journal">Choudhury G, Rabinovich R, MacNee W.Comorbidities and systemic effects of chronic obstructive pulmonary disease. Clinics in Chest Medicine. 2014;<bold>35</bold>:101-130</mixed-citation>\n</ref>'},{id:"B26",body:'<ref id="B26"><mixed-citation publication-type="journal">Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF.Body composition and mortality in chronic obstructive pulmonary disease. The American Journal of Clinical Nutrition. 2005;<bold>82</bold>:53-59</mixed-citation>\n</ref>'},{id:"B27",body:'<ref id="B27"><mixed-citation publication-type="journal">Vermeeren MA, Creutzberg EC, Schols AM, etal. Prevalence of nutritional depletion in a large out-patient population of patients with COPD.Respiratory Medicine. 2006;<bold>100</bold>:1349-1355</mixed-citation>\n</ref>'},{id:"B28",body:'<ref id="B28"><mixed-citation publication-type="journal">Agusti AG.Systemic effects of chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society. 2005;<bold>2</bold>:367-370 discussion 371-372</mixed-citation>\n</ref>'},{id:"B29",body:'<ref id="B29"><mixed-citation publication-type="journal">Vermeeren MA, Wouters EF, Geraerts-Keeris AJ, Schols AM.Nutritional support in patients with chronic obstructive pulmonary disease during hospitalization for an acute exacerbation; a randomized controlled feasibility trial. Clinical Nutrition. 2004;<bold>23</bold>:1184-1192</mixed-citation>\n</ref>'},{id:"B30",body:'<ref id="B30"><mixed-citation publication-type="journal">Brug J, Schols A, Mesters I.Dietary change, nutrition education and chronic obstructive pulmonary disease. Patient Education and Counseling. 2004;<bold>52</bold>:249-257</mixed-citation>\n</ref>'},{id:"B31",body:'<ref id="B31"><mixed-citation publication-type="journal">Creutzberg EC, Wouters EF, Mostert R, etal. Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease. Nutrition. 2003;<bold>19</bold>:120-127</mixed-citation>\n</ref>'},{id:"B32",body:'<ref id="B32"><mixed-citation publication-type="journal">Sehgal S, Dhooria S, Agarwal R.Chronic obstructive pulmonary disease and malnutrition in developing countries. Current Opinion in Pulmonary Medicine. 2017;<bold>23</bold>:139-148</mixed-citation>\n</ref>'},{id:"B33",body:'<ref id="B33"><mixed-citation publication-type="journal">Hynninen KM, Breitve MH, Wiborg AB, etal. Psychological characteristics of patients with chronic obstructive pulmonary disease: A review. Journal of Psychosomatic Research. 2005;<bold>59</bold>:429-443</mixed-citation>\n</ref>'},{id:"B34",body:'<ref id="B34"><mixed-citation publication-type="journal">Atlantis E, Fahey P, Cochrane B, etal. Bidirectional associations between clinically relevant depression or anxiety and COPD: A systematic review and meta-analysis. Chest. 2013;<bold>144</bold>:766-777</mixed-citation>\n</ref>'},{id:"B35",body:'<ref id="B35"><mixed-citation publication-type="journal">Glassman AH, Helzer JE, Covey LS, etal. Smoking, smoking cessation, and major depression. JAMA. 1990;<bold>264</bold>:1546-1549</mixed-citation>\n</ref>'},{id:"B36",body:'<ref id="B36"><mixed-citation publication-type="journal">Fergusson DM, Lynskey MT, Horwood LJ.Comorbidity between depressive disorders and nicotine dependence in a cohort of 16-year-olds. Archives of General Psychiatry. 1996;<bold>53</bold>:1043-1047</mixed-citation>\n</ref>'},{id:"B37",body:'<ref id="B37"><mixed-citation publication-type="journal">Patton GC, Hibbert M, Rosier MJ, etal. Is smoking associated with depression and anxiety in teenagers? American Journal of Public Health. 1996;<bold>86</bold>:225-230</mixed-citation>\n</ref>'},{id:"B38",body:'<ref id="B38"><mixed-citation publication-type="journal">Glassman AH, Covey LS, Stetner F, etal. Smoking cessation and the course of major depression: A follow-up study. Lancet. 2001;<bold>357</bold>:1929-1932</mixed-citation>\n</ref>'},{id:"B39",body:'<ref id="B39"><mixed-citation publication-type="journal">Wiesbeck GA, Kuhl HC, Yaldizli O, etal. Tobacco smoking and depression--results from the WHO/ISBRA study. Neuropsychobiology. 2008;<bold>57</bold>:26-31</mixed-citation>\n</ref>'},{id:"B40",body:'<ref id="B40"><mixed-citation publication-type="journal">Mineur YS, Picciotto MR.Nicotine receptors and depression: Revisiting and revising the cholinergic hypothesis. Trends in Pharmacological Sciences. 2010;<bold>31</bold>:580-586</mixed-citation>\n</ref>'},{id:"B41",body:'<ref id="B41"><mixed-citation publication-type="journal">Sinden NJ, Stockley RA.Systemic inflammation and comorbidity in COPD: A result of overspill of inflammatory mediators from the lungs? Review of the evidence. Thorax. 2010;<bold>65</bold>:930-936</mixed-citation>\n</ref>'},{id:"B42",body:'<ref id="B42"><mixed-citation publication-type="journal">Eagan TM, Ueland T, Wagner PD, etal. Systemic inflammatory markers in COPD: Results from the Bergen COPD cohort study. The European Respiratory Journal. 2010;<bold>35</bold>:540-548</mixed-citation>\n</ref>'},{id:"B43",body:'<ref id="B43"><mixed-citation publication-type="journal">Al-shair K, Kolsum U, Dockry R, etal. Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD.Respiratory Research. 2011;<bold>12</bold>:3</mixed-citation>\n</ref>'},{id:"B44",body:'<ref id="B44"><mixed-citation publication-type="journal">Marinho PE, Castro CM, Raposo MC, etal. Depressive symptoms, inflammatory markers and body composition in elderly with and without chronic obstructive pulmonary disease (COPD). Archives of Gerontology and Geriatrics. 2012;<bold>54</bold>:453-458</mixed-citation>\n</ref>'},{id:"B45",body:'<ref id="B45"><mixed-citation publication-type="journal">van Dijk EJ, Vermeer SE, de Groot JC, etal. Arterial oxygen saturation, COPD, and cerebral small vessel disease. Journal of Neurology, Neurosurgery, and Psychiatry 2004;<bold>75</bold>:733-736.</mixed-citation>\n</ref>'},{id:"B46",body:'<ref id="B46"><mixed-citation publication-type="journal">Campbell JJ 3rd, Coffey CE.Neuropsychiatric significance of subcortical hyperintensity. The Journal of Neuropsychiatry and Clinical Neurosciences. 2001;<bold>13</bold>:261-288</mixed-citation>\n</ref>'},{id:"B47",body:'<ref id="B47"><mixed-citation publication-type="journal">Dunlop DD, Lyons JS, Manheim LM, etal. Arthritis and heart disease as risk factors for major depression: The role of functional limitation. Medical Care. 2004;<bold>42</bold>:502-511</mixed-citation>\n</ref>'},{id:"B48",body:'<ref id="B48"><mixed-citation publication-type="journal">Penninx BW, van Tilburg T, Boeke AJ, etal. Effects of social support and personal coping resources on depressive symptoms: Different for various chronic diseases? Health Psychology 1998;<bold>17</bold>:551-558</mixed-citation>\n</ref>'},{id:"B49",body:'<ref id="B49"><mixed-citation publication-type="journal">Emery CF, Leatherman NE, Burker EJ, MacIntyre NR.Psychological outcomes of a pulmonary rehabilitation program. Chest. 1991;<bold>100</bold>:613-617</mixed-citation>\n</ref>'},{id:"B50",body:'<ref id="B50"><mixed-citation publication-type="journal">Emery CF, Schein RL, Hauck ER, MacIntyre NR.Psychological and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease. Health Psychology. 1998;<bold>17</bold>:232-240</mixed-citation>\n</ref>'},{id:"B51",body:'<ref id="B51"><mixed-citation publication-type="journal">ODonnell DE, McGuire M, Samis L, Webb KA.The impact of exercise reconditioning on breathlessness in severe chronic airflow limitation. American Journal of Respiratory and Critical Care Medicine. 1995;<bold>152</bold>:2005-2013</mixed-citation>\n</ref>'},{id:"B52",body:'<ref id="B52"><mixed-citation publication-type="journal">Garvey C, Bayles MP, Hamm LF, Hill K, Holland A, Limberg TM, Spruit MA.Pulmonary rehabilitation exercise prescription in chronic obstructive pulmonary disease: Review of selected guidelines. Journal of Cardiopulmonary Rehabilitation and Prevention. 2016;<bold>36</bold>:75-83</mixed-citation>\n</ref>'},{id:"B53",body:'<ref id="B53"><mixed-citation publication-type="journal">Mota S, Gell R, Barreiro E, Solanes I, Ramrez-Sarmiento A, OrozcoLevi M, etal. Clinical outcomes of expiratory muscle training in severe COPD patients. Respiratory Medicine. 2007;<bold>101</bold>(3):516-524</mixed-citation>\n</ref>'},{id:"B54",body:'<ref id="B54"><mixed-citation publication-type="journal">Weiner P, McConnell A.Respiratory muscle training in chronic obstructive pulmonary disease: Inspiratory, expiratory, or both? Current Opinion in Pulmonary Medicine. 2005;<bold>11</bold>(2):140-144</mixed-citation>\n</ref>'},{id:"B55",body:'<ref id="B55"><mixed-citation publication-type="journal">Ramirez-Sarmiento A, Orozco-Levi M, Guell R, etal. Inspiratory muscle training in patients with chronic obstructive pulmonary disease: Structural adaptation and physiologic outcomes. American Journal of Respiratory and Critical Care Medicine. 2002;<bold>166</bold>(11):1491-1497</mixed-citation>\n</ref>'},{id:"B56",body:'<ref id="B56"><mixed-citation publication-type="journal">Villafranca C, Borzone G, Leiva A, etal. Effect of inspiratory muscle training with an intermediate load on inspiratory power output in COPD.The European Respiratory Journal. 1998;<bold>11</bold>(1):28-33</mixed-citation>\n</ref>'},{id:"B57",body:'<ref id="B57"><mixed-citation publication-type="journal">ODonnell DE, Webb KA.Exertional breathlessness in patients with chronic airflow limitation. The American Review of Respiratory Disease. 1993;<bold>148</bold>(5):1351-1357</mixed-citation>\n</ref>'},{id:"B58",body:'<ref id="B58"><mixed-citation publication-type="journal">Mador MJ, Deniz O, Aggarwal A, etal. Effect of respiratory muscle endurance training in patients with COPD undergoing pulmonary rehabilitation. Chest. 2005;<bold>128</bold>(3):1216-1224</mixed-citation>\n</ref>'},{id:"B59",body:'<ref id="B59"><mixed-citation publication-type="journal">Larson JL, Covey MK, Wirtz SE, etal. Cycle ergometer and inspiratory muscle training in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. 1999;<bold>160</bold>(2):500-507</mixed-citation>\n</ref>'},{id:"B60",body:'<ref id="B60"><mixed-citation publication-type="journal">Chen R, Li X, Guan N, Guo B, Wu W, Zhou Z, Huo Y, Chen X, Zhou L.Effectiveness of neuromuscular electrical stimulation for the rehabilitation of moderate-to-severe COPD: A meta-analysis. Intl J COPD. 2016;<bold>11</bold>:2965-2975</mixed-citation>\n</ref>'},{id:"B61",body:'<ref id="B61"><mixed-citation publication-type="journal">Abdellaoui A, Prfaut C, Gouzi F, Couillard A, Coisy-Quivy M, Hugon G, Molinari N, Lafontaine T, Jonquet O, Laoudj-Chenivesse D, etal. Skeletal muscle effects of electrostimulation after COPD exacerbation: A pilot study. The European Respiratory Journal. 2011;<bold>38</bold>:781-788</mixed-citation>\n</ref>'},{id:"B62",body:'<ref id="B62"><mixed-citation publication-type="journal">Dal Corso S, Npolis L, Malaguti C, Gimenes AC, Albuquerque A, Nogueira CR, De Fuccio MB, Pereira RD, Bulle A, McFarlane N, etal. Skeletal muscle structure and function in response to electrical stimulation in moderately impaired COPD patients. Respiratory Medicine. 2007;<bold>101</bold>:1236-1243</mixed-citation>\n</ref>'},{id:"B63",body:'<ref id="B63"><mixed-citation publication-type="journal">McNamara RJ, McKeough ZJ, McKenzie DK, Alison JA.Water-based exercise in COPD with physical comorbidities: A randomised controlled trial. The European Respiratory Journal. 2013;<bold>41</bold>(6):1284-1291</mixed-citation>\n</ref>'},{id:"B64",body:'<ref id="B64"><mixed-citation publication-type="journal">Leung RW, McKeough ZJ, Peters MJ, Alison JA.Short-form sun-style tai chi as an exercise training modality in people with COPD.The European Respiratory Journal. 2013;<bold>41</bold>(5):1051-1057</mixed-citation>\n</ref>'},{id:"B65",body:'<ref id="B65"><mixed-citation publication-type="journal">Yan JH, Guo YZ, Yao HM, Pan L.Effects of tai chi in patients with chronic obstructive pulmonary disease: Preliminary evidence. PLoS One. 2013;<bold>8</bold>(4) e61806</mixed-citation>\n</ref>'},{id:"B66",body:'<ref id="B66"><mixed-citation publication-type="journal">Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM.Global burden of COPD: Systematic review and meta-analysis. The European Respiratory Journal. 2006;<bold>28</bold>:523-532</mixed-citation>\n</ref>'},{id:"B67",body:'<ref id="B67"><mixed-citation publication-type="journal">Decramer M, Janssens W, Miravitlles M.Chronic obstructive pulmonary disease. Lancet. 2012;<bold>379</bold>:1341-1351</mixed-citation>\n</ref>'},{id:"B68",body:'<ref id="B68"><mixed-citation publication-type="journal">McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y.Pulmonary rehabilitation for chronic obstructive pulmonary disease (review). Cochrane Database of Systematic Reviews. 2015;(2). DOI: 10.1002/14651858.CD003793.pub3</mixed-citation>\n</ref>'},{id:"B69",body:'<ref id="B69"><mixed-citation publication-type="other">The Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017. <ext-link ext-link-type="uri" xlink:href="http://goldcopd.org">http://goldcopd.org</ext-link>.</mixed-citation>\n</ref>'},{id:"B70",body:'<ref id="B70"><mixed-citation publication-type="journal">Evans RA, Singh SJ, Collier R, Williams JE, Morgan MD.Pulmonary rehabilitation is successful for COPD irrespective of MRC dyspnoea grade. Respiratory Medicine. 2009;<bold>103</bold>:1070-1075</mixed-citation>\n</ref>'},{id:"B71",body:'<ref id="B71"><mixed-citation publication-type="journal">Puente-Maestu L, Palange P, Casaburi R, Laveneziana P, Maltais F, Neder J, ODonnell DE,Onorati P, Porszasz J, Rabinovich R, Rossiter HB, Singh S, Troosters T, Ward S.Use of exercise testing in the evaluation of interventional efficacy: An official ERS statement. The European Respiratory Journal. 2016;<bold>47</bold>:429-460</mixed-citation>\n</ref>'},{id:"B72",body:'<ref id="B72"><mixed-citation publication-type="journal">Ringbaek T, Martinez G, Brndum E, etal. Shuttle walking test as predictor of survival in chronic obstructive pulmonary disease patients enrolled in a rehabilitation program. Journal of Cardiopulmonary Rehabilitation and Prevention. 2010;<bold>30</bold>:409-414</mixed-citation>\n</ref>'},{id:"B73",body:'<ref id="B73"><mixed-citation publication-type="journal">Steiner MC, Singh SJ, Morgan MD.The contribution of peripheral muscle function to shuttle walking performance in patients with chronic obstructive pulmonary disease. Journal of Cardiopulmonary Rehabilitation. 2005;<bold>25</bold>:43-49</mixed-citation>\n</ref>'},{id:"B74",body:'<ref id="B74"><mixed-citation publication-type="journal">Lacasse Y, Wong E, Guyatt GH, etal. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet. 1996;<bold>348</bold>:1115-1119</mixed-citation>\n</ref>'},{id:"B75",body:'<ref id="B75"><mixed-citation publication-type="book">Wasserman K, Hansen JE, Sue DY, etal. Principles of Exercise Testing and Interpretation: Including Pathophysiology and Clinical Applications. 5th ed. Philadelphia: Lippincott Williams &amp; Wilkins; 2011</mixed-citation>\n</ref>'},{id:"B76",body:'<ref id="B76"><mixed-citation publication-type="journal">Puhan MA, Chandra D, Mosenifar Z, etal. The minimal important difference of exercise tests in severe COPD.The European Respiratory Journal. 2011;<bold>37</bold>:784-790</mixed-citation>\n</ref>'},{id:"B77",body:'<ref id="B77"><mixed-citation publication-type="journal">Corhay JL, Nguyen D, Duysinx B, etal. Should we exclude elderly patients with chronic obstructive pulmonary disease from a long-time ambulatory pulmonary rehabilitation programme? Journal of Rehabilitation Medicine. 2012;<bold>44</bold>:466-472</mixed-citation>\n</ref>'},{id:"B78",body:'<ref id="B78"><mixed-citation publication-type="journal">Troosters T, Casaburi R, Gosselink R, etal. Pulmonary rehabilitation in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. 2005;<bold>172</bold>:19-38</mixed-citation>\n</ref>'},{id:"B79",body:'<ref id="B79"><mixed-citation publication-type="journal">Smid MSc E, Franssen F, Houben-Wilke S, Vanfleteren L, Janssen D, Wouters E, Spruit M.Responsiveness and MCID estimates for CAT, CCQ, and HADS in patients with COPD undergoing pulmonary rehabilitation: A prospective analysis. JAMDA. 2017;<bold>18</bold>:53e58</mixed-citation>\n</ref>'},{id:"B80",body:'<ref id="B80"><mixed-citation publication-type="journal">Langer D.Rehabilitation in patients before and after lung transplantation. Respiration. 2015;<bold>89</bold>:353-362</mixed-citation>\n</ref>'},{id:"B81",body:'<ref id="B81"><mixed-citation publication-type="journal">Wickerson L, Mathur S, Brooks D.Exercise training after lung transplantation: A systematic review. The Journal of Heart and Lung Transplantation. 2010;<bold>29</bold>:497-503</mixed-citation>\n</ref>'},{id:"B82",body:'<ref id="B82"><mixed-citation publication-type="journal">Takaoka ST, Weinacker AB.The value of preoperative pulmonary rehabilitation. Thoracic Surgery Clinics. 2005;<bold>15</bold>:203-211</mixed-citation>\n</ref>'},{id:"B83",body:'<ref id="B83"><mixed-citation publication-type="journal">Costache V, Chavanon O, St Raymond C, etal. Dramatic improvement in survival after lung transplantation over time: A single center experience. Transplantation Proceedings. 2009;<bold>41</bold>:687-691</mixed-citation>\n</ref>'},{id:"B84",body:'<ref id="B84"><mixed-citation publication-type="journal">Troosters T, Demeyer H, Hornikx M, etal. Pulmonary rehabilitation. Clinics in Chest Medicine. 2014;<bold>35</bold>:241-249</mixed-citation>\n</ref>'},{id:"B85",body:'<ref id="B85"><mixed-citation publication-type="journal">Van der Woude BT, Kropmans TJB, Douma KW, etal. Peripheral muscle force and exercise capacity in lung transplant candidates. International Journal of Rehabilitation Research. 2002;<bold>25</bold>:351-355</mixed-citation>\n</ref>'},{id:"B86",body:'<ref id="B86"><mixed-citation publication-type="journal">Mathur S, Reid WD, Levy RD.Exercise limitation in recipients of lung transplants. Physical Therapy. 2004;<bold>84</bold>:1178-1187</mixed-citation>\n</ref>'},{id:"B87",body:'<ref id="B87"><mixed-citation publication-type="journal">Wang XN, Williams TJ, McKenna MJ, Li JL, Fraser SF, Side EA, etal. Skeletal muscle oxidative capacity, fiber type, and metabolites after lung transplantation. American Journal of Respiratory and Critical Care Medicine. 1999;<bold>160</bold>(1):57</mixed-citation>\n</ref>'},{id:"B88",body:'<ref id="B88"><mixed-citation publication-type="journal">Krieger AC, Szidon P, Kesten S.Skeletal muscle dysfunction in lung transplantation. The Journal of Heart and Lung Transplantation. 2000;<bold>19</bold>:392-400</mixed-citation>\n</ref>'},{id:"B89",body:'<ref id="B89"><mixed-citation publication-type="journal">Pantoja JG, Andrade FH, Stokic DS, Frost AE, Eschenbacher WL, Reid MB.Respiratory and limb muscle function in lung allograft recipients. American Journal of Respiratory and Critical Care Medicine. 1999;<bold>160</bold>:1205-1211</mixed-citation>\n</ref>'},{id:"B90",body:'<ref id="B90"><mixed-citation publication-type="journal">Williams TJ, Patterson GA, McClean PA, Zamel N, Maurer JR.Maximal exercise testing in single and double lung transplant recipients. The American Review of Respiratory Disease. 1992;<bold>145</bold>(1):101-105</mixed-citation>\n</ref>'},{id:"B91",body:'<ref id="B91"><mixed-citation publication-type="journal">Lands LC, Smountas AA, Mesiano G, Brosseau L, Shennib H, Charbonneau M, Gauthier R.Maximal exercise capacity and peripheral skeletal muscle function following lung transplantation. The Journal of Heart and Lung Transplantation. 1999;<bold>18</bold>(2):113-120</mixed-citation>\n</ref>'},{id:"B92",body:'<ref id="B92"><mixed-citation publication-type="journal">Schuurmans MM, Benden C, Inci I.Practical approach to early postoperative management of lung transplant recipients. Swiss Medical Weekly. 2013;<bold>143</bold>:137-173</mixed-citation>\n</ref>'},{id:"B93",body:'<ref id="B93"><mixed-citation publication-type="journal">Downs AM. Physical therapy in lung transplantation. Physical Therapy. 1996;<bold>76</bold>(6):626-642</mixed-citation>\n</ref>'},{id:"B94",body:'<ref id="B94"><mixed-citation publication-type="journal">National Emphysema Treatment Trial Group. A randomized trial comparing lung volume-reduction surgery with medical therapy for severe emphysema. The New England Journal of Medicine. 2003;<bold>348</bold>(21):2059-2073</mixed-citation>\n</ref>'},{id:"B95",body:'<ref id="B95"><mixed-citation publication-type="journal">Pompeo E, Marino M, Nofroni I, Matteucci G, Mineo TC.Reduction pneumoplasty versus respiratory rehabilitation in severe emphyse- ma: A randomized study. The Annals of Thoracic Surgery. 2000;<bold>70</bold>(3):948-954</mixed-citation>\n</ref>'},{id:"B96",body:'<ref id="B96"><mixed-citation publication-type="journal">Criner GJ, Cordova FC, Furukawa S, Kuzma AM, Travaline JM, Leyenson V, OBrien GM.Prospective randomized trial comparing bilateral lung volume reduction surgery to pulmonary rehabilitation in severe chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. 1999;<bold>160</bold>(6):2018-2027</mixed-citation>\n</ref>'},{id:"B97",body:'<ref id="B97"><mixed-citation publication-type="journal">Koegelenberg CF, Theron J, Dheda K, Bruwer JW, Allwood BW, Vorster J, Groote-Bidlingmaier F, Slebos DJ, Shah PL, Herth FJF.Recommendations for the use of endoscopic lung volume reduction in South Africa: Role in the treatment of emphysema. SAMJ. 2015;<bold>105</bold>:810-815</mixed-citation>\n</ref>'},{id:"B98",body:'<ref id="B98"><mixed-citation publication-type="journal">Gao K, PM Y, JH S, He CQ, Liu LX, Zhou YB, Pu Q, Che GW.Cardiopulmonary exercise testing screening and pre-operative pulmonary rehabilitation reduce postoperative complications and improve fast-track recovery after lung cancer surgery: A study for 342 cases. Thorac Cancer. 2015 Jul;<bold>6</bold>(4):443-449</mixed-citation>\n</ref>'},{id:"B99",body:'<ref id="B99"><mixed-citation publication-type="journal">Adamsen L, Midtgaard J, Andersen C, Quist M, Moeller T, Roerth M.Transforming the nature of fatigue through exercise: Qualitative findings from a multidimensional exercise programme in cancer patients undergoing chemotherapy. European Journal of Cancer Care. 2004;<bold>13</bold>(4):362-370</mixed-citation>\n</ref>'},{id:"B100",body:'<ref id="B100"><mixed-citation publication-type="journal">Pasqua F, D\'Angelillo R, Mattei F, etal. Pulmonary rehabilitation following radical chemoradiation inlocally advanced non surgical NSCLC: Preliminary evidences. Lung Cancer. 2012;<bold>76</bold>(2):258-259</mixed-citation>\n</ref>'},{id:"B101",body:'<ref id="B101"><mixed-citation publication-type="journal">Tarumi S, Yokomise H, Gotoh M, etal. Pulmonary rehabilitation during induction chemoradiotherapy for lung cancer improves pulmonary function. Journal of Thoracic and Cardiovascular Surgery. 2015;<bold>149</bold>(2):569-573</mixed-citation>\n</ref>'},{id:"B102",body:'<ref id="B102"><mixed-citation publication-type="journal">Keays KS, Harris SR, Lucyshyn JM, MacIntyre DL.Effects of pilates exercises on shoulder range of motion, pain, mood, and upper extremity function in women living with breast cancer: A pilot study. Physical Therapy. 2008;<bold>88</bold>(4):494-510</mixed-citation>\n</ref>'},{id:"B103",body:'<ref id="B103"><mixed-citation publication-type="journal">Clay CA, Perera S, Wagner JM, Miller ME, Nelson JB, Grrenspan SL. Physical function in men with prostate cancer on androgen deprivation therapy. Physical Therapy. 2007;<bold>87</bold>(10):1325-1333</mixed-citation>\n</ref>'},{id:"B104",body:'<ref id="B104"><mixed-citation publication-type="journal">Bicego D, Brown K, Ruddick M, Storey D, Wong C, Harris SR.Exercise for women with or at risk for breast cancer-related lymphedema. Physical Therapy. 2006;<bold>86</bold>(10):1398-13405</mixed-citation>\n</ref>'},{id:"B105",body:'<ref id="B105"><mixed-citation publication-type="journal">Albrecht TA, Taylor AG.Physical activity in patients with advanced-stage cancer: A systematic review of the literature. Clinical Journal of Oncology Nursing. 2012;<bold>16</bold>(3):293-300</mixed-citation>\n</ref>'},{id:"B106",body:'<ref id="B106"><mixed-citation publication-type="journal">Bolton CE, Bevan- Smith EF, Blakey JD, etal. British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax. 2013;<bold>68</bold>:1-30</mixed-citation>\n</ref>'},{id:"B107",body:'<ref id="B107"><mixed-citation publication-type="journal">Puhan M, Scharplatz M, Troosters T, Walters EH, Steurer J.Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews. 2011;<bold>1</bold>:5305</mixed-citation>\n</ref>'},{id:"B108",body:'<ref id="B108"><mixed-citation publication-type="journal">Lacasse Y, Goldstein R, Lasserson TJ, Martin S.Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews. 2006;<bold>4</bold>:37-93</mixed-citation>\n</ref>'},{id:"B109",body:'<ref id="B109"><mixed-citation publication-type="journal">Wedzicha JA, Miravitlles M, Hurst JR, Calverley P, Albert K, Anzueto A, Criner J, Papi A, Rabe KF, Rigau D, Sliwinski P, Tonia T, Vestbo J, Wilson KC, Krishnan JA.Management of COPD exacerbations: A European Respiratory Society/American Thoracic Society guideline. The European Respiratory Journal. 2017;<bold>49</bold>:1600791</mixed-citation>\n</ref>'},{id:"B110",body:'<ref id="B110"><mixed-citation publication-type="journal">Ntoumenopoulos G.Rehabilitation during mechanical ventilation: Review of the recent literature. Intensive &amp; Critical Care Nursing. 2015;<bold>31</bold>(3):125-132</mixed-citation>\n</ref>'},{id:"B111",body:'<ref id="B111"><mixed-citation publication-type="journal">Sommers J, Engelbert RHH, Dettling-Ihnenfeldt D, Gosselink R, Spronk PE, Nollet F, van der Schaaf M.Physiotherapy in the intensive care unit: An evidence-based, expert driven, practical statement and rehabilitation recommendations. Clinical Rehabilitation 2015;<bold>29</bold>(11):1051-1063</mixed-citation>\n</ref>'},{id:"B112",body:'<ref id="B112"><mixed-citation publication-type="journal">Nydahl P, Sricharoenchai T, Chandra S, Kundt FS, Huang M, Fischill M, Needham DM.Safety of patient mobilization and rehabilitation in the intensive care unit. Systematic review with meta-analysis. Annals of the American Thoracic Society. 2017 May;<bold>14</bold>(5):766-777</mixed-citation>\n</ref>'},{id:"B113",body:'<ref id="B113"><mixed-citation publication-type="journal">Hoff J, Tjonna AE, Steinshamn S, etal. Maximal strength training of the legs in COPD: A therapy for mechanical inefficiency. Medicine and Science in Sports and Exercise. 2007;<bold>39</bold>:220-226</mixed-citation>\n</ref>'},{id:"B114",body:'<ref id="B114"><mixed-citation publication-type="journal">Menadue C, Piper AJ, van t Hul AJ, Wong KK.Non-invasive ventilation during exercise training for people with chronic obstructive pulmonary disease (review). Cochrane Data base of Systematic Reviews. 2014(5). Art. No.: CD007714</mixed-citation>\n</ref>'},{id:"B115",body:'<ref id="B115"><mixed-citation publication-type="journal">Garrod R, Mikelsons C, Paul EA, Wedzicha JA.Randomized controlled trial of domiciliary noninvasive positive pressure ventilation and physical training in severe chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. 2000;<bold>162</bold>:1335-1341</mixed-citation>\n</ref>'},{id:"B116",body:'<ref id="B116"><mixed-citation publication-type="journal">Hornikx M, Van Remoortel H, Demeyer H, etal. The influence of comorbidities on outcomes of pulmonary rehabilitation pro- grams in patients with COPD: A systematic review. BioMed Research International. 2013;<bold>2013</bold>:146-148</mixed-citation>\n</ref>'},{id:"B117",body:'<ref id="B117"><mixed-citation publication-type="journal">Carreiro A, Santos J, Rodrigues F. Impact of comorbidities in pulmonary rehabilitation outcomes in patients with chronic obstructive pulmonary disease. Revista Portuguesa de Pneumologia. 2013;<bold>19</bold>(3):106-113</mixed-citation>\n</ref>'},{id:"B118",body:'<ref id="B118"><mixed-citation publication-type="journal">Crisafulli E, Costi S, Luppi F, etal. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Thorax. 2008;<bold>63</bold>:487-492</mixed-citation>\n</ref>'},{id:"B119",body:'<ref id="B119"><mixed-citation publication-type="journal">Crisafulli E, Gorgone P, Vagaggini B, etal. Efficacy of standard rehabilitation in COPD outpatients with comorbidities. European Respiratory Journal. 2010;<bold>36</bold>:1042-1048</mixed-citation>\n</ref>'},{id:"B120",body:'<ref id="B120"><mixed-citation publication-type="journal">Walsh JR, McKeough ZJ, Morris NR, etal. Metabolic disease and participant age are independent predictors of response to pulmonary rehabilitation. Journal of Cardiopulmonary Rehabilitation and Prevention. 2013;<bold>33</bold>:249-256</mixed-citation>\n</ref>'},{id:"B121",body:'<ref id="B121"><mixed-citation publication-type="journal">McNamara RJ, McKeough ZJ, McKenzie DK, Alison JA.Water- based exercise in COPD with physical comorbidities: A ran- domised controlled trial. European Respiratory Journal. 2013;<bold>41</bold>:1284-1291</mixed-citation>\n</ref>'},{id:"B122",body:'<ref id="B122"><mixed-citation publication-type="journal">Tunsupon P, Lal A, Khamis MA, Mador MJ.Comorbidities in patients with chronic obstructive pulmonary disease and pulmonary rehabilitation outcomes. Journal of Cardiopulmonary Rehabilitation and Prevention. 2017;<bold>00</bold>:1-9</mixed-citation>\n</ref>'},{id:"B123",body:'<ref id="B123"><mixed-citation publication-type="journal">Emery CF, Shermer RL, Hauck ER, Hsiao ET, MacIntyre NR.Cognitive and psychological outcomes of exercise in a 1-year follow-up study of patients with chronic obstructive pulmonary disease. Health Psychology. 2003;<bold>22</bold>(6):598-604</mixed-citation>\n</ref>'},{id:"B124",body:'<ref id="B124"><mixed-citation publication-type="journal">Corhay J, Dang DN, Cauwenberge H, Louis R.Pulmonary rehabilitation and COPD: Providing patients a good environment for optimizing therapy. International Journal of COPD. 2014;<bold>9</bold>:27-39</mixed-citation>\n</ref>'},{id:"B125",body:'<ref id="B125"><mixed-citation publication-type="journal">Rochester CL, Vogiatzis I, Holland AE, Lareau SC, Marciniuk DD, Puhan MA, etal. An official American Thoracic Society/European Respiratory Society policy statement: Enhancing implementation, use, and delivery of pulmonary rehabilitation. American Journal of Respiratory and Critical Care Medicine. 2015;<bold>192</bold>(11):1373-1386</mixed-citation>\n</ref>'},{id:"B126",body:'<ref id="B126"><mixed-citation publication-type="journal">Vasilopoulou M, Papaioannou AI, Kaltsakas G, etal. Home-based maintenance tele-rehabilitation reduces the risk for acute exacerbations of COPD, hospitalisations and emergency department visits. The European Respiratory Journal. 2017;<bold>49</bold>:1602129</mixed-citation>\n</ref>'}],footnotes:[],contributors:[{corresp:"yes",contributorFullName:"Ipek Candemir",address:"ipekcayli@yahoo.com",affiliation:'<ul class="list"><li>Ataturk Chest Disease and Chest Surgery Research and Education Hospital, Ankara, Turkey</li></ul>'}],corrections:null},book:{id:"6097",title:"COPD",subtitle:"An Update in Pathogenesis and Clinical Management",fullTitle:"COPD - An Update in Pathogenesis and Clinical Management",slug:"copd-an-update-in-pathogenesis-and-clinical-management",publishedDate:"February 21st 2018",bookSignature:"Cormac McCarthy",coverURL:"https://cdn.intechopen.com/books/images_new/6097.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"169423",title:"Dr.",name:"Cormac",middleName:null,surname:"McCarthy",slug:"cormac-mccarthy",fullName:"Cormac McCarthy"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"56569",title:"Animal Models of Chronic Obstructive Pulmonary Disease",slug:"animal-models-of-chronic-obstructive-pulmonary-disease",totalDownloads:642,totalCrossrefCites:0,signatures:"Lillian Chow, David Smith, Khushboo Chokshi, Wendy Ezegbunam,\nPrangthip Charoenpong, Kimberly Foley, Adrian Cargill and Patrick\nGeraghty",authors:[{id:"206029",title:"Ph.D.",name:"Patrick",middleName:null,surname:"Geraghty",fullName:"Patrick Geraghty",slug:"patrick-geraghty"},{id:"206030",title:"Dr.",name:"Wendy",middleName:null,surname:"Ezegbunam",fullName:"Wendy Ezegbunam",slug:"wendy-ezegbunam"},{id:"206031",title:"Dr.",name:"Prangthip",middleName:null,surname:"Charoenpong",fullName:"Prangthip Charoenpong",slug:"prangthip-charoenpong"},{id:"206032",title:"Dr.",name:"Khushboo",middleName:null,surname:"Chokshi",fullName:"Khushboo Chokshi",slug:"khushboo-chokshi"},{id:"206033",title:"Dr.",name:"David",middleName:"N",surname:"Smith",fullName:"David Smith",slug:"david-smith"},{id:"206034",title:"Dr.",name:"Adrian",middleName:null,surname:"Cargill",fullName:"Adrian Cargill",slug:"adrian-cargill"},{id:"208906",title:"Dr.",name:"Lillian",middleName:null,surname:"Chow",fullName:"Lillian Chow",slug:"lillian-chow"},{id:"210216",title:"Dr.",name:"Kimberly",middleName:null,surname:"Foley",fullName:"Kimberly Foley",slug:"kimberly-foley"}]},{id:"58032",title:"Genetics Association and Epigenetic Changes in COPD",slug:"genetics-association-and-epigenetic-changes-in-copd",totalDownloads:349,totalCrossrefCites:0,signatures:"Rajneesh Malhotra and Outi Vaarala",authors:[{id:"207507",title:"Dr.",name:"Rajneesh",middleName:null,surname:"Malhotra",fullName:"Rajneesh Malhotra",slug:"rajneesh-malhotra"},{id:"208009",title:"Prof.",name:"Outi",middleName:null,surname:"Vaarala",fullName:"Outi Vaarala",slug:"outi-vaarala"}]},{id:"57038",title:"The Respiratory Microbiome in COPD",slug:"the-respiratory-microbiome-in-copd",totalDownloads:452,totalCrossrefCites:0,signatures:"Orla OCarroll, Joanna Peart, Eamon Mullen and Conor Burke",authors:[{id:"174352",title:"Dr.",name:"Orla",middleName:null,surname:"O'Carroll",fullName:"Orla O'Carroll",slug:"orla-o'carroll"},{id:"217910",title:"Dr.",name:"Eamon",middleName:null,surname:"Mullen",fullName:"Eamon Mullen",slug:"eamon-mullen"},{id:"217911",title:"Dr.",name:"Joanna",middleName:null,surname:"Peart",fullName:"Joanna Peart",slug:"joanna-peart"},{id:"217912",title:"Prof.",name:"Conor",middleName:null,surname:"Burke",fullName:"Conor Burke",slug:"conor-burke"}]},{id:"56825",title:"Neurocognitive Impairment as Systemic Effects of COPD",slug:"neurocognitive-impairment-as-systemic-effects-of-copd",totalDownloads:294,totalCrossrefCites:0,signatures:"Cristian Oancea, Emanuela Tudorache and Voicu Tudorache",authors:[{id:"206546",title:"Dr.",name:"Cristian",middleName:null,surname:"Oancea",fullName:"Cristian Oancea",slug:"cristian-oancea"},{id:"207947",title:"Dr.",name:"Emanuela",middleName:null,surname:"Tudorache",fullName:"Emanuela Tudorache",slug:"emanuela-tudorache"},{id:"207948",title:"Prof.",name:"Voicu",middleName:null,surname:"Tudorache",fullName:"Voicu Tudorache",slug:"voicu-tudorache"}]},{id:"56827",title:"Tobacco and Smoking Cessation",slug:"tobacco-and-smoking-cessation",totalDownloads:277,totalCrossrefCites:0,signatures:"Thomas Hering",authors:[{id:"206548",title:"Ph.D.",name:"Thomas",middleName:null,surname:"Hering",fullName:"Thomas Hering",slug:"thomas-hering"}]},{id:"57506",title:"Pulmonary Rehabilitation in COPD: Current Practice and Future Directions",slug:"pulmonary-rehabilitation-in-copd-current-practice-and-future-directions",totalDownloads:647,totalCrossrefCites:0,signatures:"Michelle Casey, Amy Mulkerns, Cliona ODonnell and Tim\nMcDonnell",authors:[{id:"208279",title:"Prof.",name:"Tim",middleName:null,surname:"McDonnell",fullName:"Tim McDonnell",slug:"tim-mcdonnell"},{id:"208280",title:"Dr.",name:"Michelle",middleName:null,surname:"Casey",fullName:"Michelle Casey",slug:"michelle-casey"},{id:"208281",title:"Dr.",name:"Cliona",middleName:null,surname:"O'Donnell",fullName:"Cliona O'Donnell",slug:"cliona-o'donnell"},{id:"208282",title:"Ms.",name:"Amy",middleName:null,surname:"Mulkerns",fullName:"Amy Mulkerns",slug:"amy-mulkerns"}]},{id:"57797",title:"Advances in Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease and Associated Conditions",slug:"advances-in-pulmonary-rehabilitation-for-chronic-obstructive-pulmonary-disease-and-associated-condit",totalDownloads:384,totalCrossrefCites:0,signatures:"Ipek Candemir",authors:[{id:"206660",title:"M.D.",name:"Ipek",middleName:null,surname:"Candemir",fullName:"Ipek Candemir",slug:"ipek-candemir"}]}]},relatedBooks:[{type:"book",id:"956",title:"Cystic Fibrosis",subtitle:"Renewed Hopes Through Research",isOpenForSubmission:!1,hash:"703f0969078948d82535b7b0c08ab613",slug:"cystic-fibrosis-renewed-hopes-through-research",bookSignature:"Dinesh Sriramulu",coverURL:"https://cdn.intechopen.com/books/images_new/956.jpg",editedByType:"Edited by",editors:[{id:"91317",title:"Dr.",name:"Dinesh",surname:"Sriramulu",slug:"dinesh-sriramulu",fullName:"Dinesh Sriramulu"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"34275",title:"The Prognosis of Cystic Fibrosis - A Clinician's Perspective",slug:"the-prognosis-of-cystic-fibrosis-a-clinician-s-perspective",signatures:"Patrick Lebecque",authors:[{id:"83586",title:"Prof.",name:"Patrick",middleName:null,surname:"Lebecque",fullName:"Patrick Lebecque",slug:"patrick-lebecque"}]},{id:"34276",title:"Radiological Features of Cystic Fibrosis",slug:"radiological-features-of-cystic-fibrosis",signatures:"Iara Maria Sequeiros and Nabil A. Jarad",authors:[{id:"78568",title:"Dr.",name:"Iara Maria",middleName:null,surname:"Sequeiros",fullName:"Iara Maria Sequeiros",slug:"iara-maria-sequeiros"},{id:"126865",title:"Dr.",name:"Nabil",middleName:null,surname:"Jarad",fullName:"Nabil Jarad",slug:"nabil-jarad"}]},{id:"34277",title:"The Cystic Fibrosis 'Gender Gap': Past Observations Present Understanding and Future Directions",slug:"the-cystic-fibrosis-gender-gap-past-observations-present-understanding-future-directions",signatures:"Sanjay H. Chotirmall, Catherine M. Greene, Brian J. Harvey and Noel G. McElvaney",authors:[{id:"39463",title:"Dr.",name:"Catherine",middleName:"M.",surname:"Greene",fullName:"Catherine Greene",slug:"catherine-greene"},{id:"42784",title:"Prof.",name:"Noel G.",middleName:null,surname:"McElvaney",fullName:"Noel G. McElvaney",slug:"noel-g.-mcelvaney"},{id:"81533",title:"Dr.",name:"Sanjay",middleName:"Haresh",surname:"Chotirmall",fullName:"Sanjay Chotirmall",slug:"sanjay-chotirmall"},{id:"128629",title:"Dr.",name:"Brian",middleName:null,surname:"Harvey",fullName:"Brian Harvey",slug:"brian-harvey"}]},{id:"34278",title:"Cystic Fibrosis and Infertility",slug:"cystic-fibrosis-and-infertility",signatures:"Maria do Carmo Pimentel Batitucci, Angela Maria Spagnol Perrone and Giselle Villa Flor Brunoro",authors:[{id:"91845",title:"Dr",name:null,middleName:null,surname:"Batitucci",fullName:"Batitucci",slug:"batitucci"},{id:"124309",title:"BSc.",name:"ngela Maria Spagnol",middleName:null,surname:"Perrone",fullName:"ngela Maria Spagnol Perrone",slug:"angela-maria-spagnol-perrone"},{id:"124310",title:"Dr.",name:"Giselle",middleName:"Villa Flor",surname:"Brunoro",fullName:"Giselle Brunoro",slug:"giselle-brunoro"}]},{id:"34279",title:"The Genetics of CFTR: Genotype - Phenotype Relationship, Diagnostic Challenge and Therapeutic Implications",slug:"the-genetics-of-cftr-genotype-phenotype-relationship-diagnostic-challenge-and-therapeutic-implicatio",signatures:"Marco Lucarelli, Silvia Pierandrei, Sabina Maria Bruno and Roberto Strom",authors:[{id:"81744",title:"Prof.",name:"Marco",middleName:null,surname:"Lucarelli",fullName:"Marco Lucarelli",slug:"marco-lucarelli"},{id:"88095",title:"Dr.",name:"Silvia",middleName:null,surname:"Pierandrei",fullName:"Silvia Pierandrei",slug:"silvia-pierandrei"},{id:"88097",title:"Prof.",name:"Roberto",middleName:null,surname:"Strom",fullName:"Roberto Strom",slug:"roberto-strom"},{id:"124716",title:"Dr.",name:"Sabina Maria",middleName:null,surname:"Bruno",fullName:"Sabina Maria Bruno",slug:"sabina-maria-bruno"}]},{id:"34280",title:"Biochemical and Molecular Genetic Testing Used in the Diagnosis and Assessment of Cystic Fibrosis",slug:"biochemical-and-molecular-genetic-testing-used-in-the-diagnosis-and-assessment-of-cystic-fibrosis",signatures:"Donovan McGrowder",authors:[{id:"79123",title:"Dr.",name:"Donovan",middleName:null,surname:"McGrowder",fullName:"Donovan McGrowder",slug:"donovan-mcgrowder"}]},{id:"34281",title:"Pseudomonas aeruginosa Biofilm Formation in the CF Lung and Its Implications for Therapy",slug:"pseudomonas-aeruginosa-biofilm-formation-in-the-cf-lung-and-its-implications-for-therapy",signatures:"Gregory G. Anderson",authors:[{id:"82957",title:"Dr.",name:"Gregory",middleName:null,surname:"Anderson",fullName:"Gregory Anderson",slug:"gregory-anderson"}]},{id:"34282",title:"Outcome and Prevention of Pseudomonas aeruginosa-Staphylococcus aureus Interactions During Pulmonary Infections in Cystic Fibrosis",slug:"outcome-and-prevention-of-pseudomonas-aeruginosa-staphylococcus-aureus-interactions-during-pulmonary",signatures:"Gabriel Mitchell and Franois Malouin",authors:[{id:"87619",title:"Dr.",name:"Francois",middleName:null,surname:"Malouin",fullName:"Francois Malouin",slug:"francois-malouin"},{id:"89089",title:"Mr.",name:"Gabriel",middleName:null,surname:"Mitchell",fullName:"Gabriel Mitchell",slug:"gabriel-mitchell"}]},{id:"34283",title:"Infection by Non Tuberculous Mycobacteria in Cystic Fibrosis",slug:"infection-by-nontuberculous-mycobacteria-in-cystic-fibrosis",signatures:"Mara Santos, Ana Gil-Brusola and Pilar Morales",authors:[{id:"87481",title:"Dr.",name:"Pilar",middleName:null,surname:"Morales",fullName:"Pilar Morales",slug:"pilar-morales"}]},{id:"34284",title:"Atypical Bacteria in the CF Airways: Diversity, Clinical Consequences, Emergence and Adaptation",slug:"atypical-bacteria-in-the-cf-airways-diversity-clinical-consequences-emergence-and-adaptation",signatures:"Marchandin Hlne, Michon Anne-Laure and Jumas-Bilak Estelle",authors:[{id:"81613",title:"Prof.",name:"Hlne",middleName:null,surname:"Marchandin",fullName:"Hlne Marchandin",slug:"helene-marchandin"},{id:"88985",title:"Prof.",name:"Anne-Laure",middleName:null,surname:"Michon",fullName:"Anne-Laure Michon",slug:"anne-laure-michon"},{id:"88986",title:"Prof.",name:"Estelle",middleName:null,surname:"Jumas-Bilak",fullName:"Estelle Jumas-Bilak",slug:"estelle-jumas-bilak"}]},{id:"34285",title:"Viral Respiratory Tract Infections in Cystic Fibrosis",slug:"viral-respiratory-tract-infections-in-cystic-fibrosis",signatures:"Dennis Wat",authors:[{id:"92549",title:"Dr.",name:"Dennis",middleName:null,surname:"Wat",fullName:"Dennis Wat",slug:"dennis-wat"}]},{id:"34286",title:"Immune Dysfunction in Cystic Fibrosis",slug:"immune-response-in-cystic-fibrosis",signatures:"Yaqin Xu and Stefan Worgall",authors:[{id:"81718",title:"Prof.",name:"Stefan",middleName:null,surname:"Worgall",fullName:"Stefan Worgall",slug:"stefan-worgall"}]},{id:"34287",title:"Channel Replacement Therapy for Cystic Fibrosis",slug:"channel-replacement-therapy-for-cf",signatures:"John M. Tomich, Urka Bukovnik, Jammie Layman and Bruce D. Schultz",authors:[{id:"79549",title:"Prof.",name:"John M.",middleName:null,surname:"Tomich",fullName:"John M. Tomich",slug:"john-m.-tomich"}]},{id:"34288",title:"Improving Cell Surface Functional Expression of Delta F508 CFTR: A Quest for Therapeutic Targets",slug:"improving-cell-surface-functional-expression-of-deltaf508-cftr-a-quest-for-therapeutic-targets",signatures:"Yifei Fan, Yeshavanth K. Banasavadi-Siddegowda and Xiaodong Wang",authors:[{id:"88330",title:"Dr.",name:"Xiaodong",middleName:"Robert",surname:"Wang",fullName:"Xiaodong Wang",slug:"xiaodong-wang"},{id:"124468",title:"Dr.",name:"Yifei",middleName:null,surname:"Fan",fullName:"Yifei Fan",slug:"yifei-fan"},{id:"124470",title:"Dr.",name:"Yeshavanth",middleName:null,surname:"Banasavadi-Siddegowda",fullName:"Yeshavanth Banasavadi-Siddegowda",slug:"yeshavanth-banasavadi-siddegowda"}]},{id:"34289",title:"Fine Tuning of CFTR Traffic and Function by PDZ Scaffolding Proteins",slug:"fine-tuning-of-cftr-traffic-and-function-by-pdz-scaffolding-proteins",signatures:"Florian Bossard, Emilie Silantieff and Chantal Gauthier",authors:[{id:"87647",title:"Prof.",name:"Chantal",middleName:null,surname:"Gauthier",fullName:"Chantal Gauthier",slug:"chantal-gauthier"}]},{id:"34290",title:"CFTR Gene Transfer and Tracking the CFTR Protein in the Airway Epithelium",slug:"cftr-gene-transfer-and-tracking-the-cftr-protein-in-the-airway-epithelium",signatures:"Galle Gonzalez, Pierre Boulanger and Saw-See Hong",authors:[{id:"84406",title:"Dr.",name:"Saw-See",middleName:null,surname:"Hong",fullName:"Saw-See Hong",slug:"saw-see-hong"},{id:"86153",title:"Prof.",name:"Pierre",middleName:null,surname:"Boulanger",fullName:"Pierre Boulanger",slug:"pierre-boulanger"},{id:"86155",title:"Dr.",name:"Galle",middleName:null,surname:"Gonzalez",fullName:"Galle Gonzalez",slug:"gaelle-gonzalez"}]},{id:"34291",title:"VIP as a Corrector of CFTR Trafficking and Membrane Stability",slug:"vasoative-intestinal-peptide-vip-as-a-corrector-of-cftr-trafficking-and-membrane-stability",signatures:"Valerie Chappe and Sami I. Said",authors:[{id:"84459",title:"Prof.",name:"Valerie",middleName:null,surname:"Chappe",fullName:"Valerie Chappe",slug:"valerie-chappe"},{id:"91057",title:"Prof.",name:"Sami",middleName:null,surname:"Said",fullName:"Sami Said",slug:"sami-said"}]},{id:"34292",title:"Pharmacological Potential of PDE5 Inhibitors for the Treatment of Cystic Fibrosis",slug:"pharmacological-potential-of-pde5-inhibitors-for-the-treatment-of-cystic-fibrosis",signatures:"Bob Lubamba, Barbara Dhooghe, Sabrina Nol and Teresinha Leal",authors:[{id:"88540",title:"Prof.",name:"Teresinha",middleName:null,surname:"Leal",fullName:"Teresinha Leal",slug:"teresinha-leal"},{id:"129673",title:"Dr.",name:"Bob",middleName:"Arthur",surname:"Lubamba",fullName:"Bob Lubamba",slug:"bob-lubamba"}]},{id:"34293",title:"Pharmacological Modulators of Sphingolipid Metabolism for the Treatment of Cystic Fibrosis Lung Inflammation",slug:"pharmacological-modulators-of-sphingolipid-metabolism-for-the-treatment-of-cystic-fibrosis-lung-infl",signatures:"M.C. Dechecchi, E. Nicolis, P. Mazzi, M. Paroni, F. Cioffi, A. Tamanini,V. Bezzerri, M. Tebon, I. Lampronti, S. Huang, L. Wiszniewski, M.T. Scupoli, A. Bragonzi, R. Gambari, G. Berton and G. Cabrini",authors:[{id:"53357",title:"Prof.",name:"Roberto",middleName:null,surname:"Gambari",fullName:"Roberto Gambari",slug:"roberto-gambari"},{id:"82889",title:"Dr.",name:"Song",middleName:null,surname:"Huang",fullName:"Song Huang",slug:"song-huang"},{id:"85366",title:"Dr.",name:"Maria Cristina",middleName:null,surname:"Dechecchi",fullName:"Maria Cristina Dechecchi",slug:"maria-cristina-dechecchi"},{id:"86524",title:"Dr.",name:"Elena",middleName:null,surname:"Nicolis",fullName:"Elena Nicolis",slug:"elena-nicolis"},{id:"86525",title:"Dr.",name:"Paola",middleName:null,surname:"Mazzi",fullName:"Paola Mazzi",slug:"paola-mazzi"},{id:"86527",title:"Dr.",name:"Moira",middleName:null,surname:"Paroni",fullName:"Moira Paroni",slug:"moira-paroni"},{id:"86528",title:"Dr.",name:"Federica",middleName:null,surname:"Cioffi",fullName:"Federica Cioffi",slug:"federica-cioffi"},{id:"86529",title:"Dr.",name:"Valentino",middleName:null,surname:"Bezzerri",fullName:"Valentino Bezzerri",slug:"valentino-bezzerri"},{id:"86531",title:"Dr.",name:"Maela",middleName:null,surname:"Tebon",fullName:"Maela Tebon",slug:"maela-tebon"},{id:"86536",title:"Dr.",name:"Ilaria",middleName:null,surname:"Lampronti",fullName:"Ilaria Lampronti",slug:"ilaria-lampronti"},{id:"86540",title:"Dr.",name:"Ludovic",middleName:null,surname:"Wiszniewski",fullName:"Ludovic Wiszniewski",slug:"ludovic-wiszniewski"},{id:"86541",title:"Dr.",name:"Maria Teresa",middleName:null,surname:"Scupoli",fullName:"Maria Teresa Scupoli",slug:"maria-teresa-scupoli"},{id:"86543",title:"Prof.",name:"Alessandra",middleName:null,surname:"Bragonzi",fullName:"Alessandra Bragonzi",slug:"alessandra-bragonzi"},{id:"86544",title:"Prof.",name:"Giorgio",middleName:null,surname:"Berton",fullName:"Giorgio Berton",slug:"giorgio-berton"},{id:"86546",title:"Dr.",name:"Giulio",middleName:null,surname:"Cabrini",fullName:"Giulio Cabrini",slug:"giulio-cabrini"}]},{id:"34294",title:"The Importance of Adherence and Compliance with Treatment in Cystic Fibrosis",slug:"the-importance-of-adherence-and-compliance-with-treatment-in-cystic-fibrosis",signatures:"Rosa Patricia Arias-Llorente, Carlos Bousoo Garca and Juan J. Daz Martn",authors:[{id:"81752",title:"Dr.",name:"Rosa Patricia",middleName:null,surname:"Arias Llorente",fullName:"Rosa Patricia Arias Llorente",slug:"rosa-patricia-arias-llorente"},{id:"88980",title:"Prof.",name:"Carlos",middleName:"Garca",surname:"Bousoo",fullName:"Carlos Bousoo",slug:"carlos-bousono"}]},{id:"34295",title:"Improving the Likelihood of Success in Trials and the Efficiency of Delivery of Mucolytics and Antibiotics",slug:"improving-the-likelihood-of-success-in-trials-and-efficiency-of-delivery-of-mucolytics-and-antibioti",signatures:"Carlos F. Lange",authors:[{id:"87618",title:"Prof.",name:"Carlos",middleName:"Frederico",surname:"Lange",fullName:"Carlos Lange",slug:"carlos-lange"}]},{id:"34296",title:"Airways Clearance Techniques in Cystic Fibrosis: Physiology, Devices and the Future",slug:"airway-clearance-techniques-in-cystic-fibrosis-physiology-devices-and-the-future",signatures:"Adrian H. Kendrick",authors:[{id:"81571",title:"Dr.",name:"Adrian",middleName:"H.",surname:"Kendrick",fullName:"Adrian Kendrick",slug:"adrian-kendrick"}]},{id:"34297",title:"The Physiotherapist's Use of Exercise in the Management of Young People with Cystic Fibrosis",slug:"the-physiotherapist-s-use-of-exercise-in-the-management-of-young-people-with-cystic-fibrosis",signatures:"Allison Mandrusiak and Pauline Watter",authors:[{id:"84089",title:"Dr.",name:"Allison",middleName:null,surname:"Mandrusiak",fullName:"Allison Mandrusiak",slug:"allison-mandrusiak"},{id:"87978",title:"Dr.",name:"Pauline",middleName:null,surname:"Watter",fullName:"Pauline Watter",slug:"pauline-watter"}]},{id:"34298",title:"Exercise Performance and Breathing Patterns in Cystic Fibrosis",slug:"exercise-performance-and-breathing-patterns-in-cystic-fibrosis",signatures:"Georgia Perpati",authors:[{id:"79721",title:"Dr.",name:"Georgia",middleName:null,surname:"Perpati",fullName:"Georgia Perpati",slug:"georgia-perpati"}]}]}]},onlineFirst:{chapter:{type:"chapter",id:"65009",title:"The Relationship between Alpha-Synuclein (SNCA) Gene Polymorphisms and Development Risk of Parkinsons Disease",doi:"10.5772/intechopen.82808",slug:"the-relationship-between-alpha-synuclein-snca-gene-polymorphisms-and-development-risk-of-parkinson-s",body:'<div class="section" id="sec_1" data-lvl="1"><h2 class="heading main-title">1. Introduction</h2><p id="p2">The most important feature of age-related neurodegenerative diseases is the slow and irreversible deterioration of brain function. PD affects the motor system and is a neurodegenerative disorder of the central nervous system [<a href="#B1" class="ref-link" data-ref-style="bibr">1</a>]. The prevalence of PD, which is known to be the second progressive neurodegenerative disease, increases with age. PD, which causes severe morbidity, has motor symptoms such as tremors, bradykinesia, muscle stiffness, and postural instability and non-motor symptoms, i.e., autonomic dysfunction, sensory symptoms, sleep disturbances, and fatigue. These symptoms occur as a result of the progressive neurodegeneration of dopaminergic neurons in the substantia nigra pars compacta, clustering of proteins within the brain, Lewy bodies, and Lewy neurites [<a href="#B2" class="ref-link" data-ref-style="bibr">2</a>, <a href="#B3" class="ref-link" data-ref-style="bibr">3</a>]. As a result of degeneration of dopaminergic neurons, movement disorder occurs, and the cause of this movement disorder is the neurotransmitter dopamine deficiency. Although the basic mechanism of neuronal death in PD is unknown, genetic and environmental factors have been found to be effective in the pathogenesis of the disease [<a href="#B4" class="ref-link" data-ref-style="bibr">4</a>].</p><p id="p3">It has been reported that many genes play a role in the pathogenesis of PD, and polymorphisms in these genes may be genetic risk factors for PD development [<a href="#B5" class="ref-link" data-ref-style="bibr">5</a>]. A large number of different DNA variants have been identified in disease genes associated with familial PD in molecular genetic analyses. These genetic variants include SNCA, Parkin (PARK2), PTEN-induced putative kinase 1 (PINK1), DJ-1 (PARK7), and leucine-rich repeat kinase 2 (LRRK2) variants [<a href="#B6" class="ref-link" data-ref-style="bibr">6</a>].</p><p id="p4">The SNCA gene plays a role in important pathways associated with PD.&nbsp;It is suggested that there is a significant relationship between SNCA levels and the risk of PD development, and SNCA levels are thought to be an important marker in the diagnosis of PD.&nbsp;Several studies have been conducted to explain the relationship between genetic polymorphisms in different regions of the SNCA gene and risk of PD [<a href="#B7" class="ref-link" data-ref-style="bibr">7</a>].</p><p id="p5">Polymorphisms that occur in different regions of the SNCA gene, an important gene for PD etiology, have been identified in relation to PD [<a href="#B7" class="ref-link" data-ref-style="bibr">7</a>, <a href="#B8" class="ref-link" data-ref-style="bibr">8</a>]. Changes in SNCA expression levels are one of the main mechanisms of SNCA to cause PD [<a href="#B7" class="ref-link" data-ref-style="bibr">7</a>, <a href="#B9" class="ref-link" data-ref-style="bibr">9</a>, <a href="#B10" class="ref-link" data-ref-style="bibr">10</a>]. As a result of polymorphisms in the 5&prime; and 3&prime; UTR regions of the SNCA gene, the binding of transcription factors and miRNAs can be altered, and promoter activity is affected. Thus, gene expression can be regulated. According to the general results from the studies aimed to investigate the relationship between SNCA gene polymorphisms and the risk of PD development, the SNCA gene and some polymorphisms of this gene have been identified as genetic risk factors in PD development [<a href="#B7" class="ref-link" data-ref-style="bibr">7</a>].</p><p id="p6">The purpose of this chapter is, in addition to giving general information about PD, to summarize the studies that investigated on the relationship between SNCA gene polymorphisms and the risk of developing PD.</p></div><div class="section" id="sec_2" data-lvl="1"><h2 class="heading main-title">2. Parkinson&rsquo;s disease</h2><p id="p7">Parkinson&rsquo;s disease (PD), the second most common neurodegenerative disease after Alzheimer&rsquo;s disease, affects approximately 1&ndash;2% of individuals over 65&nbsp;years of age [<a href="#B11" class="ref-link" data-ref-style="bibr">11</a>, <a href="#B12" class="ref-link" data-ref-style="bibr">12</a>]. The incidence of PD usually begins after 50&nbsp;years of age and increases more after 60&nbsp;years of age [<a href="#B13" class="ref-link" data-ref-style="bibr">13</a>]. The prevalence of PD increases approximately 4% in people over 85&nbsp;years of age [<a href="#B6" class="ref-link" data-ref-style="bibr">6</a>]. PD is a neurological disorder associated with increased morbidity and reduced survival [<a href="#B14" class="ref-link" data-ref-style="bibr">14</a>, <a href="#B15" class="ref-link" data-ref-style="bibr">15</a>].</p><p id="p8">PD is characterized by bradykinesia, resting tremor, rigidity, and postural instability. PD is associated with the formation of Lewy bodies [<a href="#B16" class="ref-link" data-ref-style="bibr">16</a>]. Lewy bodies of postmortem that are determined in brain autopsy specimens are the distinguishing features of PD.&nbsp;These bodies are observed in intense eosinophilic nuclei and cytoplasmic inclusions. The presence of intraneuronal protein inclusions, called Lewy bodies or Lewy neurites, is one of the neuropathological features of PD [<a href="#B17" class="ref-link" data-ref-style="bibr">17</a>].</p><p id="p9">In PD, in addition to motor symptoms, non-motor symptoms occur. Motor symptoms in PD are due to the selective loss of dopaminergic neurons in the midbrain and the axon terminals reflected in the dorsal striatum [<a href="#B18" class="ref-link" data-ref-style="bibr">18</a>]. Motor symptoms occur when neuronal cell loss reaches 80% or more as a result of progressive loss in the dopaminergic neurons of substantia nigra pars compacta [<a href="#B19" class="ref-link" data-ref-style="bibr">19</a>]. Non-motor symptoms of PD are autonomic dysfunction and cognitive impairment [<a href="#B20" class="ref-link" data-ref-style="bibr">20</a>]. The motor and non-motor symptoms of PD are caused by the loss of the dopaminergic neurons of the substantia nigra [<a href="#B21" class="ref-link" data-ref-style="bibr">21</a>, <a href="#B22" class="ref-link" data-ref-style="bibr">22</a>, <a href="#B23" class="ref-link" data-ref-style="bibr">23</a>]. PD is defined as a syndrome because it is a complex disease characterized by motor and non-motor symptoms [<a href="#B20" class="ref-link" data-ref-style="bibr">20</a>].</p><p id="p10">The majority of PD cases are sporadic cases; however, it is known that 10&ndash;15% are familial cases, and the majority of these cases are hereditary. Environmental and genetic factors play a role together in the pathogenesis of PD, which has a complex etiology [<a href="#B24" class="ref-link" data-ref-style="bibr">24</a>].</p></div><div class="section" id="sec_3" data-lvl="1"><h2 class="heading main-title">3. Protein encoded by SNCA gene</h2><p id="p11">SNCA protein is the major protein of Lewy bodies. This protein is a presynaptic phosphoprotein that has a specific tendency to aggregation that plays an important role in both hereditary and idiopathic PD [<a href="#B25" class="ref-link" data-ref-style="bibr">25</a>]. SNCA protein and fibrils constitute Lewy bodies [<a href="#B16" class="ref-link" data-ref-style="bibr">16</a>]. In Lewy bodies, SNCA protein is predominant and is therefore known to be associated with the etiology of PD.&nbsp;SNCA also has an important function in the pathological process of PD [<a href="#B26" class="ref-link" data-ref-style="bibr">26</a>, <a href="#B27" class="ref-link" data-ref-style="bibr">27</a>]. SNCA, an important component of Lewy bodies, is one of the distinctive features of PD [<a href="#B28" class="ref-link" data-ref-style="bibr">28</a>, <a href="#B29" class="ref-link" data-ref-style="bibr">29</a>, <a href="#B30" class="ref-link" data-ref-style="bibr">30</a>].</p><p id="p12">The SNCA protein, which contains 144 amino acids, found as a soluble protein, not naturally folded in the cytoplasm, is encoded by three different SNCA transcripts. The function of the SNCA protein in the brain is still not fully elucidated, but it has been found to play an important role in the neurotransmitter release and vesicle cycle at presynaptic terminals [<a href="#B6" class="ref-link" data-ref-style="bibr">6</a>]. SNCA plays an important role in the regulation of neurotransmitter release, synaptic function, and plasticity of dopaminergic neurons [<a href="#B31" class="ref-link" data-ref-style="bibr">31</a>, <a href="#B32" class="ref-link" data-ref-style="bibr">32</a>, <a href="#B33" class="ref-link" data-ref-style="bibr">33</a>].</p><p id="p13">Dopamine from presynaptic vesicles plays an important role in the normal functioning of a presynaptic complex [<a href="#B34" class="ref-link" data-ref-style="bibr">34</a>, <a href="#B35" class="ref-link" data-ref-style="bibr">35</a>, <a href="#B36" class="ref-link" data-ref-style="bibr">36</a>]. Function of the SNCA protein, which is highly expressed in the brain; is the vesicle formation required for storage and transport of dopamine. Dopamine transported from the presynaptic neuron to the postsynaptic neuron is important for smooth and coordinated movements of the body. As a result of mutations in the SNCA protein, the vesicle that required for the dopamine transport cannot form, and the aggregates are formed. These aggregates are identified as important distinguishing features in PD pathogenesis. Genetic changes known to be effective in PD pathogenesis disrupt normal function of SNCA protein [<a href="#B37" class="ref-link" data-ref-style="bibr">37</a>, <a href="#B38" class="ref-link" data-ref-style="bibr">38</a>].</p></div><div class="section" id="sec_4" data-lvl="1"><h2 class="heading main-title">4. Gene of SNCA</h2><p id="p14">The SNCA gene is localized on the fourth chromosome in the human genome. It is the first gene associated with PD that contains a pathogenic missense mutation (Ala53Thr) responsible for the disease in a large Italian family [<a href="#B6" class="ref-link" data-ref-style="bibr">6</a>]. The SNCA gene plays a role in important pathways associated with PD and encodes the presynaptic protein product. Therefore, this gene is one of the genes that are extensively studied among PD susceptibility genes [<a href="#B39" class="ref-link" data-ref-style="bibr">39</a>].</p><p id="p15">It is the first causal gene in familial PD, and it encodes SNCA with main component of Lewy bodies. Lewy bodies accumulate in neural cells in familial PD cases. The reason of this accumulation is overproduction of SNCA.&nbsp;Overproduction of normal SNCA also plays an important role in the pathogenesis of sporadic PD [<a href="#B40" class="ref-link" data-ref-style="bibr">40</a>].</p><p id="p16">The chromosomal location is presented in <a href="#F1" class="ref-link" data-ref-style="fig">Figure 1</a>.</p><figure class="media-panel" id="F1"><div class="media"><img src="/media/chapter/65009/media/F1.png" class="figure-link" alt=""></div><figcaption class="caption"><h4>Figure 1.</h4><p>Chromosomal location of SNCA gene [41].</p></figcaption></figure></div><div class="section" id="sec_5" data-lvl="1"><h2 class="heading main-title">5. Gene polymorphisms of SNCA</h2><p id="p18">Genetic predisposition plays an important role in the etiology of PD.&nbsp;Multiple linkage and genome-wide association studies (GWAS) were performed to determine genetic polymorphisms in the SNCA gene. Single-nucleotide gene polymorphisms in the SNCA gene were found to be associated with increased PD risk. Single-nucleotide polymorphisms in the SNCA gene can lead to a change in PD susceptibility, resulting in increased or decreased PD risk. Several genes and several polymorphisms of the SNCA gene have been identified in GWAS.&nbsp;It has been determined that some of these gene polymorphisms may be important risk factors especially for sporadic PD [<a href="#B26" class="ref-link" data-ref-style="bibr">26</a>]. Polymorphisms in different regions of the SNCA gene have been studied in various studies with different populations [<a href="#B7" class="ref-link" data-ref-style="bibr">7</a>]. Genetic risk factors are very important in the development of PD, and up to now, 16 loci have been identified, which are known to be associated with the development of PD.&nbsp;Very few of the PD, which is mostly sporadic, are familial. The cause of familial PD development is autosomal recessive or dominant mutations. In particular, mutagenic mutations (SNCA, LRRK2, PRKN, DJ-1, and PINK1) occurring in five genes were found to be related to familial PD.&nbsp;Six loci such as MAPT, SNCA, HLA-DRBS, BST1, GAK, and LRRK2, which are associated with sporadic PD, are also defined. In a meta-analysis of various GWAS studies, five new loci identified to be associated with idiopathic PD were identified. ACMSD, STK39, MCCC1/LAMP3, SYT11, and CCDC62/HIP1R loci are found among these loci [<a href="#B20" class="ref-link" data-ref-style="bibr">20</a>]. SNCA mutations contribute to PD development as a result of amino acid displacements and configuration changes in the encoded protein [<a href="#B41" class="ref-link" data-ref-style="bibr">41</a>, <a href="#B42" class="ref-link" data-ref-style="bibr">42</a>].</p><p id="p19">Mata et&nbsp;al. found that SNCA gene polymorphisms were important risk factors for PD development risk. In a study conducted by Mata et&nbsp;al., a significant relationship was found between SNCA plasma levels and rs356219 single-nucleotide gene polymorphism [<a href="#B43" class="ref-link" data-ref-style="bibr">43</a>]. In a study conducted with the Korean population, it was determined that the G allele of rs356219 gene polymorphism was associated with the risk of PD development [<a href="#B44" class="ref-link" data-ref-style="bibr">44</a>]. In studies conducted with populations of North America, Spain, Russia, and China, rs356219 gene polymorphism was identified as a genetic risk factor for PD development risk [<a href="#B26" class="ref-link" data-ref-style="bibr">26</a>].</p><p id="p20">In several families of Greek origin and in families of Asian, Swedish, and Polish origins, p.Ala53Thr polymorphism, one of the rare mutations in the SNCA gene, was detected [<a href="#B6" class="ref-link" data-ref-style="bibr">6</a>].</p><p id="p21">In a study that performed to investigate the relationship between rs2301134, rs2301135, rs356221, and rs11931074 gene polymorphisms and PD development risk, the significant relationship was determined between two promoter polymorphisms of the SNCA gene (rs2301134 and rs2301135 gene polymorphisms) and PD development risk. In this study, genotype frequencies in rs11931074 gene polymorphism in 3&prime; UTR region of SNCA gene were found to be significantly different in patient and control groups. In this study conducted with the Iranian population, SNCA gene polymorphisms were identified as a genetic risk factor in PD development. In another study, the relationships between the rs2301134, rs2301135, rs11931074, and rs356221 gene polymorphisms and the risk of PD development were determined in the SNCA gene. In this study, CC genotype and C allele of rs2301134 gene polymorphism were found to be related to increased PD risk. In addition, CC genotype and C allele of rs2301135 gene polymorphism and GG genotype of rs11931074 gene polymorphism were determined to be associated with decreased PD [<a href="#B6" class="ref-link" data-ref-style="bibr">6</a>]. In another study conducted with the Han-Chinese population, rs2301135 gene polymorphism was found to be an important risk factor for sporadic PD development. However, rs356221 gene polymorphism was not effective in PD development. [<a href="#B45" class="ref-link" data-ref-style="bibr">45</a>]. Mata et&nbsp;al. also found that SNCA gene polymorphisms were important risk factors for PD development risk [<a href="#B43" class="ref-link" data-ref-style="bibr">43</a>]. A meta-analysis study to determine 10 candidate single-nucleotide polymorphisms of the SNCA gene showed a significant relationship between rs11931074 gene polymorphism and PD development risk [<a href="#B28" class="ref-link" data-ref-style="bibr">28</a>]. In a study conducted in the United States, it was found that some single-nucleotide gene polymorphisms in the SNCA gene were associated with the risk of PD development, but no significant relationship was determined between rs11931074 gene polymorphism and PD development risk [<a href="#B46" class="ref-link" data-ref-style="bibr">46</a>]. In a study conducted with a South American Brazilian population, the relationship between rs2583988, rs356219, rs2736990, and rs11931074 gene polymorphisms and the risk of PD development was investigated, and the significant relationship was determined between rs356219 gene polymorphism and increased cognitive disorder in PD patients [<a href="#B13" class="ref-link" data-ref-style="bibr">13</a>]. In studies conducted with European and North American populations, rs2736990 gene polymorphism has been identified as a genetic risk factor in PD development [<a href="#B47" class="ref-link" data-ref-style="bibr">47</a>]. In another study conducted with a Chinese population, a significant relationship was found between the T allele of the rs11931074 polymorphism of the SNCA gene and the G allele and PD risk of the rs894278 polymorphism. G allele of gene polymorphism of rs11931074 was found associated with decreased progression PD risk [<a href="#B29" class="ref-link" data-ref-style="bibr">29</a>]. Primer sequences for rs2301134, rs2301135, rs356221, and rs11931074 gene polymorphisms are presented in <a href="#tab1" class="ref-link" data-ref-style="table">Table 1</a> [<a href="#B7" class="ref-link" data-ref-style="bibr">7</a>].</p><div class="table-wrap" id="tab1"><div class="table-content"><table frame="hsides" rules="groups"><col><col><col><thead><tr><th>SNPs</th><th>Forward primer (5&prime;-3&prime;)</th><th>Reverse primer (5&prime;-3&prime;)</th></tr></thead><tbody><tr><td>rs2301134</td><td>F<sub>1</sub>: AAAGGGTCCTGAGGGTGCAA<br>F<sub>0</sub>: CTGAAATTTAATCACGGTCACAGGTTA</td><td>R<sub>1</sub>: CCTGTGACTCTTCCTTAGTAGTCTCACC<br>R<sub>0</sub>: GAAAAGCCTTAGGACCGCTTGT</td></tr><tr><td>rs2301135</td><td>F: TCCACAAGAGTGCTCGTGAC</td><td>R<sub>1</sub>:CTGATTTGTCAGCGCTTCTG<br>R<sub>2</sub>: CTGATTTGTCAGCGCTTCTC</td></tr><tr><td>rs356221</td><td>F<sub>1</sub>: GTTCATAAGAGAAGCCATCCTACTA<br>F<sub>0</sub>: CATGGGTTAGGTTTCATTTTGT</td><td>R<sub>1</sub>: GTTGATCTGCAACTATAGGTTAAGAA<br>R<sub>0</sub>: ATTGGAAGCAGTTAAACCACAT</td></tr><tr><td>rs11931074</td><td>F<sub>1</sub>: AATTGTGAATATGTCTTTGACCGG<br>F<sub>0</sub>: ATTCTGTCACTGGGTAGGCAGA</td><td>R<sub>1</sub>: CAGCCTTCCAAATCATAATTCCTTA<br>R<sub>0</sub>: TCTGTAGAAAGAACCCATTTGGC</td></tr></tbody></table></div><div class="table-caption"><h3 class="heading">Table 1.</h3><div class="text"><p id="p23">Primer sequences used in PCR for single-nucleotide polymorphisms (rs2301134, rs2301135, rs356221, and rs11931074).</p></div><div class="text"><p id="p22">PCR, polymerase chain reaction; SNP, single-nucleotide polymorphism.</p></div></div></div><p id="p24">In a study conducted by Yu et&nbsp;al. with Han-Chinese population, a significant relationship was found between the risk of PD development and the polymorphism of rs7684318, which is the intronic polymorphism of the SNCA gene [<a href="#B48" class="ref-link" data-ref-style="bibr">48</a>].</p><p id="p25">Rep&nbsp;1, a complex microsatellite repeat of about 10 kilobases in length, is located in the translation start region of the SNCA gene. In some studies, a significant relationship was found between specific SNCA-Rep&nbsp;1 alleles and the risk of late onset idiopathic PD development. However, there are also studies indicating that Rep&nbsp;1 risk alleles are not a genetic risk factor for the development of idiopathic PD or that these risk alleles and PD development are inversely related [<a href="#B49" class="ref-link" data-ref-style="bibr">49</a>]. Rep&nbsp;1 polymorphic microsatellite repeat is localized in the promoter region (above 10&nbsp;kb the transcription start site) of the SNCA gene [<a href="#B49" class="ref-link" data-ref-style="bibr">49</a>]. Rep&nbsp;1&ndash;261 is a microsatellite polymorphic variant associated with an increase in SNCA mRNA levels [<a href="#B47" class="ref-link" data-ref-style="bibr">47</a>]. There are two common Rep&nbsp;1 alleles as 251 and 261&nbsp;bp in length, and functional assays about these alleles were performed. According to these functional analyses, while a significant relationship was found between the risky allele with a length of 261&nbsp;bp and the upregulation of SNCA gene expression, a significant relationship was found between protective variant 259&nbsp;bp length and decreased SNCA gene expression [<a href="#B49" class="ref-link" data-ref-style="bibr">49</a>]. In addition, variability in the length of the Rep&nbsp;1 repeat sequence is associated with PD susceptibility. Genotypes containing 263&nbsp;bp allele of this sequence were associated with increased risk of PD development, and genotypes containing 259&nbsp;bp allele were associated with decreased risk of PD development [<a href="#B42" class="ref-link" data-ref-style="bibr">42</a>]. Changes in the promoter region and genetic variations in 30 untranslated SNCA gene regions have been associated with susceptibility to PD [<a href="#B49" class="ref-link" data-ref-style="bibr">49</a>]. In the SNCA promoter (SNCA-Rep&nbsp;1), it was determined that the localized Rep&nbsp;1 and 3&prime; untranslated region polymorphisms interfered with the transcription binding regions and played an important role in increasing PD susceptibility. Thus, target regions of miRNAs that alter SNCA gene expression are formed or disappear [<a href="#B26" class="ref-link" data-ref-style="bibr">26</a>]. The significant difference was determined between Rep&nbsp;1&ndash;259 allele and low levels of SNCA mRNA in postmortem brain tissues of patients with PD.&nbsp;Rep 1 microsatellite repeat and rs2583988, rs2619363, rs2619364 gene polymorphisms were found to be a relationship between. In a study conducted with a population selected from Belgium, Germany, and Serbia, the relationship was found between Rep&nbsp;1 microsatellite repeat; rs2583988, rs2619363, and rs2619364 gene polymorphisms; and PD.&nbsp;In a study conducted with German and Japanese populations, it was observed that there was a link between intron 4 and 5&prime; and 3&prime; untranslated regions (UTRs) in the SNCA gene [<a href="#B6" class="ref-link" data-ref-style="bibr">6</a>]. In a Russian population study, TT genotype of rs2583988 and rs2619363 gene polymorphisms and the GG genotype of rs2619364 gene polymorphism were found to be associated with higher levels of SNCA mRNA [<a href="#B47" class="ref-link" data-ref-style="bibr">47</a>]. There are many small-scale studies aimed at investigating this relationship, and also, in a meta-analysis study conducted by Maraganore et&nbsp;al., in a large population selected from 11 different regions, the relationship between the rep&nbsp;1 gene polymorphism and the risk of PD development has been proven [<a href="#B42" class="ref-link" data-ref-style="bibr">42</a>].</p><p id="p26">In an analysis with the Caucasus population to investigate the relationship between 12 single-nucleotide polymorphisms and PD, including the whole SNCA gene region, it was determined that signals were collected in a 24&nbsp;kb-long region in the middle of intron 4 of the SNCA gene, and it was determined that these signals were confirmed by haplotype analysis showing the presence of a strong protective allele [<a href="#B42" class="ref-link" data-ref-style="bibr">42</a>].</p><p id="p27">In addition to these gene polymorphisms, SNCA gene polymorphisms which are known to be associated with PD include rs104893875 (G&nbsp;&gt;&nbsp;A), rs104893877 (G&nbsp;&gt;&nbsp;A), and rs104893878 (G&nbsp;&gt;&nbsp;C) gene polymorphisms. It has been reported that the polymorphism rs104893875 (G&nbsp;&gt;&nbsp;A) has been identified primarily in a multinational Spanish family. The significant relationship was determined between rs104893875 (G&nbsp;&gt;&nbsp;A) gene polymorphism and increased SNCA protein aggregation. In another study conducted with the Swedish population, as a result of rs104893877 (G&nbsp;&gt;&nbsp;A) mutation, PD and encephalopathy with cortical involvement develop. Immunoreactive Lewy neurites were detected in brain stem pigmented nuclei, the hippocampus, and temporal neocortexes of PD patients in whom this gene polymorphism was detected. In a study that is significant relationship between rs104893878 (G&nbsp;&gt;&nbsp;C) gene polymorphism and autosomal dominant PD, hypometabolism was determined in frontal, parietal, and left temporal cortexes of PD patients in whom this polymorphism was detected. As a result of postmortem examination of brain slices of these patients, Lewy bodies and neurodegeneration developed and correspondingly identified. Primer sequences for rs104893875 (G/A), rs104893877 (G&nbsp;&gt;&nbsp;A), and rs104893878 (G&nbsp;&gt;&nbsp;C) gene polymorphisms are presented in <a href="#tab2" class="ref-link" data-ref-style="table">Table 2</a> [<a href="#B38" class="ref-link" data-ref-style="bibr">38</a>].</p><div class="table-wrap" id="tab2"><div class="table-content"><table frame="hsides" rules="groups"><col><col><col><thead><tr><th>SNPs</th><th>Forward primer (5&prime;-3&prime;)</th><th>Reverse primer (5&prime;-3&prime;)</th></tr></thead><tbody><tr><td>rs104893875 (G/A)</td><td>GGCCCCGGTGTTATCTCAT (SN-75-CF) TTGTAGGCTCCAAAACCATGG (SN-75-GF)</td><td>AATTCAAAGCCCTCATTATTCTTGG (SN-75-CR) CACCATGCACCACTCCCTT (SN-75-AR)</td></tr><tr><td>rs104893877 (G&nbsp;&gt;&nbsp;A)</td><td>GGCCCCGGTGTTATCTCAT (SN-75-CF) GGAGTGGTGCATGGTGAGA (SN-77-AF)</td><td>AATTCAAAGCCCTCATTATTCTTGG (SN-75-CR) GCACAATGGAGCTTACCTGTAGC (SN-77-GR)</td></tr><tr><td>rs104893878 (G&nbsp;&gt;&nbsp;C)</td><td>TCCGTGGTTAGGTGGCTAGA (SN-78-CF) ACCAAACAGGGTGTGGCAGAAGCAG (SN-78-GF)</td><td>CACACGTTCACATTCACCTACCT (SN-78-CR1) ACCCTCTTTTGTCTTTCCAGC (SN-78-CR2)</td></tr></tbody></table></div><div class="table-caption"><h3 class="heading">Table 2.</h3><div class="text"><p id="p29">Primer sequences used in PCR for single-nucleotide polymorphisms [rs104893875 (G/A), rs104893877 (G&nbsp;&gt;&nbsp;A), and rs104893878 (G&nbsp;&gt;&nbsp;C)].</p></div><div class="text"><p id="p28">PCR, polymerase chain reaction; SNP, single-nucleotide polymorphism.</p></div></div></div><p id="p30">There are three missense mutations, A53T, A30P, and E46K, as the most common pathogenic changes of the SNCA gene. In a study conducted with the Mexican Mestizos population, a significant relationship was determined between the rs1801133 and rs3857059 allelic variations of the SNCA gene and the risk of PD development. In addition, GG genotype of rs3857059 gene polymorphism was found to be a genetic risk factor for PD development [<a href="#B50" class="ref-link" data-ref-style="bibr">50</a>]. While A18T and A29S missense mutations in patients with sporadic PD; A53T, A30P, E46K, and H50Q missense mutations in familial PD patients have been described. Dual and triple copies of the SNCA locus known to be associated with PD severity cause familial Parkinsonism [<a href="#B26" class="ref-link" data-ref-style="bibr">26</a>].</p><p id="p31">There are studies showing that there are significant relationships between some polymorphisms in the SNCA gene and the risk of sporadic PD development. It is also known that these polymorphisms are associated with increased levels of plasmatic SNCA.&nbsp;Tyrosine hydroxylase activity and dopamine release decrease as a result of SNCA overexpression. In order to investigate the relationship between SNCA gene polymorphisms and the risk of PD development, different results have been obtained in studies performed with different populations [<a href="#B13" class="ref-link" data-ref-style="bibr">13</a>].</p></div><div class="section" id="sec_6" data-lvl="1"><h2 class="heading main-title">6. Conclusions</h2><p id="p32">It is known that environmental and genetic factors play a role together in PD pathogenesis. Several studies have been carried out to investigate the relationship between gene polymorphisms and PD development risk, which are important among genetic factors, and different results have been obtained in these studies. It is thought that the differences in the results of these studies are due to of PD patient and healthy control groups&rsquo; different selection criteria and different race and populations. The identification of genetic polymorphisms that play an important role in the development of PD will enable us to have knowledge about the mechanism of PD.&nbsp;In addition, new treatment methods can be improved in order to prevent PD.&nbsp;By increasing the number of PD patients and healthy controls, different results can be obtained in studies with larger populations. As a result, in studies aimed at the relationship between SNCA gene polymorphisms and the risk of PD development, some of the SNCA gene polymorphisms were found to be genetic risk factors for PD development and play an important role in the pathogenesis of the disease.</p></div><div class="section" id="sec_7" data-lvl="1"><h2 class="heading main-title">Acknowledgments</h2><p id="p33">This chapter was performed by Nevra Alkanli and Arzu Ay in Department of Biophysics, T.C.&nbsp;Halic University Medical Faculty and Department of Biophysics, Trakya University Medical Faculty.</p></div><div class="section" id="sec_7" data-lvl="1"><h2 class="heading main-title">Conflict of interest</h2><p id="p34">We declare that there is no conflict of interest with any financial organization regarding the material discussed in the chapter.</p></div>\n',keywords:"Parkinsons disease, neurodegenerative disorders, SNCA gene polymorphisms, Lewy bodies, SNCA levels",chapterPDFUrl:"https://cdn.intechopen.com/pdfs/65009.pdf",chapterXML:"https://mts.intechopen.com/source/xml/65009.xml",downloadPdfUrl:"/chapter/pdf-download/65009",previewPdfUrl:"/chapter/pdf-preview/65009",totalDownloads:188,totalViews:0,totalCrossrefCites:0,dateSubmitted:"September 10th 2018",dateReviewed:"November 30th 2018",datePrePublished:"January 8th 2019",datePublished:null,readingETA:"0",abstract:"Parkinsons disease (PD) is a neurodegenerative disorder affecting the motor system and occurring in the central nervous system. One of the symptoms of PD is accumulation of Lewy bodies and Lewy neurites. The alpha-synuclein (SNCA) gene is part of the protein complex called Lewy body. The SNCA gene encoding a presynaptic protein product is thought to play a role in PD-related important pathways. It is suggested that there is a relationship between the risk of PD development and SNCA levels, and it is suggested that SNCA level is an important marker in PD diagnosis. Various polymorphisms have been identified in the 5 and/or 3 UTR regions of the SNCA gene, and as a result of these polymorphisms, changes occur in the binding of transcription factors. The identification of the roles of SNCA gene polymorphisms in PD development may enable the development of new methods for the treatment of PD.",reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/65009",risUrl:"/chapter/ris/65009",signatures:"Nevra Alkanli and Arzu Ay",book:{id:"6998",title:"Synucleins - Biochemistry and Role in Diseases",subtitle:null,fullTitle:"Synucleins - Biochemistry and Role in Diseases",slug:null,publishedDate:null,bookSignature:"Dr. Andrei Surguchov",coverURL:"https://cdn.intechopen.com/books/images_new/6998.jpg",licenceType:"CC BY 3.0",editedByType:null,editors:[{id:"266540",title:"Dr.",name:"Andrei",middleName:null,surname:"Surguchov",slug:"andrei-surguchov",fullName:"Andrei Surguchov"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"234410",title:"Dr.",name:"Nevra",middleName:null,surname:"Alkanli",fullName:"Nevra Alkanli",slug:"nevra-alkanli",email:"nevraalkanli@halic.edu.tr",position:null,institution:null},{id:"235954",title:"Dr.",name:"Arzu",middleName:null,surname:"Ay",fullName:"Arzu Ay",slug:"arzu-ay",email:"arzuay78@yahoo.com",position:null,institution:null}],sections:[{id:"sec_1",title:"1. Introduction",level:"1"},{id:"sec_2",title:"2. Parkinsons disease",level:"1"},{id:"sec_3",title:"3. Protein encoded by SNCA gene",level:"1"},{id:"sec_4",title:"4. Gene of SNCA",level:"1"},{id:"sec_5",title:"5. Gene polymorphisms of SNCA",level:"1"},{id:"sec_6",title:"6. Conclusions",level:"1"},{id:"sec_7",title:"Acknowledgments",level:"1"},{id:"sec_7",title:"Conflict of interest",level:"1"}],chapterReferences:[{id:"B1",body:'<ref id="B1"><mixed-citation publication-type="journal">Cilingir O, Ozkan S, Aras BD, etal. Association of functional RAGE gene polymorphisms with Parkinsons disease in a Turkish cohort. Biomedical Research. 2017;<bold>28</bold>(19):8454-8460</mixed-citation></ref>'},{id:"B2",body:'<ref id="B2"><mixed-citation publication-type="journal">Weikang C, Jie L, Likang L, etal. A meta-analysis of association between glutathione S-transferase M1 gene polymorphism and Parkinsons disease susceptibility. Open Medicine. 2016;<bold>11</bold>:578-583</mixed-citation></ref>'},{id:"B3",body:'<ref id="B3"><mixed-citation publication-type="journal">Emamzadeh FN, Surguchov A.Parkinsons disease: Biomarkers, treatment, and risk factors. Frontiers in Neuroscience. 2018;<bold>12</bold>:612 <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnins.2018.00612">https://doi.org/10.3389/fnins.2018.00612</ext-link></mixed-citation></ref>'},{id:"B4",body:'<ref id="B4"><mixed-citation publication-type="journal">Borlak J, Reamon-Buettner SM.N-acetyltransferase 2 (NAT2) gene polymorphisms in Parkinsons disease. BMC Medical Genetics. 2006;<bold>7</bold>:30. DOI: 10.1186/1471-2350-7-30</mixed-citation></ref>'},{id:"B5",body:'<ref id="B5"><mixed-citation publication-type="journal">Niu MY, Wang L, Xie AM.ApaI, BsmI, FokI, and TaqI polymorphisms in the vitamin D receptor gene and Parkinsons disease. Chinese Medical Journal. 2015;<bold>128</bold>:1809-1814</mixed-citation></ref>'},{id:"B6",body:'<ref id="B6"><mixed-citation publication-type="journal">Nuytemans K, Theuns J, Cruts M, etal. Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: A mutation update. Human Mutation. 2010;<bold>31</bold>(7):763-780. DOI: 10.1002/humu.21277</mixed-citation></ref>'},{id:"B7",body:'<ref id="B7"><mixed-citation publication-type="journal">Rahimi M, Akbari M, Jamshidi J, etal. Genetic analysis of SNCA gene polymorphisms in Parkinsons disease in an Iranian population. Basal Ganglia. 2017;<bold>10</bold>:4-7. DOI: 10.1016/j.baga.2017.08.001</mixed-citation></ref>'},{id:"B8",body:'<ref id="B8"><mixed-citation publication-type="journal">Spencer CCA, Plagnol V, Strange A, etal. Dissection of the genetics of Parkinsons disease identifies an additional association 5 of SNCA and multiple associated haplotypes at 17q21. Human Molecular Genetics. 2011;<bold>20</bold>(2):345-353. DOI: 10.1093/hmg/ddq469</mixed-citation></ref>'},{id:"B9",body:'<ref id="B9"><mixed-citation publication-type="journal">Wu-Chou YH, Chen YT, Yeh TH, etal. Genetic variants of SNCA and LRRK2 genes are associated with sporadic PD susceptibility: A replication study in a Taiwanese cohort. Parkinsonism &amp;Related Disorders. 2013;<bold>19</bold>(2):251-255. DOI: 10.1016/j.parkreldis.2012.10.019</mixed-citation></ref>'},{id:"B10",body:'<ref id="B10"><mixed-citation publication-type="journal">Westerlund M, Belin AC, Anvret A, etal. Cerebellar alpha-synuclein levels are decreased in Parkinsons disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material. The FASEB Journal. 2008;<bold>22</bold>(10):3509-3514. DOI: 10.1096/fj.08-110148</mixed-citation></ref>'},{id:"B11",body:'<ref id="B11"><mixed-citation publication-type="journal">Bertram L, Tanzi RE.The genetic epidemiology of neurodegenerative disease. The Journal of Clinical Investigation. 2005;<bold>115</bold>(6):1449-1457. DOI: 10.1172/JCI24761</mixed-citation></ref>'},{id:"B12",body:'<ref id="B12"><mixed-citation publication-type="journal">Jamshidi J, Movafagh A, Emamalizadeh B, etal. HLA-DRA is associated with Parkinsons disease in Iranian population. International Journal of Immunogenetics. 2014;<bold>41</bold>(6):508-511. DOI: 10.1111/iji.12151</mixed-citation></ref>'},{id:"B13",body:'<ref id="B13"><mixed-citation publication-type="other">Camplo CLC, Cagni FC, Figueredo D de S, etal. Variants in SNCA gene are associated with Parkinsons disease risk and cognitive symptoms in a Brazilian sample. Frontiers in Aging Neuroscience. 2017;<bold>9</bold>:198. DOI: 10.3389/fnagi.2017.00198</mixed-citation></ref>'},{id:"B14",body:'<ref id="B14"><mixed-citation publication-type="other">Zambrino CA, Zorzi G, Lanzi G, etal. Influence of strict, intermediate, and broad diagnostic criteria on the age- and sex-specific incidence of Parkinsons disease. Movement Disorders. 2000;<bold>15</bold>:819-825. DOI: 10.1002 2/1531-8257(200009)15:5&lt;819::AID-MDS1009&gt;3.0.CO;2-P</mixed-citation></ref>'},{id:"B15",body:'<ref id="B15"><mixed-citation publication-type="journal">Elbaz A, Bower JH, Peterson BJ, etal. Survival study of Parkinson disease in Olmsted County, Minnesota. Archives of Neurology. 2003;<bold>60</bold>:91-96. DOI: 10.1001/archneur.60.1.91</mixed-citation></ref>'},{id:"B16",body:'<ref id="B16"><mixed-citation publication-type="journal">Braak H, Del Tredici K, Rb U, etal. Staging of brain pathology related to sporadic Parkinsons disease. Neurobiology of Aging. 2003;<bold>24</bold>:197-211. DOI: 10.1016/S0197-4580(02)00065-9</mixed-citation></ref>'},{id:"B17",body:'<ref id="B17"><mixed-citation publication-type="journal">Spillantini MG, Schmidt ML, Lee VMY, etal. -Synuclein in Lewy bodies. Nature. 1997;<bold>388</bold>(6645):839-840. DOI: 10.1007/s11172-007-0336-1</mixed-citation></ref>'},{id:"B18",body:'<ref id="B18"><mixed-citation publication-type="journal">Hornykiewicz O.Dopamin (3-Hydroxytyramin) im Zentralnervensystem und seine Beziehung zum Parkinson-Syndrom des Menschen. Deutsche Medizinische Wochenschrift. 1962;<bold>87</bold>:1807-1810. DOI: 10.1055/s-0028-1114024</mixed-citation></ref>'},{id:"B19",body:'<ref id="B19"><mixed-citation publication-type="journal">Fearnley JM, Lees AJ.Ageing and Parkinsons disease: Substantia nigra regional selectivity. Brain. 1991;<bold>114</bold>:2283-2201. DOI: 10.1093/brain/114.5.2283</mixed-citation></ref>'},{id:"B20",body:'<ref id="B20"><mixed-citation publication-type="journal">Sassi C.Genetics of Parkinson disease. Intech Open. 2014;<bold>2</bold>:64</mixed-citation></ref>'},{id:"B21",body:'<ref id="B21"><mixed-citation publication-type="journal">Searles Nielsen S, Bammler TK, Gallagher LG, etal. Genotype and age at Parkinson disease diagnosis. International Journal of Molecular Epidemiology and Genetics. 2013;<bold>4</bold>(1):61-69. DOI: 10.1108/IJCoMA-01-2013-0001</mixed-citation></ref>'},{id:"B22",body:'<ref id="B22"><mixed-citation publication-type="journal">Haghnejad L, Emamalizadeh B, Jamshidi J, etal. Variation in the miRNA-433 binding site of FGF20 is a risk factor for Parkinsons disease in Iranian population. Journal of the Neurological Sciences. 2015;<bold>355</bold>(1-2):72-74. DOI: 10.1016/j.jns.2015.05.020</mixed-citation></ref>'},{id:"B23",body:'<ref id="B23"><mixed-citation publication-type="journal">Obeso JA, Rodriguez-Oroz MC, Goetz CG, etal. Missing pieces in the Parkinsons disease puzzle. Nature Medicine. 2010;<bold>16</bold>(6):653-661. DOI: 10.1038/nm.2165</mixed-citation></ref>'},{id:"B24",body:'<ref id="B24"><mixed-citation publication-type="other">Klein C, Westenberger A.Genetics of Parkinsons disease. Cold Spring Harb Perspectives in Medicine. 2012;<bold>2</bold>(1). DOI: 10.1101/cshperspect.a008888</mixed-citation></ref>'},{id:"B25",body:'<ref id="B25"><mixed-citation publication-type="journal">Goedert M.Alpha-synuclein and neurodegenerative diseases. Nature Reviews. Neuroscience. 2001;<bold>2</bold>:492-501. DOI: 10.1038/35081564</mixed-citation></ref>'},{id:"B26",body:'<ref id="B26"><mixed-citation publication-type="journal">Camplo CLDC, Silva RH.Genetic variants in SNCA and the risk of sporadic Parkinsons disease and clinical outcomes: A review. Parkinsons Disease. 2017;<bold>2017</bold>:4318416. DOI: 10.1155/2017/4318416</mixed-citation></ref>'},{id:"B27",body:'<ref id="B27"><mixed-citation publication-type="journal">Surguchov A.Intracellular dynamics of synucleins: Here, there and everywhere. International Review of Cell and Molecular Biology. 2015;<bold>320</bold>:103-169</mixed-citation></ref>'},{id:"B28",body:'<ref id="B28"><mixed-citation publication-type="other">Han W, Liu Y, Mi Y, etal. Alpha-synuclein (SNCA) polymorphisms and susceptibility to Parkinsons disease: A meta-analysis. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 2015; <bold>168B</bold>(2)123-134. DOI: 10.1002/ajmg.b.32288</mixed-citation></ref>'},{id:"B29",body:'<ref id="B29"><mixed-citation publication-type="journal">Liu J, Xiao Q, Wang Y, etal. Analysis of genome-wide association study-linked loci in Parkinsons disease of mainland China. Movement Disorders. 2013;<bold>28</bold>(13):1892-1895. DOI: 10.1002/mds.25599</mixed-citation></ref>'},{id:"B30",body:'<ref id="B30"><mixed-citation publication-type="journal">Chen W, Kang WY, Chen S, etal. Hyposmia correlates with SNCA variant and non-motor symptoms in Chinese patients with Parkinsons disease. Parkinsonism &amp; Related Disorders. 2015;<bold>21</bold>(6):610-614. DOI: 10.1016/j.parkreldis.2015.03.021</mixed-citation></ref>'},{id:"B31",body:'<ref id="B31"><mixed-citation publication-type="journal">Lashuel HA, Overk CR, Oueslati A, etal. The many faces of -synuclein: From structure and toxicity to therapeutic target. Nature Reviews. Neuroscience. 2013;<bold>14</bold>(1):38-48. DOI: 10.1038/nrn3406</mixed-citation></ref>'},{id:"B32",body:'<ref id="B32"><mixed-citation publication-type="journal">Bendor JT, Logan TP, Edwards RH.The function of -synuclein. Neuron. 2013;<bold>79</bold>(6):1044-1066. DOI: 10.1016/j.neuron.2013.09.004</mixed-citation></ref>'},{id:"B33",body:'<ref id="B33"><mixed-citation publication-type="journal">Eisbach SE, Outeiro TF.Alpha-Synuclein and intracellular trafficking: Impact on the spreading of Parkinsons disease pathology. Journal of Molecular Medicine. 2013;<bold>91</bold>(6):693-703. DOI: 10.1007/s00109-013-1038-9</mixed-citation></ref>'},{id:"B34",body:'<ref id="B34"><mixed-citation publication-type="journal">Burr J, Sharma M, Tsetsenis T, etal. -Synuclein promotes SNARE-complex assembly invivo and invitro. Science. 2010;<bold>329</bold>(5999):1663-1667. DOI: 10.1126/science.1195227</mixed-citation></ref>'},{id:"B35",body:'<ref id="B35"><mixed-citation publication-type="journal">Choi B-K, Choi M-G, Kim J-Y, etal. Large alpha-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking. Proceedings of the National Academy of Sciences. 2013;<bold>110</bold>(10):4087-4092. DOI: 10.1073/pnas.1218424110</mixed-citation></ref>'},{id:"B36",body:'<ref id="B36"><mixed-citation publication-type="journal">McCarthy JJ, Linnertz C, Saucier L, etal. The effect of SNCA 3 region on the levels of SNCA-112 splicing variant. Neurogenetics. 2011;<bold>12</bold>(1):59-64. DOI: 10.1007/s10048-010-0263-4</mixed-citation></ref>'},{id:"B37",body:'<ref id="B37"><mixed-citation publication-type="journal">Pandey N, Schmidt RE, Galvin JE.The alpha-synuclein mutation E46K promotes aggregation in cultured cells. Experimental Neurology. 2006;<bold>197</bold>:515-520. DOI: 10.1016/j.expneurol.2005.10.019</mixed-citation></ref>'},{id:"B38",body:'<ref id="B38"><mixed-citation publication-type="other">Anwarullah, Sultan A, Usmani MA, etal. Absence of SNCA polymorphisms in Pakistani Parkinsons disease patients. Journal of Pakistan Medical Association. 2017;<bold>67</bold>:1512</mixed-citation></ref>'},{id:"B39",body:'<ref id="B39"><mixed-citation publication-type="journal">Bekris LM, Mata IF, Zabetian CP.The genetics of Parkinson disease. Journal of Geriatric Psychiatry and Neurology. Epub ahead of print 2010;<bold>23</bold>:228e42. DOI: 10.1177/0891988710383572</mixed-citation></ref>'},{id:"B40",body:'<ref id="B40"><mixed-citation publication-type="other">Lesage S, Brice A.Parkinsons disease: From monogenic forms to genetic susceptibility factors. Human Molecular Genetics. 2009;<bold>18</bold>:R48e59. DOI: 10.1093/hmg/ddp012</mixed-citation></ref>'},{id:"B41",body:'<ref id="B41"><mixed-citation publication-type="other">SNCA Synuclein Alpha. <italic>Homo sapiens</italic> (human). HGNC:HGNC:11138</mixed-citation></ref>'},{id:"B42",body:'<ref id="B42"><mixed-citation publication-type="other">Maraganore DM, De Andrade M, Elbaz A, etal. Collaborative analysis of -synuclein gene promoter variability and Parkinson disease. The Journal of the American Medical Association. 2006;<bold>296</bold>(6). DOI: 10.1001/jama.296.6.661</mixed-citation></ref>'},{id:"B43",body:'<ref id="B43"><mixed-citation publication-type="other">Mata IF, Shi M, Agarwal P, etal. SNCA variant associated with Parkinson disease and plasma -synuclein level. Archives ofNeurology. 2010;(11):1350-1356. DOI: 10.106701/archneurol.2010.279</mixed-citation></ref>'},{id:"B44",body:'<ref id="B44"><mixed-citation publication-type="journal">Kim HJ, Kim JM, Lee JY, etal. -Synuclein polymorphism and Parkinsons disease in a tau homogeneous population. Neurology Asia. 2010;<bold>15</bold>(1):61-63</mixed-citation></ref>'},{id:"B45",body:'<ref id="B45"><mixed-citation publication-type="journal">Fang J, Yi K, Guo M, etal. Analysis of LRRK2, SNCA, and ITGA8 gene variants with sporadic Parkinsons disease susceptibility in Chinese Han population. Parkinsons Disease. 2016;<bold>2016</bold>:3474751. DOI: 10.1155/2016/3474751</mixed-citation></ref>'},{id:"B46",body:'<ref id="B46"><mixed-citation publication-type="journal">Davis AA, Andruska KM, Benitez BA, etal. Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression. Neurobiology of Aging. 2016;<bold>37</bold>(209):e1-e7. DOI: 10.1016/j.neurobiolaging.2015.09.014</mixed-citation></ref>'},{id:"B47",body:'<ref id="B47"><mixed-citation publication-type="journal">Alieva AK, Shadrina MI, Filatova EV, etal. Polymorphisms in the SNCA gene: Association with the risk of development of the sporadic form of Parkinsons disease and the level of SNCA gene expression in peripheral blood of patients from Russia. Neuroscience Medicine. 2013;<bold>4</bold>:208-214</mixed-citation></ref>'},{id:"B48",body:'<ref id="B48"><mixed-citation publication-type="journal">Yu L, Xu P, He X, etal. SNP rs7684318 of the -synuclein gene is associated with Parkinsons disease in the Han Chinese population. Brain Research. 2010;<bold>1346</bold>:262-265</mixed-citation></ref>'},{id:"B49",body:'<ref id="B49"><mixed-citation publication-type="journal">Trotta L, Guella I, Sold G, etal. SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population. Parkinsonism &amp; Related Disorders. 2012;<bold>18</bold>(3):257-262. DOI: 10.1016/j.parkreldis.2011.10.014</mixed-citation></ref>'},{id:"B50",body:'<ref id="B50"><mixed-citation publication-type="journal">Garca S, Chavira-Hernndez G, Gallegos-Arreola MP, etal. The rs3857059 variant of the SNCA gene is associated with Parkinsons disease in Mexican mestizos. Arquivos de Neuro-Psiquiatria. 2016;<bold>74</bold>(6):445-449. DOI: 10.1590/0004-282X20160061</mixed-citation></ref>'}],footnotes:[],contributors:[{corresp:"yes",contributorFullName:"Nevra Alkanli",address:"nevraalkanli@halic.edu.tr",affiliation:'<ul class="list"><li>Department of Biophysics, Faculty of Medicine, T.C.Halic University, Turkey</li></ul>'},{corresp:null,contributorFullName:"Arzu Ay",address:null,affiliation:'<ul class="list"><li>Department of Biophysics, Faculty of Medicine, Trakya University, Turkey</li></ul>'}],corrections:null},book:{id:"6998",title:"Synucleins - Biochemistry and Role in Diseases",subtitle:null,fullTitle:"Synucleins - Biochemistry and Role in Diseases",slug:null,publishedDate:null,bookSignature:"Dr. Andrei Surguchov",coverURL:"https://cdn.intechopen.com/books/images_new/6998.jpg",licenceType:"CC BY 3.0",editedByType:null,editors:[{id:"266540",title:"Dr.",name:"Andrei",middleName:null,surname:"Surguchov",slug:"andrei-surguchov",fullName:"Andrei Surguchov"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},profile:{item:{id:"60325",title:"Dr.",name:"Alessandra",middleName:null,surname:"Silvestri",email:"asilvestri@cro.it",fullName:"Alessandra Silvestri",slug:"alessandra-silvestri",position:null,biography:null,institutionString:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",totalCites:0,totalChapterViews:"0",outsideEditionCount:0,totalAuthoredChapters:"1",totalEditedBooks:"0",personalWebsiteURL:null,twitterURL:null,linkedinURL:null,institution:null},booksEdited:[],chaptersAuthored:[{title:"Therapeutical Cues from the Tumor Microenvironment",slug:"therapeutical-cues-from-the-tumor-microenvironment",abstract:null,signatures:"Stefano Marastoni, Eva Andreuzzi, Roberta Colladel, Alice Paulitti, Alessandra Silvestri, Federico Todaro, Alfonso Colombatti and Maurizio Mongiat",authors:[{id:"59586",title:"Dr.",name:"Maurizio",surname:"Mongiat",fullName:"Maurizio Mongiat",slug:"maurizio-mongiat",email:"mmongiat@cro.it"},{id:"60322",title:"Dr.",name:"Stefano",surname:"Marastoni",fullName:"Stefano Marastoni",slug:"stefano-marastoni",email:"smarastoni@cro.it"},{id:"60323",title:"Dr",name:"Roberta",surname:"Colladel",fullName:"Roberta Colladel",slug:"roberta-colladel",email:"rcolladel@cro.it"},{id:"60324",title:"Dr",name:"Eva",surname:"Andreuzzi",fullName:"Eva Andreuzzi",slug:"eva-andreuzzi",email:"eandreuzzi@libero.it"},{id:"60325",title:"Dr.",name:"Alessandra",surname:"Silvestri",fullName:"Alessandra Silvestri",slug:"alessandra-silvestri",email:"asilvestri@cro.it"},{id:"60326",title:"Dr.",name:"Alice",surname:"Paulitti",fullName:"Alice Paulitti",slug:"alice-paulitti",email:"alice.od@libero.it"},{id:"60327",title:"Dr.",name:"Alfonso",surname:"Colombatti",fullName:"Alfonso Colombatti",slug:"alfonso-colombatti",email:"acolombatti@cro.it"},{id:"101687",title:"BSc.",name:"Federico",surname:"Todaro",fullName:"Federico Todaro",slug:"federico-todaro",email:"ftodaro@cro.it"}],book:{title:"Advances in Cancer Therapy",slug:"advances-in-cancer-therapy",productType:{id:"1",title:"Edited Volume"}}}],collaborators:[{id:"46637",title:"Dr.",name:"Nathan",surname:"Wall",slug:"nathan-wall",fullName:"Nathan Wall",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:"I received my PhD in Cancer Biology from Wayne State University/Karmanos Cancer Institute/Michigan Cancer Foundation in Detroit, MI in 2000.  While there I worked for Dr. Ayad Al-Katib on the ubiquitination of Bcl2 and the novel biological agent Bryostatin 1.  I completed two post-doctoral fellowships at first (2000-2002) Yale University in the lab of Dr. Dario Altieri where I started my chosen area of  work on the inhibitor of apoptosis, Survivin.  I next (2003-2004) developed my molecular skills in the laboratory of Dr. Yang Shi at the Medical School at Harvard.  In September 2004 I was recruited to the Center for Molecular Biology & Gene Therapy, now Center for Health Disparities & Molecular Medicine at Loma Linda University.  I am joint appointed in the Depts. of Basic Sciences, Pediatrics and Radiation Medicine.  In 2008 I completed my MBA in management from the University of Redlands.",institutionString:null,institution:{name:"Loma Linda University",institutionURL:null,country:{name:"United States of America"}}},{id:"52298",title:"Prof.",name:"Oner",surname:"Ozdemir",slug:"oner-ozdemir",fullName:"Oner Ozdemir",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/52298/images/system/52298.jpg",biography:"Assoc. Prof. Dr. ner zdemir was born in Alapl, Zonguldak, Turkey on September 18, 1965. He graduated from stanbul University stanbul Medical School and become a medical doctor in 1989. His pediatric residency was completed at the Department of Pediatrics at the Childrens Hospital of stanbul Medical School, Istanbul, Turkey. His clinical fellowship training was completed at the Pediatric Allergy/Immunology program at Louisiana State University Health Sciences Ctr., New Orleans, LA. A part of his clinical fellowship training was done at the pediatric allergy/immunology program in Cincinnati Children's Hospital Medical Center, Cincinnati, OH.\nProf. zdemir's research areas are as follows: LAK-cell generation and cell-mediated cytotoxicity; human mast cell development and mast cell cytotoxicity; and apoptosis -related research. He was  1st place winner of Clemens Von Pirquet Award from ACAAI at ACAAI meeting in 2005 for the best research on allergy/asthma/immunology by a fellow in training. He has 45 international and 20 national publications, as well as 85 international and 25 national presentations.\nCurrently, he is working as Chief of Pediatrics at the third clinic associated with the division of pediatric allergy/immunology at stanbul Medeniyet University, Gztepe Teaching and Training Hospital, Kadky, Istanbul, Turkey.",institutionString:null,institution:null},{id:"60344",title:"Dr.",name:"Nathalie",surname:"Heuz-Vourch",slug:"nathalie-heuze-vourch",fullName:"Nathalie Heuz-Vourch",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"60350",title:"Prof.",name:"Virginie",surname:"Herv-Grpinet",slug:"virginie-herve-grepinet",fullName:"Virginie Herv-Grpinet",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"60902",title:"Dr.",name:"Salma",surname:"Khan",slug:"salma-khan",fullName:"Salma Khan",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Loma Linda University",institutionURL:null,country:{name:"United States of America"}}},{id:"60903",title:"MSc",name:"Malyn May",surname:"Asuncion-Valenzuela",slug:"malyn-may-asuncion-valenzuela",fullName:"Malyn May Asuncion-Valenzuela",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Loma Linda University",institutionURL:null,country:{name:"United States of America"}}},{id:"96584",title:"Dr.",name:"David",surname:"Turay",slug:"david-turay",fullName:"David Turay",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Loma Linda University",institutionURL:null,country:{name:"United States of America"}}},{id:"96585",title:"BSc.",name:"Joon",surname:"Park",slug:"joon-park",fullName:"Joon Park",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Loma Linda University",institutionURL:null,country:{name:"United States of America"}}},{id:"96587",title:"Mrs.",name:"Jessica",surname:"Jutzy",slug:"jessica-jutzy",fullName:"Jessica Jutzy",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Loma Linda University",institutionURL:null,country:{name:"United States of America"}}},{id:"96588",title:"BSc.",name:"Jon",surname:"Aspe",slug:"jon-aspe",fullName:"Jon Aspe",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Loma Linda University",institutionURL:null,country:{name:"United States of America"}}}]},generic:{page:{slug:"compacts",title:"IntechOpen Compacts",intro:"<p><strong>IntechOpen Compacts</strong> present a mid-length publishing format which bridges the gap between journal articles, book chapters, and monographs and covers content across all scientific disciplines. Compacts are the preferred publishing option for brief research reports on new topics, in-depth case studies, dissertations, or essays exploring new ideas, issues or broader topics on the subject at hand.</p>",metaTitle:"IntechOpen Compacts",metaDescription:"IntechOpen Compacts present a mid-length publishing format which bridges the gap between journal articles, book chapters, and monographs and covers content across all scientific disciplines.",metaKeywords:null,canonicalURL:"/page/compacts",contentRaw:'[{"type":"htmlEditorComponent","content":"<p>Without sacrificing the quality of carefully edited and produced peer-reviewed content, Compacts are published as part of IntechOpen&rsquo;s book collection but on faster schedules, typically 4-6 weeks after acceptance. With an average of 132,000 visitors per week, publishing in Compacts guarantees high visibility and international content sharing. As a fully Open Access publisher, the utilization of a CC BY NC 4.0 license means that other researchers will never have to pay permission fees and can adapt, use, and further build upon the material published in Compacts, eliminating any barriers to the further development of scientific research.</p>\\n\\n<p><strong>COMPACTS-SHORT FORM MONOGRAPH</strong></p>\\n\\n<ul>\\n\\t<li>50 - 130 pages</li>\\n\\t<li>Peer-reviewed</li>\\n\\t<li>Self-contained works of writing on a particular subject written by one or more authors</li>\\n\\t<li>A unique hybrid between a book chapter and monograph</li>\\n\\t<li>Online only or online and print options available</li>\\n</ul>\\n\\n<p><strong>COST</strong></p>\\n\\n<p>4,000 GBP Compacts Monograph - Short Form</p>\\n\\n<p>The final price depends on the volume of the publication and includes&nbsp;project management, editorial and peer-review services, technical editing, language copyediting, cover design, book layout, book promotion and ISBN assignment.&nbsp;</p>\\n\\n<p><em>*The price does not include Value-Added Tax (VAT). Residents of European Union countries need to add VAT based on their specific country rate. Institutions and companies registered as VAT taxable entities in their own EU member state, will not pay VAT by providing us with their VAT registration number. This is made possible by the EU reverse charge method.</em></p>\\n\\n<p>IntechOpen has collaborated with Enago, through its sister brand, Ulatus &ndash; one of the world&rsquo;s leading providers of book translation services. The services are designed to seamlessly convey the essence of your work to readers from across the globe in the language they understand. Enago&rsquo;s expert translators incorporate cultural nuances in translations to make the content relevant for local audiences while retaining the original meaning and style. With linguistic and subject expertise, Enago translators are equipped to handle all complex and multiple overlapping themes encompassed in a single book to deliver a superior quality output.</p>\\n\\n<p>IntechOpen authors that wish to use this service will receive a 20% discount on all translation services. To find out more information or get a quote, please visit:&nbsp;<a href=\\"https://www.enago.com/intech\\" target=\\"_blank\\">https://www.enago.com/intech</a>.</p>\\n\\n<p><strong>FUNDING</strong></p>\\n\\n<p>We feel that financial barriers should never prevent researchers from publishing their research. Take a look at our&nbsp;<a href=\\"/page/open-access-funding\\">Open Access Funding</a>&nbsp;page to explore funding opportunities and learn more about how you can finance your IntechOpen publication.</p>\\n\\n<p><strong>BENEFITS</strong></p>\\n\\n<ul>\\n\\t<li>Peer-review</li>\\n\\t<li>Fast publishing process: publication 4 to 6 weeks post-acceptance</li>\\n\\t<li>Language proofreading and technical formatting included in the cost</li>\\n\\t<li>Unprecedented personal support</li>\\n\\t<li>Tailor-made product: choose between online only or online and print editions of your Compacts</li>\\n\\t<li>560,000&nbsp;unique visitors per month&nbsp;guarantees high visibility and international content sharing</li>\\n\\t<li>Retain Copyright to your work</li>\\n\\t<li>Wide Dissemination&nbsp;- distribution to scientific databases and university libraries</li>\\n\\t<li>Author in the Center - signature personal approach</li>\\n\\t<li>Competitive pricing with funding opportunities</li>\\n</ul>\\n\\n<p><strong>PUBLISHING PROCESS STEPS</strong></p>\\n\\n<p>See a complete overview of all publishing process steps and descriptions&nbsp;<a href=\\"https://www.intechopen.com/how-open-access-publishing-with-intechopen-works\\">here</a>.</p>\\n\\n<p><strong>SEND YOUR PROPOSAL</strong></p>\\n\\n<p>If you are interested in publishing your book with IntechOpen, please submit your book proposal by completing the <a href=\\"/publishing-proposal\\">Publishing Proposal Form</a>.</p>\\n\\n<p>Not sure if this is the right option for you? Check out the <a href=\\"/publish\\">Publish with IntechOpen</a> page or feel free to contact us directly at <a href=\\"http://book.department@intechopen.com\\">book.department@intechopen.com</a></p>\\n\\n<p>&nbsp;</p>\\n"}]'},components:[{type:"htmlEditorComponent",content:'<p>Without sacrificing the quality of carefully edited and produced peer-reviewed content, Compacts are published as part of IntechOpen&rsquo;s book collection but on faster schedules, typically 4-6 weeks after acceptance. With an average of 132,000 visitors per week, publishing in Compacts guarantees high visibility and international content sharing. As a fully Open Access publisher, the utilization of a CC BY NC 4.0 license means that other researchers will never have to pay permission fees and can adapt, use, and further build upon the material published in Compacts, eliminating any barriers to the further development of scientific research.</p>\n\n<p><strong>COMPACTS-SHORT FORM MONOGRAPH</strong></p>\n\n<ul>\n\t<li>50 - 130 pages</li>\n\t<li>Peer-reviewed</li>\n\t<li>Self-contained works of writing on a particular subject written by one or more authors</li>\n\t<li>A unique hybrid between a book chapter and monograph</li>\n\t<li>Online only or online and print options available</li>\n</ul>\n\n<p><strong>COST</strong></p>\n\n<p>4,000 GBP Compacts Monograph - Short Form</p>\n\n<p>The final price depends on the volume of the publication and includes&nbsp;project management, editorial and peer-review services, technical editing, language copyediting, cover design, book layout, book promotion and ISBN assignment.&nbsp;</p>\n\n<p><em>*The price does not include Value-Added Tax (VAT). Residents of European Union countries need to add VAT based on their specific country rate. Institutions and companies registered as VAT taxable entities in their own EU member state, will not pay VAT by providing us with their VAT registration number. This is made possible by the EU reverse charge method.</em></p>\n\n<p>IntechOpen has collaborated with Enago, through its sister brand, Ulatus &ndash; one of the world&rsquo;s leading providers of book translation services. The services are designed to seamlessly convey the essence of your work to readers from across the globe in the language they understand. Enago&rsquo;s expert translators incorporate cultural nuances in translations to make the content relevant for local audiences while retaining the original meaning and style. With linguistic and subject expertise, Enago translators are equipped to handle all complex and multiple overlapping themes encompassed in a single book to deliver a superior quality output.</p>\n\n<p>IntechOpen authors that wish to use this service will receive a 20% discount on all translation services. To find out more information or get a quote, please visit:&nbsp;<a href="https://www.enago.com/intech" target="_blank">https://www.enago.com/intech</a>.</p>\n\n<p><strong>FUNDING</strong></p>\n\n<p>We feel that financial barriers should never prevent researchers from publishing their research. Take a look at our&nbsp;<a href="/page/open-access-funding">Open Access Funding</a>&nbsp;page to explore funding opportunities and learn more about how you can finance your IntechOpen publication.</p>\n\n<p><strong>BENEFITS</strong></p>\n\n<ul>\n\t<li>Peer-review</li>\n\t<li>Fast publishing process: publication 4 to 6 weeks post-acceptance</li>\n\t<li>Language proofreading and technical formatting included in the cost</li>\n\t<li>Unprecedented personal support</li>\n\t<li>Tailor-made product: choose between online only or online and print editions of your Compacts</li>\n\t<li>560,000&nbsp;unique visitors per month&nbsp;guarantees high visibility and international content sharing</li>\n\t<li>Retain Copyright to your work</li>\n\t<li>Wide Dissemination&nbsp;- distribution to scientific databases and university libraries</li>\n\t<li>Author in the Center - signature personal approach</li>\n\t<li>Competitive pricing with funding opportunities</li>\n</ul>\n\n<p><strong>PUBLISHING PROCESS STEPS</strong></p>\n\n<p>See a complete overview of all publishing process steps and descriptions&nbsp;<a href="https://www.intechopen.com/how-open-access-publishing-with-intechopen-works">here</a>.</p>\n\n<p><strong>SEND YOUR PROPOSAL</strong></p>\n\n<p>If you are interested in publishing your book with IntechOpen, please submit your book proposal by completing the <a href="/publishing-proposal">Publishing Proposal Form</a>.</p>\n\n<p>Not sure if this is the right option for you? Check out the <a href="/publish">Publish with IntechOpen</a> page or feel free to contact us directly at <a href="http://book.department@intechopen.com">book.department@intechopen.com</a></p>\n\n<p>&nbsp;</p>\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{sort:"featured,name"},profiles:[{id:"6700",title:"Dr.",name:"Abbass A.",middleName:null,surname:"Hashim",slug:"abbass-a.-hashim",fullName:"Abbass A. Hashim",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/6700/images/1864_n.jpg",biography:"Currently I am carrying out research in several areas of interest, mainly covering work on chemical and bio-sensors, semiconductor thin film device fabrication and characterisation.\nAt the moment I have very strong interest in radiation environmental pollution and bacteriology treatment. The teams of researchers are working very hard to bring novel results in this field. I am also a member of the team in charge for the supervision of Ph.D. students in the fields of development of silicon based planar waveguide sensor devices, study of inelastic electron tunnelling in planar tunnelling nanostructures for sensing applications and development of organotellurium(IV) compounds for semiconductor applications. I am a specialist in data analysis techniques and nanosurface structure. I have served as the editor for many books, been a member of the editorial board in science journals, have published many papers and hold many patents.",institutionString:null,institution:{name:"Sheffield Hallam University",country:{name:"United Kingdom"}}},{id:"54525",title:"Prof.",name:"Abdul Latif",middleName:null,surname:"Ahmad",slug:"abdul-latif-ahmad",fullName:"Abdul Latif Ahmad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"20567",title:"Prof.",name:"Ado",middleName:null,surname:"Jorio",slug:"ado-jorio",fullName:"Ado Jorio",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidade Federal de Minas Gerais",country:{name:"Brazil"}}},{id:"47940",title:"Dr.",name:"Alberto",middleName:null,surname:"Mantovani",slug:"alberto-mantovani",fullName:"Alberto Mantovani",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"12392",title:"Mr.",name:"Alex",middleName:null,surname:"Lazinica",slug:"alex-lazinica",fullName:"Alex Lazinica",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/12392/images/7282_n.png",biography:"Alex Lazinica is the founder and CEO of IntechOpen. After obtaining a Master's degree in Mechanical Engineering, he continued his PhD studies in Robotics at the Vienna University of Technology. Here he worked as a robotic researcher with the university's Intelligent Manufacturing Systems Group as well as a guest researcher at various European universities, including the Swiss Federal Institute of Technology Lausanne (EPFL). During this time he published more than 20 scientific papers, gave presentations, served as a reviewer for major robotic journals and conferences and most importantly he co-founded and built the International Journal of Advanced Robotic Systems- world's first Open Access journal in the field of robotics. Starting this journal was a pivotal point in his career, since it was a pathway to founding IntechOpen - Open Access publisher focused on addressing academic researchers needs. Alex is a personification of IntechOpen key values being trusted, open and entrepreneurial. Today his focus is on defining the growth and development strategy for the company.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"19816",title:"Prof.",name:"Alexander",middleName:null,surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/19816/images/1607_n.jpg",biography:"Alexander I. Kokorin: born: 1947, Moscow; DSc., PhD; Principal Research Fellow (Research Professor) of Department of Kinetics and Catalysis, N. Semenov Institute of Chemical Physics, Russian Academy of Sciences, Moscow.\nArea of research interests: physical chemistry of complex-organized molecular and nanosized systems, including polymer-metal complexes; the surface of doped oxide semiconductors. He is an expert in structural, absorptive, catalytic and photocatalytic properties, in structural organization and dynamic features of ionic liquids, in magnetic interactions between paramagnetic centers. The author or co-author of 3 books, over 200 articles and reviews in scientific journals and books. He is an actual member of the International EPR/ESR Society, European Society on Quantum Solar Energy Conversion, Moscow House of Scientists, of the Board of Moscow Physical Society.",institutionString:null,institution:null},{id:"62389",title:"PhD.",name:"Ali Demir",middleName:null,surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/62389/images/3413_n.jpg",biography:"Dr. Ali Demir Sezer has a Ph.D. from Pharmaceutical Biotechnology at the Faculty of Pharmacy, University of Marmara (Turkey). He is the member of many Pharmaceutical Associations and acts as a reviewer of scientific journals and European projects under different research areas such as: drug delivery systems, nanotechnology and pharmaceutical biotechnology. Dr. Sezer is the author of many scientific publications in peer-reviewed journals and poster communications. Focus of his research activity is drug delivery, physico-chemical characterization and biological evaluation of biopolymers micro and nanoparticles as modified drug delivery system, and colloidal drug carriers (liposomes, nanoparticles etc.).",institutionString:null,institution:{name:"Marmara University",country:{name:"Turkey"}}},{id:"61051",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"100762",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"St David's Medical Center",country:{name:"United States of America"}}},{id:"107416",title:"Dr.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Texas Cardiac Arrhythmia",country:{name:"United States of America"}}},{id:"64434",title:"Dr.",name:"Angkoon",middleName:null,surname:"Phinyomark",slug:"angkoon-phinyomark",fullName:"Angkoon Phinyomark",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/64434/images/2619_n.jpg",biography:"My name is Angkoon Phinyomark. I received a B.Eng. degree in Computer Engineering with First Class Honors in 2008 from Prince of Songkla University, Songkhla, Thailand, where I received a Ph.D. degree in Electrical Engineering. My research interests are primarily in the area of biomedical signal processing and classification notably EMG (electromyography signal), EOG (electrooculography signal), and EEG (electroencephalography signal), image analysis notably breast cancer analysis and optical coherence tomography, and rehabilitation engineering. I became a student member of IEEE in 2008. During October 2011-March 2012, I had worked at School of Computer Science and Electronic Engineering, University of Essex, Colchester, Essex, United Kingdom. In addition, during a B.Eng. I had been a visiting research student at Faculty of Computer Science, University of Murcia, Murcia, Spain for three months.\n\nI have published over 40 papers during 5 years in refereed journals, books, and conference proceedings in the areas of electro-physiological signals processing and classification, notably EMG and EOG signals, fractal analysis, wavelet analysis, texture analysis, feature extraction and machine learning algorithms, and assistive and rehabilitative devices. I have several computer programming language certificates, i.e. Sun Certified Programmer for the Java 2 Platform 1.4 (SCJP), Microsoft Certified Professional Developer, Web Developer (MCPD), Microsoft Certified Technology Specialist, .NET Framework 2.0 Web (MCTS). I am a Reviewer for several refereed journals and international conferences, such as IEEE Transactions on Biomedical Engineering, IEEE Transactions on Industrial Electronics, Optic Letters, Measurement Science Review, and also a member of the International Advisory Committee for 2012 IEEE Business Engineering and Industrial Applications and 2012 IEEE Symposium on Business, Engineering and Industrial Applications.",institutionString:null,institution:{name:"Joseph Fourier University",country:{name:"France"}}},{id:"55578",title:"Dr.",name:"Antonio",middleName:null,surname:"Jurado-Navas",slug:"antonio-jurado-navas",fullName:"Antonio Jurado-Navas",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/55578/images/4574_n.png",biography:"Antonio Jurado-Navas received the M.S. degree (2002) and the Ph.D. degree (2009) in Telecommunication Engineering, both from the University of Mlaga (Spain). He first worked as a consultant at Vodafone-Spain. From 2004 to 2011, he was a Research Assistant with the Communications Engineering Department at the University of Mlaga. In 2011, he became an Assistant Professor in the same department. From 2012 to 2015, he was with Ericsson Spain, where he was working on geo-location\ntools for third generation mobile networks. Since 2015, he is a Marie-Curie fellow at the Denmark Technical University. His current research interests include the areas of mobile communication systems and channel modeling in addition to atmospheric optical communications, adaptive optics and statistics",institutionString:null,institution:{name:"University of Malaga",country:{name:"Spain"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:5263},{group:"region",caption:"Middle and South America",value:2,count:4779},{group:"region",caption:"Africa",value:3,count:1444},{group:"region",caption:"Asia",value:4,count:9212},{group:"region",caption:"Australia and Oceania",value:5,count:825},{group:"region",caption:"Europe",value:6,count:14616}],offset:12,limit:12,total:105784},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{sort:"dateEndThirdStepPublish",topicId:"15"},books:[{type:"book",id:"8601",title:"Fixed Point",subtitle:null,isOpenForSubmission:!0,hash:"294c402de44bdd6636c0bc0ee84333ff",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/8601.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8760",title:"Topology",subtitle:null,isOpenForSubmission:!0,hash:"9fc71b0e78c2ce3dc72ec28f06e548af",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/8760.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8682",title:"Vectors",subtitle:null,isOpenForSubmission:!0,hash:"a9ea6743964f79b391b672fc667bbbf1",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/8682.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8801",title:"Integer Programming",subtitle:null,isOpenForSubmission:!0,hash:"918f29f180d8d833cb20e0f82328174d",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/8801.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8253",title:"Inverse and Ill-Posed Problems in Mathematical Analysis",subtitle:null,isOpenForSubmission:!0,hash:"d1cfb88fa591f630cf45ce668a73563f",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/8253.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7428",title:"Tensors",subtitle:null,isOpenForSubmission:!0,hash:"8b7ffb45770f52fa3c42ed81cb39924e",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/7428.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8142",title:"Number Theory",subtitle:null,isOpenForSubmission:!0,hash:"f01ca9dcabc35ad2f9c6d80321c2e900",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/8142.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8187",title:"Applications of Differential Geometry in Physics",subtitle:null,isOpenForSubmission:!0,hash:"321a71d29d5bb5428a36beb323fcc7cf",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/8187.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9328",title:"Set Theory",subtitle:null,isOpenForSubmission:!0,hash:"1a737abf2e06132ebace3080a3d3f941",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/9328.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9329",title:"Projective Geometry",subtitle:null,isOpenForSubmission:!0,hash:"0d95c6dd41591aed98cc763c63f5efac",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/9329.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9331",title:"Boundary Element Method",subtitle:null,isOpenForSubmission:!0,hash:"5b1e792472c8c6b857371263ea3226ff",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/9331.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9231",title:"Spline",subtitle:null,isOpenForSubmission:!0,hash:"a09493145c79688eb71f2889ac835586",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/9231.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:26},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:33},{group:"topic",caption:"Business, Management and Economics",value:7,count:5},{group:"topic",caption:"Chemistry",value:8,count:20},{group:"topic",caption:"Computer and Information Science",value:9,count:22},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:7},{group:"topic",caption:"Engineering",value:11,count:39},{group:"topic",caption:"Environmental Sciences",value:12,count:8},{group:"topic",caption:"Immunology and Microbiology",value:13,count:7},{group:"topic",caption:"Materials Science",value:14,count:10},{group:"topic",caption:"Mathematics",value:15,count:2},{group:"topic",caption:"Medicine",value:16,count:105},{group:"topic",caption:"Nanotechnology and Nanomaterials",value:17,count:5},{group:"topic",caption:"Neuroscience",value:18,count:6},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:11},{group:"topic",caption:"Physics",value:20,count:17},{group:"topic",caption:"Psychology",value:21,count:1},{group:"topic",caption:"Social Sciences",value:23,count:5},{group:"topic",caption:"Technology",value:24,count:4},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:1}],offset:12,limit:12,total:26},popularBooks:{featuredBooks:[{type:"book",id:"7228",title:"Blockchain and Cryptocurrencies",subtitle:null,isOpenForSubmission:!1,hash:"44c73dd3c9afa94a3db7731254babaf2",slug:"blockchain-and-cryptocurrencies",bookSignature:"Asma Salman and Muthanna G. Abdul Razzaq",coverURL:"https://cdn.intechopen.com/books/images_new/7228.jpg",editors:[{id:"206443",title:"Dr.",name:"Asma",middleName:null,surname:"Salman",slug:"asma-salman",fullName:"Asma Salman"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8011",title:"Natural Hazards",subtitle:"Risk, Exposure, Response, and Resilience",isOpenForSubmission:!1,hash:"43ca8c43ab0963f6c43350764f696b63",slug:"natural-hazards-risk-exposure-response-and-resilience",bookSignature:"John P. Tiefenbacher",coverURL:"https://cdn.intechopen.com/books/images_new/8011.jpg",editors:[{id:"73876",title:"Prof.",name:"John",middleName:"P.",surname:"Tiefenbacher",slug:"john-tiefenbacher",fullName:"John Tiefenbacher"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7836",title:"The Art of Body Contouring",subtitle:null,isOpenForSubmission:!1,hash:"983c155c9b836c8e4947bb3946694bc9",slug:"the-art-of-body-contouring",bookSignature:"Alexandro Aguilera",coverURL:"https://cdn.intechopen.com/books/images_new/7836.jpg",editors:[{id:"162339",title:"Dr.",name:"Alexandro",middleName:null,surname:"Aguilera Salgado",slug:"alexandro-aguilera-salgado",fullName:"Alexandro Aguilera Salgado"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7581",title:"Neuroprotection",subtitle:null,isOpenForSubmission:!1,hash:"0a01b892051ad12c316ddf17801b962e",slug:"neuroprotection",bookSignature:"Raymond Chuen-Chung Chang and Yuen-Shan Ho",coverURL:"https://cdn.intechopen.com/books/images_new/7581.jpg",editors:[{id:"33396",title:"Dr.",name:"Raymond Chuen-Chung",middleName:null,surname:"Chang",slug:"raymond-chuen-chung-chang",fullName:"Raymond Chuen-Chung Chang"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"2160",title:"MATLAB",subtitle:"A Fundamental Tool for Scientific Computing and Engineering Applications - Volume 1",isOpenForSubmission:!1,hash:"dd9c658341fbd264ed4f8d9e6aa8ca29",slug:"matlab-a-fundamental-tool-for-scientific-computing-and-engineering-applications-volume-1",bookSignature:"Vasilios N. Katsikis",coverURL:"https://cdn.intechopen.com/books/images_new/2160.jpg",editors:[{id:"12289",title:"Prof.",name:"Vasilios",middleName:"N.",surname:"Katsikis",slug:"vasilios-katsikis",fullName:"Vasilios Katsikis"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8892",title:"Textile Manufacturing Processes",subtitle:null,isOpenForSubmission:!1,hash:"1437c101708777875352cbfd31f6241b",slug:"textile-manufacturing-processes",bookSignature:"Faheem Uddin",coverURL:"https://cdn.intechopen.com/books/images_new/8892.jpg",editors:[{id:"228107",title:"Prof.",name:"Faheem",middleName:null,surname:"Uddin",slug:"faheem-uddin",fullName:"Faheem Uddin"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"3568",title:"Recent Advances in Plant in vitro Culture",subtitle:null,isOpenForSubmission:!1,hash:"830bbb601742c85a3fb0eeafe1454c43",slug:"recent-advances-in-plant-in-vitro-culture",bookSignature:"Annarita Leva and Laura M. R. Rinaldi",coverURL:"https://cdn.intechopen.com/books/images_new/3568.jpg",editors:[{id:"142145",title:"Dr.",name:"Annarita",middleName:null,surname:"Leva",slug:"annarita-leva",fullName:"Annarita Leva"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"3560",title:"Advances in Landscape Architecture",subtitle:null,isOpenForSubmission:!1,hash:"a20614517ec5f7e91188fe8e42832138",slug:"advances-in-landscape-architecture",bookSignature:"Murat zyavuz",coverURL:"https://cdn.intechopen.com/books/images_new/3560.jpg",editors:[{id:"93073",title:"Dr.",name:"Murat",middleName:null,surname:"Ozyavuz",slug:"murat-ozyavuz",fullName:"Murat Ozyavuz"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"1069",title:"Paresthesia",subtitle:null,isOpenForSubmission:!1,hash:"c0225cd8274b4384cd1c91e586645958",slug:"paresthesia",bookSignature:"Luiz E. Imbelloni and Marildo A. Gouveia",coverURL:"https://cdn.intechopen.com/books/images_new/1069.jpg",editors:[{id:"80284",title:"Dr.",name:"Luiz Eduardo",middleName:null,surname:"Imbelloni",slug:"luiz-eduardo-imbelloni",fullName:"Luiz Eduardo Imbelloni"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"1770",title:"Gel Electrophoresis",subtitle:"Principles and Basics",isOpenForSubmission:!1,hash:"279701f6c802cf02deef45103e0611ff",slug:"gel-electrophoresis-principles-and-basics",bookSignature:"Sameh Magdeldin",coverURL:"https://cdn.intechopen.com/books/images_new/1770.jpg",editors:[{id:"123648",title:"Dr.",name:"Sameh",middleName:null,surname:"Magdeldin",slug:"sameh-magdeldin",fullName:"Sameh Magdeldin"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7594",title:"Current Topics in Biochemical Engineering",subtitle:null,isOpenForSubmission:!1,hash:"391609f1f0cb3bba32befeb3aa40ccf3",slug:"current-topics-in-biochemical-engineering",bookSignature:"Naofumi Shiomi",coverURL:"https://cdn.intechopen.com/books/images_new/7594.jpg",editors:[{id:"163777",title:"Prof.",name:"Naofumi",middleName:null,surname:"Shiomi",slug:"naofumi-shiomi",fullName:"Naofumi Shiomi"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"878",title:"Phytochemicals",subtitle:"A Global Perspective of Their Role in Nutrition and Health",isOpenForSubmission:!1,hash:"ec77671f63975ef2d16192897deb6835",slug:"phytochemicals-a-global-perspective-of-their-role-in-nutrition-and-health",bookSignature:"Venketeshwer Rao",coverURL:"https://cdn.intechopen.com/books/images_new/878.jpg",editors:[{id:"82663",title:"Dr.",name:"Venketeshwer",middleName:null,surname:"Rao",slug:"venketeshwer-rao",fullName:"Venketeshwer Rao"}],productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:3857},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"7228",title:"Blockchain and Cryptocurrencies",subtitle:null,isOpenForSubmission:!1,hash:"44c73dd3c9afa94a3db7731254babaf2",slug:"blockchain-and-cryptocurrencies",bookSignature:"Asma Salman and Muthanna G. Abdul Razzaq",coverURL:"https://cdn.intechopen.com/books/images_new/7228.jpg",editors:[{id:"206443",title:"Dr.",name:"Asma",middleName:null,surname:"Salman",slug:"asma-salman",fullName:"Asma Salman"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8011",title:"Natural Hazards",subtitle:"Risk, Exposure, Response, and Resilience",isOpenForSubmission:!1,hash:"43ca8c43ab0963f6c43350764f696b63",slug:"natural-hazards-risk-exposure-response-and-resilience",bookSignature:"John P. Tiefenbacher",coverURL:"https://cdn.intechopen.com/books/images_new/8011.jpg",editors:[{id:"73876",title:"Prof.",name:"John",middleName:"P.",surname:"Tiefenbacher",slug:"john-tiefenbacher",fullName:"John Tiefenbacher"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7836",title:"The Art of Body Contouring",subtitle:null,isOpenForSubmission:!1,hash:"983c155c9b836c8e4947bb3946694bc9",slug:"the-art-of-body-contouring",bookSignature:"Alexandro Aguilera",coverURL:"https://cdn.intechopen.com/books/images_new/7836.jpg",editors:[{id:"162339",title:"Dr.",name:"Alexandro",middleName:null,surname:"Aguilera Salgado",slug:"alexandro-aguilera-salgado",fullName:"Alexandro Aguilera Salgado"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7581",title:"Neuroprotection",subtitle:null,isOpenForSubmission:!1,hash:"0a01b892051ad12c316ddf17801b962e",slug:"neuroprotection",bookSignature:"Raymond Chuen-Chung Chang and Yuen-Shan Ho",coverURL:"https://cdn.intechopen.com/books/images_new/7581.jpg",editors:[{id:"33396",title:"Dr.",name:"Raymond Chuen-Chung",middleName:null,surname:"Chang",slug:"raymond-chuen-chung-chang",fullName:"Raymond Chuen-Chung Chang"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8892",title:"Textile Manufacturing Processes",subtitle:null,isOpenForSubmission:!1,hash:"1437c101708777875352cbfd31f6241b",slug:"textile-manufacturing-processes",bookSignature:"Faheem Uddin",coverURL:"https://cdn.intechopen.com/books/images_new/8892.jpg",editors:[{id:"228107",title:"Prof.",name:"Faheem",middleName:null,surname:"Uddin",slug:"faheem-uddin",fullName:"Faheem Uddin"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"2160",title:"MATLAB",subtitle:"A Fundamental Tool for Scientific Computing and Engineering Applications - Volume 1",isOpenForSubmission:!1,hash:"dd9c658341fbd264ed4f8d9e6aa8ca29",slug:"matlab-a-fundamental-tool-for-scientific-computing-and-engineering-applications-volume-1",bookSignature:"Vasilios N. Katsikis",coverURL:"https://cdn.intechopen.com/books/images_new/2160.jpg",editors:[{id:"12289",title:"Prof.",name:"Vasilios",middleName:"N.",surname:"Katsikis",slug:"vasilios-katsikis",fullName:"Vasilios Katsikis"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"3568",title:"Recent Advances in Plant in vitro Culture",subtitle:null,isOpenForSubmission:!1,hash:"830bbb601742c85a3fb0eeafe1454c43",slug:"recent-advances-in-plant-in-vitro-culture",bookSignature:"Annarita Leva and Laura M. R. Rinaldi",coverURL:"https://cdn.intechopen.com/books/images_new/3568.jpg",editors:[{id:"142145",title:"Dr.",name:"Annarita",middleName:null,surname:"Leva",slug:"annarita-leva",fullName:"Annarita Leva"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7594",title:"Current Topics in Biochemical Engineering",subtitle:null,isOpenForSubmission:!1,hash:"391609f1f0cb3bba32befeb3aa40ccf3",slug:"current-topics-in-biochemical-engineering",bookSignature:"Naofumi Shiomi",coverURL:"https://cdn.intechopen.com/books/images_new/7594.jpg",editors:[{id:"163777",title:"Prof.",name:"Naofumi",middleName:null,surname:"Shiomi",slug:"naofumi-shiomi",fullName:"Naofumi Shiomi"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"3560",title:"Advances in Landscape Architecture",subtitle:null,isOpenForSubmission:!1,hash:"a20614517ec5f7e91188fe8e42832138",slug:"advances-in-landscape-architecture",bookSignature:"Murat zyavuz",coverURL:"https://cdn.intechopen.com/books/images_new/3560.jpg",editors:[{id:"93073",title:"Dr.",name:"Murat",middleName:null,surname:"Ozyavuz",slug:"murat-ozyavuz",fullName:"Murat Ozyavuz"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"1069",title:"Paresthesia",subtitle:null,isOpenForSubmission:!1,hash:"c0225cd8274b4384cd1c91e586645958",slug:"paresthesia",bookSignature:"Luiz E. Imbelloni and Marildo A. Gouveia",coverURL:"https://cdn.intechopen.com/books/images_new/1069.jpg",editors:[{id:"80284",title:"Dr.",name:"Luiz Eduardo",middleName:null,surname:"Imbelloni",slug:"luiz-eduardo-imbelloni",fullName:"Luiz Eduardo Imbelloni"}],productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"7202",title:"Interferometry",subtitle:"Recent Developments and Contemporary Applications",isOpenForSubmission:!1,hash:"8aeff7771f05136bde443a4db9410cc6",slug:"interferometry-recent-developments-and-contemporary-applications",bookSignature:"Mithun Bhowmick and Bruno Ullrich",coverURL:"https://cdn.intechopen.com/books/images_new/7202.jpg",editedByType:"Edited by",editors:[{id:"192826",title:"Dr.",name:"Mithun",middleName:null,surname:"Bhowmick",slug:"mithun-bhowmick",fullName:"Mithun Bhowmick"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7228",title:"Blockchain and Cryptocurrencies",subtitle:null,isOpenForSubmission:!1,hash:"44c73dd3c9afa94a3db7731254babaf2",slug:"blockchain-and-cryptocurrencies",bookSignature:"Asma Salman and Muthanna G. Abdul Razzaq",coverURL:"https://cdn.intechopen.com/books/images_new/7228.jpg",editedByType:"Edited by",editors:[{id:"206443",title:"Dr.",name:"Asma",middleName:null,surname:"Salman",slug:"asma-salman",fullName:"Asma Salman"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6977",title:"Embryology",subtitle:"Theory and Practice",isOpenForSubmission:!1,hash:"4620ebf60e92b453c7e4fde00cd94515",slug:"embryology-theory-and-practice",bookSignature:"Bin Wu and Huai L. Feng",coverURL:"https://cdn.intechopen.com/books/images_new/6977.jpg",editedByType:"Edited by",editors:[{id:"108807",title:"Dr.",name:"Bin",middleName:null,surname:"Wu",slug:"bin-wu",fullName:"Bin Wu"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8011",title:"Natural Hazards",subtitle:"Risk, Exposure, Response, and Resilience",isOpenForSubmission:!1,hash:"43ca8c43ab0963f6c43350764f696b63",slug:"natural-hazards-risk-exposure-response-and-resilience",bookSignature:"John P. Tiefenbacher",coverURL:"https://cdn.intechopen.com/books/images_new/8011.jpg",editedByType:"Edited by",editors:[{id:"73876",title:"Prof.",name:"John",middleName:"P.",surname:"Tiefenbacher",slug:"john-tiefenbacher",fullName:"John Tiefenbacher"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6733",title:"Mycotoxins",subtitle:"Impact and Management Strategies",isOpenForSubmission:!1,hash:"93e4e18e9fbe30a389b07568cc28c02c",slug:"mycotoxins-impact-and-management-strategies",bookSignature:"Patrick Berka Njobeh and Francois Stepman",coverURL:"https://cdn.intechopen.com/books/images_new/6733.jpg",editedByType:"Edited by",editors:[{id:"60387",title:"Prof.",name:"Patrick Berka",middleName:null,surname:"Njobeh",slug:"patrick-berka-njobeh",fullName:"Patrick Berka Njobeh"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7836",title:"The Art of Body Contouring",subtitle:null,isOpenForSubmission:!1,hash:"983c155c9b836c8e4947bb3946694bc9",slug:"the-art-of-body-contouring",bookSignature:"Alexandro Aguilera",coverURL:"https://cdn.intechopen.com/books/images_new/7836.jpg",editedByType:"Edited by",editors:[{id:"162339",title:"Dr.",name:"Alexandro",middleName:null,surname:"Aguilera Salgado",slug:"alexandro-aguilera-salgado",fullName:"Alexandro Aguilera Salgado"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7581",title:"Neuroprotection",subtitle:null,isOpenForSubmission:!1,hash:"0a01b892051ad12c316ddf17801b962e",slug:"neuroprotection",bookSignature:"Raymond Chuen-Chung Chang and Yuen-Shan Ho",coverURL:"https://cdn.intechopen.com/books/images_new/7581.jpg",editedByType:"Edited by",editors:[{id:"33396",title:"Dr.",name:"Raymond Chuen-Chung",middleName:null,surname:"Chang",slug:"raymond-chuen-chung-chang",fullName:"Raymond Chuen-Chung Chang"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8892",title:"Textile Manufacturing Processes",subtitle:null,isOpenForSubmission:!1,hash:"1437c101708777875352cbfd31f6241b",slug:"textile-manufacturing-processes",bookSignature:"Faheem Uddin",coverURL:"https://cdn.intechopen.com/books/images_new/8892.jpg",editedByType:"Edited by",editors:[{id:"228107",title:"Prof.",name:"Faheem",middleName:null,surname:"Uddin",slug:"faheem-uddin",fullName:"Faheem Uddin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7808",title:"Current Issues in Knowledge Management",subtitle:null,isOpenForSubmission:!1,hash:"93933c9bdd9d2d5fc7419959897005bf",slug:"current-issues-in-knowledge-management",bookSignature:"Mark Wickham",coverURL:"https://cdn.intechopen.com/books/images_new/7808.jpg",editedByType:"Edited by",editors:[{id:"195021",title:"Dr.",name:"Mark",middleName:null,surname:"Wickham",slug:"mark-wickham",fullName:"Mark Wickham"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8288",title:"Bacterial Cattle Diseases",subtitle:null,isOpenForSubmission:!1,hash:"f45b8b4974eb0d7de8719ef6b9146200",slug:"bacterial-cattle-diseases",bookSignature:"Hussein Abdel hay El-Sayed Kaoud",coverURL:"https://cdn.intechopen.com/books/images_new/8288.jpg",editedByType:"Edited by",editors:[{id:"265070",title:"Dr.",name:"Hussein Abdelhay",middleName:null,surname:"Essayed Kaoud",slug:"hussein-abdelhay-essayed-kaoud",fullName:"Hussein Abdelhay Essayed Kaoud"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"525",title:"Soft Computing",slug:"soft-computing",parent:{title:"Artificial Intelligence",slug:"computer-and-information-science-artificial-intelligence"},numberOfBooks:3,numberOfAuthorsAndEditors:44,numberOfWosCitations:21,numberOfCrossrefCitations:36,numberOfDimensionsCitations:66},booksByTopicFilter:{topicSlug:"soft-computing",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"6554",title:"From Natural to Artificial Intelligence",subtitle:"Algorithms and Applications",isOpenForSubmission:!1,hash:"0b018b22e9462ac7c75edbc6392b2a6e",slug:"from-natural-to-artificial-intelligence-algorithms-and-applications",bookSignature:"Ricardo Lopez-Ruiz",coverURL:"https://cdn.intechopen.com/books/images_new/6554.jpg",editedByType:"Edited by",editors:[{id:"9849",title:"Prof.",name:"Ricardo",middleName:null,surname:"Lopez-Ruiz",slug:"ricardo-lopez-ruiz",fullName:"Ricardo Lopez-Ruiz"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3123",title:"Ant Colony Optimization",subtitle:"Techniques and Applications",isOpenForSubmission:!1,hash:"6851c23288f4a6174d81d2df0b665527",slug:"ant-colony-optimization-techniques-and-applications",bookSignature:"Helio J.C. Barbosa",coverURL:"https://cdn.intechopen.com/books/images_new/3123.jpg",editedByType:"Edited by",editors:[{id:"17250",title:"Dr.",name:"Helio",middleName:"J.C.",surname:"Barbosa",slug:"helio-barbosa",fullName:"Helio Barbosa"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6122",title:"Computational Intelligence and Modern Heuristics",subtitle:null,isOpenForSubmission:!1,hash:"4cd7e6ab7c0c6664559b97ea8cd66b8b",slug:"computational-intelligence-and-modern-heuristics",bookSignature:"Al-Dahoud Ali",coverURL:"https://cdn.intechopen.com/books/images_new/6122.jpg",editedByType:"Edited by",editors:[{id:"1532",title:"Dr.",name:"Ali",middleName:null,surname:"Al-Dahoud",slug:"ali-al-dahoud",fullName:"Ali Al-Dahoud"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:3,mostCitedChapters:[{id:"8856",doi:"10.5772/7815",title:"Security and Privacy of Intelligent VANETs",slug:"security-and-privacy-of-intelligent-vanets",totalDownloads:3751,totalCrossrefCites:13,totalDimensionsCites:21,book:{slug:"computational-intelligence-and-modern-heuristics",title:"Computational Intelligence and Modern Heuristics",fullTitle:"Computational Intelligence and Modern Heuristics"},signatures:"Mahmoud Al-Qutayri, Chan Yeun and Faisal Al-Hawi",authors:null},{id:"8860",doi:"10.5772/7812",title:"Heuristics of Social Process Design",slug:"heuristics-of-social-process-design",totalDownloads:1351,totalCrossrefCites:4,totalDimensionsCites:10,book:{slug:"computational-intelligence-and-modern-heuristics",title:"Computational Intelligence and Modern Heuristics",fullTitle:"Computational Intelligence and Modern Heuristics"},signatures:"Gilbert Ahamer",authors:null},{id:"8852",doi:"10.5772/7819",title:"A Variation of Particle Swarm Optimization for Training of Artificial Neural Networks",slug:"a-variation-of-particle-swarm-optimization-for-training-of-artificial-neural-networks",totalDownloads:1696,totalCrossrefCites:4,totalDimensionsCites:7,book:{slug:"computational-intelligence-and-modern-heuristics",title:"Computational Intelligence and Modern Heuristics",fullTitle:"Computational Intelligence and Modern Heuristics"},signatures:"Masood Zamani and Alireza Sadeghian",authors:null}],mostDownloadedChaptersLast30Days:[{id:"63017",title:"Convolutional Neural Networks for Raw Speech Recognition",slug:"convolutional-neural-networks-for-raw-speech-recognition",totalDownloads:678,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"from-natural-to-artificial-intelligence-algorithms-and-applications",title:"From Natural to Artificial Intelligence",fullTitle:"From Natural to Artificial Intelligence - Algorithms and Applications"},signatures:"Vishal Passricha and Rajesh Kumar Aggarwal",authors:[{id:"256038",title:"Prof.",name:"Rajesh",middleName:null,surname:"Aggarwal",slug:"rajesh-aggarwal",fullName:"Rajesh Aggarwal"},{id:"256039",title:"Mr.",name:"Vishal",middleName:null,surname:"Passricha",slug:"vishal-passricha",fullName:"Vishal Passricha"}]},{id:"63970",title:"Some Commonly Used Speech Feature Extraction Algorithms",slug:"some-commonly-used-speech-feature-extraction-algorithms",totalDownloads:352,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"from-natural-to-artificial-intelligence-algorithms-and-applications",title:"From Natural to Artificial Intelligence",fullTitle:"From Natural to Artificial Intelligence - Algorithms and Applications"},signatures:"Sabur Ajibola Alim and Nahrul Khair Alang Rashid",authors:[{id:"224685",title:"Dr.",name:"Sabur",middleName:"Ajibola",surname:"Alim",slug:"sabur-alim",fullName:"Sabur Alim"},{id:"225647",title:"Prof.",name:"Nahrul Khair",middleName:null,surname:"Alang Rashid",slug:"nahrul-khair-alang-rashid",fullName:"Nahrul Khair Alang Rashid"}]},{id:"8850",title:"Effective Knowledge Acquisition by Means of Teaching Strategies",slug:"effective-knowledge-acquisition-by-means-of-teaching-strategies",totalDownloads:1722,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"computational-intelligence-and-modern-heuristics",title:"Computational Intelligence and Modern Heuristics",fullTitle:"Computational Intelligence and Modern Heuristics"},signatures:"Marek Woda",authors:null},{id:"39688",title:"Ant Colony Optimization Toward Feature Selection",slug:"ant-colony-optimization-toward-feature-selection",totalDownloads:2995,totalCrossrefCites:2,totalDimensionsCites:2,book:{slug:"ant-colony-optimization-techniques-and-applications",title:"Ant Colony Optimization",fullTitle:"Ant Colony Optimization - Techniques and Applications"},signatures:"Monirul Kabir, Md Shahjahan and Kazuyuki Murase",authors:[{id:"154612",title:"Prof.",name:"Kazuyuki",middleName:null,surname:"Murase",slug:"kazuyuki-murase",fullName:"Kazuyuki Murase"}]},{id:"62760",title:"Cellular Automata and Randomization: A Structural Overview",slug:"cellular-automata-and-randomization-a-structural-overview",totalDownloads:232,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"from-natural-to-artificial-intelligence-algorithms-and-applications",title:"From Natural to Artificial Intelligence",fullTitle:"From Natural to Artificial Intelligence - Algorithms and Applications"},signatures:"Monica Dasclu",authors:[{id:"249893",title:"Prof.",name:"Monica",middleName:null,surname:"Dascalu",slug:"monica-dascalu",fullName:"Monica Dascalu"}]},{id:"62992",title:"Learning Algorithms for Fuzzy Inference Systems Using Vector Quantization",slug:"learning-algorithms-for-fuzzy-inference-systems-using-vector-quantization",totalDownloads:269,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"from-natural-to-artificial-intelligence-algorithms-and-applications",title:"From Natural to Artificial Intelligence",fullTitle:"From Natural to Artificial Intelligence - Algorithms and Applications"},signatures:"Hirofumi Miyajima, Noritaka Shigei and Hiromi Miyajima",authors:[{id:"259341",title:"Dr.",name:"Hiromi",middleName:null,surname:"Miyajima",slug:"hiromi-miyajima",fullName:"Hiromi Miyajima"},{id:"259372",title:"Dr.",name:"Hirofumi",middleName:null,surname:"Miyajima",slug:"hirofumi-miyajima",fullName:"Hirofumi Miyajima"},{id:"259373",title:"Dr.",name:"Noritaka",middleName:null,surname:"Shigei",slug:"noritaka-shigei",fullName:"Noritaka Shigei"}]},{id:"8852",title:"A Variation of Particle Swarm Optimization for Training of Artificial Neural Networks",slug:"a-variation-of-particle-swarm-optimization-for-training-of-artificial-neural-networks",totalDownloads:1696,totalCrossrefCites:4,totalDimensionsCites:7,book:{slug:"computational-intelligence-and-modern-heuristics",title:"Computational Intelligence and Modern Heuristics",fullTitle:"Computational Intelligence and Modern Heuristics"},signatures:"Masood Zamani and Alireza Sadeghian",authors:null},{id:"61402",title:"Query Morphing: A Proximity-Based Approach for Data Exploration",slug:"query-morphing-a-proximity-based-approach-for-data-exploration",totalDownloads:232,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"from-natural-to-artificial-intelligence-algorithms-and-applications",title:"From Natural to Artificial Intelligence",fullTitle:"From Natural to Artificial Intelligence - Algorithms and Applications"},signatures:"Jay Patel and Vikram Singh",authors:[{id:"228092",title:"Mr.",name:"Vikram",middleName:null,surname:"Singh",slug:"vikram-singh",fullName:"Vikram Singh"},{id:"228093",title:"Mr.",name:"Jay",middleName:null,surname:"Patel",slug:"jay-patel",fullName:"Jay Patel"}]},{id:"39584",title:"Scheduling in Manufacturing Systems  Ant Colony Approach",slug:"scheduling-in-manufacturing-systems-ant-colony-approach",totalDownloads:1621,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"ant-colony-optimization-techniques-and-applications",title:"Ant Colony Optimization",fullTitle:"Ant Colony Optimization - Techniques and Applications"},signatures:"Mieczyslaw Drabowski and Edward Wantuch",authors:[{id:"15491",title:"D.Sc.",name:"Mieczyslaw",middleName:null,surname:"Drabowski",slug:"mieczyslaw-drabowski",fullName:"Mieczyslaw Drabowski"},{id:"152506",title:"Prof.",name:"Edward",middleName:null,surname:"Wantuch",slug:"edward-wantuch",fullName:"Edward Wantuch"}]},{id:"64164",title:"Formative E-Assessment of Schema Acquisition in the Human Lexicon as a Tool in Adaptive Online Instruction",slug:"formative-e-assessment-of-schema-acquisition-in-the-human-lexicon-as-a-tool-in-adaptive-online-instr",totalDownloads:241,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"from-natural-to-artificial-intelligence-algorithms-and-applications",title:"From Natural to Artificial Intelligence",fullTitle:"From Natural to Artificial Intelligence - Algorithms and Applications"},signatures:"Guadalupe Elizabeth Morales-Martinez, Yanko Norberto Mezquita-Hoyos, Claudia Jaquelina Gonzalez-Trujillo, Ernesto Octavio Lopez-Ramirez and Jocelyn Pamela Garcia-Duran",authors:[{id:"251445",title:"Dr.",name:"Guadalupe",middleName:"Elizabeth",surname:"Morales-Martinez",slug:"guadalupe-morales-martinez",fullName:"Guadalupe Morales-Martinez"},{id:"251446",title:"Dr.",name:"Ernesto",middleName:null,surname:"Lopez-Ramirez",slug:"ernesto-lopez-ramirez",fullName:"Ernesto Lopez-Ramirez"},{id:"251448",title:"BSc.",name:"Jocelyn",middleName:null,surname:"Garcia-Duran",slug:"jocelyn-garcia-duran",fullName:"Jocelyn Garcia-Duran"},{id:"259836",title:"Dr.",name:"Claudia Jaquelina",middleName:null,surname:"Gonzalez-Trujillo",slug:"claudia-jaquelina-gonzalez-trujillo",fullName:"Claudia Jaquelina Gonzalez-Trujillo"},{id:"259837",title:"Dr.",name:"Yanko",middleName:null,surname:"Mezquita-Hoyos",slug:"yanko-mezquita-hoyos",fullName:"Yanko Mezquita-Hoyos"}]}],onlineFirstChaptersFilter:{topicSlug:"soft-computing",limit:3,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[{type:"book",id:"9441",title:"Ocean Thermal Energy Conversion (OTEC) - Past, Present, and Progress",subtitle:null,isOpenForSubmission:!0,hash:"b0f6032c45ead7f1cb11bb488bfcd48d",slug:null,bookSignature:"Prof. Albert S. Kim and Dr. Hyeon-Ju Kim",coverURL:"https://cdn.intechopen.com/books/images_new/9441.jpg",editedByType:null,editors:[{id:"21045",title:"Prof.",name:"Albert S.",middleName:null,surname:"Kim",slug:"albert-s.-kim",fullName:"Albert S. Kim"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8878",title:"Advances in Microfluidic Technologies for Energy and Environmental Applications",subtitle:null,isOpenForSubmission:!0,hash:"7026c645fea790b8d1ad5b555ded994d",slug:null,bookSignature:"Dr. Yong Ren",coverURL:"https://cdn.intechopen.com/books/images_new/8878.jpg",editedByType:null,editors:[{id:"177059",title:"Dr.",name:"Yong",middleName:null,surname:"Ren",slug:"yong-ren",fullName:"Yong Ren"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9431",title:"Future Smart and Sustainable Cities and Infrastructures",subtitle:null,isOpenForSubmission:!0,hash:"37ca01618d7f291efb11a4d115b9cb63",slug:null,bookSignature:"Dr. Sara Shirowzhan and Dr. Kefeng Zhang",coverURL:"https://cdn.intechopen.com/books/images_new/9431.jpg",editedByType:null,editors:[{id:"273838",title:"Dr.",name:"Sara",middleName:null,surname:"Shirowzhan",slug:"sara-shirowzhan",fullName:"Sara Shirowzhan"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8890",title:"Optimization of Wind Energy Conversion Systems",subtitle:null,isOpenForSubmission:!0,hash:"a2ce9419202c074e3aee8dff0d87326c",slug:null,bookSignature:"Prof. Karam Youssef Maalawi",coverURL:"https://cdn.intechopen.com/books/images_new/8890.jpg",editedByType:null,editors:[{id:"18593",title:"Prof.",name:"Karam",middleName:"Youssef",surname:"Maalawi",slug:"karam-maalawi",fullName:"Karam Maalawi"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8896",title:"Sustainable Mobility",subtitle:null,isOpenForSubmission:!0,hash:"c5b28b438521dcd383df9b6e797ec462",slug:null,bookSignature:"Dr. Bernardo Llamas, Dr. Marcelo F. Ortega and Dr. Eugenia Sillero",coverURL:"https://cdn.intechopen.com/books/images_new/8896.jpg",editedByType:null,editors:[{id:"169368",title:"Dr.",name:"Bernardo",middleName:null,surname:"Llamas",slug:"bernardo-llamas",fullName:"Bernardo Llamas"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9455",title:"From Mathematical Models to Decisions - A Novel View on Data Science",subtitle:null,isOpenForSubmission:!0,hash:"8065ce10d99b15f386547915e2b5fb54",slug:null,bookSignature:"Dr. Joerg Fliege and Dr. Walter Holweger",coverURL:"https://cdn.intechopen.com/books/images_new/9455.jpg",editedByType:null,editors:[{id:"304178",title:"Dr.",name:"Joerg",middleName:null,surname:"Fliege",slug:"joerg-fliege",fullName:"Joerg Fliege"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8871",title:"Renewable Energy - Resources, Challenges and Applications",subtitle:null,isOpenForSubmission:!0,hash:"e00c59554fb355c16623c62064ecc3bb",slug:null,bookSignature:"Dr. Mansour Al Qubeissi, Dr. Ahmad El-Kharouf and Associate Prof. Hakan Serhad Soyhan",coverURL:"https://cdn.intechopen.com/books/images_new/8871.jpg",editedByType:null,editors:[{id:"241686",title:"Dr.",name:"Mansour",middleName:null,surname:"Al Qubeissi",slug:"mansour-al-qubeissi",fullName:"Mansour Al Qubeissi"}],productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9420",title:"Risk Assessment in Air Traffic Management",subtitle:null,isOpenForSubmission:!0,hash:"91e95c7c9fc0be27b80a269a9fa81d90",slug:null,bookSignature:"MSc. Javier Alberto Perez Castan and MSc. Alvaro Rodriguez Sanz",coverURL:"https://cdn.intechopen.com/books/images_new/9420.jpg",editedByType:null,editors:[{id:"222047",title:"MSc.",name:"Javier Alberto",middleName:null,surname:"Perez Castan",slug:"javier-alberto-perez-castan",fullName:"Javier Alberto Perez Castan"}],productType:{id:"1",chapterContentType:"chapter"}}],offset:8,limit:8,total:11},humansInSpaceProgram:{},teamHumansInSpaceProgram:{},route:{name:"book.detail",path:"/books/artificial-neural-networks-methodological-advances-and-biomedical-applications",hash:"",query:{},params:{book:"artificial-neural-networks-methodological-advances-and-biomedical-applications"},fullPath:"/books/artificial-neural-networks-methodological-advances-and-biomedical-applications",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()</script><script src="//cdnintech.com/web/frontend/www/dist/manifest.2509d95849ada7fe3993.js" defer="defer"></script><script src="//cdnintech.com/web/frontend/www/dist/vendor.8bcb89411cbd7a7e7ea9.js" defer="defer"></script><script src="//cdnintech.com/web/frontend/www/dist/app.4b8d60a89a0755da921f.js" defer="defer"></script></div></body></html>